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1 
Summary 
This work focuses on the biochemical and biophysical characterization of highly 
interesting metallo-proteins and is divided in two main projects. The first project regards 
the characterization of the iron-based enzyme ETHE1 from Homo sapiens, which is 
fundamental for detoxification from highly reactive persulfide species and whose 
specific mutations on the structural gene or on its regulatory sequences cause 
ethylmalonic encephalopathy. Moreover, ETHE1 was reported to be involved in 
apoptosis and cancer through the interaction with transcription factors such as NF-kB 
and p53. The protein has been studied by a number of techniques, noticeably XAS (X-
ray absorption spectroscopy), SAXS (Small Angle X-ray Scattering Spectroscopy), 
Mössbauer spectroscopy and ITC (Iso-Thermal Calorimetry). 
The second project is based on XAS analysis and method development applied to 
metallo-proteins that are likely to have a substantial impact on basic and applied science. 
The mononuclear [Fe]-hydrogenase Hmd from Methanocaldococcus jannaschii has 
been extensively investigated by XANES and EXAFS analysis in the native and 
inhibited forms. This study revealed the major determiners of the electronic structure of 
this unique hydrogenase iron site and shed light on the chemicophysical requirements 
for the heterolysis of molecular hydrogen. In addition, I contribute to the 
characterization of the optically excited state of a bis (µ-oxo)-dicopper(III) complex 
mimicking the potential di-oxo to µ-oxo transition in tyrosinases active site. We took 
advantage of two cooperative approaches: pumped-XAS and an innovative combination 
of EXAFS spectroscopy and resonant Raman scattering. I present also the XAS analysis 
results obtained on the protein ABCE1, which is one of the most conserved proteins in 
the evolution of eukaryotes and archaea. ABCE1 is essential for cell viability and is a 
unique ATP-binding-cassette protein bearing iron-sulfur clusters. 
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2 
Zusammenfassung 
Diese Arbeit beschäftigt sich mit der biochemischen und biophsikalischen 
Charakterisierung von hochinteressanten Metalloproteinen und gliedert sich in zwei 
Hauptprojekte. Das erste Projekt behandelt das humane eisenabhängige Enzym ETHE1, 
welches essentiell für die Entgiftung reaktiver Persulfide ist und von dem Mutationen 
der kodierenden Gensequenz oder regulatorischer Sequenzen für die Entstehung von 
Ethylmalonsäure-Enzephalopathie verantwortlich sind. Darüber hinaus wurde berichtet, 
dass  ETHE1 durch Interaktion mit den Transkriptionsfaktoren NF-kB und p53 an 
Apoptose und der Entstehung von Leber Krebs beteiligt ist. Dieses Protein wurde in E. 
coli überexpression und mittels XAS (Roentgenabsorptionsspektroskopie), SAXS 
(Roentgenkleinwinkelstreuung), Moessbauerspektroskopie und ITC (Isothermale 
Titrationskaloriemetrie) untersucht. 
Das zweite Projekt umfasst die XAS-Analyse und neuartiger Ausweitungs  Methoden 
zum studium von Metalloproteinen, denen große Bedeutung in der Grundlagenforschung 
und angewandten Forschung zugeschrieben wird. Die mononukleare [Fe]-Hydrogenase 
Hmd von Methanocaldococcus jannaschii wurde eingehend in ihrer nativen und 
inhibierten Form durch XANES und EXAFS studiert. Diese Untersuchung deckte die 
wichtigsten Faktoren für die elektronische Strukturs der einzigartigen Hydrogenase- 
Eisenbindungsstelle auf, und brachte neue Erkenntnisse über die chemisch-
physikalischen Bedingungen der Heterolyse von molekularem Wasserstoff. Zusätzlich 
beschreibe ich die Charakterisierung des optisch angeregten Zustandes einer  (µ-oxo)-
dicopper(III) Verbindung, die den möglichen “di-oxo zu  µ-oxo”-Übergang im aktiven 
Zentrum von Tyosinasen nachäffen. Dazu nutzten wir zwei komplementäre Ansätze: 
pumped XAS und eine innovative Kombination aus EXAFS und resonanter Raman-
Streuung. Ich präsentiere desweiterer die Ergebnisse der XAS-Analyse des Proteins 
ABCE1, das eines der konserviertesten Proteine in der Evolution der Eukarya und 
Archaea darstellt. ABCE1 ist wichtig für das Ueberleben der Zelle und enthält eine 
einzigartige ATP-Bindungskassette, die auf Eisen-Schwefel Clustern basiert. 
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1 Introduction 
Enzymes catalyze a wide range of chemical reactions. The variety of function is 
achieved partly because proteins can incorporate in their active sites cofactors such as 
small organic molecules, single metal atoms, or clusters containing metal and non-metal 
atoms. Strikingly, almost half of all known enzymes require a metal for their activity.[7] 
Biochemists developed their interest on ‘metalloproteins, particularly since the 1950s, 
when the first X-ray crystal structure of a protein (sperm whale myoglobin) indicated the 
presence of an iron atom. A lot has been understood about which metal ions are 
commonly found in metalloenzymes and their ligand specificity. In addition, we are 
much closer to understanding the mechanisms by which metalloenzymes catalyze such a 
wide range of complex chemical reactions. However, after more than half a century of 
research by chemists, biochemists and cell biologists, many discoveries remain to be 
made. 
In this work, I focus on two related projects. The first concerns the biochemical and 
biophysical characterization of the human metalloprotein ETHE1, which is fundamental 
for survival and development of metazoa towards the adult age. The second concerns X-
ray Absorption Spectroscopy (XAS) application and method development. XAS is a 
powerful synchrotron-based technique used for determining the local geometric and/or 
electronic structure of matter and herein applied to study the metal centers of proteins, 
and bioinorganic compounds. 
1.1 Ethylmalonic encephalopathy protein 1 
ETHylmalonic Encephalopathy protein 1 (ETHE1), also known as Hepatoma 
Subtracted-cDNA library Clone One (HSCO), is a protein with Metallo-β-Lactamase 
(MβL) superfamily fold (Fig. 1 A).  ETHE1 has been found in metazoa and plants. It is 
not known why is absent in mesozoa and protozoa. Speculations led to the possibility 
that its codifying sequence might derive from the duplication of an ancient ancestor gene, 
which evolved gaining a functionality that is not necessary for protozoa and mesozoa. 
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Thus, the gene could have been lost by the ancestor organism. Alternatively, it might 
derive from horizontal genetic transfer virus/viroid mediated. 
1.1.1 Homo sapiens ETHE1 
Homo sapiens ETHE1 (HsETHE1) is a 254 aminoacids (aa) MβL superfamily protein 
codified by a gene lying on the long arm of the chromosome 19 (19q13.31). More 
information can be found on the GeneCards web site (www.genecards.org) under the 
gene card identifier (GIFtS) = GC19M048702. Studies on human cells highlighted that 
the protein is localized mainly in the mitochondrial matrix, but can be found also within 
the cytoplasm and the nucleus.[8,9] The protein is addressed to the mitochondrial matrix 
by an N-terminal localization sequence.[10] ETHE1 is then thought to be activated as an 
enzyme through the cleavage of a short peptide at the N-terminus. Recently, exploiting 
MALDI-TOF mass spectrometry it has been defined that the aminoacids from 1 to 7 are 
cut away during the translocation into the mitochondrion.[11] There is evidence that 
HsETHE1 is often overexpressed in Hepato-Cellular Carcinoma (HCC).[8] Moreover, it 
is able to inhibit p53 dependent apoptosis by two ways[12] and it is strictly involved in 
Ethylmalonic Encephalopathy (EE).[9,10] The structure of the homologous enzyme 
 
 
Fig. 1: ETHE1 introduction. 
A) Metallo β-lactamase superfamily fold. B) Scheme of NF-kB1 shuttling model. ETHE1 is able to shuttle NF-kB1 from the 
nucleus to the cytoplasm. C) Some symptoms (petechiae and acrocyanosis) characterizing the ethylmalonic encephalopathy 
phenotype are visible on an affected infant’s body. D) Schematics of the ETHE1-stimulated p53 degradation pathway. 
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from Arabidopsis thaliana has been reported.[13] Recently, it has been proved that 
ETHE1 is an essential sulfur dioxygenase involved in the detoxification from highly 
reactive persulfide species.[11] 
1.1.2 HsETHE1 and hepatocellular carcinoma 
Hepato-cellular carcinoma is one of the most frequent carcinomas in the world. It 
evolves extremely rapidly and it is fatal. Indeed, the expectancy of life is about six 
months after the first diagnosis. In a work of 2002, Hisako Higashitsuji et al.[8] 
analyzed 30 hepato-cellular carcinomas. In 20 of them, ETHE1 was found over 
expressed. This work shows that HsETHE1 binds RelA, which is one of the 2 proteins 
forming the most common Nf-kB type transcription factors. The interaction takes place 
in the nucleus. Wherein, HsETHE1 is able to shuttle Nf-kB to the cytoplasm (Fig. 1 B). 
As a consequence of the failed transcription by Nf-kB, the caspase 9 is inhibited. Thus, 
HsETHE1 blocks p53-dependent apoptosis induced by DNA damage triggering 
tumorigenesis. Moreover, the protein exhibits anti-apoptotic activity in human cells 
exposed to DNA-damaging agents by suppressing the transcriptional activity of p53.[12] 
ETHE1 specifically associates with histone deacetylase 1 (HDAC1) and forms a ternary 
complex with p53 in the nucleus. This interaction enhances deacetylation of p53 at 
Lys3737/382 by HDAC1 (Fig. 1 D). Deacetylated p53 becomes a facilitated target of the 
ubiquitin-proteasome system. Thus, ETHE1 increases ubiquitylation and degradation of 
p53, reducing the protein availability. ETHE1 is therefore a promising target for HCC 
treatment and its characterization could give a contribution to the development of 
therapeutic strategies to restore the appropriate p53 response in cancer. 
1.1.3 HsETHE1 and ethylmalonic encephalopathy 
Ethylmalonic Encephalopathy (EE) (OMIM #602473) is a devastating infantile 
autosomal recessive metabolic disorder affecting the brain, the gastrointestinal tracts and 
the peripheral vessels.[14] It affects mainly Mediterranean people and who bears this 
disease dies within the first decade of life. In three works, Tiranti et al. showed that in 
all 47 (on the whole) analyzed patients affected by EE, the ethe1 gene was mutated in 
Introduction 
_______________________________________________________________________ 
 
6 
both allelic loci.[9,10,15] Specific mutations in this gene are always associated to the 
disease. More than thirty independent mutations have been reported to cause the 
disease.[16] All of them led, or to the loss of the gene’s product, or they involved highly 
conserved aminoacids. Tiranti et al. also revealed that HsETHE1 is a mitochondrial-
matrix protein whose N-terminal sequence is processed during its internalization.[9] 
This cleavage takes place between Arg7 and Val8 and is supposed to turn on the 
enzymatic activity of the protein.[11] EE is characterized by a specific phenotype and 
biochemical, metabolic findings. The patients show: a) psychomotor regression and 
hypotonia due to inhibition of Cytochrome c Oxidase (COX) activity; b) progressive 
encephalopathy with symmetrical lesions in the basal ganglia and brainstem, eventually 
leading to global neurological failure; c) vasculopathic petechiae and orthostatic 
acrocyanosis; d) chronic diarrhoea; e) EthylMalonic Aciduria (EMA) associated with 
methyl-succinic aciduria, high plasmatic levels of C4-C6 acylglycine and C4-C5 
acylcarnitine species; f) lactic aciduria. The latter symptoms (e and f) are also the 
hallmark of Short Chain Acyl-CoA Dehydrogenase (SCAD) deficency.[17] The 
aetiology can presently be entirely explained by the loss of ETHE1 physiological 
activity, which was discovered and described by Tiranti et al. in 2009.[11,18] 
1.1.4 AtETHE1 structure 
In 2006, McCoy et al. presented the structure of ETHE1 from Arabidopsis thaliana 
(AtETHE1) (Fig. 2 A).[13] They found that the protein is a homodimer with one iron 
bound to the active site (B2- MβL; Fig. 2 B), even if the protein, as HsETHE1, still 
keeps conserved all the aminoacids usually responsible of the binding of two metals 
(B1- and B3-MβL). AtETHE1 misses a 2 helix bundle present in AtGLX2-5. This results 
in the formation of a dimerization interface. The comparison with the structurally highly 
related Glyoxalases ΙΙ from Arabidopsis thaliana showed that AtETHE1 possesses the 
same highly conserved substrate-binding aminoacids, but they also showed that these are 
in slightly different positions. Moreover, AtETHE1 has a smaller cavity for substrate 
binding, because the C-terminus covers much of the active site leading to reaction 
chemistry different from Glyoxalase II enzymes. AtETHE1 and HsETHE1 share an 
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identity of 54% and a similarity of 66%, which is surprising for protein so evolutionarily 
distant. A three dimensional molecular model of HsETHE1 has been build using the 
SWISS-MODEL server (web page: http://swissmodel.expasy.org/).[19] It is worthy to 
notice that the HsETHE1 structural model shows the presence of the conserved metal 
binding aminoacids (His 59, 61, 64, 175, Asp 32, 63, 134; add 21 to get the full length 
protein aminoacid number) packed in proximity (3-5 Å from each other). The model 
shows a conserved Tyrosine (177/198) pointing towards the active site at about 7 Å from 
the iron ion and the characteristics c-terminal part arching over above the active site (Fig. 
3). 
Here, the aminoacid sequence alignment of AtETHE1 (PDB sequence) with respect to 
HsETHE1 is presented: 
 
-: aa potentially important for metal binding 
-: b-sheet 
-: helix 
-: Mutation in EE 
_: Same aa 
 
 
 
 
 
Fig. 2: AtETHE1 structure and metal binding site. 
A) Three dimensional structure of homodimeric ETHE1 from Arabidopsis thaliana represented in cartoon style: red, α-helixes; 
ocean-green, β-sheets; green, loops; grey, linkers between secondary structures. In scaled ball and stick the metal binding site of 
each subunit is represented: black, the carbons; red, the oxygens; light sky-blue, the nitrogens; sky-blue, the iron. B) Zoom in the 
metal binding site. Scaled ball and stick representation: black, the carbons; red, the oxygens; light violet-blue, the nitrogens; 
violet-blue, the iron. The figure shows the iron coordination sphere and the potential second binding site aminoacids. 
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                            (12)  
                              1       10        20        30        40        50        60        70        80 
                              |        |         |         |         |         |         |         |         | 
AtETHE1: ---------------------KLLFRQLFENESSTFTYLLADVSHPDKPALLIDPVDKTVDRDLKLIDELGLKLIYAMNTHVHADHVTGTGLLKTKLPGVK 
HsETHE1: MAEAVLRVARRQLSQRGGSGAPILLRQMFEPVSCTFTYLLGDRES--REAVLIDPVLETAPRDAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQ 
 
                 90       100       110       120       130       140       150       160       170       180 
                  |         |         |         |         |         |         |         |         |         |                       
AtETHE1: SVISKASGSKADLFLEPGDKVSIGDIYLEVRATPGHTAGCVTYVTGEGADQPQPRMAFTGDAVLIRGCGRTDFQEGSSDQLYESVHSQIFTLPKDTLIYP 
HsETHE1: SVISRLSGAQADLHIEDGDSIRFGRFALETRASPGHTPGCVTFVLNDHS------MAFTGDALLIRGCGRTDFQQGCAKTLYHSVHEKIFTLPGDCLIYP 
 
                190       200       210       220       230       240 
                  |         |         |         |         |         |                                          
AtETHE1: AHDYKGFEVSTVGEEMQHNPRLTKDKETFKTIMSNLNLSYPKMIDVAVPANMVCGLQDVPSQAN 244 
HsETHE1: AHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFAVPANMRCGVQTPTA--- 254 
 
The alignment has been carried out using the server ClastalW2 at the European 
Bioinformatics Institute web site and successively manually refined. 
 
 
Fig. 3: AtETHE1 active site. 
Electrostatic surface representation of the molecular model of HsETHE1: red, the negatively charged regions; blue, the positively 
charged regions; grey, the neutral regions; green, the c-terminal part of the protein; blue-marine, the conserved metal-binding site 
aminoacids. The tyrosine 18 is represented as stick style: red, the oxygens; grey, the carbons. The image was created with PyMol: 
http://pymol.sourceforge.net/. 
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1.1.5 HsETHE1 activity 
Recently, Valeria Tiranti and her collaborators revealed that HsETHE1 is a sulfur 
dioxygenase[11] involved in a pathway for detoxification from excess of sulfide (H2S), 
which accumulates to toxic levels in ethylmalonic encephalopathy.  The sulfide 
detoxification system is fundamental for metazoa. In fact, H2S is a gastro transmitter 
acting as a signaling molecule, but at supraphysiological concentration it is a powerful 
inhibitor of COX (Cytochrome c Oxidase)[6,20,21] and of SCAD (Short Chain Acyl-
CoA Dehydrogenase) activity.[11,17] H2S is released by bacteria in large amounts in the 
lumen of the large intestine, is vasoactive and at high concentrations is toxic to 
endothelial cells. Taken together, these considerations explain the biochemical marks 
found in patients affected by EE: COX deficiency, ethylmalonic aciduria in the urine, 
high levels of C4 and C5 acylcarnitine species in the blood, acrocyanosis, petechiae, 
chronic diarrhea, and neurodevelopmental delay and regression. H2S disposal is carried 
out by a mitochondrial system[22] that uses sulfide as a respiratory substrate (Fig. 4).[23] 
The system comprises SQR (Sulfide:Quinone Oxidoreductase), SDO (Sulfur Di-
Oxigenase), Rhodanase and SO (sulfite oxidase).[22] The final products are sulfate 
(SO42-, major sulfur metabolite in mammalian urine) and thiosulfate (metabolically inert). 
In this pathway, SQR produces at a cysteine residue a persulfide (R-SSH), which is 
transferred to a thiophilic acceptor such as glutathione, forming GSSH. The latter 
compound is the natural substrate of ETHE1. GSSH is unstable and highly reactive. 
Molecular oxygen (O2) and water (H2O) is then used by ETHE1 (the mitochondrial-
matrix sulfur dioxygenase) to oxidize the sulfane sulfur persulfide (R-SSH) to sulfite 
(H2SO3) and restore the R-SH acceptor. Reaction: 
 
The structurally and functionally closest enzymes known are the glyoxalases-II  
 
The structurally and functionally closest enzymes known are the glyoxalases-II (GLX2). 
The comparison between the Arabidopsis thaliana structures of ETHE1 and GLX2s 
shows that they share the same highly conserved substrate and metallo binding 
aminoacids and that these are in different positions.[13]Interestingly, also the GLX2 
GSSH + H2O + O2 → GSH + SO32- 2H+ 
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enzymes are active against a derivative of glutathione, hydrolyzing S-(2-
hydroxyacyl)glutathione to glutathione and a 2-hydroxy carboxylate. It is then worth to 
notice that the conserved aminoacids of HsETHE1 comprise motifs present in the 
ZiPD/tRNaseZ MβL-fold protein.[24] 
1.1.6 HsETHE1 metal binding site(s) 
ETHE1 is a protein with Metallo-β-Lactamase (MβL) superfamily fold (Fig. 1 A). These 
proteins are enzymes bearing one or two metals in their active sites.[25,26] Following 
the revised Ambler structural classification,[27] MβL are divided in B1, B2, B3 and β-
CASP families. The B1 family shares sequence and structural homology with the B2, 
while the B3 is only structurally related to B1 and B2. B1 and B3 usually contain 2 
Fig. 4: Model of the mitochondrial sulfide-oxidation system. 
Membrane-bound sulfide:quinone oxidoreductase (SQR) oxidizes sulfide (H2S) to the level of elemental sulfur, simultaneously 
reducing a cysteine disulfide bond so that a persulfide group is formed at one of the cysteine residues (SQR-SSH).[6] The 
electrons are fed into the respiratory chain via the quinone pool (Qox ⁄Qred), and finally transferred to oxygen by cytochrome 
oxidase (complex IV). A sulfur dioxygenase in the mitochondrial matrix oxidizes persulfides to sulfite (H2SO3), consuming 
molecular oxygen and water. The final reaction is catalyzed by a sulfur transferase, which produces thiosulfate (H2S2O3) by 
transferring a second persulfide from the SQR to sulfite. 
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metal ions and they show a broad substrate spectrum. Instead, B2 enzymes are full 
active with one metal ion and posses a narrower substrate spectrum. The metal ions 
exploited by MβL for their activity are commonly Zn2+ and/or Fe2+, but they are usually 
able to bind also other metals such Mn2+/3+ and Ni2+. The β-CASP family is involved in 
DNA and RNA metabolism and repair. Enzymes with MβL fold can have sundry 
activities, ranging from hydrolysis of β-lactames to glyoxalase ΙΙ activity, as well as 
arylsulfatase, CMP-NeuAc hydrolase, cAMP phosphodiesterase, DNase and RNase 
activity. The metal binding residues are commonly histidines, aspartates, glutamate, 
waters, but some have sulfur affinity and need a cysteine residue as ligand to be 
active.[28,29] Sulfur-based molecules are commonly used as MβL inhibitors.[30,31] 
Bridging ligands are also common, as in the tRNase Z family proteins, where an 
aspartate is bridging two zinc ions.[32-34] The structure from Arabidopsis thaliana 
reveals a mononuclear iron binding site that classifies ETHE1 as a B1 MβL according to 
the Ambler classification.[13,27] In the structural model the iron has an octahedral 
coordination comprising histidine and oxygen ligands. A similar coordination is found in 
a number of mononuclear iron dioxygenases such as the lipoxygenase, the α-keto acid-
dependent enzymes, the isopenicillin-N synthetase, the ethylene forming enzymes and 
pterin-dependent hydroxylases[35-37] This fits very well the recent discovery that 
ETHE1 is a sulfur dioxygenase.[11] The mononuclear-iron dioxygenases show a wide 
variety of mononuclear iron binding sites.[35-37] The iron ions can be ferric or ferrous, 
with five or six ligands bound to the metal. It can posses different geometries, such as 
trigonal bipyramidal or square pyramidal in case of penta-coordinated iron centers, and 
octahedral, for exa-coordinated iron centers. The iron site in AtETHE1’s structure is 
defined by two histidines, one aspartate and three solvent-oxygens. This coordination 
possesses the 2-his-1-carboxylate facial triad motif in common with the iron(II) high 
spin oxygen-activating dioxygenases (α-keto acid dependent enzymes, isopenicilline-N 
synthetase, ethylene-forming enzyme, pterin dependent hydroxylase, naphthalene 
dioxygenase).[35-37] In particular, considering the activity and the metal coordination 
sphere modeled in the structure from Arabidopsis thaliana, HsETHE1’s iron binding site 
should be considered highly similar to the isopenicilline-N synthetase one, which 
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catalyzes the formation of isopenicilline-N from α-(L-R-aminoadipoyl)-L-cysteinyl-D-
valine (ACV). ACV binds the iron with its sulfur atom during catalysis. Besides, beyond 
HsETHE1, another mononuclear iron sulfur dioxygenase is known in human and its 
structure is reported.[38,39] This enzyme is a cysteine dioxygenase (CDO), converting 
cysteine residues in cysteine sulfinates and thereby carrying out a reaction very similar 
to the persulfide dioxygenase activity of ETHE1. Nevertheless, the cysteine dioxygenase 
has substantial differences respect ETHE1. CDO has a cupin superfamily fold as the α-
keto acid-dependent dioxygenases and the iron ion in the active form of the enzyme has 
an unusual tetrahedrically coordinated iron with three histidine and a solvent oxygen as 
ligands.[39] On the other hand, the enzyme has been found also in different non-active 
states with nickel or zinc bound and in octahedral geometry comprising the three 
histidines and three solvent molecules.[38] 
The understanding at molecular level of HsETHE1 has important implications because it 
sheds light on: 
• The basis for an action against ethylmalonic encephalopathy and hepatocellular 
carcinoma. 
• The molecular reasons for the variety of reactions that ETHE1-like enzymes are 
able to perform. 
• The sulfur detoxification system in humans and likely in all metazoa and 
superior plants. 
• The general requirement for substrate dioxygenation. 
• The physical-chemical properties that nature chose for sulfur oxidation. 
• Improve our understanding of apoptosis. 
1.2 X-ray Absorption Spectroscopy (XAS) 
X-ray Adsorption Spectroscopy (XAS) is a powerful spectroscopic method based on 
synchrotron radiation.[40] In a homodisperse phase, XAS is able to determine the local 
environment of a given element with high resolution. XAS is very effective for studying 
the architecture, disorder and electronic structure of (in principle) any site of a given 
element up to about 5 angstrom (Å) radius from the absorber. During my doctorate, I 
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worked on BioXAS, which focuses on the metal sites of proteins. Synchrotron radiation 
is applied to excite deep electrons by scanning an energy range from about one hundred 
and fifty electron volts before the adsorption edge characteristic for the metal under 
study, up to several hundreds of electron volts (eV) after the main adsorption edge. In 
the dominant adsorption process, an electron is ejected from the core and a 
photoelectron is emitted in the form of a spherical wave (for our purposes, its description 
as wave is more convenient than its description as particle). The adsorption energy value 
varies, depending on the nature of the metal (the binding energies of the core electrons 
grow monotonically with the atomic number), as well as on the edge we want to excite. 
In different words, we can choose which metal to excite and if involving electrons in the 
most deep shell or higher shell electrons (electrons in higher energy orbitals). The 
characteristic resulting spectra can be divided in two parts: X-ray Absorption Near Edge 
Structure (XANES) (Fig. 5 A) and Extended X-ray Absorption Fine Structure (EXAFS) 
spectra (Fig. 5 A, B). The XANES spectrum comprises energies from about -20 eV 
below up to 50 eV above the adsorption edge. It allows study the electronic structure of 
metal centers. The shape and position of the X-ray absorption edge serve as fingerprints 
of a specific binding motif and, if good reference systems are available, allow the 
determination of oxidation states, number of ligands and symmetry of the coordination 
 
 
Fig. 5: XAS principles. 
A) Example of X-ray Absorption Spectroscopy spectrum. Here the copper L and K edges are considered. For the K-edge a zoom 
in of the spectrum is present. The division in the XANES and EXAFS parts is also shown. In the upper right part there is a zoom 
in of the XANES part. B) Example of a K-edge XAS spectrum of Yttrium. In the upper part, the EXAFS region of the spectrum 
and the interference path between the outgoing photoelectron and the incoming scattered waves originating the characteristic 
undulatory behavior of the EXAFS are presented. 
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sphere. In fact, both edge position and electronic structure of a system depend on the 
nature of the donor groups. It is worth to notice that XANES is mainly a qualitative 
approach, since there is no “XANES equation” due to the difficulties to interpret 
quantum mechanical events correlated to many-body multiple scattering events 
dominating the XANES. The EXAFS spectrum comprises the energy range from 5 eV 
up to 400/1650 eV above the absorption edge. It is characterized by an undulatory 
behaviour caused by the interference effects between the outgoing photoelectron wave 
and its component backscattered by the surrounding atoms (Fig. 5 B). The interference 
pattern modifies the probability of the photoeffect (the adsorption coefficient is 
changing): 
 
0
0
μ
μμχ −≡  
 
χ is the fractional change in the absorption coefficient function (oscillatory part); µ is the 
absorption coefficient of an element in a particular environment at a particular energy 
and µ0 in the theoretical absorption coefficient of the absorber alone. Thereby, while the 
adsorption spectrum is scanned by changing the photon energy, the energy of the 
photoelectron changes and its wavelenght varies. Consequently, the interference with the 
scattered photons changes from constructive to destructive and back again. This creates 
the characteristic spectra (Fig. 5 B). EXAFS can give us information about the nature of 
the metal-ligands, about the thermal and structural disorder of individual components 
and highly precise information about the coordination distances. Commonly, the 
working environment for analysis is not in the energy space, but in the more convenient 
photoelectron wavevector space, which is dependent from the wavenumber (number of 
wavelengths per unit distance). The wavevector is an independent variable that is 
proportional to momentum rather than energy. Since energy is conserved, excess energy 
given by E - E0 is conserved by being converted in the kinetic energy of the 
photoelectron wave. Since wavelengths are dependent of kinetic energies, the 
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photoelectron wave (de Broglie wavelength) propagates through the EXAFS region with 
a velocity υ when the wavelength of the photoelectron is scanned. 
This is the equation for the conversion of the energies to wavenumbers: 
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Where, me is the resting mass of the electron, υ is the electron speed (me υ = 
photoelectron momentum), h is the Planck constant, E is the energy and ħ is h/2π. 
The fundamental basic equation governing the EXAFS as a function of the 
photoelectron wavenumber for a given j shell is the following: 
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S2 is the amplitude reduction factor. If we know the scattering amplitude fj(k) and the 
phase shift σj(k) of the neighbouring atoms, which depend on the atomic number (Z) of 
the scattering atom, and we know the mean free path λ(k), we can determine: 
 
• R: distance to neighbouring atom 
• N: coordination number of the atoms in a shell 
• σ2: mean square disorder of neighbour distance 
 
This equation takes in account also the inelastic scattering through the term: )(2 kRje λ− . 
Successively, the Fourier transform (FT) allow us to switch from the k space to the 
radial distribution function space (R space, or space of the distances).  The FT of χ(k) is: 
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Where kn is the k weighting. The Fourier transform can have different k weightings. This 
is used to distinguish between high and low Z scatterers around the absorber atom. An 
element with low mass (like oxygen) will scatter mainly at lower k-values, while an 
element with high mass (like zinc) will scatter significantly at higher k-values. Therefore, 
the weighting of the Fourier transformation will emphasize the important scatterer in a 
specific region. The distances found in the Fourier transformation is about 0.2–0.5 A° 
shorter than the actual distances due to the energy dependence of the phase factors in the 
sine function. I focused on X-ray Absorption Spectroscopy (XAS) of highly important 
metallo-proteins. The project involves the opportunity to explore and develop a powerful 
spectroscopic technique and to widen my knowledge on metallo-proteins by 
collaborating with experts on the individual systems. Moreover, XAS has been applied 
on HsETHE1 and can be performed on ETHE1-like metallo-proteins. 
EXAFS data reduction and normalization was carried out using the program KEMP[41] 
or the program KEMP2, which is under development by Dr. Gerd Wellenreuther.[42] 
XANES and EXAFS analysis were performed with the programs WinXAS[43], 
Excurve98[44] and ATHENA.[45] XANES simulation were made with the program 
FEFF.[46] 
1.2.1 Mononuclear [Fe]-hydrogenases 
I performed EXAFS and XANES analysis of the protein Hmd from 
Methanocaldococcus jannaschii (jHmd). Hmd are mononuclear-iron hydrogenases 
([Fe]-hydrogenases). They represent one of three classes of hydrogenases, not 
phylogenetically related to each other, but sharing striking similarities.[2,47] The name 
Hmd stands for H2-forming methylene-tetrahydromethanopterin (methylene-H4MPT) 
dehydrogenase, because its function is the reduction of methenyl-H4MPT+ (acceptor) to 
methylene-H4MPT through the transfer of an hydride (Fig. 6 A).[4,48]  
In contrast to other hydrogenases, Hmd lacks iron-sulfur clusters and exploits only one 
metal-ion, which is incorporated in an iron guanylyl pyridone cofactor (FeGP) (Fig. 6 
B).[3,49] The cofactor can be extracted, purified and studied separately from the 
apoprotein, and the active enzyme can be reconstructed by incubation of the isolated 
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cofactor with the apo-form of the enzyme.[3] Due to the presence of a single metal-ion, 
this enzyme is an ideal target for studying the relationship between electronic structure 
and hydrogen activation. Our understanding of [Fe]-hydrogenases is still at the 
beginning. The first biophysical studies on [Fe]-hydrogenases were carried out only 
recently.[50-53]  Infra Red (IR) spectroscopy studies showed that Hmd’s iron binds 2 
carbon monoxide (CO) molecules and that the enzyme can be inhibited upon binding of 
an additional CO or a cyanide (CN), while incubated in, respectively CO or CN 
atmosphere at room temperature.[52] The inhibition by CN is a peculiar characteristic, 
not common with the other hydrogenases, which are inhibited only by CO. Mössbauer 
and EPR spectroscopy revealed the presence of a low spin iron with an unclear oxidation 
state that can be assigned as 0 or 2+ with equal probability.[53] The iron within the 
extracted cofactor has the same oxidation state. The enzyme is light and oxygen 
sensitive (UV-A/blue) and the FeGP cofactor is even temperature sensitive.[51] Upon 
UV-A/blue-light illumination, both CO molecules are irreversibly flashed off from the 
active site, which results in the loss of the enzyme activity. EXAFS on Hmd from 
Methanothermobacter marburgensis (mHmd) and Hmd from Methanocaldococcus 
jannaschii (jHmd) clearly showed the presence of two COs and sulfur chelating the iron. 
Besides, the iron site has been modeled with one additional O/N, in case of mHmd, or 
two additional O/Ns, in case of jHmd and its isolated cofactor. Additional light ligands 
such as oxygens and nitrogens might have been present as iron chelator, but the strong 
contribution of the COs (multiple scatterers) and the sulfur (strong scatterer) limited 
further assumptions and modeling. A XANES study revealed the extraordinary intensity 
Fig. 6: Hmd hydride acceptor and cofactor. 
A)  Hydride acceptor: Hmd reversibly reduces methenyl-H4MPT+ (acceptor) to methylene-H4MPT. B) Guanylyl pyridone 
cofactor. This cofactor can be extracted from Hmd and studied separately.[3] 
Introduction 
_______________________________________________________________________ 
 
18 
of Hmd’s pre-edge peak, which is unique among iron binding proteins.[50] The structure 
of the cofactor[49] and the x-ray diffraction structure of apo-Hmd[54] have been 
available, respectively since 2004 and 2006. Further developments of our scientific 
knowledge on Hmd are presented in the results chapter dedicated to the mononuclear 
[Fe]-hydrogenase. 
Gain knowledge on the active site of Hmd may lead towards biomimetic methods for 
efficient generation and utilization of H2.[55] Therefore, I consider of high interest to 
shed light on the [Fe]-hydrogenases requirements for H2 activation and thus on the 
characteristics of the iron core. 
1.2.2 [Cu2L2(µ-O)2]I2 
I collaborate to the characterization of the optically excited state of a bis (µ-oxo)-
dicopper(III) species mimicking the potential di-oxo to µ-oxo transition in the tyrosinase 
(monophenol monooxygenase) active site (Fig. 7 A). Tyrosinase is a wide spread 
copper-containing enzyme present in plant and animal tissues that catalyzes the 
production of melanin and other pigments from tyrosine by oxidation. 
Specific mutations in the tyrosinase active site resulting in impaired tyrosinase 
 
 
Fig. 7: Tyrosinase metal binding site and Cu-based model complex. 
A) Ball and stick representation of the tyrosinase metal binding site: sea green, coppers atoms; red, the oxygens; blue, the nitrogens, 
black, the carbons. B) First bis(-oxo)dicopper(III) complex mimicking the tyrosinase metal binding site stable at room temperature. 
[5]  
Introduction 
_______________________________________________________________________ 
19 
production leads to type I oculocutaneous albinism. This is a hereditary disease that 
affects one in every 17,000 person.[56] Understanding the requirements of this enzyme 
for its activity is strictly connected to the understanding of the chemical basis of 
oculocutaneous albinism, which are related with hematologic-storage disease, 
susceptibility to skin cancer, and optic neuronal defects, as well. The use of model 
complexes mimicking the tyrosinase’s active metal binding site it can surely be a fruitful 
bottom-up approach to the problem. 
Here, we compare two approaches aimed to structurally characterize such states: we 
exploited an innovative combination of pumped-XAS and resonant Raman scattering, 
which allows to efficiently studying the charge-transfer within complexes in their 
ground and excited state. My contribution consists in the set up and collection of the 
pumped-XAS data. 
 
Fig. 8: [Cu2L2(µ-O)2]I2 formation and pumped-XAS experimental set up. 
A) Potential Oxo-form (O-state) and B) Peroxo-form (P-state) of complexes modeling hemocyanin and tyrosinase metal binding 
sites.  C) Formation of [Cu2L2(µ-O)2]I2 (right) upon oxidation of [Cu(L)I] with dioxygen at 25 °C monitored by the absorption 
intensity for λmax (366 nm). D) Left: spectral distribution of the light emitted by our UV source. Centre: UV-excitation of the 
sample. Right: setup for the pumped-XAS experiment. The [Cu2L2(μ-O)2]I2 solution is excited with optics of the UV-source 
(black). The multi-element fluorescence detector and the safety shield (Kapton, orange) are also shown. 
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The relaxation of excited states into the ground state provides new insights in the 
dynamics of the systems under study. The dynamics of metal-donor interactions is 
particularly interesting for the molecular biology and bioinorganic chemistry 
communities. We focused on a system mimicking the Cu2O2-core in hemocyanin and 
tyrosinase. These proteins share the binuclear copper binding site, as well as most of the 
structural features.[57] 
In both metallo-proteins, molecular oxygen binds to two copper ions in the side-on 
peroxo mode (P-state).[58] Complexes modeling these features have the potential to 
serve as highly specific oxidation catalysts.[59] Typically, these systems are stable at 
cryogenic temperatures only.[60] 
Recently, the first system stabilizing the O-state at room temperature has been presented 
(Fig. 7 B).[5] It is formed within several hours by the reaction of molecular oxygen with 
the Cu(I)-complex, Cu(L)I with L = Bis(guanidin) N1,N3 -Bis[bis(2,2,6,6-
tetramethylpiperidin-1-yl)methylen]propan-1,3-diamin = (B(TMPip)G2p), as visualized 
by the increasing absorption at 366 nm (Fig. 8 A-C). Here, we compare strategies to 
characterize this excited state, either by optical-pumping (Fig. 8 D; optical source with 
λmax at 365nm, in line with the Raman active transition), or by resonance Raman 
spectroscopy. 
1.2.3 The ATP binding cassette protein ABCE1 
ABCE1 (ATP-binding cassette, sub-family E (OABP), member) is one of the most 
conserved proteins in the evolution of eukaryotes. Initially, the protein was identified as 
the RNase L inhibitor in the innate immune response and called RLI1.[61] It was 
subsequently shown that the assembly of the HIV-1 capsids requires ABCE1 in a strictly 
ATP-dependent manner.[62] Recently, an even more fundamental and general role was 
proposed in the process of translation initiation and ribosome biosynthesis.[63-66] 
ABCE1 was found to interact with translation initiation factors, such as eIF2, eIF3, eIF5, 
the 40S ribosomal subunit and several ribosomal RNAs. Depletion of the protein causes 
defects in the assembly of the pre-initiation complex, in rRNA processing, and in the 
accumulation of ribosomal subunits inside the nucleus. Thus, ABCE1 has a fundamental 
Introduction 
_______________________________________________________________________ 
21 
role in translation initiation, ribosome 
biosynthesis and in HIV-1 capsid 
assembly. ABCE1 is a unique ATP 
Binding Cassette (ABC) protein 
because it bears an N-terminal 
consensus sequence for the binding of 
an iron-sulfur cluster, which is an 
uncommon feature for ABC proteins. 
This N-terminal region includes eight 
conserved cysteine residues with the 
CX4CX3CX3CPXnCX2CX2CX3P 
consensus sequence. 
A specific incorporation of iron and 
the interaction with members of the 
Fe-S cluster assembly machinery have 
been demonstrated.[63] However, 
information regarding the type and 
structural organization of the Fe-S 
cluster was not available. Thus, ABCE1 is an extremely interesting target and I 
collaborate to its characterization by XAS analysis. Within this thesis I present the XAS 
work I carried on ABCE1 from Sulfolobus solfactaricus.[67] Recently, the X-ray 
structure of the complete ABCE1 protein from Pyrococcus abyssi at the nominal 
resolution of 2.8 Å has been reported (Protein Data Bank (PDB): 3BK7) (Fig. 9) 
1.3 Aim of the projects 
The projects aim to characterize biochemically and biophysically highly interesting 
metalloproteins. A wide spectrum of techniques has been applied on the protein ETHE1, 
while XAS analysis has been applied on all the other studied samples (proteins and 
bioinorganic complexes). 
 
Fig. 9: X-ray diffraction structure of the protein ABCE1 from 
Pyrococcus abyssi (PDB: BK7). 
The protein is represented as cartoon: red, α-helixes; marine-green, 
β-sheets; grey, loops and linker regions. In the figure, the iron-sulfur 
clusters and the ATP molecules bound to the protein are highlighted 
in scaled ball and sticks representation: black, carbons; red, 
oxygens; blue, nitrogens; violet, iron; yellow, sulfur; orange, 
phosphorus. 
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1.3.1 ETHE1 project 
HsETHE1 is a non-heme mononuclear-iron sulfur dioxygenase fundamental for proper 
sulfur detoxification in metazoan. It has been found overexpressed in a vast percentage 
of patients affected by HCC and it is able to inhibit p53 dependent apoptosis by two 
ways. Moreover, it is strictly involved in EE, a severe recessive metabolic disease. For 
the above reasons it is an extremely interesting target. The project aims to characterize 
biochemically and biophysically ETHE1 from Homo sapiens. Gain knowledge about 
this enzyme may lead to understand how to keep ETHE1-related HCCs under control 
and to find a specific therapy for EE. In order to gain knowledge about the 
physicochemical properties of HsETHE1, with particular focus on its active metallo 
binding site, the protein has been investigated by several techniques, such as: X-ray 
Absorption Spectroscopy (XAS), Small Angle X-ray Scattering (SAX), Total X-ray 
Reflection Fluorescence (TXRF), Mass Spectrometry (MS), Isothermal Titration 
Calorimetry (ITC), substrate screening, enzyme kinetics, crosslinking, Circular 
Dichroism (CD), Light Scattering techniques (DLS, SLS), Electron Paramagnetic 
Resonance (EPR), Mössbauer spectroscopy, site directed mutagenesis, surface entropy 
reduction. 
1.3.2 XAS project 
The XAS projects aim to the characterization of highly interesting metalloproteins and 
bioinorganic complexes. The architecture and the electronic structure of the metal 
centers have been investigated by X-ray Absorption Spectroscopy. The proteins were 
probed at synchrotron XAS beamlines and the collected data were primarily processed 
for background subtraction, data reduction and normalization. Successively, EXAFS 
and/or XANES analysis were applied. XAS gave us information on the metal-center 
geometry, oxidation state, type, number and distances of the metal ligands and disorder 
level of individual components of the system. The acquired knowledge may be fruitfully 
applied to clean energy technology development (hydrogenases; low cost H2 
production), understand the nature of reactions involving charge transfer processes 
(tyrosinase model systems) and inhibit HIV capsid assembly (ABCE1). 
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2 Materials and methods 
The materials and methods section has been divided in: 
• Cloning 
• Protein expression 
• Protein purification 
• Protein characterization 
Herein, I present separately the material used and the methods applied, except for the 
protein characterization chapter, where the exploited apparatus and the modality of their 
usage are treated together. Moreover, on the behalf of the text fluency I created an 
appendix (Appendix A) containing a list of the used material with the relative suppliers. 
2.1 Cloning 
The cloning procedure covers the steps from the amplification of the source DNA till the 
preparation of the expression clones. The general practice has been the following: the 
source gene is amplified by Polymerase Chain Reaction (PCR) using specific primers 
bearing sequences designed for subsequent insertion in specific plasmid vectors. The 
destination vector is amplified with high copy number E. coli strains and purified. The 
PCR products are then purified from solution or from agarose gel. The purified PCR 
products (pPCRp) and the destination vectors are cut with opportune restriction enzymes. 
At this point, in case of standard cloning, the digested pPCRp and the plasmids are 
purified from restriction enzymes and they are legated together using a ligase enzyme. In 
the case of Ligase Independent Cloning (LIC), the pPCRp and the vectors are treated 
before with T4-polymerase and after with a phosphatase in specific reaction mixtures, 
and then mixed. In each case, the ligation products are used to transform E. coli strains. 
Usually, the first transformation is done using strains able to propagate plasmids in high 
copy number. The transformed cells are let growth and the cultures are plated on agar 
and incubated over night. Once obtained the transformants, some colonies are picked 
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and checked for the presence of the insert with different techniques such colony PCR, or 
with alternative restriction enzyme digestion followed by Agarose Gel Electrophoresis 
(AGE). The integrity of the cloned gene sequence is then checked by sequencing. The 
final vectors are amplified and purified again and the DNA is used to transform E. coli 
strains optimized for expression. The very same procedure is applied to find the final 
expressing clones bearing the vector with the expected sequence in the right position and 
orientation. All the desired clones are used to grow minicultures from which glycerol 
stocks are prepared and kept at -80°C. 
2.1.1 Material for cloning 
The material for cloning derived from internal sources or from the following companies: 
ImaGenes, New England BioLabs, Finnenzyme, Fermentas, BioRad, Sigma Aldrich, 
Stratagene, Macherey Nagel, and Qiagen (see Appendix A for details). 
 
The sequence of HsETHE1 cDNA: 
Homo sapiens ETHE1 ; Entrez Nucleotide NM_014297; 
atggcggaggctgtactgagggtcgcccggcggcagctgagccagcgcggcgggtctggagcccccatcct
cctgcggcagatgttcgagcctgtgagctgcaccttcacgtacctgctgggtgacagagagtcccgggagg
ccgttctgatcgacccagtcctggaaacagcgcctcgggatgcccagctgatcaaggagctggggctgcgg
ctgctctatgctgtgaatacccactgccacgcggaccacattacaggctcggggctgctccgttccctcct
ccctggctgccagtctgtcatctcccgccttagtggggcccaggctgacttacacattgaggatggagact
ccatccgcttcgggcgcttcgcgttggagaccagggccagccctggccacaccccaggctgtgtcaccttc
gtcctgaatgaccacagcatggccttcactggagatgccctgttgatccgtgggtgtgggcggacagactt
ccagcaaggctgtgccaagaccttgtaccactcggtccatgaaaagatcttcacacttccaggagactgtc
tgatctaccctgctcacgattaccatgggttcacagtgtccaccgtggaggaggagaggactctgaaccct
cggctcaccctcagctgtgaggagtttgtcaaaatcatgggcaacctgaacttgcctaaacctcagcagat
agactttgctgttccagccaacatgcgctgtggggtgcagacacccactgcctga 
2.1.1.1 Primers 
The primers were chosen in order to clone the wild type form of HsETHE1 and a 
number of truncated forms: In vivo, the enzyme is directed to the mitochondrion through 
an N-teminal tag and then a short peptide at the terminus is cleaved.[10] This cleavage is 
predicted to create the active for of the enzyme. The site where the cut takes place was 
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not clear when most of the clones were made, but estimated to be within the first 20 
aminoacids. For example the TargetP (http://www.cbs.dtu.dk/services/TargetP/) server 
predicted the truncation of the first 11 aa, while 
MITOPROT(http://ihg.gsf.de/ihg/mitoprot.html predicted the truncation after the first 21 
aa. Moreover, exploiting predictors available on the web (such as PONDR, DisEMBL, 
RONN, DISOPRED2, GlobProt and DRIP-PRED), I have found that the protein is 
potentially disordered at the N-terminal part till aa 24 and at the C-terminal part in 
correspondence of the last 4 aa. 
 
Primers for ligase dependent cloning 
Primers for wt-HsETHE1cloning 
Forward primer used for the insertion of wild type HsETHE1 (wt-HsETHE1) in the 
pETM-11 or pETM-13 vectors: 
 
5’-ctgacagta|catgtcggcggaggctgtactgagg-3’ 
 
- = restriction site (PciI); PciI produces the same sticky ends as NcoI, which is the only 
restriction site available for ligation of the 5’end of the DNA to the 3’available end at 
the multiple cloning site of the vector. NcoI cuts in the ETHE1 gene) 
 - = first original protein codon: the previous atg and tcg codons are respectively the 
starting codon and a codon codifying for a serine. The latter was not present in the 
original sequence and is an obliged construct artifact. In fact, a codon starting with a “t” 
is necessary because of the specific restriction site used. 
 
Reverse primer for the insertion of wt- HsETHE1 in the pETM-11 or pETM-13 vectors: 
                   Stop 
                   |  | 
5’-ctgacagtc|tcgagctatcaggcagtgggtgtctgcac-3’ 
 
- = restriction site (Xho1) 
- = original protein termination codon 
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Reverse primer without stop codon for the insertion of wt- HsETHE1 in pETM-13 
vector and fuse the gene with a C-terminal histidine tag:                
                   
5’-ctgacagtc|tcgagggcagtgggtgtctgcacccc-3’ 
 
- = restriction site (Xho1) 
- = original protein codon 
 
Primers for Δ14-HsETHE1 cloning: 
Forward primer used for the insertion of HsETHE1 lacking the first 14 aminoacids (Δ14-
HsETHE1) in the pETM-11 or pETM-13 vectors: 
 
5’-ctgccatga|catgtctcagcgcggcgggtctgga-3’ 
 
- = restriction site (PciI); 
- = first original protein codon: the previous atg and tct codons are respectively the 
starting codon and a codon codifying for a serine. The latter was not present in the 
original sequence and is a construct artifact. 
 
The reverse primer is the same as for wt-HsETHE1. 
 
Primers for Δ24-HsETHE1 cloning: 
Forward primer used for the insertion of HsETHE1 lacking the first 24 aminoacids (Δ24-
HsETHE1) in the pETM-11 or pETM-13 vectors: 
 
5’-ctgccatga|catgttgctgcggcagatgttcgagcct-3’ 
 
- = restriction site (PciI); 
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- = original protein codon: the previous atg and ttg codons are respectively the starting 
codon and a codon codifying for a leucine. The latter is the same aminoacid present in 
the original sequence. Therefore the real shortening is of 23 aa. 
 
The reverse primer is the same as for wt-HsETHE1.  
 
Primers for ligase independent cloning 
LIC primers should be like the following: 
 
Forward primer:  5’-cagggcgccatg-3’-gene of interest 
Reverse primer:  5’-gacccgacgcggtta-3’-gene of interest (rev. comp.) 
 
The complementary overhangs are shown in red. The start codon (forward primer) and 
the stop codon (reverse primer) are underlined. 
 
Primers for Δ14-HsETHE1-Δ4 (14E4) cloning 
N.B.: the resulting PCR products don’t need to be digested by restriction enzymes, 
according to the protocol for LIC. 
 
Forward primer used for the insertion of HsETHE1 lacking the first 14 aminoacids and 
the last 4 aa (Δ14-HsETHE1-Δ4; 14E4) in the pETM-11_LIC vector: 
 
5’-cagggcgccatgcagcgcggcgggtctgga-3’ 
 
Reverse primer used for the insertion of HsETHE1 lacking the first 14 aminoacids and 
the last 4 aa (Δ14-HsETHE1-Δ4; 14E4) in the pETM-11_LIC vector: 
 
5’-gacccgacgcggttattactgcaccccacagcgcatgtt-3’ 
 
Primers for Δ19-HsETHE1-Δ4 (19E4) cloning 
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Forward primer used for the insertion of HsETHE1 lacking the first 19 aminoacids and 
the last 4 aa (Δ19-HsETHE1-Δ4; 19E4) in the pETM-11_LIC and pETM-20 vectors: 
 
5’-cagggcgccatgggagcccccatcctcctgcgg-3’ 
 
The reverse primer is the same as for Δ14-HsETHE1-Δ4. 
 
Primers for Δ7-HsETHE1-Δ4 (7E4) cloning 
Forward primer used for the insertion of HsETHE1 lacking the first 7 aminoacids and 
the last 4 aa (Δ7-HsETHE1-Δ4; 7E4) in the pETM-11_LIC vector: 
 
5’-cagggcgccatggtcgcccggcggcagctg-3’ 
 
The reverse primer is the same as for Δ14-HsETHE1-Δ4. 
 
Site directed mutagenesis (sdm) 
Three primers were designed for the creation of four mutants (MutA, B, C). 
Below the HsETHE1 cDNA and aminoacid sequences are respectively shown. The 
bases target of mutation are highlighted in red: 
 
1       10        20        30        40        50        60        70        80 
|        |         |         |         |         |         |         |         | 
atggcggaggctgtactgagggtcgcccggcggcagctgagccagcgcggcgggtctggagcccccatcctcctgcggca 
 
81      90       100       110       120       130       140       150       160 
|        |         |         |         |         |         |         |         | 
gatgttcgagcctgtgagctgcaccttcacgtacctgctgggtgacagagagtcccgggaggccgttctgatcgacccag 
 
161    170       180       190       200       210       220       230       240   
|        |         |         |         |         |         |         |         | 
tcctggaaacagcgcctcgggatgcccagctgatcaaggagctggggctgcggctgctctatgctgtgaatacccactgc 
 
241    250       260       270       280       290       300       310       320 
|        |         |         |         |         |         |         |         | 
cacgcggaccacattacaggctcggggctgctccgttccctcctccctggctgccagtctgtcatctcccgccttagtgg 
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321    330       340       350       360       370       380       390       400 
|        |         |         |         |         |         |         |         | 
ggcccaggctgacttacacattgaggatggagactccatccgcttcgggcgcttcgcgttggagaccagggccagccctg 
 
401    410       420       430       440       450       460       470       480 
|        |         |         |         |         |         |         |         | 
gccacaccccaggctgtgtcaccttcgtcctgaatgaccacagcatggccttcactggagatgccctgttgatccgtggg 
 
481    490       500       510       520       530       540       550       560 
|        |         |         |         |         |         |         |         | 
tgtgggcggacagacttccagcaaggctgtgccaagaccttgtaccactcggtccatgaaaagatcttcacacttccagg 
 
561    570       580       590       600       610       620       630       640 
|        |         |         |         |         |         |         |         | 
agactgtctgatctaccctgctcacgattaccatgggttcacagtgtccaccgtggaggaggagaggactctgaaccctc 
 
641    650       660       670       680       690       700       710       720 
|        |         |         |         |         |         |         |         | 
ggctcaccctcagctgtgaggagtttgtcaaaatcatgggcaacctgaacttgcctaaacctcagcagatagactttgct 
 
721    730       740       750       760    765 
|        |         |         |         |    | 
gttccagccaacatgcgctgtggggtgcagacacccactgcctga 
 
 
1       10        20        30        40        50        60 
|        |         |         |         |         |         | 
MAEAVLRVARRQLSQRGGSGAPILLRQMFEPVSCTFTYLLGDRESREAVLIDPVLETAPR 
 
61      70        80        90       100       110       120 
|        |         |         |         |         |         | 
DAQLIKELGLRLLYAVNTHCHADHITGSGLLRSLLPGCQSVISRLSGAQADLHIEDGDSI 
 
121    130       140       150       160       170       180 
|        |         |         |         |         |         | 
RFGRFALETRASPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAKTLYHSVHE 
 
181    190       200       210       220       230       240 
|        |         |         |         |         |         | 
KIFTLPGDCLIYPAHDYHGFTVSTVEEERTLNPRLTLSCEEFVKIMGNLNLPKPQQIDFA 
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241    250   254 
|        |   | 
VPANMRCGVQTPTA 
 
Mutants: 
• MutA: [E206A, E208A]_Δ7HsETHE1Δ4 
• MutB: [K66A,E67A] _Δ7HsETHE1Δ4 
• MutC: [E44A]_Δ7HsETHE1Δ4 
 
Primers for site SDM 
Primer used for creating the E206, 208A mutations: 
 
5'-agtgtccaccgtggcggaggcgaggactctgaacc-3' 
 
Primer used for creating the K66A, E67A mutations 
 
5'-atgcccagctgatcgcggcgctggggctgc-3' 
 
Primer used for creating the E44A mutation 
 
5'-tgggtgacagagcgtcccgggaggc-3' 
 
Expressed products 
Most of the work has been carried out using a cleavable N-terminal histidine tag coming 
from the vector. The expressed protein product possesses the following organization: 
 
  His Tag              TEV ETHE1 
     |                  |    | 
MKHHHHHHPMSDYDLPTTENLYFQ|GAM|-Protein 
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2.1.1.2 Kits used for 
cloning 
During cloning commercially 
available kits were used for DNA 
amplification, purification and 
mutagenesis. The kits were 
purchased from Nagel, Qiagen or 
Stratagene (see Appendix A for 
details). 
2.1.1.3 Plasmid vectors 
All the plasmid vectors were 
provided by Arie Geerlof from 
an internal library. The vectors 
are the following: pETM-11 (can 
fuse a 6-histidine tag and a 
Tobacco Etch Virus (TEV) 
protease cleavage site at the N-
terminal or at the C-terminal), 
pETM-13 (can fuse a 6-histidine 
tag at the C-terminal), pETM-
11_LIC (can fuse a 6-histidine 
tag and a TEV protease cleavage 
site at the N-terminal or at the C-
terminal), pETM-20_LIC (Fig. 
10). 
2.1.1.4 Bacterial Strains 
The bacterial strains used were mainly prepared internally by lab members. The cells 
were initially propagated and then made competent through a chemical procedure. The 
 
Fig. 10: HsETHE1 cloning vectors. 
Maps of the three plasmid-vectors used for cloning and expression of  the 
HsETHE1 constructs. A) pETM11. B) pETM13. C) pETM11_LIC. 
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purchased cells are the Top10 (Invitrogen) and the Solopack (Invitrogen). The strains 
used are: DH5α, Top10, Solopack, Nova Blue, BL21(DE3), BL21(DE3)-pLys, 
BL21(DE3)-Star, BL21(DE3)-Rosetta, BL21(DE3)-RIL, Origami. 
2.1.1.5 Agarose Gel Electrophoresis (AGE) apparatus 
The AGE devices used were or the BioRad Power PAC 300 or the Consort EV243. 
2.1.1.6 Polymerase Chain Reaction (PCR) apparatus 
The PCR apparatus used were or the Mastercycle gradient or the Mastercycle personal 
purchased from Eppendorf AG. 
2.1.2 Methods for cloning 
This section treats the protocols used during cloning. The preparation of all the reactions 
is ideally performed under sterile conditions. The water used for cloning was sterilized 
milliQ water. All the media were sterilized before usage. 
2.1.2.1 Gene amplification 
HsETHE1 gene was amplified by growing cultures of the bacterial clones transformed 
with a vector containing the cDNA sequence of the protein and/or by PCR. 
2.1.2.1.1 Amplification by cell culture 
At the very beginning, the DH10B TonA E. coli cells, containing the pCMV-SPORT6 
vector with the Homo sapiens ETHE1 cDNA insertion, were grown over night (o/n) at 
37°C, in 5 ml LB cultures in presence of Ampicillin (100mg/mL: 1000X), at 200 rpm. 
After each transformation, some randomly picked colonies were grown, amplifying the 
inner plasmid (o/n at 37°C, in 5 ml LB cultures in presence of the proper antibiotic, at 
200 rpm). The extracted DNA was needed to check the presence of the insert by 
restriction enzyme digestion test, for sequencing, to have positive vector ready for new 
transformations, and for storage. 
2.1.2.1.2 Amplification by PCR 
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Every time the insertion of HsETHE1 cDNA in a vector was necessary, the DNA has 
been amplified exploiting specific primers. 
The protocol used for PCR amplification can vary in dependence of the annealing and 
melting temperatures of the primers and of the level of stringency I wanted to reach. In 
general the protocol has been the following: 
 
Mix: 
• Polymerase buffer-10X 
• dNTPs 50/200µM final concentration 
• Primers 1µM final concentration 
• Template: 1/20 ng/µL 
• Polymerase 0.5/1 µL 
• Autoclaved milliQ water 
 
PCR program: 
1. 94°C 5’ 
2. 94°C 30’’ 
3. 50/65°C 30/45’’ (dependent on the specific annealing temperature of the primers) 
4. 72°C 30’’/1’ per Kb (it is dependent on the polymerase) 
30 x steps 2-4 
5. 72°C 7’ 
6. 4°C ∞ 
 
At this stage the DNA may be purified directly from the solution or from gel after AGE. 
Store at -20°C. 
Le positive controls are made using a known DNA template and primers known to be 
working. 
For the negative controls no DNA template is added to the PCR reaction mixture.  
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2.1.2.2 Agarose Gel Electrophoresis (AGE) 
AGE standard procedure: 
1. Mix AGE commercial buffer (10x) with agarose 0.5/2% (long plasmids/PCRp). 
2. Boil the solution till complete solubilization of the agarose. 
3. Pour the hot mixture in the gel chamber. 
4. Add ethidium bromide (1:25000/50000) and mixed. 
5. Ones polymerized I add AGE buffer till all the gel is covered. 
6. Load samples (1-20µL) and one or more DNA ladders (5µL). 
7. Run the gel applying a constant voltage chosen within the range of 80/120 milli 
volts. 
8. Let run for 30’/1h. 
2.1.2.3 DNA purification 
The DNA was purified with commercially available kits and kept at -20°C: plasmid 
extraction, PCR and gel extraction purification kits. As protocol, I followed the 
manufacturer instructions. 
2.1.2.4 DNA digestion 
The digestion of the DNA with restriction endonucleases has been done in the following 
cases: 
• To create complementary ends for ligation. The standard ligation plasmids 
(within the MCS (Multiple Cloning Site)) and the PCRp have been digested (PciI, 
XhoI enzymes). 
• To cut the plasmid used for LIC (BsaI enzyme). During LIC only the plasmids 
needs to be cleaved with restriction enzymes. 
• To check for the presence of the insert after cloning (PciI, XhoI, NcoI, XbaI). 
The construct DNA has been digested in order to create fragments with expected 
length. On the basis of the obtained fragments it is possible to sort out if whether 
an insert of proper length is present or not. 
Materials and methods 
_______________________________________________________________________ 
35 
• To cut away the host derived DNA strand after amplification for site directed 
mutagenesis (DpnI). During SDM, the entire vector is amplified by PCR, 
creating a construct with one strand bearing the specific mutations and one 
coming from the host, used as template and not bearing the mutations. The host 
strand possesses methylations on specific adenine nucleotides and it is 
recognized and cleaved by the restriction endonuclease DpnI. 
 
Restriction enzyme digestion protocol 
 
Mix: 
• Reaction buffer-10X 
• Restriction enzymes-20X 
• DNA material (up to µgs) 
 
Procedure: 
• 4h at 37°C 
• Heat inactivation: 20’ at 70°C 
 
At this stage the DNA may be purified with PCR purification kit. 
Storage at -20°C. 
2.1.2.5 DNA ligation 
The ligation of DNA has been achieved by two different procedures. One technique is 
based on the use of the ligase enzyme. The other system takes advantage of the creation 
of special complementary overhangs in the vector and insert. These overhanging sticky 
ends are long enough for the very specific, enzyme-free annealing of the two DNA. 
2.1.2.5.1 Ligase dependent cloning 
During ligase dependent cloning the acceptor linearized and successively purified (from 
gel or solution) vector is linked to the digested and purified (from gel or solution) gene 
of interest through the joining of complementary blunt or sticky ends present on both the 
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vector and the gene. The ligase is able to create a new covalent bond between the 
phosphate group present on a 5’ terminus of one DNA molecule and the 3’carbon of the 
sugar ring of the 3’terminus. During this work I used two different types of ligases. One 
is the standard T4 DNA ligase and the other enzyme is called “quick” ligase and is an 
engineered enzyme able to ligate DNA with faster catalysis than the standard T4 DNA 
ligase. 
The protocol used for standard ligation is the following: 
 
Mix: 
• Ligase buffer-10X (T4 DNA ligase) /-2X (quick ligase) 
• Ligase 1µL 
• Linearized vector ~50ng 
• Insert: ng insert = ng vector x bp insert/ bp vector (usually, insert:vector = 2/3:1) 
 
Procedure: 
• 4h to o/n at 16°C (T4 DNA ligase) / 5’ 25°C (quick ligase) 
• Heat inactivation: 15’ at 70°C (T4 DNA ligase) / 15’ at 65°C (quick ligase) 
 
At this stage the DNA may be purified with PCR purification kit. 
Storage at -20°C. 
2.1.2.5.2 Ligase Independent Cloning (LIC) 
During LIC no enzyme is needed for ligation. The vector is treated with the restriction 
enzyme BsaI. The vector is then dephosphorilated in order to avoid self annealing. 
Afterwards, or the vector is purified from gel, avoiding the presence of not digested 
DNA, or is directly treated with T4 DNA polymerase in the presence of dTTP. Because 
of the 3'--> 5' activity of the polymerase, the bases are removed from both 3' ends until 
the first thymidine (T) residue is reached. This leads to two specific overhangs in the 
LIC vector of 10 and 12 bases, respectively, which allow the specific, ligase-
independent annealing reaction. In the mean time the pure insert PCR product is treated 
with T4 DNA polymerase in the presence of dATP. Finally, the T4 polymerase treated 
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insert and vector are mixed in an annealing reaction and incubated for some minutes. 
The mixture is then directly used for transformation.  
 
Vector digestion with BsaI 
 
Mix: 
• BsaI buffer-10X 
• LIC vector DNA 5 μg (for more than 20 reactions) 
• BsaI (10 units/μL) 20X 
• Add sterile water up to the final volume 
 
Procedure: 
• 1h at 50°C 
• Heat inactivation: for 20’ at 70°C 
 
Vector dephosphorilation 
 
Mix: 
• Vector BsaI-digested reaction mix 50 µL 
• Phoshatase buffer-10X 
• Antarctic phosphatase (5 units/µL) 30X 
• Add sterile water up to the final volume 
 
Procedure: 
• 1h at 42°C 
• Heat inactivation: for 5’ at 70°C 
 
At this step the vector may be purified from agarose gel. 
Storage at -20°C. 
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T4 DNA polymerase treatment of the vector 
 
Mix: 
• T4 DNA polymerase buffer-10X 
• BsaI-digested LIC vector 600 ng (for ~20 annealing reactions) 
• dTTP (100 mM) 40X 
• DTT (100 mM) 20X 
• BSA-100X 
• T4 DNA polymerase (3 units/μl) 50X 
• Add sterile water up to the final volume 
 
Procedure: 
• 30’ at 22°C/room temperature 
• Heat inactivation: for 20’ at 75°C 
 
The LIC prepared vector solution obtained in this way can be used directly in the 
annealing reaction or purified with a PCR purification kit. Take care that the final vector 
concentration is 10-20 ng/μL. 
Storage at -20°C. 
 
T4 DNA polymerase treatment of the insert 
 
Mix: 
• T4 DNA polymerase buffer-10X 
• PCR product 0.2 pmol (for ~10 annealing reactions) 
 
The DNA concentration can be determined using the absorbance at 260 nm (assuming 
A260 = 1 is 50 ng/μl). To calculate the DNA concentration in pmol/μl the following 
equation has been applied: 
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number of base pairs x 0.65 = ng/pmol 
 
• dATP (100 mM) 0.5 μL 
• DTT (100 mM) 20X 
• BSA 100X 
• T4 DNA polymerase (3 units/μl) 50X 
• Add sterile water up to the final volume 
 
Procedure: 
• 30’ at 22°C/room temperature 
• Heat inactivation: 20’ at 75°C 
 
At this step the insert DNA may be purified from gel or from solution with a PCR 
purification kit. 
Storage at -20°C. 
 
Annealing of the insert and LIC-vector 
 
Mix: 
• Insert DNA 0.02 pmol 
• LIC prepared vector DNA 25-50 ng 
 
The control ligation is carried out with sterile water instead of the insert. 
The amount of LIC prepared vector DNA needed depends on the size of the vector and 
the molar ration of vector to insert (normally 1:2 or 1:3 is used). 
 
Procedure: 
• 5’ at 22°C/room temperature 
• EDTA (25 mM) 1µL 
• Mix gently by stirring the solution with the tip 
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• 5 at 22°C/or room temperature 
2.1.2.6 Transformation of Escherichia coli strains 
The transformations have been carried out using a standard protocol: 
• Thaw the appropriate amount (~50/200 µL reaction) of competent cells on ice. 
• Transfer 5-100 ngs of the vector DNA to a 1.5-ml microfuge tube and incubate 
on ice for at least 5’. 
• Add 50/100 μL aliquots of competent cells. 
• Incubate the tubes for 30’ on ice. 
• Heat shock the cells for 45’’ at 42°C. 
• Place the tubes immediately on ice and incubate for at least 2’. 
• Add 200/1000 μL SOC or LB media to each tube and incubate for 1 hour at 37°C 
at 200 rpm in a shaker/incubator. 
• Spin for 1 min at 5,000 rpm in a microfuge centrifuge. 
• Remove 3/4 of the supernatant and resuspend the cells in the remaining medium. 
• Plate out the cell suspension on a LB agar plate containing the proper antibiotics. 
• Incubate the plates overnight at 37°C. 
The positive control is the transformation of an aliquot of competent cells with a known 
vector bearing the same resistance. 
The negative control is an LB-agar plate with not transformed competent cells, which 
followed the same transformation procedure without the addition of the vector DNA. 
2.1.2.7 Clones selection 
After successful transformation of a host with a new prepared construct, we can be sure 
that those cells have our vector inside, but the colonies needs to be checked for the 
presence of the wanted insert into the internalized plasmid. Two methods have been 
applied for checking the presence of the insert. One method exploits restriction enzyme 
digestion, the other is a technique called colony PCR. 
 
Colony test by restriction endonucleases 
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1. Pick some colonies and plate them on an opportunely gridded agar dish 
containing the appropriate antibiotic. Each colony must be placed in its own slot. 
The plate is incubated o/n at 37°C. This ensures to possess not only the vectors 
of potential positive colonies, but also the clones them self. 
2. At the same time, some cells of each colony are used for inoculating a 10ml LB 
culture. The cultures are grown o/n at 37°C, at 200 rpm, in the presence of the 
proper antibiotics. Before the cultures reach an Optical Density at 600 nm (OD600) 
of 1 an aliquot can be used for preparing a glycerol stock that may be kept in 
case of positivity of the tested colony. 
3. The day after, the plasmids of each clone culture are extracted with a plasmid 
extraction kit. 
4. Part of the extracted DNA is digested with opportunely chosen restriction 
enzymes. 
5. The resulting DNA is then checked by AGE for presence of DNA fragments of 
the expected size. 
6. Keep the extracted DNA of the positive colonies. 
 
Colony test by colony PCR 
1. Prepare a PCR reaction mixture of opportune volume without polymerase. The 
primers used for the colony PCR are a primer used for amplify the gene of 
interest and a standard primer which is flanking the cloning site of the vector. 
Usually these primers are the forward primer of the insert and the reverse T7 
primer. In this way we can be confident that if we detect a DNA fragment 
corresponding to our insert, this comes from the vector. This is particularly 
useful in the case one treats genes coming from common species like human. In 
fact, there can always be some DNA contamination from external sources. 
2. Divide the master mix in as many aliquots as the number of colony to test, plus 2 
aliquots for positive and negative controls. 
3. Pick some colonies and plate them on an opportunely gridded agar dish 
containing the appropriate antibiotic. Each colony must be placed in its own slot. 
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The plate is incubated o/n at 37°C. This ensures to possess not only the vectors 
of potential positive colonies, but also the clones them self. 
4. At the same time, some cells of each colony are used for inoculating a PCR 
reaction mixture. 
5. The polymerase is added. The Taq polymerase is used because in this phase we 
don’t care much about the fidelity of the enzyme (proofreading activity) and the 
Taq polymerase doesn’t have proofreading activity and it is cheap. 
6. The amplified DNA is then checked by AGE for the presence of the insert. 
7. Use the positive colonies previously plated on a grated LB-agar dish to produce 
small LB cultures (~5/10mL). The cultures are grown o/n at 37°C in the presence 
of the proper antibiotics, at 200 rpm. Before the cultures reach an Optical 
Density at 600 nm (OD600) of 1 an aliquot can be used for preparing a glycerol 
stock that may be kept in case of positivity of the tested colony. 
8. The day after, the constructs of each clone culture are extracted with a plasmid 
extraction kit. 
9. Keep the extracted DNA of the positive colonies. 
2.1.2.8 Sequencing 
The sequencings have been carried out by the company Eurofins MWG Operon.  For 
sequencing 1µg of dried out DNA has been used for each sequencing (1 direction, using 
1 primer). In order to cover all the sequence of the gene, both the forward and reverse 
standard T7 primers were exploited. The clones bearing the construct with the expected 
sequence are kept. The others are discarded together with the relative extracted DNA 
and glycerol stocks. 
2.1.2.9 Clones storage 
The clones were stored in glycerol stocks, which are used to preserve a ready to use 
clone. The stocks are stored at -80°C. 
 
Procedure: 
• Prepare an autoclaved 70% glycerol solution 
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Add 300 µL of a growing culture to 700 µL of the 70% glycerol solution 
• Mix and keep at -80°C 
2.2 Protein expression 
Protein expression is the key step for protein production. During this work the proteins 
were expressed in E. coli strains (BL21 (DE3)-like strains). The procedure I used for the 
expression of HsETHE1 consist in inoculate a small amount of LB medium (20-100 mL) 
with the E.coli clone expressing the protein of interest and let it grow over night at 37°C. 
The obtained procedure is used to set up a large scale culture (1-6 liters). The cells are 
grown at 37°C for 3-5 hours and then the expression of the protein is induced. The 
induction can be done upon chemical addition (IPTG) or it is self-induced in the medium 
by chemical depletion (glucose). The protein is expressed for about 20 hours before cell 
harvesting. 
2.2.1 Materials for Protein expression 
The material for protein expression has been bought from the following companies: 
Carl-ROTH, NALGENE, BRAND, Sigma Aldrich, Schott Duran, Eppendorf, Infors, 
Riedel Haën (see Appendix A for details). 
2.2.2 Methods for protein expression 
This section treats the protocols used during protein expression. The preparation of all 
the cell cultures is ideally carried on under sterile conditions. The water used was 
sterilized milliQ water. All the media were sterilized before usage. 
2.2.2.1 Protein expression in Luria-Bertani medium 
LB medium has been exploited for: 
• Cell cultures (20/100 mL) used to inoculate large scale expression cultures (1/6 
L): pre-cultures. 
• Protein expression and solubility tests (10/50 mL): to check the protein 
expression levels and confinement in the host. The cells are disrupted, the 
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soluble fraction is separated from the unsoluble fraction and the two components 
are checked by PAGE to evaluate expression level and solubility. The 
overexpressed protein can be found or in the cytoplasm, or in the inclusion 
bodies, or in a combination of both. The inclusion bodies are biological-
membrane based confinement compartments where the overexpressed protein 
accumulates when poorly soluble or toxic for the host. The expression levels and 
solubility may be varied by: 
o changing expression vector 
o changing the gene of interest construct 
o varying the temperature at which the protein is expressed 
o varying the IPTG concentration 
 
Mix: 
• 20 g/L LB 
• Antibiotics: e.g. ampicillin (100 mg/mL: 1000X); kanamicin (100 mg/mL: 
2000X); chloramphenicol (34 mg/mL:1000X). 
• Expressing clone cells: from glycerol stock (5/10 µL) (pre-cultures) or directly 
from cells picked up from a colony grown on agar-plate solid medium 
(expression test cultures). 
 
Procedure: 
• Grow the culture o/n at 37°C, 200 rpm 
• In the case of the expression test cultures, IPTG (0.1/1 mM final concentration) 
is added at an OD600 of ~0.6 in order to induce the T7-promoter-dependent 
expression of the heterologue protein. The culture is then left o/n at 37°C, 200 
rpm 
2.2.2.2 Protein expression in ultra rich Auto-Inducing Medium (AIM) 
AIM has been exploited for large scale expressing cultures. The ultra rich AIM used 
during this work is called ZYP. 
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Mix: 
• ZY (for 1L ZYP) (autoclaved) 
o Tryptone 10 g 
o Yeast extract 5 g 
o H2O 925 mL 
• NPS 20X (autoclaved; pH 6.75) 
o (NH4)SO4 0,5 M 
o KH2PO4 1 M 
o Na2HPO4 1 M 
• 5052 50X (autoclaved) 
o Glycerol 10% 
o Glucose 1% 
o Lactose 4% 
o H2O 
• MgSO4 1000X (autoclaved) 
o MgSO4 1 M 
• antibiotics (filtered) 
o Ampicillin (100 mg/mL) 1000X 
o Kanamicin (100 mg/mL) 500X 
o Chloramphenicol (34 mg/mL) 1000X 
• ammonium iron(II) sulfate 1000X 
o Fe(II)(NH4)2(SO4)2 200 mM 
• pre-culture 
o 50X final volume 
 
Procedure: 
• Grow at 37°C, 200 rpm till the OD600 reaches a value of 2/5. 
• Switch to the desired temperature for expression (25°C has been found to be the 
optimal temperature for HsETHE1 overexpression). 
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• Incubate o/n at 200 rpm. 
• Harvest the cells. 
 
i.e.: the expression of the protein is induced in the culture by the lactose as soon as the 
glucose source is consumed. 
The final OD600 reached by the culture should be between 10 and 15. 
2.2.2.3 Protein expression in minimal medium 
The minimal medium is exploited in the case it is desirable to avoid contaminants and 
impurities deriving from rich media, or when it is needed to have total control on the 
components of the medium. In this work minimal medium culture has been used to 
control the availability of specific microelements, such as iron, zinc, nickel and 
manganese. 
The minimal medium used during this work is called M9. 
 
Mix: 
• M9 5X (1 L, pH7.5): 
o KH2PO4 15 g/L 
o (NH4)SO4 6.25 g/L 
o Na2HPO4 30 g/L 
o NaCl 2.5 g/L 
o H2O 895 mL 
• MgSO4 1000X 
o MgSO4 1 M 
• Glucose (filtered with a 0.2 µm cut-off membrane) 50X 
o Glucose 0.2 g/mL 
• Antibiotics (filtered) 
o kanamicin (100 mg/mL) 500X 
• Metal solution 1000X 
o Fe(II)(NH4)2(SO4)2 200 mM or 
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o Zn2SO4 200 mM or 
o Mn2SO4 200 mM or 
o Ni2(SO4) 200 mM or 
• Pre-culture 
o 50X final volume 
 
Procedure: 
• Grow the culture at 37°C, 200 rpm, till the OD600 reaches a value of 0.6. 
• Add IPTG (0.1/1 mM final concentration) to induce the expression. 
• Grow o/n at 25°C, 200 rpm. 
• Harvest the cells. 
2.3 Protein purification 
The protein purification is a necessary step to obtain a significant amount of protein 
suitable for research. Initially, the cultured cells containing the protein of interest are 
disrupted and the protein is withdrawn to the soluble fraction (surnatant). The surnatant 
is divided from the unsoluble fraction containing all the lipophilic material. Successively, 
multiple chromatographic purification steps follow. The first step is a metal affinity 
chromatography, with which most of the impurities are discarded. During this step the 
protein binds to the resin of the column thanks to the N-terminal histidine tag, which 
possesses high affinity for the metal ions bound to the resin of the column. Typically, the 
exploited metal is Ni(II), but also Co(II), Zn(II), Cu(II), Fe(III) or other metal ions.. I 
personally always took advantage of Ni(II). At this stage, the tag is removed through 
proteolytic cleavage by the TEV protease. TEV, which bears a histidine tag itself, the 
uncut protein and the cleaved tags are then removed exploiting another step of metal 
affinity chromatography. Afterwards, the protein undergoes to size exclusion 
chromatography. If the olo-form of HsETHE1 is needed, the above mentioned are the 
essential purification steps. Otherwise, the apo-form (metal-free protein) can be 
produced from the olo-one. In order to purify apo-HsETHE1, the as isolated form is 
incubated in a partially denaturing solution in presence of deferoxamine (specific iron 
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chelator). The stripped iron ion is removed by extensive dialysis against metal-free 
buffer. 
2.3.1 Materials for protein purification 
The material for protein expression has been bought from the following companies: 
Carl-ROTH, Soltec Ventures, Sigma Aldrich, Invitrogen, New England BioLabs (NEB), 
Fluka, Merck, Omni Life Science, Eppendorf, Sorvall, Bandelin, Avanti, Amersham 
Bioscience, BioRad, Pharmacia, Sartorium Stedim, Millex GP, MILLIPORE, 
NALGENE, Ikamag RCT, Heidolph, Thermo Scientific (see Appendix A for details). 
2.3.2 Methods for protein purification 
A robust and reproducible protocol for the production of pure HsETHE1 and its metal-
free (apo) form has been established. 
The production of as isolated protein takes four days. 
• Day 1: a small culture in LB is set up (see par. Deicated to protein expression). 
• Day 2: a large scale culture in AIM is set up and the protein is expressed o/n. 
• Day 3: the protein is extracted from the cells and undergoes to the first 
purification step (IMAC). The protein is incubated with TEV protease o/n. 
• Day 4: the protein is purified from TEV, uncleaved protein and free histidine 
tags present in solution. The protein is then purified by SEC. 
2.3.2.1 Sample preparation 
• The cells overexpressing HsETHE1 are harvested in 1 liter centrifuge tubes. 
• The cells are centrifuged for 1h at 4°C, at 6000 rpm. 
• The surnatant is discarded. 
• The cell pellet is resuspended in buffer A. 
• The resuspension is promptly sonicated on ice in 20’ cycles, comprising a 
sonication period of 0.1 s followed by a resting period of 0.9 s. 
• The cell lysate is ultracentrifuged at 4°C, at 20000 rpm for 30’. 
• The surnatant is collected and ultracentrifuged again for 30’. 
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• The surnatant is collected and filtered with a 0.45 µm cut-off filter. 
• The surnatant is filtered with a 0.22 µm cut-off filter. 
 
The solution is now ready to be loaded onto a chromatographic column, and should be 
kept at 4°C for a short period (no more than some hours), otherwise TCEP and protease 
inhibitors must be added to the solution. 
The unsoluble and soluble fractions can be analyzed by PAGE to check expression 
performance. 
2.3.2.2 Immobilized Metal Affinity Chromatography (IMAC) 
The IMAC purification has been carried out using both a peristaltic pump (sample 
loading and column preparation and cleaning) and the AKTA purifier apparati (sample 
elution). The columns used are the 5 mL HiTrap IMAC HP from Amersham Bioscience. 
Preferably, the elution should be performed at 4°C to enhance protein stability.  
 
Peristaltic pump 
• Column washing with 5 column volumes (CV) H2O 
• Column metal-recharging with 3.5 mL filtered 0.1 M NiSO4 solution 
• Column washing 10 CV H2O 
• Column equilibration with 10 CV buffer A 
• Sample loading (the flow through is collected) 
• Sample washing with 5 CV buffer A (the flow through is collected) 
 
AKTA purifier 
• Sample washing with 5 CV buffer A 
• Sample elution with a gradient of 0 to 80% buffer B (100 to 20% buffer A) in 10 
CV. The protein starts to be eluted at 32 % buffer A (180 mM). The buffer B 
percentage is held at 40% (220 mM) till the protein UV280 peak begins to 
decrease. This procedure has been found to be the more efficient in terms of 
protein purity. The eluate is collected in 1.5 mL fractions. 
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• The fractions with an UV280 signal greater than 100 mAU can be checked by 
PAGE and/or mixed 
• Column washing of bound remains with 5 CV buffer B (the flow through is 
collected) 
 
PAGE can be used to check for the presence and purity of the protein in every fraction, 
comprising also the washing eluates and the flow through. 
 
Peristaltic pump 
• Metal stripping with 5 CV 0.1 M EDTA pH 8.0 
• Column cleaning with 5 CV 1 M NaOH 
• Column washing with 10 CV H2O 
 
The column is kept at 4°C. For long term storage the column is loaded with a 70% 
ethanol solution. 
2.3.2.3 Estimation of the protein concentration 
The protein concentration has been estimated applying the calculated absorbance at 280 
nm and the extinction coefficient of the protein (calculated with ProtParam web server 
tool, which is available on the ExPASy web site, the Expert of Protein Analysis System) 
to the Lambert-Beer equation: 
 
A = - log(I/Io) 
 
A = εdc 
 
A: the absorbance 
I: intensity of the transmitted light 
I0: intensity of the incident light 
ε: extinction coefficient 
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d: optical path (constant for a determined apparatus: usually 0.1 or 1 cm) 
c: concentration 
2.3.2.4 Digestion with TEV protease 
• The IMAC purified protein solution (15/30 mL) is concentrated until about 10 
mL. Small volumes allow a grater yield of digested protein. 
• The protein concentration is then estimated and the TEV protease is added to the 
solution to a 1:100 ratio with the protein 
• The protein is incubated with TEV o/n at ambient temperature TA 
2.3.2.5 Purification from the TEV and uncleaved protein 
HsETHE1 is purified from the TEV, from the uncleaved protein and the delivered free 
tags, through IMAC step purification. In this case, we are interested in the unbound 
fraction, containing the digested protein. The TEV, which is fused with a histidine tag 
itself, the uncleaved protein and the free tags, bind to the resin. A peristaltic pump and a 
dedicated HiTrap IMAC HP column have been used during this purification step. 
 
Peristaltic pump 
• Column washing with 5 column volumes (CV) H2O 
• Column metal-recharging with 3.5 mL filtered 0.1 M NiSO4 solution 
• Column washing 10 CV H2O 
• Column equilibration with 10 CV buffer C (high salt concentration inhibits the 
TEV and improve the binding to the resin) 
• The sample is diluted 5/10 times with buffer C in order that the Imidazole 
concentration goes from ~200 mM down to ~ 20/40 mM. 
• The sample is filtered through a 0.22 µm cut-off membrane 
• Sample loading 
• The flow through with the digested protein is collected and kept at 4°C. 
• Column washing of bound remains with 5 CV buffer B (the flow through is 
collected) 
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• Metal stripping with 5 CV 0.1 M EDTA pH 8.0 
• Column cleaning with 5 CV 1 M NaOH 
• Column washing with 10 CV H2O 
 
PAGE can be used to check for the presence and purity of the protein in every fraction, 
comprising also the washing eluates and the flow through. 
The column is kept at 4°C. For long term storage the column is loaded with a 70% 
ethanol solution. 
2.3.2.6 Size Exclusion (SE)/ Gel Filtration (GF) chromatography 
Size Exclusion Chromatography (SEC) has been performed using or a Superdex 75, or a 
Superdex 200 column. In each case, the column volume is about 120 mL.  
 
• The column is equilibrated with 1.5 CV buffer S/H 
• The TEV digested protein is concentrated until a maximum value of 20 mg/mL 
or to a volume ~ 5 mL 
• The sample is filtered through a 0.22 µm cut-off membrane 
• The sample is loaded into a proper loop attached to the column and injected onto 
the column during a personally designed running program 
• The protein elutes between 57 and 70 mL using the Superdex 75 column and 
between 73 and 90 mL using the Superdex 200 column 
• The fractions with an UV280 signal greater than 100 mAU can be checked by 
PAGE and/or mixed 
• Column washing with 1.5 CV H2O 
 
PAGE can be used to check for the presence and purity of the protein in every fraction. 
At this stage the protein is usually of high purity, metal contamination free, at a 
concentration of 8-10 mg/mL. The protein yield at this step is about 100 mg/L of AIM 
culture. 
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2.3.2.7 Production of metal-free HsETHE1 
The production of the metal-free form of HsETHE1 (apo-HsETHE1) is a necessary step 
in order to carry on metal titration with isothermal Calorimetry (ITC). The following is 
the final optimal protocol established for the purification of the apo-protein. 
 
• Pure HsETHE1 solution it is mixed with the buffer Apo in a ratio 1:1 
• The protein is incubated o/n at 4°C 
• The protein is then extensively dialyzed (dialysis membrane cut-off of 8 kDa) 3 
times against 5 L of metal-free buffer H, at 4°C under stirring. The dialysis can 
be extended for half a day, or for an entire day, as soon as the protein is kept at 
4°C. 
• The protein is collected and filtered before usage or storage 
2.3.2.8 Protein storage 
The protein has been stored at 4°C for very short periods (up to few days) or at -80°C for 
long periods. Glycerol can be added to the protein before conservation to enhance 
stability. A concentration from 5 to 30 % of glycerol can be used without problems. 
2.4 Protein characterization 
The characterization of HsETHE1 is the main goal of this project. HsETHE1 has been 
characterized by a number of biophysical and biochemical techniques to gain innovative 
knowledge on this enzyme. Within this chapter, each technique have been described 
independently. 
2.4.1 Poly Acrylamide Gel Electrophoresis (PAGE) 
PAGE is a great technique in order to verify the purity of a preparation, and to evaluate 
the molecular weight of the protein species present in solution. 
PAGE can be performed in native or in denaturing conditions, using SDS in the 
preparation buffers and DTT in the protein dye. During this work I used the Sodium 
Dodecyl Sulfate - Poly Acrylamide Gel Electrophoresis (SDS-PAGE). SDS is able to 
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unfold the proteins (denaturation) through the hydrophobic moiety and supply negative 
charges through the hydrophilic part. In this way, the proteins can run drifted by the 
applied electric potential at a speed dependent exclusively on the particles size, which is 
proportional to their molecular weight. 
The PAGE apparatus used was purchased from Invitrogen. Sometime, also the gels were 
bought from Invitrogen, but usually they were self-made exploiting a caster designed by 
Dr. Young-Hwa Song and constructed by the EMBL workshop. The gels can be of 
different type. I have been using glycine, tricine and bis-tris type gels. The gels can be 
divided in two parts: the stacking gel part, where the proteins are loaded into wells and 
they run through the lane irrespectively of their size (the polymeric net forming the gel is 
very wide), and the separating gel part, where the particles are separated in respect of 
their size. 
During the run the gels are soaked in a running buffer that must be compatible with the 
gel type in use. 
 
Chemicals used for Poly Acrylamide Gel Electrophoresis  
See Appendix A for details. 
 
Buffers and solutions for Poly Acrylamide Gel Electrophoresis 
The following buffers and solution were used for PAGE: 
• Tricine running buffer 
• Tricine gradient gels 
• Glycine separating gel buffer 
• Glycine stacking gel buffer 
• Bis-tris gel running buffer 
• Bis-tris separating gel buffer 
• Bis-tris stacking gel buffer 
• Gel staining solution 
• Gel destaining solution 
See Appendix A for details. 
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Procedure 
• The samples are mixed with the protein loading dye and they are heated up to 
90°C to stimulate denaturation. 
• The PAGE device is prepared with the ready to use gel soaked in running buffer. 
• The samples are loaded into the gel wells. Commonly, at least one lane of the gel 
is dedicated to the protein markers, which supply a mixture of protein of known 
molecular weight for comparison. 
• A constant potential of 120/200 eV is applied and the gel is left run for about 
60/40’. 
• When the run is complete, the gels are stained and destained leaving the dye in 
complex with the proteins. In this way, the protein bands on each lane can be 
optically distinguishable. 
2.4.2 Dynamic Light Scattering (DLS) 
The DLS supplies information about the polydispersity and the hydrodynamic radius of 
the protein in solution.[68] 
 
Material 
See Appendix A for details. 
 
Procedure 
• The protein solution is filtered through a 0.22 µm membrane or centrifuged at 
14000 rmp for 15’. 
• The cuvette is carefully cleaned to prevent the presence of dust. 
• 20 µL of the protein solution is introduced into the UV cuvette. 
• The solution is tested for the intensity and stability of the signal. The intensity of 
the scattering signal should be lower than 10 million count rates per second and 
the fluctuation should be less than 1000 count rates up and down. If the 
conditions are not satisfied there are multiple possibilities: the protein is too 
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concentrated (intensity too high); in the protein solution are present aggregates; 
there is still dust in the solution. The best condition for monodispersity should be 
sought, for example changing buffer, salts concentration, reducing agent type and 
concentration. 
• Run the experiment with an acquisition time of 10s per data point collecting from 
20 to 30 measurements. 
 
In general, the resulting hydrodynamic radius should be between 2 and 5 nm and the 
polydispersity less than 20%. 
2.4.3 Protein stability 
The stability of the protein has been checked in different conditions. The effect of DTT 
on the protein has been investigated. Different reducing agents in various concentrations 
have been tested. Different storage temperatures have been tried to find the best way to 
preserve the protein for long time. The stability in different buffers at different pHs has 
been tested with a Thrmofluor device to find the solution in which the protein results 
more stable. In this technique, the protein is incubated with a regent (Sypro Orange) that 
binds to the hydrophobic moieties of the proteins emitting light at a 470/570 nm 
wavelenght after excitation at 300 nm. 
 
Material for protein stability investigation 
See appendix A for details. 
 
DTT influence test 
• 50 mM DTT are added to a 5 mg/mL HsETHE1 solution under N2 flux. 
• The mixture is incubated for 5’. 
• A UV-Vis spectrum of the mixture is taken and compared with the spectra of the 
DTT-free protein. 
• Check the protein conditions after a night. 
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Reducing agent sensitivity test 
• 21 samples are prepared (20 conditions plus 1 negative control with no reducing 
agent inside. The protein concentration has been 5 mg/mL each sample): 
o 5 sample β-mercaptoethanol at the concentrations of: 2, 5, 10, 20, 50 mM. 
o 5 sample with DTT at the concentrations of: 1, 2, 5, 10, 20 mM. 
o 5 sample with TCEP at the concentration of: 0.2, 0.5, 1, 2, 5 mM. 
o 5 sample with dithionite at the concentrations of: 0.2, 0.5, 1, 2, 5 mM. 
• The solutions are incubated for 1 h at TA. 
• The samples are centrifuged at 14000 rpm for 15’. 
• Check for protein precipitation by eye and with an optical microscope. 
• Analyze the samples with the DLS and check the polydispersity and 
hydrodynamic radius of the species in solution. 
 
The used concentrations are related to the reducing capacity of each individual 
compound and to the maxima concentrations at which these compounds are commonly 
used in protein science. 
 
Low temperatures stability test 
Protein samples of 10 mg/mL have been subjected to different temperatures (TA, 4, -20, 
-80 °C) . The protein solutions have been incubated for one month and the protein 
degradation has been checked optically after centrifugation and by SDS-PAGE at fixed 
intervals of time (after 1 day, 2 days, 1 week, 2 weeks, 3 weeks and 1 month). 
 
Differential buffers stability screening 
• 1 µL of Sypro Orange is added to 1 mL of protein at a concentration of 1 mg/mL. 
• 5 µL of the solution are added to 95 out of the 96 wells of the screening plate. 
Each well contains a final volume of 50 µL.  
• The solutions obtained are screened with the cycler for increasing of absorbance 
at 470 nm during a temperature gradient going from 16 up to 90 degrees. 
Materials and methods 
_______________________________________________________________________ 
58 
• The solutions where the signal intensity rises up at the higher temperature 
represent the best conditions. 
2.4.4 Static Light Scattering (SLS) 
SLS it is used to gain information about the oligomeric state and molecular weight of the 
species present in solution.[69] 
 
Material 
See appendix A for details. 
 
Procedure 
• Connect the SLS machine to an AKTA purifier, following the manufacturer 
instruction. 
• Load 500 µL of a 1 mg/mL protein sample into a proper loop connected to the 
purifier. 
• Start the purifier and be sure to start the acquisition by the SLS at the same 
moment the sample is injected into the column. 
• A the end of the run check with the ASTRA software that the SLS scattering 
signal is aligned with the AKTA UV280 signal. In case, the program allows you 
to make the proper alignment. 
• Check that the scattering signal corresponding to the protein peak is flat. If this is 
not the case, probably multiple oligomeric/aggregation states are present in 
solution. The best condition for monodispersity should be sought, for example 
changing buffer, salts concentration, reducing agent type and concentration. 
• Select only the homogeneous scattering signal corresponding to the UV peak of 
interest and analyze the data with the ASTRA software. 
 
The software, on the basis of a standard measurement and relative parameters (usually 
BSA is used) and on the basis of the elution volume and extinction coefficient of the 
protein, calculates the molecular weight of the species of interest. 
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2.4.5 Crosslinking 
The crosslinking it has been used as alternative method to check the oligomeric state of a 
protein in solution.[70] The crosslink has been achieved by two different techniques: the 
chemical and the physical crosslink. The first exploits chemical reagents in order to 
introduce covalent bonds between ε-amino groups of lysine residues present on the surface 
of the protein (if any!). If the protein is oligomeric, then the monomers should crosslink 
through the lysines present on the interaction interface. The second method is a UV-A 
driven unspecific crosslink. Covalent bonds are introduced between interacting 
molecules upon ionizing irradiation. 
The resulting sample can be checked by SDS-PAGE. 
 
Material 
See Appendix A for details. 
 
Procedure 
Chemical crosslinking: 
• Prepare 7 sample (50 µL final volume) for each protein: 
o Protein + 0.1% glutaraldheyde  
o Protein + 0.2% glutaraldheyde 
o Protein + 0.3% glutaraldheyde 
o Protein + 0.4% glutaraldheyde 
o Protein + 0.5% glutaraldheyde 
o Protein alone (negative control) 
o Protein + 2.5% glutaraldheyde + BSA (100 µL final volume, 1 mg/ml 
concentration of BSA and HsETHE1) 
• Incubation for 1h 
• Stop the reaction by addition of 10 μl of 1 M Tris-HCl, pH 8.0. 
UV crosslinking: 
• Prepare 7 samples for each protein and mix one with BSA (100 µL final volume, 1 
mg/ml concentration of BSA and HsETHE1) 
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• Take 5 samples with the protein and the sample with the protein plus BSA and 
expose the samples to the radiation of a UV transilluminator: expose individual 
samples for a dedicated time 30’’, 1’, 2’, 3’, 4’, 5’. The Protein + BSA sample is 
exposed for 5’ and represent the negative-interaction control. The remaining 
sample is used as negative control. 
Check all the results by SDS-PAGE. 
2.4.6 Total X-ray Reflection Fluorescence (TXRF) 
TXRF spectrometry is a powerful x-ray based technique that allows quantitative 
investigation of a number of elements present in a sample.[71] Recent development 
improved considerably its application for biological purposes.[72] The target is hit with 
an x-ray beam at ideally 180 degrees respect a surface where the specimen is placed, and 
the fluorescence emissions at 90°C is acquired. Potentially, TXRF can discriminate the 
elements from silicon to uranium (depending on the standards used) with a detection 
limit in the lower pg, ppb and ppm-regions (pico/micro molar in solution). Herein, the 
considered elements have an atomic number ranging within the scandium and gallium 
ones, which were used as standards. In this case, TXRF gives very precise metal 
quantification for first row transition metals. 
TXRF has been useful for testing: 
• metal-protein correlation 
• metal contamination 
This technique requires little volumes (~20μL) and low concentrations of protein (20-
50μM) and the collected data are quick to analyze for standard measurements. Moreover, 
no cooling is needed. The disadvantages are limited to the high precision requested for 
the used volumes and the time needed for each measurement. In fact, for each sample, 
three specimens are probed for statistical purposes and usually, more than one sample 
needs to be probed in order to perform comparisons. Every data collection of a specimen 
takes about 1 hour. TXRF experiments and data analysis were carried out by myself. 
Access to the instrumentation (PicoTAX) was kindly provided by Peter Freimann of the 
“Institute Bundesamt fuer Seeschiffahrt und Hydrographie” in Hamburg). 
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TXRF was applied on all the purified protein batches and buffers for quality control. 
Moreover, TXRF was used on each ITC experiment sample: apo-protein, buffers, and 
metal solutions. This procedure was essential for quality check and for the determination 
of the precise metal concentration in the solutions titrated during ITC experiments. 
 
Material 
See Appendix A for details. 
 
Procedure 
For the preparation of 5 µL drop specimens: 
• Prepare an intermediate standard solution (use a balance with one hundred of 
milligram sensitivity): 
o 20 mg/L gallium 
o 200 mg/L scandium 
• Mix 20μL of each sample with 2 µL of standard solution. (final concentrations: 2 
mg/mL gallium, 28.68 µM; 20 mg/mL scandium, 420 µM) 
• Place 5 µL of each resulting solutions at the center 3 individual plexies: you 
should have 5 µL triplicates for every sample. 
• Leave dry out at 37°C. 
• Measure the fluorescence for 5000 seconds each specimen. 
• Convert the “spx” output files of the PicoTAX program in “mca” files. 
• Analyze the data with PyMCA. 
• Crate a table resuming all the PyMCA output values of the measurements. 
 
i.e.: when the specimens are dried out we assume that the standards were already present 
in solution and thus, that their concentration in the solution was 1:10 the intermediate 
solution and not 1:11 (we add 2 µL to 20 µL!). 
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2.4.7 Isothermal Titration Calorimetry (ITC) 
ITC is a powerful method to study the thermodynamics of chemical interactions such as 
protein-protein, protein-molecule, or even protein-ion interactions.[73] 
ITC is a quantitative technique that can directly measure the binding affinity (Ka), 
enthalpy changes (ΔH), and binding stoichiometry (n) of the interaction between two or 
more molecules in solution. From these initial measurements Gibbs energy changes 
(ΔG), and entropy changes (ΔS), can be determined using the relationship: 
 
ΔG = -RTlnK = ΔH-TΔS 
 
The enthalpy changes during time are calculated respect a reference cell. ITC systems 
use a cell feedback network to differentially measure and compensate for heat produced 
or absorbed between the sample and reference cell. 
2.4.7.1 The ITC experiment 
 
Materials 
See Appendix A for details. 
 
Procedure 
• Dialyze the protein o/n against a metal free buffer. Concentrate/dilute the protein 
to a concentration of 20/50 µM. 
• Use the dialysis buffer to prepare a metal solution (~ 450 µL per experiments, 
but a bigger volume is needed for comfortable loading): the concentration 
depends on the binding affinity for the protein and on the protein concentration. 
Usually the concentration ranges between 0.1 and 1 mM. 
• Set the sample chamber jacket temperature to the constant temperature of 25°C. 
• Select a proper computer path where to save the results. 
• Wash with water and equilibrate with buffer the ITC sample chamber. 
• Wash with water and equilibrate with buffer the ITC injections syringe. 
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• Degass the sample and the binding partner solution using the proper device, 
which is part of the ITC system. 
• Load the sample into the sample chamber avoiding bubbles. 
• Open the syringe and load the partner solution avoiding bubbles. Pour the liquid 
up and down till no bubbles are present. 
• Close the syringe. 
• Purge two times the liquid into the syringe. 
• Introduce the syringe into the apparatus. 
• Set the parameters on the main control window: 30 injections; reference power at 
20; delay at 60; stirring speed at 307; feedback mode to high; ITC eq. to fast and 
auto; 1st injection of 3 µL with 6 s injection; 29 injection of 10 µL with 20 s 
injections; spacing time between injection of 240 s; filter period of 2. 
• Set the concentrations used on the main control window (this is fundamental for 
the correct interpretation of the results. 
• Run the experiment: the machine with equilibrate the temperatures of the sample 
cell with the reference cell after addition of the solution. After the machine starts 
the stirring of the syringe (in order to mix properly the solution during injections). 
At this point the machine needs to equilibrate the sample and reference chamber 
taking in account the stirring if the syringe. Afterward the experiment starts. 
• Analyze the data with the Origin software. 
2.4.7.2 Solutions used in the ITC experiments 
 
Materials 
See Appendix A for details. 
 
Solutions 
All the solution were prepared using the apo-HSETHE1 dialysis buffer and filtered with 
a 0.22 µm cut-off membrane. The metal concentrations were calculated by TXRF and 
refer to representative experiments. 
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The following metal solutions have been prepared: 
• Fe(II)(NH4)(SO4)2 100 µM + dithionite 5 mM 
• Fe(III)-citrate-NTA(n) (iron concentration of 90 µM in the presented results) 
• Prepare a solution 10 mM iron citrate and 20 mM NTA. 
• Dissolve the compounds in the apo-protein dialysis buffer. 
• Vortex extensively. 
• Quick filter the solution. 
• This procedure should give an iron(III) stock solution at a concentration of about 
1 mM. 
• Ni(II)SO4 235 mM  
• Zn(II)Cl 135 mM 
• Mn(II)Cl 300 mM 
• GSH 1 mM 
The metal concentrations used depended on the protein concentrations and on single 
preparations. It is important to notice that often the metal concentrations supposed 
during preparation were not the real ones. TXRF was carried out after each experiment 
to determine the exact metal concentrations. Only then, the results were analyzed and 
interpreted. The results of TXRF have been also used to determine standard protocol to 
obtain defined concentrations prior to the experiments. 
2.4.8 Optical absorption spectrophotometry 
Spectrophotometry is a technique able to quantify the incident light absorption of a 
solution respect to another.[74] The absorption values are then used to: 
• Fingerprint the characteristic absorption spectrum of a solution within a selected 
range of wavelengths (220-750 nm). 
• Calculate the concentration of the species in solution (280 nm) 
• Evaluate a cell culture density (600 nm). 
The commonly used bench-top spectrophotometers have the possibility to span 
wavelengths from 190 to 900 nm. Typically, I used the spectrophotometer or to carry on 
UV-Vis experiments, or for measuring the protein concentration, which can be 
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calculated through the Lambert-Beer equation knowing the extinction coefficient of the 
target molecule, its absorbance at 280 nm and assuming that is the only species in 
solution (pure protein solution in this case). 
 
Lambert-Beer equation: 
 
A = - log(I/Io) 
 
A = εdc 
 
A: the absorbance 
I: intensity of the transmitted light 
I0: intensity of the incident light 
ε: extinction coefficient 
d: optical path (constant for a determined apparatus: usually 0.1 or 1 cm) 
c: concentration 
 
Material 
See Appendix A for details. 
 
Method 
• Using the Eppendorf spectrophotometer: 
o A volume of 200-1000 µLs of a blank solution (same composition of the 
sample solution, but without the species you want to measure the 
absorbance of) is placed into a 1 mL cuvette. 
o Set its absorbance as the zero point. 
o A volume of 200-1000 µLs of the sample solution are placed into a 1 mL 
cuvette. 
o The absorbance respect the blank is measured. 
• Using the Nanodrop: 
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o 2 µL of a blank solution are directly placed on the “sample surface” (the 
beam path is passing through the centre of the “sample surface”). 
o Set the zero point. 
o Clean the surface and place on it 2 µL of the sample solution 
o Measure the absorbance. 
2.4.9 Mass Spectrometry (MS) 
Mass spectrometry has been used to check the integrity of the protein in solution and to 
get information about the molecular weight of the HsETHE1- dimer in solution.[75] 
 
Materials 
See Appendix A for details. 
 
Procedure 
• Prepare the matrix solution: 
o SAPA 10 mg/mL 
o Acetonitril 30% 
o TFA 0.1% 
• Put 1µL of the matrix and 1µL of the protein solution on a spot of a sample grid-
plate 
• Leave the drop to dry out 
• Take shots at different spots 
2.4.10 Circular Dichroism (CD) spectroscopy 
CD spectroscopy measures differences in the absorption of left-handed polarized light 
versus right-handed polarized light which arise due to structural asymmetry.[76] The 
absence of regular structure results in zero CD intensity, while an ordered structure 
results in a spectrum which can contain both positive and negative signals. In general, 
this phenomenon will be exhibited in absorption bands of any optically active molecule. 
Thereby, circular dichroism is exhibited by biological molecules because of their 
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dextrorotary and levorotary components. Even more important is that alpha helix of 
proteins and the double helix of nucleic acids have CD spectral signatures representative 
of their structures. Many compounds can absorb differently left/right polarized light so 
that the composition of the used buffers must be chosen carefully. Any compound which 
absorbs in the region of interest (250 - 190 nm) should be avoided. A buffer or detergent 
or other chemical should not be used unless it can be shown that the compound in 
question will not mask the protein signal. For instance imidazole cannot be used below 
220 nm and chlorine must be avoided. In general, any chemical that is unnecessary for 
protein stability/solubility should be left out. Obviously, the protein purity is also very 
important for the results. Filtering of the solutions (0.02 um syringe filters) may improve 
signal to noise ratio. 
 
Circular dichroism spectroscopy is particularly good for: 
• Determining whether a protein is folded or not. 
• Characterizing the secondary or tertiary structure of a protein. 
• Comparing structures 
• Studying the conformational stability of a protein under variable conditions. 
• CD is excellent for finding solvent conditions that increase the melting 
temperature. 
• Studying conformational changes. 
 
Determination of Protein Secondary Structure by Circular Dichroism 
Secondary structure can be determined by CD spectroscopy in the "far-UV" spectral 
region (190-250 nm). At these wavelengths the chromophore is the peptide bond, and 
the signal arises when it is located in a regular, folded environment.  
Alpha-helix, beta-sheet, and random coil structures each give rise to a characteristic 
shape and magnitude of CD spectrum.  
 
Information About Protein Tertiary Structure from Circular Dichroism 
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The CD spectrum of a protein in the "near-UV" spectral region (250-350 nm) can be 
sensitive to certain aspects of tertiary structure. At these wavelengths the chromophores 
are the aromatic amino acids and disulfide bonds, and the CD signals they produce are 
sensitive to the overall tertiary structure of the protein.  
Signals in the region from 250-270 nm are attributable to phenylalanine residues, signals 
from 270-290 nm are attributable to tyrosine, and those from 280-300 nm are 
attributable to tryptophan. Disulfide bonds give rise to broad weak signals throughout 
the near-UV spectrum. The presence of significant near-UV signals is a good indication 
that the protein is folded in a well-defined structure. 
 
Material 
See Appendix A for details. 
 
Procedure 
• Prepare protein solution samples in phosphate buffer salt free at the 
concentrations of 0.5, 1.0, 1.5 mg/mL. 
• Centrifuge the samples at 14000 rpm 4°C for 15’. 
• Filter the sample by a 0.22 µm cut-off membrane. 
• Switch on the nitrogen flux (the sample should be in oxygen free atmosphere 
because of the absorption of the oxygen in the UV range). 
• Open the pumps for temperature control. 
• Measure protein-free buffers and protein samples following the manufacturer 
instructions. 
• Analyze the data with the JASCO software. 
2.4.11 Crystallization 
Crystallization is the necessary step to carry on an x-ray diffraction experiment aiming 
to solve the three dimensional structure of a target molecule or supramolecular structure. 
Protein crystallization occurs when the concentration of protein in solution is greater 
than its limit of solubility in a given solvent and so the protein solution is in a 
Materials and methods 
_______________________________________________________________________ 
69 
superstaturated state. Crystals start growing by a process called "nucleation". Nucleation 
can either start with the molecules themselves (we'll call this unassisted nucleation), or 
with the help of some solid matter already in the solution (assisted nucleation). Once a 
solution is saturated, or a melt nears the solidification point, solid material starts to form. 
If the molecules come together in a random arrangement, they do not occupy the closest 
packed space. However, if the molecules come together in an ordered array, they pack 
together in a much smaller space such that the packing uses less space and is also of 
lowest energy. This ordered array pattern repeats itself regularly in 3 dimensions, and 
the crystal is the macroscopic object we see as a result.  
Crystallization has been tried exploiting the facility[77] available at EMBL-Hamburg 
and by manual crystallization set up for conditions optimization and spherulites seeding. 
 
Material 
See Appendix A for details. 
 
Procedure 
I tested for crystallization different protein constructs (Δ14-HsETHE1, Δ14-HsETHE1-
Δ4, Δ19-HsETHE1-Δ4, Apo-Δ14-HsETHE1-Δ4, Δ7-HsETHE1-Δ4, HsETHE1-MutA, 
HsETHE1-MutB, HsETHE1-MutC), at different concentrations (8, 10, 20 mg/mL, 1 
mM, 2mM), different temperatures (19, 4 °C), different reducing conditions. I exploited 
the bio-robot available at the high throughput crystallization facility of EMBL-Hamburg, 
or I set up the crystallization plates manually for optimizations, pre crystallization tests 
(Hampton-PCT) and seeding. The biorobot prepared 96 conditions per screen on a 
Greiner Low Profile plate, using the sitting drop technique. The crystallization drops had 
a volume from 1 to 2 µL with a protein:reservoir ratio of 1:1. Hundreds of conditions 
have been tested, using standard crystallization screening plates, e.g. Hampton_Index, 
Hampton_Crystal, Hampton_Grid, Jena (1-10), Quiagen_ClassicI, Quiagen_ClassicII, 
Quiagen_PEGI, Quiagen_PEGII, Quiagen_Pact. Manual screenings were carried out on 
24 well plates with the hanging drop method. The drops were about 2 µL in volume. 
Besides, I applied the reductive methylation on HsETHE1 in order to add methyl-groups 
to the lysines exposed on the protein surface. In this way, I aimed to enhance the protein 
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monodispersity by lowering of the surface entropy and thereby boosting the probability 
of crystallization. 
 
Reductive methylation protocol 
The reductive methylation was optimized for proteins. To avoid side reaction, the 
protein should be put in a non-reducing buffer. The protein was used at a concentration 
of 5 mg/mL. 
 
Material 
See Appendix A for details. 
 
Procedure 
1. Add 20 µL of 1 M dimethyl-borane complex every mL of protein solution. 
2. Add 40 µL of 1 M formaldehyde every mL of protein solution. 
3. Incubate on ice for 2h. 
4. Repeat steps 1 to 3. 
5. Add 10 µL of 1 M dimethyl-borane complex every mL of protein solution. 
6. Incubate 24h on ice. 
7. Exchange the buffer by dialysis, or repeated concentration-dilution steps. 
8. Perform a SEC on the reductively methylated protein. 
 
Crystallization trials 
EMBL-Hamburg facility crystallization screens: the protein solutions are supplied 
directly to the technician responsible of the facility. See Appendix A for details about 
the construct used and the conditions tested. 
2.4.12 Substrate screening 
Substrate screenings have been performed to check whether HsETHE1 is able to 
perform any of the more common MβL-like activities: lactamase, phosphatase, aryl-
sulfatase and esterase. 
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Material 
See Appendix A for details. 
 
Procedure 
The experiments were carried out at the pH values of 7.2 and 8.5, corresponding to the 
mean values found in the human cytoplasm[78] and mitochondrial matrix,[79] 
respectively. The reason behind the choice is that the protein has been found in the 
cytoplasm, in the nucleus and in the mitochondrial matrix. An exception is the esterase 
activity test, were the experiment was carried in a pH of 8.0. 
The experiments were performed using UV-96-well-plates and 200 µL reaction 
solutions per well. The substrates working concentration it has been of 10 mM (2 µmols), 
but for Nitrocefin, were it was 100 µM, and nitrophenyl acetate, were it was 350 µM. 
The enzymes concentrations are calculated in order that at least 2 µmols of substrate are 
processed in less than 1 hour. 
 
Prepare: (in TrisHCL and phosphate buffers) 
• As isolated HsETHE1 160 µM (>700 µL), 50 µL/well, final concentration of40 
µM 
• Apo-HsETHE1 160 µM. (>1400 µL), 50 µL/well, final concentration of 40 µM 
• Ammonium iron sulfate solution 1 mM; final target concentration: 80 µM. 
• EDTA solution: 0.1 mM. final target concentration: 10 mM. 
• ZiPD stock solution: 100 µM; 25 µM final concentration. 
• Penicillinase type III solution: 32 U/mL; 0.4 U/well. 
• Antarctic phosphatase: 5000 U/mL; 500 U/well. 
• Aryl-sulfatase type VIII: 800 U/mL; 40 U/well. 
• Esterase: 8 U/mL; 0.1 U/well. 
• Nitrocefin (final concentration of 100 µM): 
o Add 2 mg Nitrocefin to 200 µL DMSO 
o Take 100 µL and add 1.9 mL buffer pH 7.2 
o Take the remaining 100 µL and add 1.9 mL buffer pH 8.5 
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• bis-p-nitrophenyl phosphate: dissolve in buffer 10% DMSO to get a solution 
20mM; final concentration of 10 mM. 
• p-nitrophenyl phosphate: 100 mM; final concentration of 10 mM. 
• p-nitrochatecol sulfate: 100 mM; final concentration of 10 mM. 
• p-nitrophenyl sulfate: 100 mM; final concentration of 10 mM. 
• Glucose-3-sulfate: 100 mM; final concentration of 10 mM. 
• p-nitrophenyl acetate: 3.5 mM; final concentration of 350 µM. 
o Dissolve in methanol at a volume of 10% the desired one. Fill up with 
water. The final concentration we want in the well is 350 µM. 
• Final set up of the plates in a dark room. 
 
During these experiments 2 plates were set up. One plate was set to cover the lactamase, 
phosphatase and aryl-sulfatase activity and another testing the esterase activity (Fig. 11). 
N.B.: Glyoxalases II are the ETHE1 structurally closest enzymes known so far. The 
glyoxalases II reaction produces D-lactate and reduced glutathione (GSH) from S-D-
lactoyl-glutathione. The glyoxalase II reaction was not tested, because it was reported 
that ETHE1 doesn’t have such activity.[9] 
Fig. 11: Substrate screenings. 
A) The lactamase, phosphatase and aryl-sulfatase activity are tested at 2 different pHs. B) The esterase activity is tested (pH 8.0). 
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2.4.13 Small Angle X-ray Scattering 
SAXS can supply structural information of macromolecules between 5 and 25 nm, or up 
to 150 nm for highly ordered repetitive systems.[80] SAXS is used for the determination 
of the microscale or nanoscale structure of particle systems in terms of averaged particle 
sizes, shapes, distribution, and surface-to-volume ratio. SAXS is a small-angle scattering 
(SAS) technique. The elastic scattering of X-rays (with a wavelength of about 0.1-0.2 
nm) is collected at low angles (~ 0.1-10°). This angular range contains information about 
the shape and size of macromolecules, characteristic distances and more. The materials 
can be solid or liquid. The method is accurate and in principle non-destructive, but 
radiation damage can always occur and affect the sample under measurement. 
 
Material 
The data were collected at the EMBL beamline X33 of the storage ring DORIS III 
(DESY, Hamburg, Germany). See Appendix A for details. 
 
Procedure 
• Prepare protein samples at different concentrations: 
o E.g: 1, 2, 3, 5 mg/mL 
o I carried out experiments on olo-HsETHE1 and apo-HsETHE1 in the 
presence and absence of the reducing agent TCEP. 
• Collect the data at 10°C. 
• The data are normalized to the intensity of the transmitted beam and radially 
averaged; the scattering of the buﬀer is subtracted and the curves are scaled for 
protein concentration. The low angle data measured at lower protein 
concentrations were extrapolated to infinite dilution and merged with the higher 
concentration data to yield the final composite scattering curves. 
• Data processing: using the program package PRIMUS.[81] 
• The forward scattering I(0) and the radius of gyration Rg are evaluated using the 
Guinier approximation and assuming that at very small angle (s < 1.3/Rg) the 
intensity is represented as I(s) = I(0) exp(-(sRg)2/3). 
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• The molecular mass (MM) of the solute is evaluated by comparison of the 
forward scattering with that from reference solution of bovine serum albumin 
(MM = 66 kDa). The excluded volume of the hydrated particle was computed 
from the small angle portion of the data (s<0.25 Å -1) using the equation:[1] 
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• Distance distribution function p(r): the distance distribution function p(r) gives 
the relative number of distances of two points inside the particle as a function of 
the distance r. It is obtained from the intensity I(q) as: 
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The limits of integration are from 0 to , which means that in practice the 
experimental intensity has to be extrapolated to q=0. 
 
Ab initio shape determination 
The “shape scattering” curve was further used to generate the low resolution ab initio 
shapes of HsETHE1 by the programs DAMMIN[82] and DAMMIF.[83] Both programs 
represent the particle shape by an assembly of densely packed beads and employ 
simulated annealing to construct a compact interconnected model fitting the 
experimental data Iexp(s) by minimizing the discrepancy between experimental and 
simulated spectra:  
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N is the number of experimental points, c is a scaling factor and Icalc(s) and σ(sj) are the 
calculated intensity and the experimental error at the momentum transfer sj, respectively. 
A dozen DAMMIN and DAMMIF runs were performed to check the stability of solution. 
These models were averaged to determine common structural features using the 
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programs DAMAVER[84] and 
SUPCOMB[85]. The latter program 
aligns two arbitrary low or high 
resolution models represented by 
ensembles of points by minimizing a 
dissimilarity measure called normalized 
spatial discrepancy (NSD). The program DAMAVER generates the average model of 
the set of superimposed structures and also specifies the most typical model. 
2.4.14 X-ray Absorption Spectroscopy (XAS) 
The general aspects of XAS are discussed in paragraph 1.2. 
2.4.14.1 Synchrotron beamlines 
XAS experiments were carried out at the following beamlines: 
• E4 (DORIS III, EMBL, DESY, Hamburg, Germany) 
• C1 (DORIS III, EMBL, DESY, Hamburg, Germany) 
• D2 (DORIS III, EMBL, DESY, Hamburg, Germany) 
• SuperXAS (SLS, Villigen, Swiss) 
• ID26 (ESRF, Grenoble, France) 
• BM 7-3 (SSRL, SLAC National Accelerator Laboratory, California, U.S.A) 
See Appendix A for details about the beamlines. 
2.4.14.2 XAS measurements 
Experiments were carried out in absorption or in fluorescence mode. When measuring in 
fluorescence the sample holder has been kept typically at 45°C respect the source and 
the detector. The samples were kept constantly at liquid nitrogen (LN) temperature 
(77°K) in the proper sample holders (Fig. 12). They had biological (proteins) or 
synthetic (bioinorganic metallo-complexes) origin. The proteins had a concentration 
ranging from 0.5 to 3 mM and often the protein solution contained glycerol in a 
percentage within 0 and 30%. Glycerol has been used as cryoprotectant and to increase 
 
Fig. 12: EXAFS sample holder design. 
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homodispersity. The bioinorganic compounds were or lyophilized or in solution with a 
concentration always higher than 1 mM. Every sample underwent to multiple scans. The 
number of scans depended on the obtained signal to noise ratio, which depends on the 
sample concentration. The number of scans ranges typically from 2 to 15. The duration 
of each scan varied from 20` to 2 h. The scans start from about 150 eV before the 
absorption edge to energies about 400 eV (k = 10 Å-1) to 1650 eV (K = 20 Å-1) above 
the edge. 
2.4.14.3 Data processing (background removal, data reduction, 
normalization) 
Data reduction and normalization was carried out using the program KEMP[41] or the 
program KEMP2,[86] under constant development by Dr. Gerd Wellenreuther. 
The spectra were evaluated for radiation damage. 
The general procedure has been the following: 
• Evaluation of the quality of the spectra and of potential radiation damage. 
• Select good spectra. 
• Average spectra. 
• Background subtraction. 
• Deglitching. 
• Spline determination. 
• Normalization. 
• K space determination (wave number against EXAFS amplitude). 
2.4.14.4 EXAFS analysis 
The EXAFS data analysis has been performed with the programs Excurve98[44] and 
occasionally ATHENA for spectra analysis and smoothing.[45] 
The data were analyzed in the K3 weighted space and the relative FT space. Excurve98 
has been used to minimize the R-factor and Fit-Index (FI) functions. 
The R-factor gives a quality of the fit of the EXAFS data in K-space: 
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( )( )∑ −= Ni thiiiEXAFS xkR %1001 exp χχσ  
 
The Fit-Index is an absolute index of goodness of fit: 
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The minimization of these functions provides theoretical spectra fitting the experimental 
ones. These models are calculated starting from a number of variable parameters given 
to the program as input for the minimization calculation. When the best, meaningful 
model has been obtained the refined parameters represent our analysis results. The 
parameters are: 
• Number of ligands 
• Type of ligand 
• Distance from the absorber 
• Debye-Waller factors (disorder factors) 
• Geometric parameters 
Another important information can be extracted from the EXAFS parameters obtained 
from analysis: the Bond Valence Sum (BVS).[87-90] The BVS is an empirical approach 
developed by I. D.  Brown for analysis of the crystal structures of solids.[91,92]. The 
assumption is that the BVS surrounding an atom or ion is equal to its oxidation state. 
 
∑=
i
ijj sz  
 
Zj is the oxidation state of the target ion and sij is the BVS. 
The valences of the individual bonds can be calculated from the observed bond lengths. 
 
( )[ ]brRs ijij /exp 0 −=  
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( ) Nijij Rrs −= 0/  
 
rij is the observed bond length, R0 and N are constants that are dependent upon the 
nature of the ij pair, and b is usually taken to be 0.37. The R0 value can be viewed as a 
bond length of unit valence. The usual procedure was to assume an oxidation state and 
to use a previously determined R0 value appropriate to the bond being considered. 
2.4.14.5 XANES analysis 
XANES analysis were carried out with the program XinXAS[43]. The program has been 
used for pre-edge peak area calculation and qualitative ab initio XANES spectra 
evaluation. The exact edge position and derivatives were calculated with the program 
KaleidaGraph 4.0 (Synergy Software). 
2.4.14.6 XANES simulations 
The XANES simulations were performed exploiting the FEFF software.[93]. FEFF is 
supplied with an input file containing the geometrical coordinates of all atoms 
considered in the ligands shells. The coordinates came from the available PDB structures 
or from the EXAFS parameter files derived from 3D-structure-based EXAFS 
refinements. The program was used to calculate the theoretical spectra and the Local 
Density Of States (LDOS: describes the space-resolved number of states at each energy 
level that are available to be occupied. A high DOS at a specific energy level means that 
there are many states available for occupation. A DOS of zero means that no states can 
be occupied at that energy level). Outputs evaluation were carried out with the programs 
KaleidaGraph 4.0 (Synergy Software) and ATHENA.[45] 
2.4.15 Electron Paramagnetic Resonance (EPR) spectroscopy 
Electron paramagnetic resonance (EPR) spectroscopy is a technique for studying 
chemical species with one or more unpaired electrons.[94] In biology is frequently used 
to investigate paramagnetic transition-metals in proteins. The basic physical concepts of 
EPR are based on electron-spin excitations. Because most stable molecules have all their 
Materials and methods 
_______________________________________________________________________ 
79 
electrons paired, the EPR technique restricted to paramagnetic species. However, this 
limitation also means that the EPR technique possesses great specificity, since ordinary 
chemical solvents and matrices do not give rise to EPR spectra. 
The degeneracy of the electron spin states is lifted when an unpaired electron is placed 
in a magnetic field, creating two spin states, ms = ± ½, where ms = - ½, the lower energy 
state, is aligned with the magnetic field. The spin state on the electron can flip when 
electromagnetic radiation is applied. In the case of electron spin transitions, this 
corresponds to radiation in the microwave range. 
 
The energy difference between the two spin states is given by the equation 
 
BghEEE βν ==−=Δ −+  
 
where h is Planck’s constant (6.626 x 10-34 J s-1), v is the frequency of radiation, ß is 
the Bohr magneton (9.274 x 10-24 J T-1), B is the strength of the magnetic field in Tesla, 
and g is known as the g-factor.  The g-factor is a unitless measurement of the intrinsic 
magnetic moment of the electron, and its value for a free electron is 2.0023.  The value 
of g can vary, however, and can be calculated by rearrangement of the above equation, 
i.e., 
 
B
hg βν=  
 
using the magnetic field and the frequency of the spectrometer. Since h, v, and ß should 
not change during an experiment, g values decrease as B increases. The concept of g can 
be roughly equated to that of chemical shift in NMR. 
 
Materials and methods for EPR 
HsETHE1 has been dialyzed o/n against 5 L of HEPES 50 mM, NaCl 100 mM, TCEP 
1mM, pH 8.0. The protein solution used was 50 µL 1mM. 
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X-Band EPR spectra were recorded on a Bruker ELEXSYS E500 spectrometer equipped 
with the Bruker standard cavity (ER4102ST) and a helium flow cryostat (Oxford 
Instruments ESR 910). Microwave frequencies were calibrated with a Hewlett-Packard 
frequency counter (HP5352B), and the field control was calibrated with a Bruker NMR 
field probe (ER035M). Spin quantification was accomplished by double integration of 
the experimental derivative spectra and comparison with an iron standard. Only linear 
corrections were invoked for adjustments of the experimental baseline. 
2.4.16 Mössbauer spectroscopy 
In 1957 Rudolf Mossbauer achieved the first experimental observation of the resonant 
absorption and recoil-free emission of nuclear γ-rays in solids during his graduate work 
at the Institute for Physics of the Max Planck Institute for Medical Research in 
Heidelberg Germany.[95] The Mossbauer effect can be described very simply by 
looking at the energy involved in the absorption or emission of a γ-ray from a nucleus. 
When a free nucleus absorbs or emits a γ-ray to conserve momentum the nucleus must 
recoil, so in terms of energy: 
 
recoilnsitionnucleartraray EEE −=−γ  
 
When in a solid matrix the recoil energy goes to zero because the effective mass of the 
nucleus is very large, the momentum can be conserved with negligible movement of the 
nucleus. So, for nuclei in a solid matrix: 
 
nsitionnucleartraray EE −γ  
 
This is the Mossbauer effect, which results in the resonant absorption/emission of γ-rays 
and gives us a means to probe the hyperfine interactions of an atoms nucleus and its 
surroundings. A Mossbauer spectrometer system consists of a γ-ray source that is 
oscillated toward and away from the sample by a “Mossbauer drive”, a collimator to 
filter the γ-rays, the sample, and a detector.  The primary characteristics looked at in 
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Mossbauer spectra are isomer shift (IS), quadrupole splitting (QS), and magnetic 
splitting (MS or hyperfine splitting). These characteristics are effects caused by 
interactions of the absorbing nucleus with its environment. Isomer shift is due to slightly 
different nuclear energy levels in the source and absorber due to differences in the s-
electron environment of the source and absorber. The oxidation state of an absorber 
nucleus is one characteristic that can be determined by the IS of a spectra. For example 
due to greater d electron screening Fe2+ has less s-electron density than Fe3+ at its 
nucleus which results in a greater positive IS for Fe2+. For absorbers with nuclear 
angular momentum quantum number I > ½ the non-spherical charge distribution results 
in quadrupole splitting of the energy states. For example Fe with a transition from I=1/2 
to 3/2 will exhibit doublets of individual peaks in the Mossbauer spectra due to 
quadrupole splitting of the nuclear states. In the presence of a magnetic field the 
interaction between the nuclear spin moments with the magnetic field removes all the 
degeneracy of the energy levels resulting in the splitting of energy levels with nuclear 
spin I in 2I + 1 sublevels.  
 
Materials and methods for Mössbauer spectroscopy 
For preparation of the Mössbauer sample, metallic 57Fe (Chemotrade, 96% enrichment) 
was dissolved in 75% (v/v) HCl and 25% methanol (used as proton exchanger) at 75ºC 
o/n under shaking.. The obtained 57FeCl3 solution concentration was determined from 
the difference in weight of the metal bar before and after treatment. The obtained 
solution was diluted till a concentration of 100 mM. The solution was directly added to 
the cell culture medium to a final concentration of 100 μM. 57Fe-HsETHE1 has been 
dialyzed o/n against 5 L of HEPES 50 mM, NaCl 100 mM, TCEP 1mM, pH 8.0. The 
protein solution used was 500 µL 1mM. 
Mössbauer spectra were recorded with alternating constant acceleration. The minimum 
experimental line width of the spectrometer was 0.24 mm s-1 (full width at half-height). 
The sample temperature was kept constant either in an Oxford Instruments Variox or in 
an Oxford Instruments Mössbauer-Spectromag cryostat. The latter is a split-pair 
superconducting magnet system for applied fields of up to 8 T, where the temperature of 
the sample can be varied in the range of 1.5-250 K. The field at the sample is 
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perpendicular to the γ-beam. The 57Co/ Rh source (1.8 GBq) was positioned at room 
temperature inside the gap of the magnet system at a zero-field position. Isomer shifts 
are quoted relative to iron metal at 300 K. 
2.4.17 Molecular visualization tools 
The following programs have been used for molecular visualization, structural analysis 
and molecular building: PyMol (v. 2.r1; http://www.pymol.org/), DS Visualizer (v. 2.5; 
http://accelrys.com, RasMol (v. 2.7; http://rasmol.org), Spdbv (v. 4.0; http://spdbv.vital-
it.ch), UCSF Chimera[96] (v. 1.4; http://www.cgl.ucsf.edu/chimera/), VMD (v. 1.8; 
http://www.ks.uiuc.edu/Research/vmd). 
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3 Results 
This chapter is devoted to the results obtained about the biochemical and biophysical 
characterization of HsETHE1 and about the XAS characterization of highly interesting 
bioinorganic compounds and metallo-proteins, such as [Cu2L2(μ-O)2]I2, the mononuclear 
[Fe]-hydrogenases Hmd and the [Fe-S]-cluster dependent ATP binding cassette protein 
ABCE1. 
3.1 Biochemical and biophysical characterization of 
Homo sapiens ETHE1 
Broaden our knowledge about HsETHE1 could lead to defeat the devastating, infantile, 
metabolic disorder known as ethylmalonic encephalopathy and to fight a common form 
of liver cancer (HCC). 
3.1.1 Cloning 
Several construct have been created starting from the wild type full length sequence of 
HsETHE1. Different cloning techniques have been used (see par. 2.1.2.5) and the LIC 
protocol was the more efficient method. In Fig. 13 there is an example of an agarose gel 
showing the run of two pETM vectors and HsETHE1 pPCRps. 
The following constructs have been created as discussed in par. 2.1: 
wt-HsETHE1_pETM11; Δ14-HsETHE1_pETM11; Δ24-HsETHE1_pETM11; 
wt-HsETHE1_pETM13; Δ14-HsETHE1_pETM13; Δ24-HsETHE1_pETM13; 
Δ14-HsETHE1-Δ4_pETM-11_LIC; Δ19-HsETHE1-Δ4_pETM-11_LIC; 
Δ19-HsETHE1-Δ4_pETM-20_LIC; 
Δ7-HsETHE1-Δ4_pETM-11_LIC; 
MutA-HsETHE1_pETM-11_LIC; 
MutB-HsETHE1_pETM-11_LIC; 
MutC-HsETHE1_pETM-11_LIC; 
MutD-HsETHE1_pETM-11_LIC. 
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The constructs have been used to transform the 
following cell lines: 
 
Plasmid propagation cell lines 
DH5α, Top10, Solopack, Nova Blue. 
 
Protein expression cell lines 
BL21(DE3), BL21(DE3)-pLys, BL21(DE3)-Star, 
BL21(DE3)-Rosetta, BL21(DE3)-RIL, Origami. 
The BL21(DE3) cell line is the used for most of 
the constructs overexpression. 
3.1.2 Expression and purification 
• Tests were carried to check for the protein 
expression level and its localization, favoring the constructs resulting in the 
expression of the protein within the soluble fraction (Tab. 1). The addition of 
Fe(II)(NH4)2SO4 to the cultures increased significantly the quantity of cells and 
protein without affecting its ratio in the soluble fraction. 
Eventually, the constructs: 
• Δ14-HsETHE1_pETM11 
• Δ14-HsETHE1-Δ4_pETM-11_LI 
• Δ7-HsETHE1-Δ4_pETM-11_LIC 
• MutA-HsETHE1_pETM-11_LIC 
• MutB-HsETHE1_pETM-11_LIC 
• MutC-HsETHE1_pETM-11_LIC 
were used to follow up with the purification. 
 
As isolate HsETHE1-constructs purification 
Fig. 13: Agarose gel of HsETHE1 and 
plasmid vectors DNA. 
Agarose gel showing the DNA of the vectors 
pETM-13 (first lane), pETM-11 (second lane), 
and PCR reaction products from the 
amplification of HsETHE1 (lanes 5-7). 
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The protein constructs have been expressed in ultra rich auto-inducing media for ~23h at 
25°C, until an OD600 greater than 10. The harvested cells were centrifuged and the 
obtained pellet has been resuspended in TrisHCl 50 mM, NaCl 200 mM, imidazole 20 
mM, pH 8.0, and sonicated for the cell lysis. The lysate was immediately 
ultracentrifuged and the surnatant (soluble fraction) collected and filtered through a 0.22 
µm cut-off membrane. SDS-PAGE showed the protein levels before induction, after 
 Expression Soluble frac. 1st Pur. 
IMAC 
2nd Pur. 
TEV 
3rd Pur 
SEC 
wtE-his6 ? × 
   
∆14E-his6 ? 1/2 ? ? ? 
∆24E-his6 ? 1/4 
   
wtE ? × 
   
∆14E ? 1/2 
   
∆24E ? × 
  
? 
Δ14EΔ4-his6 ? 3/4 ? ? 
 
Δ19EΔ4-his6 ? 1/4 
   
Δ19EΔ4-trx-his6 ? 1/4 
   
∆7EΔ4-his6 ? 1/2 ? ? ? 
MutA: 
[E206A,E207A, 
E208A]_∆7EΔ4-his6 
? 1/2 ? ? ? 
MutB: 
[E206A,E207A, 
E208A,E44A]_∆7EΔ4-his6 
? 1/2 ? ? ? 
MutC 
[E206A,E207A, 
E208A,K66A,E67A]_ ]_∆7
EΔ4-his6 
? 1/2 ? ? ? 
MutD 
[E24A,K66A,E67A]_Δ7Hs
EΔ4-his6 
? 1/2 ? ? ? 
Tab. 1: HsETHE1 constructs.  
All proteins were expressed in the selected cell lines. The protein fraction  that has been found  in the soluble fraction, and which 
steps of purification were performed (1st Pur.: immobilized metal affinity chromatography; 2nd Pur.: purification from TEV, 
uncleaved protein and cleaved tags; 3rd Pur.: size exclusion chromatography). 
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induction, in the unsoluble fraction, in the soluble fraction and in the flow through (FT) 
of the surnatant loaded onto the IMAC column (Fig. 14). Successively, the surnatant 
underwent through an IMAC purification step and the main absorption (A280) peak was 
tested by SDS-PAGE as well (Fig. 14). Usually, the protein yield was > 100 mg/L 
culture and the column got saturated. This resulted in the oversaturation of the UV280 
signal of the purifier internal spectrophotometer. Under saturating conditions the protein 
eluted from the column typically had higher purity. Afterwards, the protein fractions 
corresponding to the main peak were pulled together and the HsETHE1-construct was 
incubated o/n with TEV protease at Ta for the cleavage of the his6-tag (Fig. 15). The day 
after, the protein solution has been diluted 10 times and loaded on another IMAC 
column to separate the HsETHE1 construct from the TEV (endowed with a his6-tag 
itself) and from the cleaved tags. The so obtained protein solution was concentrated to 
 
Fig. 14: HsETHE1 IMAC 
First step of purification: IMAC chromatogram and  SDS-PAGEs. In the chromatogram, the main peak shows the oversaturation of 
the UV280 signal due to the abundance of the protein. The upper gel picture shows the cell lysate fraction before induction (Pre), the 
cell fraction after expression (Post), the unsoluble (Uns) and the soluble (Sol) fractions after sonication and ultracentrifugation, and 
the flow through (FT) of the soluble fraction loaded into the IMAC column. The gel in the bottom shows the IMAC main peak 
fractions. 
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~10 mg/mL and loaded onto a SEC column for the 
separation from remaining impurities and for 
buffer exchange. The protein elutes between 57 
and 70 mL using the Superdex 75 column and 
between 73 and 90 mL using the Superdex 200 
column. The protein fractions were checked by 
SDS-PAGE and the pure ones (purity > 98%) have 
been collected giving pure HsETHE1-constructs 
(Fig. 16) in TrisHCl or HEPES 20 or 50 mM, NaCl 
100 mM, TCEP 1 mM pH8.0. 
 
Metal-free HsETHE1 purification 
I developed a reproducible and robust protocol to 
obtain high quality apo-protein. This was a 
fundamental requirement for metal titration 
experiments by ITC. I initially tried the metal stripping with different concentration of 
EDTA (bivalent cations chelator), phenanthroline (chromogenic iron chelator, which 
appears red if the bound to Fe2+ and blue if bound to Fe3+) and deferoxamine mesylate 
(specific iron-ion chelator). These compounds alone were not capable to withdraw the 
metal from the protein. I tried the same procedure in the presence of different 
concentration of urea. Eventually, an o/n incubation of the protein in 2M urea and 
50mM of deferoxamine and subsequent extensive multiple dialysis with metal free 
buffer yielded metal-free HsETHE1, as shown by TXRF (see par. 3.1.7).  
3.1.3 Protein stability 
For protein stability we can refer both to the tendency to form aggregates, precipitates or 
degradation products.  HsETHE1 had never shown degradation products. Within this 
paragraph, each time I refer to the stability of the protein, I refer to its tendency to form 
large aggregates inclined to precipitation.   
HsETHE1 possesses 9 cysteine residues and none is thought to be involved in inter-
molecule or intra-molecules disulfide bridges. Therefore, the addition of a reducing 
Fig. 15: HsETHE1 TEV cleavage. 
Second step of purification: SDS-PAGE of 
HsETHE1+his6-tag prior and after TEV protease 
cleavage of the tag. The white lines show the 
different running fronts of the not cleaved (left) 
and cleaved forms (right). 
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agent keeping the protein sulfurs in reduced state is mandatory in order to obtain stable 
protein solution. When DTT was added to a HsETHE1 solution the protein partially 
precipitated. I repeated the experiment adding DTT under N2 flux and this time the 
protein solution, initially turned darkish and after some hours lost its color and the 
protein precipitated (Fig. 17 A, B). This suggested that the mercapto-based reducing 
compounds (R-SH) could have an effect on the iron-bound active site of the protein and 
that oxygen may be involved. The UV-Vis spectra of the protein in the absence and in 
the presence of DTT revealed that the absorption profile is changing in the whole region 
from 250 to 550 nm, especially at 300 and 450 nm, which can be an indication of metal-
sulfur charge transfer (Fig. 17 D).[97,98] 
Besides, I tested a variety of reducing agents, including β-mercaptoethanol, DTT, 
dithionite (not mercapto-based compound) and TCEP. The solutions were analyzed for 
aggregation by an optical microscope. The results showed clearly that β-
mercaptoethanol and in particular DTT have a deleterious effect on the stability of the 
 
Fig. 16: HsETHE1 SEC. 
Third step of purification: the picture shows a SEC chromatogram of HsETHE1 obtained with a Superdex200 1660 column and the 
SDS-PAGE of the eluted fractions. The main peak corresponds to the protein elution peak and is highlighted by a red oval. A red 
line is marking the protein elution volume (centered at 82 mL). The SDS-PAGE shows a sample of the protein solution before 
loading onto the column (Load) and the eluted fraction corresponding to the protein peak. 
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protein, which started to aggregate and 
form a precipitate after centrifugation 
(Fig. 17 C). Such effect was not 
detectable when dithionite or TCEP 
were used. Considering the efficiency 
and stability of TCEP, this compound 
has been selected as standard reducing 
agent for this work on HsETHE1. 
In order to look for an optimal 
condition for protein storage, the 
stability of HsETHE1 at different 
temperatures had been checked: Ta, 4, -
20 and -80°C. Samples of protein were 
left for one month at different 
temperatures and the protein was 
checked for precipitation at defined 
intervals of time: after 1 day, 2 days, a 
week, 2 weeks, 3 weeks and 1 month. 
• Ta: stable for 2 days-1 week. 
• 4°C: stable for 1-2 weeks. 
• -20°C: totally unstable. The protein precipitates immediately if frozen at -20°C 
and quickly thawed. 
• -80°C: The protein is quite stable. Little precipitation (5%) is found after thawing, 
independently from the time spent at this temperature. 
To optimize the storage at -80°C, glycerol had been added to the protein solution, which 
was quickly frozen in LN and stored at -80°C. This procedure prevented any kind of 
precipitation. Glycerol in a concentration of about 5/10% is enough for the protein 
stabilization. Thereby, the optimal condition for HsETHE1 storage is at -80°C, after a 
quick freeze in LN in the presence of 10% glycerol. 
I looked also for the best buffer able to enhance the stability of HsETHE1 in solution. 
 
Fig. 17: reducing agents test. 
Influence of reducing agents on HsETHE1. A) Addition of DTT 
50 mM to a 5 mg/mL HsETHE1 solution under N2 flux. The 
solution turns darkish. B) The same protein solution of A after o/n 
incubation. The color is lost and the protein is fully precipitated. 
C) Protein solution after incubation with different reducing agents. 
Protein precipitation is visible for the solutions enriched with β-
mercaptoethanol and particularly with DTT. D) UV-Vis spectra of 
a HsETHE1 solution without reducing agents (upper) and with 20 
mM DTT (lower).  
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For this purpose, a thermofluor machine has been used, testing 96 conditions. The 
experiment showed that TrisHCL and HEPES based buffers where optimal for the 
stability of the protein. The pH effect is more consistent. The protein prefers pHs from 4 
to 5 and from 7 to 9, which is consistent with the isoelectric point of most of the used 
protein constructs that is about 6.0. During all preparations and experiments, HEPES or 
TrisHCl based buffers at the pH of 8.0, with the addition of NaCl 100/200 mM and 
TCEP 1mM, have been used. 
3.1.4 Oligomeric state and exact mass determination 
The oligomeric state and the exact Molecular Mass (MM) of HsETHE1 have been 
determined by SLS, crosslinking and MS. 
3.1.4.1 Crosslinking experiment 
Crosslinking experiments carried out with UV-A light and with a chemical crosslinker 
showed clearly that HsETHE1 is present in solution as a dimer (otherwise, would have 
been unlikely to detect the dimer formation in denaturing conditions). In fact, the protein 
ran mainly as monomer and dimer during SDS-PAGE (Fig. 18). 
3.1.4.2 Static Light Scattering (SLS) 
SLS showed us that the protein is prompt to aggregate if not kept under optimal 
conditions. In fact, to carry out a successful SLS experiment the protein must be freshly 
 
Fig. 18: SDS-PAGE of the cross-linking experiment samples. 
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prepared or optimally conserved and fresh TCEP must be present in the buffer. SLS 
revealed that the protein in solution is a homodimer, in similarity with AtETHE1.[13] 
Moreover, SLS estimated the molecular mass of the dimer to be 52.8 kDa (Fig. 19). 
3.1.4.3 Mass Spectrometry (MS) 
MS performed on the native protein provided interesting quantitative information about 
the monomer and dimer molecular mass and qualitative information about the strength 
of the homodimeric interaction. MS determined a molecular mass for the monomer of 
26.7 kDa and it was also able to detect and determine the mass of the dimer of 53.4 kDa 
(Fig. 20). The detection of the ETHE1 dimer under MS conditions suggests that the 
interaction between the subunits is strong. 
 
Fig. 19: SLS spectrum of HsETHE1. 
The blue line represents the UV280 signal corresponding to the chromatographic protein peak. The blue spots represent the 
scattering signal deriving from the protein. Between the line and the spots, a table shows the parameter values resulting from the 
data analysis. The red circle is highlighting the molecular mass found for HsETHE1 in solution: 52.8 kDa, corresponding to a 
dimer. 
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The overall results of the SLS, crosslinking and MS experiments demonstrated that 
HsETHE1 is a homodimer in solution with a molecular mass of 53.1 kDa (average 
between the MM calculated with SLS and MS). The expected MM predicted by 
ProtParam (www.expasy.org) was of 53 kDa. 
3.1.5 Substrate screening 
The β-lactamase, phosphatase, and arylsulfatase activities were tested in one experiment 
using the following potential substrates: nitrocefin (β-lactam), bis(p-
nitrophenyl)phosphate, p-nitrocatechol sulfate and p-nitrophenyl sulfate. Nitrocefin turns 
from yellow to red/dark red (max absorption at 486 nm) upon hydrolysis. Anyhow, 
under standard conditions, due to its sensitivity to light and different pHs, it can turn 
orange over time because of spontaneous hydrolysis (Fig. 21, column 1). The other 
compound solutions turn from colorless to yellow/orange or from light-yellow to 
yellow/orange (p-nitrocatechol sulfate), with maximum of absorption at 405 nm upon 
hydrolysis. The protein used was HsETHE1 as isolated, the apo-form with addition of 
iron and the apo-form in presence of EDTA. The negative controls were carried out 
Fig. 20: Mass spectrometry spectrum of HsETHE1 as isolated. 
The spectrum shows the peaks corresponding to the monomer (26.7 kDa) and the dimer (53.4 kDa) ofHsETHE1. 
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using the substrates with no enzymes and glucose-3-sulfate, which is not a substrate of 
any used enzyme. For the positive controls I used: penicillinase type III, alacaline 
phosphatase and sulfatase type VIII, all commercially available. Also the zinc 
phosphodiesterase ZiPD was used. ZiPD is a MβL-like protein, thereby it is structurally 
related to ETHE1. ZiPD is able to hydrolyze bis(p-nitrophenyl)phosphate.[99] The 
activity was tested at pH 8.5 (tris buffer) and 7.2 (phosphate buffer), corresponding to 
the mean physiological values, respectively found in the mitochondrial matrix[79] and in 
the cytoplasm[78] of human cells. The results show a mild detectable β-lactamase 
activity for the apo-HsETHE1+iron, but not for the protein as isolated (Fig. 21). A 
similar β-lactamase activity is present for ZiPD. Further experiments showed that the 
hydrolysis of nitrocefin cannot be addressed to the protein (data not shown). Thus, no 
significant β-lactamase, phosphatase, arylsulfatase and sulfatase activities were detected. 
Besides, I probed the esterase activity using p-nitrophenyl acetate. The reaction can be 
followed by the change in color from colorless to yellow upon hydrolysis. As negative 
controls, I used the substrate with no enzyme and simple buffer with no substrate and no 
enzyme. The positive control consisted of substrate incubated with a commercially 
available esterase. The results show esterase activity for apo-HsETHE1+iron (Fig. 22). 
 
Fig. 21: Results of a substrate screening test. 
Substrate screening carried out to test the lactamase, phosphatase and aryl-sulfatase activity of HsETHE1. On the left there is a 
schematic representation of the experiment shown on the right. On the bottom right, a legend for the interpretation of the results is 
given (from 0 to 100% activity). The experiment has been carried at two pHs. The results for the two different pHs are 
complementary, except for Nitrocefin (columns 1 and 7), where the pH-sensitivity is reflected in the spontaneous hydrolysis 
observed at pH 8.5. The results show a mild activity for apo-HsETHE1 in the presence of 2 molar excess of ammonium iron sulfate. 
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Further experiments proved that the 
hydrolysis was due to the presence of 
free iron-ions in solution, which acted as 
catalyst for the hydrolysis. 
It is worth to notice that HsETHE1 is 
structurally very similar to the 
glyoxalase ΙΙ enzymes, which are able to 
hydrolyze S-(2-hydroxyacyl)-
glutathione to glutathione and 2-
hydroxy-carboxylate. The glyoxalase II 
activity was not probed because it was 
already tested with negative results.[9] 
3.1.6 UV-Vis and the 
interaction with reduced 
glutathione 
The UV-Vis spectrum of HsETHE1 has been recorded looking for signature features. No 
particular feature characterizes the HsETHE1 UV-Vis spectrum (Fig. 23 A). 
During experiments aimed to test spectrophotometrically the sulfur dioxygenase activity 
of HsETHE1 independently from oxygen consumption measurements, I found an 
unexpected color change. The protein became blue upon addition of the following 
reaction mixture: 
 
 
 
The products are GSSH and GSH, which correspond to the substrate of HsETHE1 and to 
one of the products of the protein reaction, respectively. Batch experiments with 
individual components of reaction 2 revealed that the responsible for the color gaining 
was reduced glutathione (GSH). This is highly interesting because GSH may have a 
regulatory activity on the enzyme. HsETHE1 activity experiments indicate that GSH is 
GSSG + H2S → GSH + GSSH 
Fig. 22: Results of the esterase activity test. 
On the left it is shown a schematic representation of the 
experiment presented on the right. On the bottom left, a legend 
for the interpretation of the results is given (from 0 to 100% 
activity). The results showed a mild esterase activity for apo-
HsETHE1 in the presence of 4 molar excess of ammonium iron 
sulfate. Further experiments (data not shown) proved that the 
hydrolysis is due to free-iron in solution. 
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unlikely to have inhibitory effect on the 
enzyme.[11] In fact, excess of GSH is 
used in these experiments in order to 
produce the substrate GSSH. 
To further investigate the interaction 
between the protein and GSH, I 
performed UV-Vis and ITC 
experiments. The UV-Vis spectra 
showed an increase of the absorbance at 
325 and 600 nm for the sample 
protein+GSH that can be addressed only 
to an interaction between the two 
molecules (Fig. 23). Intriguingly, these 
absorption peaks are more intense and at 
higher wave-length than those observed 
for HsETHE1 in presence of DTT (see 
par. 3.1.3; Fig. 17) Similar absorption 
spectra are reported for oxy-hemocyanin 
(350 and 580nm), a binuclear-copper 
oxygen-carrying protein, that appears 
blue in the presence of oxygen[100] and 
for the Co2+-substituted β-lactamase 
from A. hydrophila.[28] 
3.1.7 Total X-ray Reflection 
Fluorescence (TXRF) 
TXRF has been applied to 
 
Fig. 23: HsETHE1 UV-Vis. 
This picture shows the UV-Vis spectra of HsETHE1 in solution. 
A) The same sample with the addition of reduced glutathione. B) 
An iron(II) solution with the addition of reduced glutathione. 
The solvent used is the protein buffer (C). Spectra A and B 
revealed that reduced glutathione has an effect on the protein 
UV-Vis spectra. This is particularly evident around 325 and 600 
nm. Spectrum C is used as control and confirmed that the effect 
is not due to the only presence of glutathione or the interaction 
of glutathione with iron. 
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• Check for metal contamination of the buffers. 
• Investigate the iron:protein ratio. 
• Check the quality of the protein preparations for XAS. 
• Check the quality of the apo-protein preparations. 
 
Tab. 2: TXRF results on the as isolated and metal-free HsETHE1. 
A) Example of TXRF analysis results for HsETHE1 as isolated (P30=protein; P30_B=buffer). B, C) Another example of TXRF 
analysis results for HsETHE1 as isolated. The results for the buffer (P15_B) are shown in B. The results for the protein (P15) are 
shown in C. D) Example of TXRF analysis results for the metal-free protein (Apo11F_B= buffer; Apo11F=protein). E) Another 
example of TXRF analysis results for the metal-free protein (Apo11_B=buffer; Apo10=protein). The protein concentration used in 
the experiments was of about 57 µM for the protein as isolated and 40 µM for the metal-free protein. The results in A show that the 
iron: protein ratio is 1:1, respect the protein –free buffer where the iron concentration approaches basal levels. The results in D and E 
show that the iron concentration in the protein-free buffer and in the apo-protein preparation is comparable. 
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TXRF showed that the buffers used were transition metals free, even when they were not 
treated with chelex. The iron:protein ratio has been always found to be of 1:1 (Tab. 2 A, 
B, C). Moreover, thanks to TXRF it has been possible to develop a robust and 
reproducible protocol for the apo-HsETHE1 production. This has been a necessary step 
in order to perform reliable ITC titration experiments (Tab. 2 D, E). Thereby, in terms of 
metal quantification, TXRF should be thought as powerful technique for standard 
quality check of protein preparations and solutions. 
3.1.8 Isothermal Titration Calorimetry (ITC) 
I carried out a large number of microcalorimetric experiments in order to determine the 
stoichiometry and the binding constants for different metals and reduced glutathione. 
3.1.8.1 Metal titration 
In these experiments HsETHE1 has been titrated with different metal solutions obtained 
using the very same protein buffer. The tested metals were Fe(II), Fe(III), Zn(II), Mn(II), 
Ni(II), Co(II). The ferrous solution consisted of ammonium iron sulfate in the presence 
of dithionite. The ferric solution was obtained mixing Fe(III)-citrate with NTA (Nitrilo 
Triacetic Acid) in a ratio 1:2, giving equilibrium to multiple species (Fe(III)-NTAn). In 
this case, we can observe the interaction only if the affinity of Fe(III) for HsETHE1 is 
higher than the affinity for NTA and thus the dissociation constant we would observe is 
not a measure of the real affinity of the protein for the metal free in solution, but lower. 
We refer to this dissociation constant as “observed dissociation constant” (Kobs). The 
other metal-titrating solutions consisted of zinc chloride, manganese chloride, nickel 
sulfate and cobalt chloride. In each case, the metals were resuspended and solubilized 
using the apo-protein dialysis buffer, which contained 1mM of the reducing agent TCEP, 
which is thought to don’t affect the oxidation state of the iron,[101] although this 
possibility cannot be excluded.[102] 
Achieving the best conditions for the experiments has not been straightforward. The 
main issues were: 
1. Difficulty to handle the metal solutions, especially Fe(II) and Fe(III). 
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2. Use the proper concentration of metal to avoid a dilution enthalpy affecting 
significantly the signal to noise ratio. 
3. Find a protocol that allows obtaining always the same amount and proper 
concentration of metal in the titrating solution (this is particularly a problem for 
the ferric solutions, due to its poor solubility). 
4. Get an optimized protein concentration on the basis of the metal one. The apo-
protein concentration should be low enough to allow the titration to reach the 
saturation point and not too low so that the signal is not lost. 
In order to solve these issues, I took advantage of a cooperative method coupling TXRF 
and ITC experiments. TXRF allowed the measurement of the metal amount in every 
solution used in the measurements. The experiments revealed that the protein interacts 
with the iron present in the Fe(III)-citrate-NTA(n) solution in a 1:1 stoichiometry (Kobs = 
1.65µM) and with Ni(II) in a 1:0.65 stoichiometry (Kd = 31.6µM) (Fig. 24 A, B). Thus, 
the affinity for Fe(III) is at least 20 times that for Ni(II). Moreover, no interaction is 
observed titrating with Fe2+, Zn2+, Mn2+ and Co2+ indicating a high specificity. The 
undetected interaction with Fe(II) was unexpected, because metal stripping experiments 
with phenanthroline, EPR and Mössbauer spectroscopy clearly detect the presence of 
iron(II). This can be explained from the fact that the iron(III) may turn to an iron(II) 
upon charge transfer from an anionic coordinating ligand such as aspartate and/or 
hydroxide (see par. 3.1.10.1). In this case, the metal reduction would be due to the high 
covalency of the metal/anionic-ligand bond. Commonly, the MβL proteins possess a 
comparable or lower metal affinity and lower specificity. For example the affinity of 
ETHE1 for iron is higher than the affinity that the ZiPD/tRNaseZ/ElaC1 
phosphodiesterase MβL proteins have for both their zinc binding sites (dissociation 
constant between 2 and 30 µM).[103] These proteins are also able to bind other metals 
such as nickel and manganese.  
3.1.8.2 Glutathione titration 
ITC titration experiments have been carried out to investigate the interaction of 
HsETHE1 with reduced glutathione. The ITC experiment shows a mild interaction 
HsETHE1/GSH (Fig. 24 C). The data were fitted considering a different number of 
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potential sets of sites. Here, I present the most reasonable fitting obtained using two sets 
of sites. The ratio GSH:protein for the first site is 1:1 with a Kd of 146 µM and 1:10 for 
the second set with a Kd. Unfortunately, these values must not be considered critical. 
The results indicate an interaction of the protein with GSH, but the data were not 
covering enough of the binding curve, thus preventing any precise quantification. Any 
further attempt to improve the data collection led to irreproducible and inconsistent 
results. 
3.1.9 Small Angle X-ray Scattering (SAXS) 
SAXS has been exploited to gain structural information about olo- and apo- HsETHE1 
in solution. 
3.1.9.1 SAXS on olo-HsETHE1 
SAXS have been applied to HsETHE1 at different concentrations (2, 5 mg/mL) in the 
absence and presence of the reducing agent TCEP. SAXS experiments showed that olo-
Fig. 24: Results of ITC experiments. 
A) Titration with Fe(III)-citrate-NTA(n). The iron:protein ratio is about 1:1 and the calculated Kobs from the Ka shown in the 
picture, is 1.65 µM. B) Titration with Ni(II)sulfate. The nickel:protein ratio is 0.65:1 and the Kd is 31.6 µM. C) Titration with 
reduced glutathione. The data were fitted with 1 and 2 sets of sites. Here is shown the more meaningful result with two set of 
sites. The GSH:protein ratio for the first site is about 1:1 and for the second is about 10:1. The dissociation constants are both of 
about 150 µM. The results in C must be considered only indicative of an interaction. In fact, it is not possible to rely on the 
calculated parameters because the curve comprises only the central part of a typical interaction curve. This is the reason why in C 
the errors are not given. Every attempt to optimize the experiment led to inconsistencies. 
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HsETHE1 forms large aggregates (70-250 kDa) in oxidizing conditions. When TCEP is 
added (1 mM), the solution becomes homodisperse by DLS. SAXS revealed that 
HsETHE1 possesses a radius of gyration of 2.5 nm (Tab. 3). The experimental spectrum 
of HsETHE1 has been fitted to the theoretical SAX spectra of AtETHE1 as monomer 
and dimer (extracted from PDB: 2GCU) (Fig. 25 A). The fitting is very good for the 
dimeric form till a momentum transfer of 0.25, indicating that HsETHE1 in solution is a 
dimer closely resembling AtETHE1. A bad fitting has been achieved when using 
monomeric AtETHE1. Nevertheless the calculated molecular mass (Tab. 03) is closer to 
the monomer. The wrong estimation of the molecular mass is assigned to a 
miscalculation of the exact protein concentration at the beginning of the experiments. 
The concentration should have been roughly twice the estimated one. Successively, a 
low resolution model of dimeric HsETHE1 has been build from the experimental data 
(Fig. 25 C). The protein results globular and high ordered. 
HsETHE1 
concentrations; TCEP 
concentration 
Rg, nm Porod 
volume, nm3 
MM(I0), kDa Nº of monomers 
fitting the low 
resolution models 
Olo 2 mg/mL; 1mM 2.5 ±   2% 73 ± 10% 29 ± 10% 2* 
Olo 5 mg/mL; 1mM 2.5 ±   3% 72 ± 10% 27 ± 10% 2* 
Apo 1 mg/mL; 1 mM 7.6 ± 26% 254 ± 10% 166 ± 10% 6± 1 
Apo 2 mg/mL; 1mM 8.8 ± 11% 531 ± 10% 231 ± 10% 9± 1 
Apo 3 mg/mL; 1mM 11.2 ±   8% 560 ± 10% 333 ± 10% 12± 1 
Apo 5 mg/mL; 1 mM 12.0 ± 10% 625 ± 10% 400 ± 10% 15± 1 
Apo 10 mg/mL; 1 mM 12.9 ± 10% 730 ± 10% 434 ± 10% 16± 1 
 
Tab. 3: HsETHE1 SAXS parameters. 
Parameters resulting from SAXS analysis on olo- and apo-HsETHE1 at various concentrations. In the first column, the 
concentrations of protein and TCEP used are given. The second column shows the radius of gyration found for the different 
species. The third column shows the Porod volume: excluded volume of the hydrated particle calculated from the Porod 
equation.[1] The fourth column s shows molecular mass estimated from the I0. The fifth column shows how many monomers 
can fit each oligomeric low resolution model. *: here the radius of gyration, the scattering curve and the low resolution model fit 
perfectly the dimeric HsETHE1. The wrong estimation of the molecular mass is assigned to a miscalculation of the exact protein 
concentration at the beginning of the experiments. The concentration should have been roughly twice the estimated one. 
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3.1.9.2 SAXS on apo-HsETHE1 
Pilot experiments have been performed using various concentrations of apo-protein (1, 3, 
5 mg/ml) and in the absence and presence of TCEP. SAXS reveals that apo-HsETHE1 
forms ~700 kDa aggregates under oxidizing conditions. When TCEP is added to the 
 
Fig. 25: Results of SAXS experiments. 
A) SAXS experimental spectrum of HsETHE1 (blue) compared to the theoretical spectrum of the AtETHE1 dimer (red). S, the 
momentum transfer, is expressed in Å-1. I  is the intensity of the signal. B) Comparison between the experimental spectrum of 
HsETHE1 and the spectra of apo-HsETHE1 at two different concentrations (1, 2 mg/ml). C) Low resolution model of 
HsETHE1. The dimeric structure of AtETHE1 has been fitted inside. D) Plot of the molecular mass of the apo-species against 
the protein concentration. E) Comparison between hexameric (1 mg/ml) and nonameric (2 mg/ml) rigid body refinement 
models of apo-HsETHE1. F) Example of apo-HsETHE1 low resolution model at 2 mg/ml. Inside, a rigid body refinement 
model of nonameric  AtETHE1 have been fitted. 
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solution, these aggregates broke down and the apo-protein results in a lower molecular 
weight homodisperse solution shown by DLS. Successively, a second round of 
experiments has been carried out on apo-HsETHE1 in the presence of TCEP at the 
protein concentrations of 0.2, 0.5, 1, 2, 3, 5, 10 mg/mL. SAXS showed that the metal-
free protein forms supramolecular structures. The analysis revealed that globular 
structured units form these aggregates. The molecular masses (MMs) were calculated 
through the extrapolation of the I0 and the volumes were calculated from the Porod 
equation.[1] (Tab. 3). The encountered masses resulted closed to integer numbers of 
monomeric ETHE1 units. We plotted the MMs against the protein concentration and we 
observed a crescent sigmoid-like distribution (Fig. 25 D). The SAXS expert collaborator 
(Alexey Kiknhey) and me compared the SAXS curves resulting from the measurement 
of different protein concentration solutions, solved and compared the distance 
distribution functions for each sample. The SAXS curves show different intensities at 
low angles, which explain the different masses and exhibit small, but detectable 
differences at higher angles. This is an indication that the overall shape is similar, but 
not the same. Hence, the distance distribution function showed that the supramolecular 
structures probed were different. We can conclude that the observed increase in size 
towards higher concentrations is not due to intermolecular interaction artifacts, but is 
real. Unfortunately, due to the intrinsic averaging nature of SAXS we cannot state that at 
a given concentration we have a defined number of units forming these structures, but 
we can argue that the observed size of these particles in solution is proportional to the 
concentration of the protein. We proceeded building low resolution models of these 
supramolecular species. Strikingly, the low resolution models show that apo-HsETHE1 
forms filaments (chain-like). Monomers and dimmers of AtETHE1 have been fitted to 
the low resolution models. Only the monomers could be nicely fitted. Hence, rigid body 
refinement has been applied to build from the monomers chain-like structures able to fit 
the experimental data (Fig. 25 E). Finally, we superimposed the rigid body models to the 
relative low resolution models, obtaining nice fits (Fig 25 F). 
These results taken together demonstrate that the metal-free form of ETHE1 is 
particularly sensitive to oxidizing conditions. In presence of TCEP, the apo-protein is 
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not able to dimerize properly and forms chain-like oligomers of a size proportional to 
the protein concentration. 
Likely, in vivo cells must ensure that the protein is kept always charged with iron in 
order to avoid protein aggregation and deposition. 
3.1.10 X-ray Absorption Spectroscopy (XAS) 
Several XAS experiments have been carried out on HsETHE1 in order to investigate its 
metal binding site. Pilot experiments were made at DESY (beamline D2, EMBL 
Hamburg, DESY). These were not successful due to the instability and aggregation 
tendency of HsETHE1 in the used conditions. Thus the results were ambiguous and not 
trustworthy. Further experiments were carried out at ESRF (beamline BM26A-Doubble, 
ESRF, Grenoble; bending magnet source). The quality of the protein preparation 
improved, but we could exploit the EXAFS spectra only up to kmax = 10 Å-1, underlining 
that the quality of the collected data was still not satisfying. The results kept ambiguity 
about which of the two potential metal binding sites is occupied. 
Eventually, HsETHE1 2.9 mM in HEPES 50 mM, NaCl 100 mM, TCEP 1 mM, glycerol 
30 %, pH 8.0 has been measured at the iron K-edge at the BioXAS beamline 7-3 
(wiggler source), SSRL, Stanford, California, in the presence and absence of GSH. We 
know that HsETHE1 is very sensitive to mercaptans (see par. 3.1.3), that the substrate is 
glutathione persulfide (GSSH) and one of the products is GSH. This means that the iron 
in the active site should possess some affinity for thio-groups and thereby the enzyme 
might bind to some mercapto-component present in the buffer or dragged out from the 
purification. The possibility of a sulfur ligand was already taken into account before the 
experiments; in fact, the protein in the presence of GSH has been measured and analyzed 
as well. GSH is not only one of the products of HsETHE1 reaction, but is also able to 
turn the protein solution to light blue modifying its UV-Vis spectra (see par. 3.1.6). 
The outputs of these experiments represent our best data set and the result of their 
analysis is presented. The EXAFS can be exploited till kmax = 14 Å-1, which is a great 
improvement in terms of data quality. 
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3.1.10.1 EXAFS on HsETHE1 
The iron K-edge EXAFS spectra of Δ14-HsETHE1-Δ4 and Δ14-HsETHE1-Δ4 in the 
presence of two molar excess of GSH have been analyzed. 
The experimental k3-weighted EXAFS spectra of the two samples are characterized by 
the typical imidazole ligands signature at k = 4.5 Å-1 (Fig. 26). Comparing the 
experimental Fourier Transform (FT) of the two samples we can immediately observe 
 
Fig. 26: HsETHE1 EXAFS. 
Example of EXAFS  fittings of HsETHE1 as isolated and in the presence of GSH. On the left column (A, C), the  EXAFS Fourier 
transforms (FTs) spectra  are shown, while on the right (B, D) the relative k3-weighted EXAFS spectra are presented. The black 
lines represent the experimental data. The broken lines represent the theoretical curves. A, B) FT and EXAFS spectra of as 
isolated HsETHE1. Here, the potential iron coordination spheres are schematically shown within the picture. C, D) FT and 
EXAFS spectra of HsETHE1 in the presence of GSH. The iron coordination sphere scheme is presented within the picture. 
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that the two spectra show many similarities and some important differences. Firstly, the 
main peaks have a slightly different intensity, which is higher for the as isolated protein. 
HsETHE1 in the presence of GSH possesses a more intense shoulder on the same peak 
at about 2.4 Å. Its peak at 2.85 Å is more intense than the corresponding one in the as 
isolated form. The peaks at 3.25 and at 4.25 Å characterizing the contributions of the 
non-bonding imidazole multiple scattering atoms have different intensities as well. In 
the case of the as isolated form, the peak at 3.25 Å has higher intensity, while the one at 
4.25 has lower intensity, indicating that the Debye-Waller factors are not the leading 
responsible of these differences or a change in the angle of the imidazoles rings. 
Moreover, the peak at 3.8 Å is shifted to 3.6 Å in the as isolated form. This a priori 
information tell us that in both cases the iron it is bound to imidazole ligands and that 
HsETHE1 in the presence of GSH might have a sulfur ligand coordinating the iron. In 
addition, the different intensities and the peak shifts suggest some geometrical 
rearrangements in presence of GSH. 
The experiments were simulated using the exact curved wave theory.[104] The spectra 
were k3-weighted for best modeling (see par. 1.2). The considered energy range spanned 
from a wavenumber (k) of 3 till 14 Å-1. Imidazole, carbonyl, oxygen, peroxo-groups and 
sulfur were assumed as potential ligands. All atoms within a ligand were considered as 
part of the same unit. This allowed considering multiple scattering events within a unit, 
or among all atoms. The units have been used in the refinements rigid bodies 
(constrained refinement).[44] The disorder parameters (Debye-Waller factors; 2σ2) were 
restrained to a range from 0.002 to 0.025 Å2. The Debye-Waller factors of the not 
coordinating imidazole-atoms were constrained on the basis of empirical data 
(experience) taking into account their distance from the absorber. In general, it is a good 
assumption/approximation to consider the Debye-Waller factors of the second (C2, C4) 
and third (N1, C5) imidazole shells, respectively 1.6 and 2.1 times the Debye-Waller 
factor of the donor atom (N3/Nε). The imidazole and the carbonyl coordination were 
refined by iterating the distances and the Debye-Waller factors of the pivotal (directly 
coordinating) atoms. The rotational, twist and tilt angles of the imidazole and carbonyl 
units were also refined. Two hundred iterations were made each round of refinement. 
The analysis has been initially carried out using an ideal geometry. Successively, the 
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coordinates and thus the geometry of the iron binding sites of two PDB structures have 
been applied as starting parameters: 
The HsETHE1 conserved metal binding residues (by homology with AtETHE1, 
glyoxalase 2 and ZiPD/RNaseZ, data not shown) create two potential metal binding sites 
closed to each other. Thanks to the available ETHE1 structure from Arabidopsis 
thaliana, we can assume that one site (site 1) could form an octahedral 6-fold-
coordination site with two histidines, one carbonyl and up to three oxygens 
(hydroxides/waters). The other (site 2) could form a tetragonal pyramidal 5-fold-
coordination site comprising three histidines, one carbonyl and up to one oxygen. Also 
the possibility of the presence of dioxygen (molecular oxygen) has been taken into 
account as linear or bidentate peroxo-form. The structural coordinates of an octahedral 
and of a tetragonal pyramidal iron binding sites have been extracted to build specific 
PDB files, which were then used for refinement: 2GCU (AtETHE1, 1.48 Å nominal 
resolution; site 1) 1AR5 (cambialistic SOD, 1.6 Å nominal resolution; site 2). Only the 
iron and the coordinating groups were considered in the calculations. In the case of 
histidines, the imidazole moieties were kept for refinement. In the case of aspartate, only 
the carbonyl group was used. As needed, oxygens have been substituted by a sulfur atom 
or by a dioxygen-group for refinement. 
When the ideal geometry has been applied to the refinements, the analysis couldn’t 
distinguish between the two potential metal binding sites. Instead, when the analysis was 
carried out starting from structural coordinates, the results strongly favored the 
octahedral binding site. A large number of different scenarios have been taken into 
account, considering the information we possess about the active site of other non-heme 
mononuclear iron dioxygenases.[35-37,105] Eventually, the analysis of as isolated 
HsETHE1 in the as isolated form reveals an iron coordinated by 2 NεIm (nitrogen epsilon 
of the Imidazole ring) at 2.16 Å, 1Ocarbonyl (oxygen of the carbonyl group) and 2 Owater 
(oxygen of a solvent molecule referred as water on the basis of its distance from the iron 
ion) at 2.10 Å and an Oxygen at 1.93 Å. This model is supported by the Mössbauer 
spectrum (see par. 3.1.12). Imidazol and carboxylate distances are typical for high spin 
2-his 1-carb facial triad mononuclear iron dioxygenases.[35-37,106] Instead, a short 
Fe(II)-oxygen bonds at such distance have been found exclusively in two different cases: 
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• In the extradiol dioxygenase upon extradiol bidentate binding.[37] Here, EXAFS 
analysis found one oxygen is bound at 2.10 and one at 1.93 Å. 
• In the naphthalene 1,2 dioxygenase (NDO) (a Rieske dioxygenase), where, in the 
presence of a substrate analogue (indol) and O2, a peroxo group binds in a 
bidentate manner the iron-ion.[36] In this case, a crystallographic study found 
one oxygen at about 1.8 and one at 2.0, which is in good agreement with Fe-
Operoxo bond lengths obtained from the EXAFS analysis of the model compound 
[Fe(N4Py)(η2-O2)]+ (1.93 Å; N4Py = N-(bis(2-pyridyl)-methyl)-N,N-bis(2-
pyridylmethyl)-amine), and from the crystal structure of a heme/copper complex 
with a µ-η1:η2-peroxo bridge (1.89 and 2.03 Å). 
Hydroxide can also bind iron(III) at about 1.9 Å. For example, EXAFS studies of yellow 
soybean lipoxygenase-1 (SLO-1) show the presence of a short (1.88 Å) bond, which has 
been assigned to a hydroxide. This model has been excluded because from XANES, 
EPR (see par. 3.1.12) and Mössbauer (see par. 3.1.11) we demonstrated the only 
presence of an Fe(II) species. On the other hand the possibility of an hydroxide-Fe(II) 
bond at 1.94 Å stabilized by hydrogen bonding network might exist. 
From the results of the analysis three potential scenarios are emerging (Tab. 4): 
1. 6-ligand (6C) octahedral geometry with 2 NεIm, 1Ocarbonyl and 2 Owater and an 
Oxygen at 1.94 Å. 
2. 6-ligand (6C) octahedral geometry with 2 NεIm, 1Ocarbonyl and 1 Owater and a 
peroxo anion bound with both oxygens, one at 2.10 and one 1.94 Å. 
3. 6-ligand (6C) octahedral geometry with 2 NεIm, 1Ocarbonyl bidentate with one 
oxygen at 2.07 and one at 1.92 Å, and 2 Owater. 
The EXAFS models for these three cases are very similar and led to the best scored 
refinements (Tab. 4, Fig. 26 A, B). The first scenario would be unique, in fact, Fe(II) 
hydroxide-bound has never been detected. The second scenario cannot be excluded 
because the non-heme iron(II-high spin) enzymes are described as oxygen activating 
enzymes, On the other hand, the conformation with a peroxo-group bound should be 
Results 
_______________________________________________________________________ 
108 
rather unstable and its presence as stable ligand would be not less surprising. The third 
HsETHE1 EXAFS analysis 
N Fe L R 2σ2 EF Φ R 
 
 
HsETHE1 as isolated 
(2 Im, 3 Ocarb/w,  1 OOH) 
 
2 
3 
1 
 
 
 
 
 
 
Fe 
Fe 
Fe 
 
 
 
 
 
Nε 
Ocarb/w 
OOH 
Ǻ 
 
 
 
 
2.16(3) 
2.09(1) 
1.92(2) 
Ǻ2
 
 
 
 
0.006(7) 
0.007(3) 
0.007(3) 
eV 
 
 
 
 
-2(1) 
x103 
 
 
 
 
0.6357 
 
 
 
 
 
 
27.1 
 
HsETHE1 as isolated 
(2 Im, 3 Ocarb/w,/peroxo, 1 
Operoxo) 
 
2 
3 
1 
 
 
 
 
 
 
Fe 
Fe 
Fe 
 
 
 
 
 
Nε 
Ocarb/w/peroxo 
Operoxo 
 
 
 
 
 
2.16(5) 
2.10(2) 
1.94(3) 
 
 
 
 
0.007(7) 
0.007(7) 
0.007(7) 
 
 
 
 
 
-2(1) 
 
 
 
 
 
0.6587 
 
 
 
 
 
 
27.3 
 
HsETHE1 as isolated 
(2 Im, 3 Ocarb/w, 1 Ocarb) 
 
2 
3 
1 
 
 
 
 
Fe 
Fe 
Fe 
 
 
 
 
Nε 
Ocarb/w 
Ocarb 
 
 
 
 
2.17(1) 
2.07(1) 
1.92(6) 
 
 
 
0.005(2) 
0.002(3) 
0.011(7) 
 
 
 
 
-3(1) 
 
 
 
 
 
0.5912 
 
 
 
 
 
25.7 
 
HsETHE1 + GSH 
(1S, 2 Im, 2 Ocarb/w  1 
OOH) 
 
1 
2 
3 
1 
 
 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
 
S 
Nε 
Ocarb/w/peroxo 
Operoxo 
 
 
 
 
 
2.36(3) 
2.15(6) 
2.06(3) 
1.89(3) 
 
 
 
 
0.01(1) 
0.008(9) 
0.002(7) 
0.002(7) 
 
 
 
 
 
0(1) 
 
 
 
 
 
 
0.8687 
 
 
 
 
 
 
32.8 
 
 
HsETHE1 + GSH 
(2 Im, 3 Ocarb/w, 1 OOH) 
 
2 
3 
1 
 
 
 
 
 
Fe 
Fe 
Fe 
 
 
 
 
Nε 
Ocarb/w 
OOH 
 
 
 
 
2.19(4) 
2.08(2) 
1.90(4) 
 
 
 
0.007(4) 
0.004(6) 
0.004(6) 
 
 
 
 
-11(1) 
 
 
 
 
 
0.9526 
 
 
 
 
 
37.7 
 
 
Tab. 4: HsETHE1 EXAFS parameters. 
Parameters of the best models obtained for the EXAFS analysis of HsETHE1. The numbers (n) of ligand atoms (L) to the iron ion, 
their distance to the iron ion (R), the  respective Debye-Waller factor (2σ2), the C–O, the Fermi energy for all shells (EF), and the 
fit index (Φ) and the REXAFS (R) indicating the quality of the fit are shown. The geometry has meen modeled as well in ochtahedral 
and tetragonal pyramidal conformations. As starting points for the modelization, the structures of AtETHE1 (PDB: 2GCU; 
ochtahedral) and of the cambialistic SOD (PDB: 1AR5; tetragonal pyramidal) have been used. The results presented in the table 
refers to an ochtahedral 6-fold coordination geometry. 
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possibility has been found in the rieske dioxygenase, where an aspartate residue is 
chelating in a bidentate manner the iron ion. In principle, this would be the favored 
scenario, but would also require a displacement of the aspartate residue that is hard to 
imagine grounding on the AtETHE1 structure. Thereby, I consider the short-bound 
oxygen as part of a water-solvent molecule, which is stabilized at about 1.9 Å by the 
electronic structure at the iron ion. 
For HsETHE1 in the presence of GSH (HsETHE1-GSH) the scenario is slightly 
different. In this case the best model is achieved assuming a coordination sphere 
comprising 1 S at 2.26 Å, 2 NεIm at 2.15 Å, 1Ocarbonyl and 1 Owater at 2.07 Å and an 
Oxygen at 1.89 Å (Tab. 4, Fig. 26 C, D). Interestingly, even in this case the modeling 
requires the presence of an oxygen donor at about 1.9 Å. This suggests that the GSH 
binds to the iron ion, explaining the color and UV-Vis changes observed upon addition 
of this product of the physiological reaction (see par. 3.1.6) and that the protein might be 
inhibited or kept bound by its own product. Unfortunately, ITC experiments could not 
strongly support the interaction, giving inconsistent and not reproducible results (see par. 
3.1.8.2). Reasonable EXAFS fits with slightly worst r-factor and fit-index have been 
obtained using the two imidazoles, 1 carboxylate, 2 waters and 1 shortly bound oxygen 
configuration. This result underlines the possibility of a mixture of sulfur bound and 
unbound forms in the protein preparation measured. 
It is of interest that the estimated Fe-L (Fe-Ligand) distances were found to be higher 
than the Fe-L distances in case of a low spin iron(II). These are compatible with a high 
spin iron(II). In fact, in the latter case the energy levels of the different molecular 
orbitals in the iron electronic structure have similar energy. As a consequence, many 
electrons occupy quantum states at similar energies. According to the Pauli’s exclusion 
principle, the electrons with similar quantum states need greater physical distance from 
each other. This causes the boundary of the electron density of the iron to increase, 
which makes the electron density become less dense. As a result, the ionic radius of the 
iron augments (from 0.61 Å of a low spin to 0.78 Å of a high spin iron(II)).[107] 
Consequently, the bond length established between the donor groups and the metal 
increases. To gain further information from the EXAFS, another important parameter 
can be taken in consideration: the Bond Valence Sum (BVS) (see par. 
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2.4.14.4).[87-92] BVS it is an empirical approach that allows to postulate the metal 
oxidation state from the M-L bond lengths, knowing the oxidation-state-independent 
bond distances (R0). R0 can be viewed as a bond length of unit valence. The assumption 
is that the BVS of a jth atom or ion is close to the oxidation state zj. In the case of the 
iron ion, we can refer to the R0 estimated for iron-O/N bonds.[89] The BVS for 
HsETHE1 iron ion has been calculated assuming a R0 of 1.745, in between the R0 of an 
iron(II, low spin)-L (1.734) and iron(III, low spin)-L (1.759).[89] The BVS resulted of 
about 2.4, which suggests the presence of an iron(II). 
In conclusion, HsETHE1 iron ion has an octahedral geometry and binds to the 2his, 
1carb facial triad, which is typical for high-spin non-heme iron(II) oxygenases. The iron-
triad ligands bond lengths suggest the high-spin nature of the iron ion. The other three 
positions resulted fully occupied by oxygen ligands, one of which has been modeled at 
about 1.9 Å and features the HsETHE1 iron-binding site. Moreover, exploiting EXAFS 
refinements based on structural 3D-coordinates we can have geometrical information 
 
Fig. 27: HsETHE1 XANES spectra. 
Experimental  normalized-XANES spectra of HsETHE1 as isolated (blue lines) and in presence of GSH (red lines). A) The 
picture shows the comparison of the XANES of as isolated HsETHE1 and HsETHE1 + GSH. The projection of the edge position 
is shown. The overall curves shape is very similar, but not identical. Differences between peak intensities are noticeable for the 
pre-edge, 1st maximum and 1st minimum peaks. These differences are assigned to geometry distortion rather than to different 
coordination number in agreement to the EXAFS results. The picture in picture shows a comparison of the metal binding sites of 
HsETHE1 and HsETHE1 + GSH according to the coordinates extracted from the EXAFS refinements. The perpendicular front 
ligands have been removed for clarity of the picture. It is noticeable that the HsETHE1 + GSH (red) has a higher geometry 
distortion than the as isolated from. B) 1st derivative of the same spectra within 7100 and 7150 eV. In the pictures, the 1s→3d 
transition states and the estimated absorption edge positions are marked by black broken lines. 
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suggesting a significant distortion of the iron site from ideal centrosymmetry, 
particularly for HsETHE1 in presence of GSH, which EXAFS detected to be bound to 
the iron ion. Eventually, the similarities with non-heme mononuclear high-spin iron(II) 
dioxygenases and the BVS suggests the presence of a ferrous iron centre. The presented 
results fully agree with the Mössbauer analysis carried on HsETHE1 (see par. 3.1.11-12). 
3.1.10.2 XANES on HsETHE1 
The experimental normalized XANES spectra of HsETHE1 as isolated and in the 
presence of GSH have been analyzed. A general comparison of the XANES spectra 
shows that their overall shape is very similar, but not identical. In fact, the intensities of 
the pre-edge peak and first maximum and first minimum within the white-line range of 
energy are slightly different (Fig. 27 A). This has been assigned to the different 
geometric distortion of the metal binding site. In particular, the first white-line maxima 
in HsETHE1 as isolated and in the presence of GSH are found at 1.64 and 1.58, 
respectively, while the first minima reside at 0.82 and 0.84 (Fig. 27 A). Thereby, the as 
isolated form presents a more intense first maximum and a less intense first minimum, 
which are characteristics of a change in the coordination sphere and/or in the 
centrosymmetry distortion. Very similar XANES spectra were reported for different 
forms of the tyrosine hydroxylase.[108] 
The first and second derivatives of the spectra where calculated in order to more 
efficiently follow the pre-edge 1s→3d transition on the spectra (Fig. 27 B; 28). From the 
first derivatives of the spectra I calculated the edge position to be at 7122.5 eV for both, 
assuming an E0 (from Fe-reference foil) of 7111.2 eV.[108] The first derivatives 
highlight a 2-fold splitting of the white-line centered at 7123 eV (Fig. 27 B). This 
characteristic is assigned to two different transitions to highly energetic unoccupied 
orbitals. Within the pre-edge peak range (7110-7116 eV) we can distinguish the splitting 
of the pre-edge peak in two smooth sub-peaks. This characteristic has been here 
assigned to high-spin octahedral (Oh) iron sites.[40,108,109] 
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In case of iron(II) complexes, this two peaks originate from the (t2g)2(eg)2→(t2g)2(eg) and  
(t2g)2(eg)2→(t2g)(eg)2 transitions, corresponding to the 4T1g, 4T2g and 4T1g states. Usually, 
these transitions are pointed at about 7111.3(2), 7112.2(4) and 7113.4(3) eV and the first 
two typically overlay and form a unique peak. As a consequence, two pre-edge peaks are 
visible at about 7111.5 and 7113.5 eV, respectively. In case of iron(III) complexes the 
peaks originate from the (t2g)3(eg)2→(t2g)2(eg)2 and (t2g)3(eg)2→(t2g)3(eg)1 transitions, 
corresponding to the 5T2 and 5E states. These two transitions are usually found at 
7112.9(5) and 7114.3(5) eV and split by no more than 1.5 eV. Focusing on the two 
visible peaks, for both forms their position is at about 7111.4(2) and 7113.5 (2) eV. 
These positions fits very well the pre-edge peak positions found for a number of 
octahedral high spin iron(II) model complexes[109,110] and enzymatic sites, such as in 
the tyrosine hydroxylase[108] and in the soybean lipoxygenases.[111]  
Sample Number of 
peaks fitted 
Pre-edge 
peaks energy 
position 
eV 
Pre-edge peak 
energy 
intensity 
10-2eV2 
Total pre-
edge peak 
intensity 
10-2eV2 
HsETHE1 as 
isolated 
2 7111.3 
7113.6 
8.5(9) 
2(2) 
10(1) 
HsETHE1 as 
isolated 
3 7109.3 
7111.5 
7113.7 
1.9(9) 
7.3(9) 
1.7(9) 
11(3) 
HsETHE1 + 
GSH 
2 7111.5 
7113.5 
2.5(1) 
14.1(3) 
16.6(5) 
HsETHE1 + 
GSH 
3 7106.3 
7111.4 
7113.5 
0.1(9) 
3.2(9) 
15.2(9) 
18(3) 
 
Tab. 5: HsETHE1 pre-edge peak analysis. 
 Pre-edge peaks analysis. The pre-edge peak features has been fitted using 2 or 3 pseudo-Voigt peaks. The total areas reveal that 
the iron geometry is distorted, in particular for the protein in the presence of GSH. Interestingly, the HsETHE1 as isolated pre-
edge peaks can be nicely fitted assuming two peaks, one bigger at lower energy and one smaller at higher energy. This scenario is 
inverted for HsETHE1 + GSH. This characteristic can be directly observed into the 2nd derivatives of the experimental XANES 
spectra.  
Results 
_______________________________________________________________________ 
113 
Moreover, as mentioned above, these peaks are typically distant 2 eV from each other. 
Instead, the pre-edge peaks of octahedral high spin iron(III) complexes are commonly 
distant 1.5 eV from each other and shifted about 1.5 eV towards higher energies. I 
calculated the pre-edge peak areas using either two or three pseudo-Voigt peaks. The 
results using three peaks sounded artificial, considering the intrinsic energy resolution of 
the Si[220] monochromator at the Fe K-edge of 0.4 eV, but for comparison, the obtained 
values are presented (Tab. 5). The areas under the pre-edge peaks were determined to be 
8.5 and 2 eV2, respectively for the lower and higher energy peaks of the as isolated form, 
and 2.5 and 14.1 eV2 , respectively for the lower and higher energy pre-edge peaks of 
HsETHE1 + GSH (Tab. 5).  Thus, their intensities are swapped. This can be nicely 
observed if we zoom in the second derivatives between 7110 and 7115 eV, where the 
two pre-edge peaks of the two forms look mirrored. (Fig 28 A, B). This means that for 
HsETHE1 as isolated, the probability of the configuration (t2g)2(eg) (4T1g, 4T2g transitions 
at about 7111 eV) is higher than the probability of the configuration (t2g)(eg)2 (4T1g 
transition at about 7113.5 eV) . The reasons for this reside in the electronic structure of 
the iron site and they are still unclear. 
The total areas are under the pre-edge peaks are 10 and 16.6 eV2 for HsETHE1 as 
isolated and in presence of GSH, respectively. These peaks are very intense and they 
 
Fig. 28: HsETHE1 XANES pre-edge peak analysis. 
A) Zoom-in the as isolated HsETHE1 XANES spectra (full black line). The 1st (broken blue line) and 2nd (broken red line) 
derivatives are also presented. B) As A, but the spectra refers to HsETHE1 + GSH. 
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indicate, or a lower coordination number (about 4), or that the geometry is highly 
distorted from ideality.  
In conclusion, the pre-edge peak analysis revealed that HsETHE1 bears a high spin 
iron(II). This is in perfect accordance with EPR and Mössbauer analysis results (see par. 
3.1.11-12). The theoretical three pre-edge peak transitions forming the double pre-edge 
peak are highlighted in Fig. 27 B. Moreover, according to the EXAFS results (see par. 
3.1.10.1; Fig. 27 A, picture in picture), which favors a hexa-coordination, the total pre-
edge peak area indicates a significant centrosymmetric distortion from ideality. The 
diversities between the XANES of the as isolated and GSH enriched forms are assigned 
to geometric distortion of the metal binding site rather than to a different coordination 
number, particularly for the GSH enriched protein that possesses a significantly higher 
total pre-edge peak area (Tab. 5). This geometrical rearrangement has been assigned to 
the interaction of HsETHE1 with GSH, which binds the iron ion as presented in the 
EXAFS analysis.  
3.1.11 Electron Paramagnetic Resonance (EPR) 
EPR has been applied on HsETHE1 in the as isolated state deriving from the same batch 
used for XAS analysis. The results revealed that the protein is EPR silent. Ruling out the 
possibility of an iron(IV), which has been observed only as intermediate during oxido-
reductive enzymatic reactions,[112] this result suggests the unique presence of iron(II) 
in high or low spin configuration. 
3.1.12 Mössbauer spectroscopy 
The electronic structure of HsETHE1 has been investigated by Mössbauer spectroscopy 
to further investigate the protein iron oxidation state, its coordination number and the 
nature of the ligands. 
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Mössbauer analysis detected the 
presence of two sub-spectra 
representing two iron(II) sites in 2:1 
ratio (Fig. 29, Tab. 6). Each sub-
spectrum is formed by two doublets. 
One doublet represents about two 
thirds (68%) of the iron and shows an 
Isomer Shift (I.S./δ; mm/s) of 1.28 
mm/s. The second doublet has a δ = 
1.27 mm/s. Thereby, both sub-spectra 
show very high isomer shift, as it is 
typically found for 6-ligand 
coordination spheres with weak field 
ligands only. This result rules out 
sulfur coordination. The large isomer 
shift is compatible with only ferrous 
high spin iron. This scenario is similar to the one presented for the benzoate dioxygenase 
(BZDO), where the enzyme in the resting state exhibits two doublets, but with lower 
splitting.[113] In BZDO, one doublet represents about the 75% of the iron and has ΔEQ  
of 3.1 mm/s and δ of 1.26 mm/s while the other doublet exhibits ΔEQ  of 2.0 mm/s and a 
δ 1.27 mm/s. These data indicate that also BZDO high spin iron in two different 
electronic environments. 
The doublets differ significantly by Quadrupole Splitting (Q.S./ΔEQ; mm/s), i.e. in the 
(a)symmetry of coordination. They have very high quadrupole splittings giving rise to 
important geometrical considerations. The majority species showed a ΔEQ = 3.71 mm/s, 
which indicates a large splitting of the t2g orbitals. This is the result of a considerable 
geometrical distortion from ideality in terms of angles and bond lengths. This is in 
perfect agreement with the EXAFS results (see par. 3.1.10.1) that revealed the presence 
of an oxygen ligand at about 1.9 Å from the iron and a consistent distortion from an 
ideal octahedral geometry. The minority species, which differs substantially from the 
other state only in the quadrupole splitting, possesses a ΔEQ = 2.80 mm/s. This scenario 
 
Fig. 29: Mössbauer spectrum of HsETHE1. 
The analysis revealed two subspectra corresponding to two iron 
site states in a ratio 2:1. Both subspectra show high isomer shift, 
typical of hexacoordinated iron centers, with weak field ligands 
only. The two configurations differ exclusively by quadrupole 
splitting, i.e. in the (a)symmetry of coordination.  
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not only indicates that the minority species has a less distorted geometry, but also 
suggests a flexibility of the iron binding site that can be crucial for HsETHE1 
functionality. Notably, the minority species exhibits Mössbauer parameters very similar 
to those of another mononuclear iron dioxygenases, the phenylalanine and tyrosine 
hydroxylases.[114] 
In conclusion, the Mossbauer results of HsETHE1 are consistent with a non-heme 
mononuclear iron(II) high spin dioxygenases. 
The next step would be to carry out further Mössbauer spectroscopy experiments for 
characterizing the iron spectral changes upon addition of GSH and upon triggering the 
enzymatic reaction through the addition of a reaction mixture where the unstable 
substrate is freshly formed. In fact, even if the turnover would be at low rate (~10%), 
Mössbauer spectroscopy is able to detect small traces of such species. In this way, we 
should gain insight to the geometrical and electronic changes featuring the reaction cycle. 
3.1.13 Crystallization 
So far, the crystallization of HsETHE1 has not been successful. Hundreds of 
crystallization conditions have been screened exploiting different construct (see par. 
2.4.11). Nevertheless, the protein gave no crystals suitable for X-ray diffraction studies. 
The construct Δ14-HsETHE1 supplied spherulites-like pseudo-crystalline formations at 
the following conditions: Mg formate 0.1M, PEG 3350 15%; ammonium sulfate 1.4 M, 
MES 0.1 M pH 6.0, PEG 3350 (Fig. 30). The spherulites were growing slowly within 
2/3 months. These conditions were optimized manually by varying the concentration of 
salt and PEG and they were used for seeding. Up to now, only the spherulites were 
reproduced and no protein crystal formed. The construct Δ7-HsETHE1-Δ4 yielded 
I.S. (δ) Q.S. (ΔEQ) FWHM Rel. I.[%] 
1.28 3.71 0.36 67.95 
1.27 2.80 0.50 32.05 
 
Tab. 6: HsETHE1 Mössbauer parameters. 
Parameters obtained from Mössbauer spectroscopy analysis of HsEthe1. I.S.: Isomer Shift (δ). Q.S.: Quadrupole Splitting (ΔEQ). 
FWHM.: Full Width at Half Maximum. Rel. I.: Relative Intensity of the two subspectra. 
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reproducible crystals in different conditions, i.e. ammonium acetate 0.2 M, bis-tris 0.1 M 
pH 6.5, PEG 3350 25%; HEPES pH 7.5, PEG 6000 10%, MPD 5%;; Zn acetate 0.2 M, 
PEG 3350 20%. Unfortunately, synchrotron based crystal tests revealed that the crystals 
were formed exclusively by salt. 
3.1.14 Hypothetic HsETHE1’s reaction mechanism 
The working hypothesis for HsETHE1's reaction mechanism is summarized in Fig. 31. 
The mechanism has been proposed on the basis of our results and considering the 
reaction mechanism proposed for other non-heme mononuclear high spin iron(II) 
dioxygenases, such as the biosynthetic oxidases.[35] The cycle starts with the resting 
state of the ferrous metal binding site (A). Here, the iron ion is coordinated by the 1-
carboxylate 2-imidazole triad and by three water's oxygens. The substrate (GSSH) enters 
the active site, displaces two water molecules and binds to the iron (B), which is now 
penta-coordinated and bound to a sulfur ligand. The  iron ion is now ready to accept and 
activate an oxygen molecule. The O2 binding displaces the last water molecule and 
forms a Fe(III)-superoxo complex (C). The superoxo has a radical character and triggers 
the attack to the sulfur affording the creation of a peroxo-iron-sulfur circular form 
species (D). The sulfur donor starts its oxidation process (S1+). At this point, two 
possibilities are presented: a) Formation of a sulfoxycation radical and of an metal-
bound activated oxygen radical atom (E1). The sulfur is now S3+. From E1, the 
 
Fig. 30: HsETHE1 crystallization spherulites. 
Spherulite-like formations obtained from oHsETHE1 crystallization trials. From A to C is presented an example of spherulites formed after 
10 days (A), 1 month (B) and 2 months (C) in Ammonium Sulfate 1.4 M; MES 0.1 M pH 6.0; PEG 3350 and reducing conditions given by 
TCEP. 
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metal-bound activated oxygen radical atom attacks the sulfur donor (E1b). b) Formation 
of a sulfur-peroxo intermediate and reintroduction of a water molecule (E2). Then, from 
E2 or E1b the formation of a Fe-S sulfonate intermediate takes place (F). The sulfur is 
now in the oxidation state 3+. Then, the nucleophylic attack of a water molecule to the 
iron triggers the S-S and Fe-S bond breaking, affording the products:    During Fe-S 
bond lysis the sulfur leaves the last electron to the iron ion, concluding the oxidation 
 
Fig. 31: Proposed catalytic mechanism for HsETHE1. 
The overall reaction equation is presented in the centre of the picture. A) Resting state. B) Substrate (GSSH) binding and two waters 
displacement. The iron is now pentacoordinated with a sulfur ligand. C) O2 binding, displacement of a water molecule and formation 
of a Fe(III)-superoxo complex. The superoxo has a radical character that triggers the attack to the sulfur. D) Formation of a peroxo-
iron-sulfur ring. Here the sulfur donor starts the oxidation process.  E1) Formation of a sulfoxy-cation radical and of metal-bound 
activated oxygen radical atom. The sulfur is now in the 2+ oxidation state. E1b) The metal-bound activated oxygen radical atom 
attacks the sulfur donor. The sulfur is further oxidized to 3+. E2) Possibility of a sulfur-peroxo intermediate and reintroduction of a 
water molecule. The sulfur would be in the 2+ oxidation state. F) Formation of a Fe-S-sulfonate intermediate. The sulfur is in a 3+ 
oxidation state. Then, the nucleophylic attack of a water molecule to the iron triggers the S-S and Fe-S bond breaking and the final 
oxidation of the sulfur donor to a 4+ oxidation state. Other two water molecules can re-establish the resting state. The picture has 
been produced with the ChemSketch software ACD/Labs® (Advanced Chemistry Development®). 
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process (S4+). Other two water molecules can re-establish the resting state. It is worth to 
consider that herein the iron ion passes through the oxidation state III (C, D, E1, E1b, F). 
However, in step E1 the iron ion might be at oxidation state IV as oxo-Fe(IV).[35-37] 
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3.2 X-ray Absorption Spectroscopy applications and 
methods development 
This chapter is dedicated to the results obtained by XAS studies on the mononuclear 
[Fe]-hydrogenase Hmd from Methanocaldococcus jannaschii, on the optical exited state 
of a bis(µ-oxo)-dicopper(III) species and on the ATP binding cassette protein ABCE1. 
3.2.1 XAS study of the mononuclear [Fe]-hydrogenases Hmd 
The mononuclear [Fe]-hydrogenase Hmd from Methanocaldococcus jannaschii (jHmd) 
has been investigated by a synergic combination of EXAFS and XANES analysis. 
3.2.1.1 jHmd: EXAFS analysis 
EXAFS analysis was performed on jHmd wild type reconstituted (the iron-coordinating 
cofactor has been isolated and the olo-protein was then reconstituted), under the 
conditions used for crystallization[2], on two forms inhibited by carbon monoxide (CO) 
or cyanide (CN) and on the mutants C176A and C176S.[4] Initially, the analysis of 
jHmd was carried out taking into account the available information on the [FeFe]- and 
[NiFe]-hydrogenases,[47] on a previous work about jHmd and Hmd from 
Methanothermobacter marburgensis (mHmd)[50] and on the jHmd X-ray diffraction 
model supplied by our collaborators.[2] Successively, the 3D structure of the mutant 
C176A has been available from our collaborators, opening the doors for a remodeling of 
jHmd iron-site.[4] 
The experiments were simulated with Excurve9.3, using the exact curved wave 
theory.[104] The spectra were k3-weighted for best modeling. The considered energy 
range spanned from a wavenumber (k) of 3 till 14 Å-1. All atoms of a same ligand group 
were considered as part of the same unit. This allowed considering multiple scattering 
events within a unit, or among all atoms, which is extremely important in the presence of 
intense multiple scatterers such as CO and CN ligands. 
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n Fe L R 2σ2 RCx(Ǻ) EF Φ 
A 
 
mHmd as isolated 
2 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
O 
S 
Oa 
 
Ǻ 
 
 
1.801 (4) 
2.034 (6) 
2.308 (3) 
2.922 (4) 
Ǻ2
 
 
0.0084 (8) 
0.007 (1) 
0.0051 (6) 
0.0083 (5) 
Ǻ 
 
 
1.121 (8) 
 
 
eV 
 
 
-9.0 (4) 
 
 
 
x103
 
 
0.1196 
 
 
B 
 
mHmd + KCN 
2 
1 
1 
1 
2 
1 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
Cb 
O 
S 
Oa 
Nb 
 
 
 
 
1.789 (4) 
1.971 (8) 
1.997 (9) 
2.343 (9) 
2.926 (5) 
3.151 (7) 
 
 
0.0061 (6) 
0.005 (1) 
0.016 (1) 
0.016 (1) 
0.010 (6) 
0.005  (1) 
 
 
 
1.137 (9) 
1.180 (15) 
 
 
 
 
-9.7 (4) 
 
 
3 
 
 
0.1710 
 
C 
 
jHmd rec. wt (1) 
2 
2 
1 
2 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
Ca 
O 
S 
Oa 
 
 
 
1.813 (5) 
2.004 (5) 
2.34 (1) 
2.923 (8) 
 
0.007 (1) 
0.007 (1) 
0.008 (1) 
0.013 (1) 
 
 
1.100 (13) 
 
 
 
-7.3 (4) 
 
 
3
 
0.4825 
 
D 
 
jHmd rec. wt (2) 
2 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
O 
S 
Oa 
 
 
 
 
1.792 (4) 
2.040 (9) 
2.321 (4) 
2.934 (4) 
 
 
0.0077 (9) 
0.013 (2) 
0.0071 (8) 
0.0081 (5) 
 
 
 
1.142 (8) 
 
 
 
 
-8.9 (4) 
 
 
3
 
 
0.2005 
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E 
 
jHmd cry 
2 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
O 
S 
Oa 
 
 
 
 
1.795 (5) 
2.03 (1) 
2.351 (6) 
2.921 (7) 
 
 
0.007 (1) 
0.008 (2) 
0.007 (1) 
0.0098 (9) 
 
 
 
1.12 (1) 
 
 
 
 
-8.3 (7) 
 
 
3 
 
 
0.3643 
 
F 
 
jHmd (CO-i) 
2.5(4) 
1 
1 
2.5(4) 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
O 
S 
Oa 
 
 
 
 
1.80(1) 
1.93(2) 
2.332(9) 
2.968(8) 
 
 
0.003(2) 
0.001(1) 
0.014(2) 
0.007(1) 
 
 
 
1.16(2) 
 
 
 
-10.2(6) 
 
 
 
0.2676 
G 
 
jHmd (CN-i) 
2 
1 
1 
1 
2 
1 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
Cb 
O 
S 
Oa 
Nb 
 
 
 
1.76(1) 
2.10(2) 
1.88(1) 
2.33(2) 
2.920(9) 
3.14(1) 
 
 
 
0.005(1) 
0.0246(1) 
0.004(2) 
0.019(2) 
0.009(1) 
0.003(1) 
 
 
 
1.16(2) 
1.04(3) 
 
 
 
-5(1) 
 
 
 
0.4754 
H 
 
jHmd rec. wt (2-new) 
2 
1 
1 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
Cc 
O 
N 
S 
Oa 
 
 
 
 
1.769(5) 
1.88(1) 
2.052(9) 
2.052(9) 
2.335(4) 
2.939(3) 
 
 
0.0050(7) 
0.0020(1) 
0.014(2) 
0.014(2) 
0.0064(7) 
0.0025(4) 
 
 
 
1.170 (8) 
 
 
 
 
 
 
-10.6(5) 
 
 
 
 
 
 
 
0.1664 
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I 
 
jHmd C176A 
1.5 
1 
1 
1 
1 
1.5 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
Cc 
O 
N 
S 
Oa 
 
 
 
 
1.76(1) 
1.87(7) 
2.01(1) 
2.01(1) 
2.303(7) 
2.922(7) 
 
 
0.010(3) 
0.0038(3) 
0.005(1) 
0.005(1) 
0.005(1) 
0.004(1) 
 
 
 
1.16 (2) 
 
 
 
 
 
 
-12(1) 
 
 
 
 
 
 
0.2758 
 
 
 
L 
 
jHmd C176S 
1.75 
1 
1 
1 
1 
1.75 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
Cc 
O 
N 
S 
Oa 
 
 
 
 
1.75(1) 
1.83(2) 
1.997(8) 
1.997(8) 
2.295(7) 
2.91(1) 
 
 
0.017(8) 
0.0029(2) 
0.005(1) 
0.005(1) 
0.0048(9) 
0.003(2) 
 
 
 
1.16 (2) 
 
 
 
 
 
 
-10.4(8) 
 
 
 
 
 
 
0.3685 
 
 
 
M 
 
mHmd wt (new) 
2 
1 
1 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
C 
O 
N 
S 
Oa 
 
 
 
 
1.77 (1) 
1.85 (2) 
2.043 (8) 
2.043 (8) 
2.314 (3) 
2.925 (3) 
 
 
0.009 (3) 
0.004 (4) 
0.012 (1) 
0.012 (1) 
0.0047 (6) 
0.0075 (4) 
 
 
 
1.155 (13) 
 
 
 
 
 
 
-9.6 (4) 
 
 
 
 
 
 
0.1179 
 
 
 
Tab. 7: jFHmd EXAFS parameters. 
EXAFS parameters resulting from the analysis of several mononucear [Fe]-hydrogenase samples. The numbers (n) of ligand atoms 
(L) to the iron ion (Fe), their distance to the iron ion (R), the respective Debye-Waller factor (2σ2), the C–O/C-N distance, the Fermi 
energy for all shells (EF), and the fit index (Φ), indicating the quality of the fit, are shown. A) As isolated Methanothermobacter 
marburgensis Hmd (mHmd).[50] B) Cyanide inhibited mHmd.[50] C) Reconstituted Methanocaldococcus jannaschii Hmd 
(jHmd).[50] D) Reconsitituted jHmd sample with higher quality and metal concentration.[2] E) jHmd in the crystallization 
conditions.[2] F) Carbon monoxide inhibited jHmd.[2] G) Cyanide inhibited jHmd.[2] H) Reinterpretation of the reconstituted jHmd 
model presented in D.[4] I) jHmd C176A mutant.[4] L) jHmd C176S mutant.[4] M) Reinterpretation of the mHmd wild type model 
presented in A.[115] 
 
The so defined units have been used as rigid bodies. The disorder parameters (Debye-
Waller factors; 2σ2) were restrained from 0.002 to 0.025 Å2. The rotational, twist and tilt 
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angles of the CO/CN units were also refined, considering the carbons as pivotal atoms. 
Up to two hundred iterations were made each round of refinement. The overall results 
are summarized in table 7 (Tab. 7). 
3.2.1.1.1 jHmd EXAFS-model[2] 
The jHmd XAS data were analyzed up to 800 eV above the edge, corresponding to a 
wavenumber k = 14 Å-1. jHmd iron ion was known to bind CO, sulfur and the FeGP 
cofactor (Fe-Guanidyl-Pyridone cofactor) through a nitrogen atom of the heterocyclic 
ring bound to the guanidyl moiety.[50] The known ligands can be clearly addressed in 
the 3D structure. The remaining electron donors were not well understood. In the 3D 
model our collaborators observed an electron density at about 2 Å from the iron, which 
was assigned to a solvent molecule. Another electron density was found at the site where 
the molecular hydrogen is supposed to bind, at about 2.5 Å from the iron ion. The 
chemical nature of this ligand is unknown, and its electron density cannot definitely be 
 
Fig. 32: Hmd EXAFS analysis. 
A, B, C) Respectively, the EXAFS, FT and 3D model of jHmd wild type iron binding site as firstly published.[2]. D, E, F) 
Respectively, the EXAFS, FT and 3D model of jHmd wild type iron binding site as lately published.[4]. It is clear from the spectra 
that the new model fits much better the data. In C and F the atoms are represented in scaled ball and stick: violet, the iron; black, the 
carbon; red, the oxygens; blue, the nitrogens; yellow, the sulfur. 
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assigned as a monatomic or diatomic ligand, although it is clearly connected with that of 
the iron.[2] 
Looking at the k3-weighted wave vector experimental spectra we could observe a phase 
shift at about k = 9 Å-1, which can be due to multiple scattering effects (Fig. 32 A, D). 
Besides, looking at the relative FT, it was evident the presence of three main peaks at 
about 1.75, 2.35 and 2.9 Å. These peaks fitted very well the assumption of CO ligands, 
represented by the peaks at 1.75 and 2.9 Å, and sulfur ligands, represented by the peak at 
2.35. The analysis confirmed that jHmd wild type (jHmd-wt) EXAFS is dominated by 
the contributions of two COs at 1.792 Å and a sulfur at 2.321 Å. In fact, these are strong 
scatterers, in particular the COs, which give multiple scattering contributions. The 
presence of a soft ligand (O/N) could also be nicely fitted at 2.04 Å. On the basis of 
mutational studies,  the sulfur is assigned to cysteine 176 of jHmd and the soft ligand to 
the nitrogen electron donor of the FeGP cofactor. Notably, another O/N contribution 
could be introduced in the model at 2.03 Å with no worsening of the fit quality (Fig. 32 
B, E). 
Successively, based on the results obtained for the reconstituted wild type form, the 
EXAFS of jHmd in the crystallization conditions and inhibited by CO or CN has been 
analyzed as well. The results revealed that, within the error margins, jHmd-iron 
coordination sphere in the crystallization conditions is analogue to the reconstituted 
jHmd (protein separate from the cofactor and reassembled back). CO inhibited jHmd 
showed the presence of another carbon monoxide as iron ligand in partial occupancy 
(0.5). The EXAFS analysis of the CN inhibited form revealed the presence of a CN 
molecule with full occupancy at 2.10 Å from the iron. Interestingly, the Fe-O/N distance 
in the CO inhibited form (1.93 Å) is sensibly shorter than in jHmd-wt. In the CN 
inhibited form something similar could be observed, but in this case the O/N ligand 
exhibited an even shorter distance (1.88 Å). Besides, the CN inhibited form exhibits also 
the COs molecules at a shorter distance respect all the other forms (1.76 Å). CO and CN 
are strong back bonding electron donors due to their nature of σ-donor/π-accepting 
ligands.[116] Thus, they strongly contribute to the electron delocalization at the iron ion. 
This means that they affect markedly the electronic structure of the iron and their 
influence is detected by EXAFS as differences in the Fe-L distances. 
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3.2.1.1.2 Revisited jHmd EXAFS-model[4,115] 
In 2008, the structure of the jHmd mutant C176A has been solved, revealing a unique 
and unexpected scenario. In fact, it became evident that the FeGP cofactor was not 
bound to the iron only by the pyridinol nitrogen, but also by an acyl-carbon of a 
carbonyl arm branching off from the pyridinol moiety. This kind of coordination has 
never been observed within an enzyme. In the crystal structure, the iron ion is in 
octahedral geometry. The mutant C176A possesses an alanine instead of the cysteine 
responsible for the binding of the iron. The cysteine is here substitute by a thiol group 
from a DTT molecule present in the buffer, which also supplies an oxygen atom. Carbon 
monoxide molecules occupy the other two positions. 
Under the light of this new iron ion coordination sphere model, I carried out the EXAFS 
analysis on the jHmd mutants C176A and C176S and the reinterpretation of the results 
on jHmd wild type reconstituted[2] and mHmd wild type as isolated[50]. The outcome 
of the analysis is an outstanding fit (Tab. 7 H-M): For all the four samples the results 
revealed not only the presence of a carbon ligand at an intermediate distance from the 
O/N and the CO-carbon donors (at about 1.87 Å), but was able to distinguish between 
the contributions of the nitrogen and an oxygen electron donors. As the nitrogen ligand 
is substituted by an oxygen atom the quality of the model worsen and vice versa. This is 
uncommon and not expected, in fact, the scattering contributions of oxygen and nitrogen 
are typically undistinguishable. The whole coordination sphere is then comprised by 2 
COs (environmental), 1S (from protein or DTT), 1C and 1N (cofactor) and a potential 
oxygen (solvent) (Fig. 32 D-F). It is also important to notice that models lacking the 
oxygen ligand give comparable fit quality, indicating the uncertainty on the sixth 
binding site. Anyhow, the presence of alternative donor atoms (e.g. sulfur, chlorine, 
phosphorus, beryllium, lithium, hydrogen) have been taken into account, but led to 
inconsistencies with the EXAFS data. The comparison between the previous and the 
revisited model of jHmd iron binding site clearly show the improvement of the model 
quality (Fig. 32). 
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This scenario is unique and was 
hard to predict based on the raw 
EXAFS data. In fact, it would have 
been rejected in the absence of 
additional information because of 
the large number of refined 
parameters. Indeed, the 
contributions of C and N/O can 
hardly be detected, because they 
partially cancel out each other over 
a wide k-range (from k = 4.5 to k = 
8.5 Å-1) (Fig. 33). The simulation 
of these contributions requires 
individual Fe-L distances, which 
have been excluded deliberately in 
the initial refinements.  
3.2.1.2 jHmd: XANES 
analysis[117] 
The XANES spectra of the reconstituted wild type mononuclear [Fe]-hydrogenase jHmd 
(jHmd-wt), its cyanide inhibited form (jHmd-CN) and five model complexes have been 
extracted from the XAS spectra and investigated, in order to shed light on the electronic 
structure of jHmd iron ion. The analysis supplied information about the oxidation state 
of the metal ion, about the strong influence of the ligand type on the edge position and 
spectrum shape, about the impact that the coordination geometry has on the XANES and 
about the fundamental contribution of the cofactor’s electron donors to fine tune the 
electronic structure of the iron ion.  
 
Fig. 33: Single scatterer contributions to Hmd EXAFS. 
A, B) Individual EXAFS contributions of jHmd wild type iron binding 
site as firstly modeled.[2] C, D) Individual EXAFS contributions of 
jHmd wild type iron binding site as lately modeled. In C we can observe 
that the contributions of the nitrogen, the oxygen and the carbon are in 
opposite phase, thus partially canceling each other in the region 
highlighted in yellow. This explains why it has been so hard to 
hypothesize at priori the whole coordination sphere. 
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3.2.1.2.1 Experimental XANES analysis: model complexes and jHmd 
Since the iron coordination in Hmd is unique, its XANES cannot be compared with 
spectra of known systems. Thus, we selected model compounds as anchor points for 
assessing the influence of iron oxidation state and its coordination sphere on the 
spectroscopic features. These model compounds are octahedral or five-coordinated low 
spin iron centers with electron donors groups similar to the ligands in the enzyme. The 
data from Fe(II)(edt)(CO)2(PMe3)2 (A, edt = 1,2-ethanedithiolate), [K(18-crown-
6)]2[Fe(0)(CN)2(CO)3] (B), K[Fe(0)(CN)(CO)4] (C), K3[Fe(III)(CN)6] (D) and 
K4[Fe(II)(CN)6] (E) are presented (Fig. 34). The two iron hexacyanides, D and E, were 
selected to enlighten the influence of the metal oxidation state on the absorption edge 
profiles. Both formal Fe(0)-compounds highlight the differences between CN and CO 
groups on the electronic structure of the metal ion: CO is a good σ donor and a strong π 
acceptor, while CN- is a good σ donor and π acceptor. This affects Δ0 (octahedral ligand 
field splitting energy: is the splitting between the nonbonding t2g orbitals and the mildly 
anti-bonding eg* orbitals). It is interesting to notice that the presence of either of these 
ligand makes the iron ion in the low spin configuration increasing sufficiently Δ0. 
Compound A shows the influence of P/S donors. 
The XANES spectra of all samples reveal strong differences in rising edge position and 
shape (Fig. 35). The hexacyanides D and E are highly symmetrical and only differ in the 
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Fig. 34: Structural sketches of Hmd model complexes. 
On the left: structure of the [Fe]-hydrogenase octahedral metal binding site. The iron is coordinated to: S-Cys176, two CO and the 
pyridinol-sp2-hybridized nitrogen and the acyl-carbon of the cofactor. An ‘‘unknown” donor, here represented as X, is associated to 
the iron trans to the acyl carbon. This is considered the vacant position ready for H2 binding. The position of CO trans to pyridinol-
nitrogen could not unambiguously be determined by X-ray crystallography, but it is estimated from the X-ray crystal structure of the 
mutant C176.[4]
 
The model complexes are represented in A – E: A) Fe(II)(edt)(CO)2(PMe3)2; B) [K(18-crown-6)]2[Fe(0)(CN)2(CO)3]; 
C) K[Fe(0)(CN)(CO)4]; D) K3[Fe(III)(CN)6]; E) K4[Fe(II)(CN)6]. For B – E, only the anions are shown. 
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formal oxidation state of the iron, which 
results in highly similar XANES spectra. 
The small shift in their absorption edges 
reflects the slightly different effective 
charges at the iron ion. In compounds B 
and C, the iron is in the formal oxidation 
state 0. These penta-coordinated 
complexes are structurally similar, 
differing only in the relative ratio of 
CO/CN- donors. This similarity is 
reflected by their XANES (green and 
blue lines in Fig. 35). The differences 
observed in the peak intensities are 
ascribed to the exchange of one CO by 
CN-, which here influences in this case 
only the matrix element for the 
unoccupied orbitals, but not their energy 
levels.[116] In compound A, the Fe(II) ion is bound to two CO ligands, two sulfur and 
two phosphine donors. The S and P donor ligands mimic to some extent the sulfur and 
nitrogen ligands bound to Fe in Hmd and they strongly affect the spectrum. jHmd-CN 
shares with the wild type the position of the pre-edge peak as well as the maxima and 
minima above the edge, but not the relative intensities, which indicate a higher 
symmetry for jHmd-CN (Fig. 36). 
White lines (main peak formed by the rising edge and the following minimum): 
D and E white-lines are very sharp, in line with the high symmetry of these iron centers. 
The penta-coordinated complexes B and C differ in the relative ratio of CO/CN- donors. 
Their white-lines are less sharp, indicating a lower level of symmetry and the observed 
diversities between each other are due to the effect of the different backbonding 
properties of CO and CN-. In compound A, the low-symmetry of the iron coordination 
results in a broadened white-line. jHmd-wt XANES revealed characteristics very similar 
to compound A. The higher white-line intensity in jHmd-CN is indicative of a higher 
Fig. 35: Hmd and model complexes XANES. 
Comparison among the experimental XANES of the model 
complexes and jHmd-wt. Black line: jHmd-wt; black broken 
line: jHmd-CN; red line: Fe(II)(edt)(CO)2(PMe3)2 (A); blue 
line: [K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B); green line: 
K[Fe(0)(CN)(CO)4] (C); orange line: K3[Fe(III)(CN)6] (D); 
purple line: K4[Fe(II)(CN)6] (E). 
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symmetry. This is in line with the pre-
edge peak area that is much smaller for 
jHmd-CN than for jHmd-wt (see 
below, Tab. 8) Moreover, The first 
derivative of the XANES spectra helps 
identifying fine features. The jHmd-wt 
derivative is characterized by the 
splitting of the second peak into three 
peaks representing unoccupied orbitals 
(white-line range: from 7115 to 7130 
eV). This feature is absent in the 
inhibited form (Fig. 36). The presence 
of the characteristic can be considered as an indicator of the active form of jHmd. 
Absorption edges: 
The absorption edges reflect the influence of both the formal oxidation state of the iron 
and of its ligands. The exact absorption edge positions where calculated from the first 
derivatives of the XANES spectra, following the definition: the exact edge position 
corresponds to the first maximum of the XANES first derivative within the white line 
rising edge energy window (Fig. 37, Tab. 8). 
In accordance with its formal charge, the ferrocyanide compound (E) has an edge 
position at lower energies than the ferricyanide D, 7127 eV and 7127.5 eV, respectively 
(orange and purple lines in Fig. 37). As expected, both edge positions are at lower 
energies with respect to D and E. Interestingly, the edges of B and C differ by 1 eV from 
each other (B-edge = 7125 eV; C-edge = 7124 eV), although they are both Fe(0). This 
difference indicates the sensitivity of the effective charges at the metal ion. A shows a 
profound influence of the ligand type. Here, the donors P and S strongly affect the edge 
position, which is shifted towards lower energies by 7.5 eV from the other ferrous 
compound E (7126.6 eV). In accordance, the edge positions of jHmd-wt and jHmd-CN 
are similar to that of A, revealing a comparable effective charge at the iron ion and 
suggesting an analogue formal oxidation state. 
Pre-edge peak areas: 
 
Fig. 36: Hmd-wt and Hmd-CN XANES comparison. 
Comparison between the jHmd-wt and jHmd-CN XANES and 
their first derivatives. Blue lines, jHmd-wt; red lines, jHmd-CN. 
Results 
_______________________________________________________________________ 
131 
This feature is frequently used as 
a measure of the symmetry and 
homogeneity of the iron 
coordination and is usually a good 
indication of the coordination 
number.[109,110,118,119] 
Deviation from an ideal 
octahedral coordination increases 
the 1s to 3d/4p transition 
probability and thus the pre-edge 
peak intensity. In line with their 
octahedral iron-coordination and 
their homogenous ligand sphere, 
the hexacyanides D and E possess 
the smallest pre-edge peak 
intensity (1 and 2x10-2 eV) (Tab. 
8). Complex A exhibits a pre-edge 
peak intensity of about 9x10-2 eV, 
which reflects the heterogeneity of its octahedral ligand set. Complexes B and C are 
square pyramidal (penta-coordinated) and as a consequence, the areas are higher. An 
interesting case is complex B with an area of only 9x10-2 eV. This indicates higher 
symmetry potentially caused by the compensation of π-accepting and π-donating ligands. 
For jHmd-wt and jHmd-CN the largest pre-edge peak intensities are observed, indicating 
a highly distorted geometry at the iron site. jHmd-wt pre-edge peak is extraordinarily 
intense (60×10-2 eV) and is twice of that of the inhibited form (28×10-2 eV). These 
differences point towards a correlation between distortions of the active site geometry 
and catalytic activity of Hmd. In fact, in contrast to complex A, the octahedral symmetry 
is much more distorted in the enzyme, pointing to a specific tuning of the electronic 
structure (and thus most likely of the reactivity) by the protein environment, namely by 
the pockets harboring the CO groups. This hypothesis is supported by the much smaller 
pre-edge peak intensity observed for the isolated FeGP-cofactor.[50] Interestingly, such 
Sample edge 
position 
pre-edge peak 
position 
1s→3d pre-edge peak 
area 
 
 
jHmd-wt 
 
eV 
 
7119.2(2) 
eV 
 
7112.7(2) 
10-2 eV 
 
60(1) 
jHmd-CN 7117.0(2) 7112.7(2) 28(2) 
A 7116.0(2) 7112.0(2) 9(2) 
B 7124.6(2) 7112.9(2) 8(1) 
C 7123.8(2) 7112.6(2) 18(2) 
D 7127.4(2) 7112.3(2) 2(1) 
E 7126.6(2) 7111.9(2) 1(1) 
 
Tab. 8: Edge and pre-edge peak parameters of Hmd and model 
complexes. 
Edge positions, pre-edge peak positions and pre-edge peak areas for 
jHmd-wt, jHmd-CN and the model complexes. In parentheses the error 
margins on the last digit are given. 
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big pre-edge peak intensities have never 
been reported for any other protein-
bound iron ion. 
Another consideration is worth to be 
mentioned. The model compounds were 
chosen to illustrate the two competing 
effects determining the edge position 
and the metal-ligand distances: metal 
oxidation state and ligand type. An 
additional effect becomes apparent: the 
overall shape of the XANES depends on 
the homogeneity of electron donors, 
which reflects in the geometry. Besides, 
the more cyanide molecules are bound to 
the iron, the sharper is the white-line. A 
confirmation of the trend comes from 
compound A. Its coordination is 
heterogeneous and with no cyanides and the white line is small and broadened. 
3.2.1.2.2 XANES simulations: model complexes and jHmd 
To gain further insights in the electronic structure of the iron ion in [Fe]-hydrogenases, 
in silico simulations of the XANES spectra of the model systems and jHmd-wt were 
carried out with the program FEFF8.2 (see par. 2.4.14.6). Simulations of the model 
systems XANES served as a proof of principles and defined the required cluster size in 
this study. I analyzed both the XANES and their first derivatives highlighting 
homologies and differences among spectra. It is worth to remember that no “XANES 
equation” is available due to the difficulties to interpret quantum mechanical events 
correlated to many-body multiple scattering events dominating the XANES. Hence, our 
approach is purely qualitative. 
 
 
Fig. 37: Hmd and model complexes edge positions. 
Comparison between the edge positions of the model 
compounds, jHmd-wt and jHmd-CN. Black line, jHmd-wt; 
black broken line, jHmd-CN; red line, Fe(II)(edt)(CO)2(PMe3)2 
(A); blue line: [K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B); green 
line: K[Fe(0)(CN)(CO)4] (C); orange line: K3[Fe(III)(CN)6] (D); 
purple line: K4[Fe(II)(CN)6] (E). For each sample, the edge 
position  (first maximum of the first derivative in the rising 
edge) is indicated (straight lines). 
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n Fe L R 2σ2 RCx(Ǻ) EF Φ 
 
 
jHmd-wt 
2 
1 
1 
1 
1 
2 
 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
 
 
Ca 
C 
O 
N 
S 
Oa 
Ǻ 
 
 
1.776(3) 
1.91(1) 
2.49(7) 
2.05(1) 
2.304(7) 
2.936(8) 
Ǻ2 
 
 
0.0053(8) 
0.0053(8) 
0.004(4) 
0.0053(8) 
0.008(3) 
0.004(1) 
Ǻ 
 
 
1.16(1) 
eV 
 
 
-1.9(7) 
x103 
 
 
0.1691 
 
jHmd-CNi 
2 
1 
1 
1 
2 
1 
 
 
 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
 
Ca 
Cb 
O 
S 
Oa 
Nb 
 
 
 
1.76(1) 
2.10(2) 
1.88(6) 
2..33(2) 
2.920(9) 
3.14(1) 
 
 
0.005(1) 
0.0246(1) 
0.004(2) 
0.019(2) 
0.009(1) 
0.003(1) 
 
 
1.16(2) 
1.04(3) 
 
 
-5(1) 
 
 
 
 
0.4754 
 
(A): 
Fe(II)(edt)(CO)2(PMe3)2 
2 
2 
2 
2 
 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
S 
P 
Oa 
 
 
 
 
1.781(6) 
2.31(3) 
2.26(4) 
2.946(5) 
 
 
 
0.006(1) 
0.004(7) 
0.004(7) 
0.007(1) 
 
 
 
1.16(1) 
 
 
 
-5.3(5) 
 
 
 
0.1902 
 
(B): K2[Fe(0)(CN)2(CO)3] 
3 
2 
3 
2 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
 
Ca 
Cb 
Oa 
Nb 
 
 
 
1.763(3) 
1.865(6) 
2.926(3) 
3.048(6) 
 
 
0.0010(8) 
0.0010(8) 
0.0010(4) 
0.0010(4) 
 
 
1.163(9) 
1.18(1) 
 
 
-1.8(4) 
 
 
0.1578 
 
(C):  K[Fe(0)(CN)(CO)4] 
4 
1 
4 
1 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
Ca 
Cb 
Oa 
Nb 
 
 
 
1.796(4) 
1.94(1) 
2.952(5) 
3.10(2) 
 
 
0.0068(8) 
0.0068(8) 
0.0080(6) 
0.0080(6) 
 
 
1.156(9) 
1.16(3) 
 
 
-1.2(5) 
 
 
0.1830 
 
(D):  K3[Fe(III)CN6] 
6 
6 
 
 
Fe 
Fe 
 
 
Cb 
Nb 
 
 
 
1.932(2) 
3.095(3) 
 
 
0.0040(4) 
0.0057(4) 
 
 
1.163(5) 
 
 
-4.6(3) 
 
 
0.1535 
 
(E):  K4[Fe(II)CN6] 
6 
6 
 
 
Fe 
Fe 
 
 
Cb 
Nb 
 
 
 
1.911(3) 
3.079(3) 
 
 
0.0045(5) 
0.0047(4) 
 
 
1.168(6) 
 
 
-3.6(4) 
 
 
0.1972 
Tab. 9: EXAFS parameters of jHmd and model complexes. 
The table shows the parameter extracted after structure-based EXAFS refinement of jHmd-wt and the compounds A, B, C, D, E. The 
numbers (n) of ligand atoms (L), their distance to the iron ion (R), the respective Debye-Waller factor (2σ2), the C–O or C–N bond 
length (RCX), the Fermi energy for all shells (EF), and the fit index (Φ), indicating the quality of the model. 
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In order to carry out the simulations, 
the atomic coordinates of the systems 
under study are necessary. Firstly we 
tried the simulations using the 
available x-ray diffraction coordinates 
either of the model complexes (kindly 
supplied by our collaborator Thomas B. 
Rauchfuss, Department of Chemistry, 
University of Illinois, USA) or of 
jHmd in the revisited model (kindly 
supplied by our collaborator Seigo 
Shima, Max-Planck-Institute für 
terrestrische Mikrobiologie, Marburg, 
Germany). 
Successively, I performed EXAFS 
refinements exploiting the 
experimental data and the 3D 
structures of the samples (structure-
based EXAFS refinement). The atomic coordinates of the obtained EXAFS models have 
been extracted and used for the simulations (Tab. 9, Fig. 38). The outcome of the 
simulations clearly demonstrated that using the coordinates extracted from the structure-
based EXAFS refinement the simulations were better representing the experimental data, 
in particular of jHmd. 
The principal features of the model complexes XANES spectra have been reproduced: 
the curves trend, the sequence of the rising edge positions and the white-lines correlation 
with the symmetry and homogeneity of the coordination sphere (Fig. 39, coloured lines). 
Only the relative intensities and thus the magnitude of the transition matrix element are 
not adequately modeled. This result was the prerequisite to proceed on the analysis of 
jHmd XANES. Amazingly, the positions of maxima and minima and the general shape 
of the experimental data have been reproduced for the enzyme as well, suggesting the 
agreement between the electronic states in jHmd-wt and the simulation (Fig. 39 black 
 
Fig. 38: Hmd metal binding site. 
Ball and stick representation of the [Fe]-hydrogenase jHmd 
octahedral metal binding site as modeled by structure-based 
EXAFS analysis: violet, 
 
the iron; black, the carbons; blue, the 
nitrogen; red, the oxygens; yellow, the sulfur. The iron is 
coordinated to: the Cys176-sulphur, two CO and the pyridinol-
sp2-hybridized nitrogen and the acyl-carbon of the cofactor. An 
‘‘unknown” donor represented as an oxygen, is associated to the 
iron trans to the acyl carbon. This is considered the vacant position 
ready for H
2 
binding.  
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line, Fig. 40 A). Again, only the 
relative intensities and thus the 
magnitude of the transition matrix 
element are not adequately modeled. 
In the first derivative of the simulated 
spectrum, the distinctive 3-fold split 
white line peak is preserved, 
highlighting the existence of three 
narrow energy levels ascribed to three 
unoccupied orbitals (Fig. 40 B). As 
already mentioned in a previous 
paragraph, this electronic feature is 
disrupted upon inhibition by cyanide: 
CN- binding alters significantly the 
electronic structure of the iron ion. 
This change, as well as the saturation 
of the coordination sphere of the iron(II), is relevant to its inhibitory effect. Compared to 
the model systems, jHmd-wt simulations differ as much as the experimental data from 
compounds B – F, but for compound A the similarities are even higher than in the 
experimental data. The rather similar curves even share the edge position, pointing 
towards a ferrous ion.  
In order to evaluate the impact of individual donors on the electronic structure of jHmd-
wt, I successively omitted one of them at the time in the simulations and compared the 
resulting curves with the fully coordinated jHmd iron site spectrum. Here, I focused on 
first derivatives to highlight the impact on the electronic structure. Omitting one of the 
two CO ligands (CO1 and CO2) has a strong influence on the entire XANES spectrum, 
in the energy interval from 7120 to 7170 eV, in line with their intense multiple scattering 
contributions (Fig. 41 A, B). The differences between these simulations show the 
importance of the geometry. In the XANES simulations the geometry is taken into 
account by multiple scattering contributions (from the central iron ion to a donor, 
continuing via the central iron atom to the donor in trans position and back to the iron 
 
Fig. 39: Hmd XANES simulation. 
Comparison among the simulated XANES of the model systems 
and jHmd-wt. Black line: jHmd-wt; red line 
Fe(II)(edt)(CO)2(PMe3)2 (A); blue line: [K(18-crown-
6)]2[Fe(0)(CN)2(CO)3] (B); green line: K[Fe(0)(CN)(CO)4] (C); 
orange line: K3[Fe(III)(CN)6] (D); purple line: K4[Fe(II)(CN)6] 
(E). 
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ion); for CO1 this multiple scattering 
pathway includes the sulfur (2.3 Å away 
from the iron ion) and for CO2 the 
nitrogen atom opposite to CO2 (2.0Å 
away from the metal ion) resulting in 
different phase and amplitude of these 
contributions. Interestingly, in both spectra 
the 3-fold white line split present in the 
first derivative of jHmd-wt experimental 
spectrum is conserved, indicating that 
these ligands cannot strongly contribute to 
the energy of the three unoccupied orbitals. 
Similarly, the sulfur contribution to this 
feature is milder than expected on this 
region. Instead, the region from 7138 to 7155 eV is appreciably affected (peak following 
the white line in the XANES) (Fig. 41 E). The cofactor donors mainly influence the 
region from 7115 to 7150 eV (Fig. 41 C, D). In particular, the white line is affected. 
Pyridinol-N and acyl-C omissions markedly change the 3-fold split feature, indicating 
their function in fine tuning the electronic structure. The result reveals the essential 
contributions of the acyl-carbon and of the cofactor nitrogen to the electronic structure 
were visualized by changes in the three unoccupied orbitals of the rising edge.  In the 
crystal structure, because of its planarity, the heterocyclic ring of the cofactor is present 
in a pyridinol and not in a pyridone tautomeric form, and therefore the nitrogen atom is 
in a π accepting sp2 configuration. The pyridinol group in particular, if the hydroxyl 
group is in a deprotonated state, can have ligand back-bonding properties similar to 
those of cyanide, which acts as an iron ligand in the [NiFe]- and [FeFe]-
hydrogenases.[120,121] Moreover, due to the aromaticity of the pyridinol group, the 
acyl-carbon, as the nitrogen, is in a π accepting sp2 configuration leading to back-
bonding properties likely more similar to carbon monoxide. 
 
Fig. 40: Hmd simulated and experimental XANES. 
Comparison between experimental and calculated spectra of 
jHmd-wt. The XANES (A) and its 1st derivative (B) is shown. The 
full lines represent the experimental data, while the broken lines 
represent the simulations. 
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Thus, the electron density around the iron 
ion must be highly delocalized and the 
contributions of the COs and cofactor 
electron donors appears stronger than 
typical enzyme metal binding species, 
hence fading the influence of sulfur. 
When removing the “solvent-oxygen” 
from the simulation we obtained a small 
effect on the beginning of the rising edge 
(Fig. 41 F, from 7117 to 7132 eV). The 
triplet is conserved. 
The above results highlight the distinctive 
contribution from each of the six ligands. 
The differing contributions of the two CO 
ligands suggest that they play a key 
electronic role, as expected because of 
their strong tendency to back-bond. They 
forced the iron in the low spin state and 
they promote the electron delocalization 
at the iron ion.   
The comparison of the jHmd-wt XANES 
with the model complexes identified the 
ferrous complex A as a mimic for the 
enzyme’s electronic structure. Moreover, 
Hmd-wt and complex A share the CO 
and sulfur ligand types. Based on this 
similarity, the identical absorption edge 
positions allow concluding that the 
enzyme harbors a ferrous ion. 
 
Fig. 41: Hmd-ligands contributions to the XANES. 
Comparison between the first derivative of jHmd-wt XANES 
simulation in the full coordination (dotted lines) and in 
simulations where one donor at the time is omitted (full lines). 
A) CO1 knockout, B) CO2 knockout, C) acyl-C of the cofactor 
knockout, D) pyridynol-N of the cofactor knockout, E) 
Cys176-S knockout, F) oxygen knockout. 
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3.2.2 [Cu2L2(µ-O)2]I2 exited state characterization[122] 
The ground state of [Cu2L2(μ-O)2]I2 (L = B(TMPip)G2p) has been characterized by Cu-
K edge XAS at 20 K (Fig. 42 A). Four light ligands (O / N) binding to each Cu ion have 
been identified. The Cu-Cu contribution is refined to a metal-metal distance of 2.84 Å. 
The absorption edge position points towards a change from Cu(I) to Cu(III) upon 
formation of the complex (Fig. 8). The transmission and fluorescence signals were 
monitored at 8990 eV upon optical excitation at room temperature to characterize the 
excited state of the complex. The collected spectra show that while the transmission 
increases immediately, the fluorescence follows with few seconds delay (Fig. 42 B). The 
reasons for this behavior are enigmatic: The UV-light might have heated up the sample 
causing lower absorption of X-rays in the 1 mm thick cuvette. Successively, a small 
percentage of the Cu-complex precipitated prior to the disruption of the experiment at 
elevated temperatures. Thus, after switching off the UV light the transmission decreases 
below the starting point. Other differences in the XANES with and without UV-light 
illumination could not be identified for a variety of concentrations, indicating a too low 
UV-photon intensity. This is in line with the lifetime of the excited state, which is 
estimated to Δt ≈ h/ΔE ≈ h/ 0.2 eV ≈ 20 fs based on the width of the resonance Raman 
peaks. At the given UV intensity ~1016 photons are generated per second; considering 
the absorption probability of ~40% in 1 mm solution only a small fraction of the 1015 Cu 
ions irradiated by the 1 x 1 mm2 X-ray beam are optically excited when the pulsed 
synchrotron beam hits the sample. Therefore, the characterization of optical excitation 
states by XAS might only be feasible with the help of a synchronized, pulsed UV-source. 
Although, even in this case the total power absorbed by the sample might cause similar 
artifacts. Hence, in order to elucidate the structural changes induced upon charge-
transfer we exploited a more elegant and instrumentally less demanding approach. 
Resonance Raman spectroscopy does not require a full occupancy of the excited state, 
because only the excited molecules contribute. Thus, experiments can be performed at 
lower laser intensities. The Raman spectrum of [Cu2L2(μ-O)2]I2 exhibits strong 
vibrational excitations that can be assigned to the bending vibration of the copper-
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oxygen core at 114.3 cm-1 and its integer multiples. For a given local symmetry the 
structural change is calculated from the Huang-Rhys parameter given by the intensity 
decrease in the Raman spectra.[5,60] As previously reported,[5] the copper oxygen 
distance increases by 0.01 Å and the oxygen-oxygen distance decreases by 0.13 Å. So 
far, the limited stability of such complexes restricted the measurements to cryogenic 
temperatures. This experiment enabled a direct comparison of cryogenic and room 
temperature conditions. Below the freezing point of the solvent THF (165 K) additional 
contributions become apart (Fig. 42 C, green curve). These peaks can be assigned to 
THF (Fig. 42 C, dotted blue line). Due to the huge relative difference in intensity and 
similar energy transfers, no subtractive calculations were applied to the spectra in order 
to avoid artifacts. The induced structural changes show no temperature dependence.  
3.2.3 ABCE1 protein: XAS characterization 
The edge shape of the XANES spectra (Fig. 43 A) can be used as a fingerprint for the 
electronic structure of the metal ions. ABCE1 XANES resembles the one reported for 
oxidized hydrogenase II from Clostridium pasteurianum, which harbors [4Fe-4S]2+ 
clusters.[123] Typical features are the resonance in the rising edge and the rather flat 
maximum followed by a sharp minimum. The pre-edge peak intensity of about 21x10-2 
eV2 is consistent with a four ligands coordination sphere (4C) and with an oxidized iron-
sulfur cluster. The extracted fine structure (EXAFS) is dominated by a 
 
Fig. 42: Results of EXAFS, XANES and resonance Raman spectroscopy on [Cu2L2(μ-O)2]I2. 
A) EXAFS and corresponding FT plus XANES. B) Normalized transmission and fluorescence at 8990 eV. C) Raman spectra of 
[Cu2L2(μ-O)2]I2 and THF at 350.7 nm. For data at 293 K and 77 K 10 minutes were given to reach stable temperature. Data 
around the melting point of THF (165 K) were taken while cooling down (144K/145K). 
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single frequency with a shift at about 8 Å-1 (Fig. 43 B). The high intensity at wave 
numbers larger than 10 Å-1 in biological samples indicates the presence of a multinuclear 
metal center. This is consistent with the peak at about 2.8 Å in the corresponding Fourier 
 
 
Fig. 43: XAS analysis of ABCE1. 
A) Iron K-edge X-ray absorption spectrum of ABCE1 from Sulfolobus solfataricus. B) Iron K-edge, k3 weighed, EXAFS spectrum and 
C) the corresponding Fourier transform. The EXAFS is dominated by two contributions, the Fe-4S signal at 2.29 Å ±0.01 Å and the Fe-
3Fe signal at 2.74 Å ±0.01 Å. The Debye-Waller factors (2σ2) for these contributions were refined to 0.010 ±0.001 Å2 and 0.008 ±0.001 
Å2, respectively. EF was –3 eV ±1 eV. 
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transformation (FT) (Fig. 43 C). The high intensity of the main peak at about 2.3 Å in 
the FT points towards a homogenous first coordination sphere formed by sulfur ligands. 
The FT is very similar to the one observed for the [4Fe-4S]2+ clusters mentioned 
above.[123] Models based on the assumption of [4Fe-4S]2+ clusters resemble the data 
very well. All attempts to replace one of the sulfur ligands in the fit by light atoms such 
as oxygen or nitrogen lead to artificially long Fe-O/N distances. Thus, recognizable 
contributions above 10% of the average ligand sphere are excluded. The Fe-S distance 
of 2.29 Å and the Fe-Fe distances of 2.74 Å match the literature values for oxidized 
[4Fe-4S] clusters very well.[124] 
Conclusions and discussion 
_______________________________________________________________________ 
142 
4 Conclusions and discussion 
This section summarizes and discusses the results presented so far about the biochemical 
and biophysical characterization of the human protein ETHE1 and about the XAS 
analysis of the mononuclear [Fe]-hydrogenase Hmd from Methanocaldococcus 
jannascii, the (µ-oxo)-dicopper(III) species [Cu2L2(µ-O)2]I2 and the protein ABCE1 
from Sulfolobus solfataricus. 
4.1 Homo sapiens ETHE1 characterization 
The non-heme mononuclear-iron sulfur dioxygenase ETHE1 from Homo sapiens has 
been cloned and expressed in E. coli. The protein has been purified (purity > 98%) and 
characterized biochemically and biophysically. Both a robust and reproducible protocol 
for the production of HsETHE1 and its metal-free form have been developed.  
I demonstrate that the protein is sensitive to oxidizing conditions and requires non- thiol-
based reducing agents such as TCEP to don’t aggregate. With the help of this protocol, 
the protein can be stored for long periods at -80°C upon quick freezing in a buffer 
containing TCEP and glycerol. I proved by SLS, MS and crosslinking experiments (see 
par. 2.4.4, 5, 9) that HsETHE1 is a dimer in solution. No lactamase, phosphatase, aryl 
sulfatase and esterase activity has been detected for this enzyme. But, I discovered that 
HsETHE1 interacts with one of its supposed reaction products (GSH) gaining a light 
blue color. This change is detectable by UV-Vis. Apo-HsETHE1 has been titrated with 
metals. The experiments proved that the protein possesses high metal specificity. Under 
reducing conditions, it is able to bind with high affinity iron(III) in complex with NTA 
and with low affinity nickel ions. SAXS showed that HsETHE1 in solution is a dimer 
whose low resolution structure matches tightly the 3D structural model of AtETHE1. 
Moreover, SAXS showed that the metal-free protein is extremely sensitive to oxidizing 
conditions and that under reducing conditions it is no longer able to dimerize, forming 
chain like supramolecular structures from globular metal-free protein units. This means 
that, in vivo, cells must ensure that the protein is kept charged with iron, avoiding 
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protein aggregation and deposition. This might be achieved through a specific and still 
unknown metallo-chaperone. 
EXAFS revealed an octahedral iron-binding geometry. The iron ion coordinates a 2-
imidazole/1-carboxylate triad, which is typical of the non-heme mononuclear high spin 
iron(II) dioxygenases[35-37,105,114] and 3 oxygen atoms. Intriguingly, one of the 
coordinating oxygens is predicted to be at an atypically short distance, previously 
observed only in iron(III)-OH bonds, in the extradiol dioxygenase upon substrate 
binding, and in bidentate iron(II)-peroxo complexes.[36,37,105,114] XANES analysis 
showed an octahedral hexa-coordinated iron(II) high spin metal centre, which is 
consistent with the proposed EXAFS model. Mössbauer spectroscopy results exhibit the 
presence of two distinct states in which the protein seems to be in equilibrium. Both 
states correspond to octahedral high spin iron(II) ions coordinated by weak field ligands, 
which is in perfect agreement with the overall XAS analysis. The difference between the 
two states resides in the symmetry of the iron ion site. One state represents about the 
68% of the population and is geometrically more distorted. I also presented the potential 
enzymatic reaction mechanism, in which molecular oxygen is reduced and highly 
reactive glutathione persulfide species are oxidizes with formation of sulfite and reduced 
glutathione. In this mechanism, the iron is transiently oxidized to a ferric iron. 
Thus, HsETHE1 is a homodimeric [Fe]-dioxygenase. Its iron binding site possesses 
characteristics in common with other oxygen activating high spin mononuclear iron 
dioxygenases[36], but also unique features (short Fe-O distance). The mononuclear non-
heme high spin iron(II) enzymes bind and activate dioxygen to catalyze a variety of key 
biochemical transformations, including many of medical, pharmaceutical and 
environmental significance. These enzymes utilize high-spin iron(II) active sites and 
additional reducing equivalents from cofactors or substrates to couple the reduction of 
O2 and the dioxygenation of a substrate.[114] 
Besides, HsETHE1 in the presence of GSH has been studied by EXAFS. GSH is not 
only a product of ETHE1 reaction, but it is the major endogenous antioxidant produced 
by the cells of any organism.[125] The analysis showed the possibility that reduced 
glutathione directly binds to the iron ion by its sulfur atom in substitution of oxygen. 
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In conclusion, I elucidate the physical-chemical properties of a protein, which is a key 
element in the sulfur detoxification pathway and extremely important from the medical 
point of view due to its involvement in ethylmalonic encephalopathy, apoptosis and 
cancer. The gained knowledge on the ethylmalonic encephalopathy protein ETHE1 will 
be invaluable for attempts to further characterize this class of enzymes. In the future, it 
will be desirable to carry out further Mössbauer experiments aimed to investigate the 
ETHE1-GSH interaction and to study ETHE1 during its activity. Even if the turnover 
would be at low rate (~10%), Mössbauer spectroscopy is able to detect small traces of 
such species. Thereby, through spectral modifications we could understand the 
geometrical and electronic changes taking place during the reaction cycle. Moreover, 
obtaining the three dimensional structure of ETHE1 will allow describing in detail the 
reaction mechanism, the origin of the effects of the mutation found in ethylmalonic 
encephalopathy and the specifics of its interaction with protein partners. 
4.2 X-ray Absorption Spectroscopy applications and 
methods development  
The overall view of the results obtained about the biophysical characterization by XAS 
analysis of the [Fe]-hydrogenase jHmd, the tyrosinase-metal-binding-site mimicking 
compound [Cu2L2(μ-O)2]I2 and the protein ABCE1, are here presented and discussed. 
4.2.1 Mononuclear [Fe]-hydrogenase 
The XAS analysis carried out on the Hmd hydrogenase from Methanocaldococcus 
jannascii revealed an unique coordination and electronic structure of the iron ion at the 
enzyme’s active site. The coordination sphere is distorted octahedral and comprises two 
carbon monoxides, one sulfur ligand supplied by a cysteine residue in the protein, the 
FeGP cofactor, which binds the iron in a bidentate manner through a pyridinol nitrogen 
and an acyl carbon, and a solvent molecule at the site where the molecular hydrogen is 
supposed to bind. The cofactor coordination is unique. Unique because no biological 
system is known to exploit such iron-acyl interaction. Besides, the backbonding 
properties of the acyl monoxides together with the backbonding properties of the 
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cofactor (given by the acyl-pyridinol system) promote a strong electron delocalization at 
the iron ion, which is fundamental for the enzymatically active high spin state of the 
metal. In this scenario, while the two CO ligands ensure low-spin state, the arrangement 
of the other four donors tune the reactivity toward H2, which is activated at the labile site 
trans to the acyl ligand. Interestingly, an acyl group coordinating an enzyme’s metal has 
only been reported for the acetyl-CoA synthase/decarbonylase reaction as possible 
intermediate in the formation of acetyl-CoA from CO and a methyl group.[126,127] 
Here, the acyl group binds a nickel ion. 
In addition, I demonstrate the importance of the geometry and of the cofactor’s 
contributions to fine tune the sophisticated electronic structure of the iron ion. The 
geometrical distortion contributes to the molecular orbital fine energy splitting and the 
cofactor donors are essential to properly tune the orbitals energy levels. 
jHmd iron ion formal oxidation state has been matter of debate.[50] Both Mössbauer and 
XAS couldn’t supply a clear answer about the oxidation state of the iron because of the 
intrinsic ambiguity of the spectroscopic results. By XANES analysis, it has been 
possible to assign the oxidation state to 2+ that is also consistent with the iron’s XANES 
of the hydrogen-sensing [NiFe]-hydrogenase HoxC subunit from Ralstonia eutropha, 
which is accepted as iron(II).[128] 
The overall results supply novel and important knowledge about mononuclear 
hydrogenases iron sites and on molecular hydrogen activation in general. Hydrogenases 
have a reactivity at least comparable with that of platinum, which is used industrially to 
catalyze hydrogenation.[2,55] H2 is considered a major fuel in future energy technology, 
but the amounts of catalyst required for large scale H2 production and use will require 
alternatives to platinum, which is expensive and not abundant. One approach of current 
research is to learn from hydrogenases. The results of this work may provide a useful 
knowledge for designing new biomimetic catalysts aiming at cheaper and greener 
generation and utilization of H2.[55] A lot of effort is presently put on the creation of 
such biomimetic compounds. Recently, thanks to our collaborator T.H. we analyzed a 
novel iron-acyl-thiolato complex: the cyanide derivative 
Et4N[Fe(SPh)(Ph2PC6H4CO)(13CN)(CO)2] So far, this complex revealed striking 
similarities with the CN inhibited form of jHmd (data not shown). Moreover, several 
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model compounds mimicking the metal centers of hydrogenase and able to interact with 
protons and/or H2 have recently been reported.[129-133]  
4.2.2 [Cu2L2(µ-O)2]I2 exited state 
Optical excited molecules play an increasingly important role in research at light sources. 
We exploited two synergic approaches: pumped-XAS and an innovative combination of 
EXAFS spectroscopy and resonant Raman scattering, to structurally characterize the 
ground and the excited states of a complex mimicking the active site of tyrosinases: 
[Cu2L2(μ-O)2]I2. So far, the limited stability of such complexes restricted measurements 
to cryogenic temperatures, but [Cu2L2(μ-O)2]I2 is the first µ-oxo dicopper complex stable 
at room temperature. 
The pumped-XAS study shows that the X-ray transmission through the sample at the 
energy of 8990 eV increases immediately upon optical excitation, and the fluorescence 
signal follows with a few seconds delay. The reasons for these observations have been 
assigned to experimental artifacts, such as the increasing of the temperature due to UV 
light irradiation, protein precipitation and chemical reactivity of the compound solvent 
against the sample holder material or against the glue used to seal the cuvette. No other 
differences in the XANES could be detected upon irradiation because of a too low UV-
photon intensity. Hence, XAS might only be feasible with the help of a synchronized, 
pulsed UV-source.  
With resonance Raman scattering spectroscopy, the experiments can be performed at 
lower laser intensities because only the exited states contribute to the final signal. The 
Raman spectrum of [Cu2L2(μ-O)2]I2 exhibits strong vibrational excitations assigned to 
the bending vibration of the copper-oxygen core at 114.3 cm-1 and its integer multiples. 
The analysis shows that the copper-oxygen distance increases by +0.01 Å and the 
oxygen-oxygen distance decreases by -0.13 Å. This behavior has no temperature 
dependence. 
Whenever the local symmetry of the system allows such approach (in a centrosymmetric 
molecule, asymmetrical stretching and bending will be Raman inactive. In fact, only 
transitions where the polarizability of the molecule changes can be observed and a 
change in polarizability is compatible with preservation of the center of symmetry)[134], 
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resonant Raman spectroscopy is experimentally by far less demanding than pumped 
XAS experiments. Eventually, the combination of resonant Raman spectroscopy and X-
ray absorption spectroscopy can give direct access to structural and electronic 
parameters of optical excited systems. In future, resonance Raman experiments at copper 
M-edges at free electron laser sources such as FLASH (DESY, Hamburg, Germany) 
may provide novel information to further characterize the optical exited state of 
[Cu2L2(μ-O)2]I2. 
4.2.3 ABCE1 
ABCE 1 is essential for the viability of all eukaryotes and archaea due to its involvement 
in translation initiation and/or ribosome biosynthesis. ABCE1 is a unique ATP binding 
cassette protein superfamily because of the presence of Fe-S clusters. In this study, I 
determined the type and coordination of the Fe-S clusters in ABCE1 from Sulfolobus 
solfataricus.  
XAS demonstrates the presence of diamagnetic [4Fe-4S]2+ clusters. XANES showed 
that the clusters were in their oxidized state from comparison with known systems.[123] 
EXAFS is consistent with this. The analysis revealed a homogeneous coordination 
sphere of the iron ions formed by four sulfurs and three iron ions. The calculated Fe-L 
distances are matching very well the literature.[124] Recently, the X-ray structure of the 
complete ABCE1 protein from Pyrococcus abyssi at the nominal resolution of 2.8 Å has 
been solved (Protein Data Bank (PDB): 3BK7) (Fig. 9).[135] The reported atomic 
structure is in total agreement with our results. 
The fundamental role of ABCE1 in RNase L inhibition, HIV capsid maturation, 
translation initiation and ribosome biosynthesis,[61,62,64-66,136] suggests that the two 
essential diamagnetic [4Fe-4S]2+ clusters identified in this study are involved in 
recognition and modification of RNA assemblies. 
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5 Outlook 
1. Characterization of the [Fe]-dioxygenase ETHE1 from Homo sapiens 
I performed a biochemical and biophysical characterization of the human protein 
ETHE1. Several techniques have been applied for studying this enzyme fundamental for 
human development and likely for all metazoa and superior plants. The knowledge on 
HsETHE1 I gained here will be a solid basis for attempts to further characterize this 
class of enzymes. In future, it will be desirable to carry out Mössbauer spectroscopy 
experiments to study HsETHE1's iron site while the protein performs its activity. This 
will help understanding changes in the oxidation state and coordination sphere of the 
iron ion during substrate oxidation, providing further insights into HsETHE1's reaction 
mechanism and biological sulfur dioxygenation. Besides, Mössbauer spectroscopy can 
be applied to determine changes in the electronic structure of the iron ion in presence of 
the reaction product GSH. Studying on the atomic level HsETHE1 and the interaction 
with protein partners by X-ray crystallography or NMR may allow to describe in detail 
the reaction mechanism, the origin of the loss of function observed in ethylmalonic 
encephalopathy, and its roles inside the cell. Ultimately, the acquired knowledge may 
lead to the development of a therapy against ethylmalonic encephalopathy and inhibition 
of the enzyme might improve chemotherapy of liver cancer. 
2. X-ray Absorption Spectroscopy applications and method development 
Taking advantage of X-ray Absorption Spectroscopy, I in addition shed light on the 
physical-chemical properties of other highly interesting metalloproteins and model 
complexes, such as the [Fe]-hydrogenase (Hmd), the tyrosinase model complex 
[Cu2L2(μ-O)2]I2 and the ATP binding cassette protein ABCE1. Comprehend in detail the 
metal binding sites of these enzymes is a crucial challenge towards clean energy 
technology development (hydrogenases; low cost H2 production), understanding the 
nature of reactions involving charge transfer processes (tyrosinase model systems) and 
blocking HIV capsid assembly (ABCE1). 
2a. XAS on [Fe]-hydrogenase jHmd's iron site 
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Hydrogenases are catalysts with efficiency comparable to platinum, which is used 
industrially to catalyze hydrogenation. However, platinum is expensive and not 
abundant. H2 is considered a major fuel in future energy technology and the demand of 
catalyst for large scale H2 production will require alternatives to platinum. Learning 
from hydrogenases may provide the knowledge for designing new biomimetic catalysts 
aiming at cheaper and greener generation and utilization of H2. So far, three types of 
hydrogenases have been discovered. Despite they are not phylogenetically related and 
their different protein fold, the active sites reveal amazing similarities as result of 
convergent evolution presumably drift by special chemical requirements for H2 
activation. In all three types the iron (in [FeFe]- hydrogenase the iron proximal to the 
4Fe–4S cluster) is redox inactive, low-spin, in the oxidation state II and bound to at least 
one sulfur and three p-accepting ligands such as CO, cyanide and/or a pyridinol that are 
arranged similarly in a square-pyramidal or octahedral geometry. Our results supply 
novel and important information about mononuclear hydrogenases iron sites and on 
molecular hydrogen activation in general. In the future, would be desirable to proceed on 
the characterization of the electronic structure of Hmd iron by creating new inhibitors 
and new model compounds. Their state, activity and interactions can be studied by 
complementary techniques ,as it has been done so far and even beyond, exploiting in 
silico methods such DFT (Density Functional Theory). 
2b. Characterization of a tyrosinase model complex in its optical exited state 
We exploited two synergic approaches, pumped- XAS and an innovative combination of 
EXAFS spectroscopy and resonant Raman scattering, to structurally characterize the 
ground and the excited states of a complex mimicking the active site of tyrosinases: 
[Cu2L2(μ-O)2]I2, the first µ-oxo complex stable at room temperature. We determined the 
geometrical changes characterizing the same kind of electron transfer described for 
tyrosinases. This information can be used to understand the oxygenation process 
performed by these enzymes. In future, the experimental artifacts encountered in our 
pumped-XAS experiments must be overcome. In fact, while in resonance Raman 
scattering the experiments can be performed at lower laser intensities (only the exited 
states contribute to the final signal), effective pumped-XAS might only be feasible with 
the help of a synchronized, pulsed UV-laser source. Being able to perform such 
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experiments is desirable, because understanding reactivity on an atomic or orbital level 
plays an increasingly important role in research at light sources. The combination of 
resonant Raman spectroscopy and pumped X-ray absorption spectroscopy would give 
direct access to structural and electronic parameters of optical excited systems. The 
acquired knowledge can be used in advanced technology. Sundry applications can 
benefit from this research. For example, nanobiomedicine could improve the rational 
design of carriers that can be functional at target locations upon specific irradiation. 
Photoactivable enzymes, protein transporters, or channels can be selectively regulated 
by lasers. Cosmetics can improve the development of molecules able to efficiently 
protect against UV radiation. In general, the rational design of sensors able to couple a 
photoresponse with a specific activity can have a broad spectrum of application in 
modern technology. 
2c. X-ray Absorption Spectroscopy analysis of the unique ATP binding cassette 
protein ABCE1's iron-sulfur cluster: 
The ATP binding cassette protein ABCE1 is essential for the viability of all eukaryotes 
and archaea. Studying the functionality of ABCE1 can shed light on its activity in 
translation initiation, ribosome biosynthesis, HIV-capsid assembling and RnaseL 
inhibition. Because of the presence of Fe-S clusters, ABCE1 is also a unique ATP 
binding cassette superfamily protein. Exploiting XAS we revealed which type of Fe-S 
clusters the protein carries and their oxidation state. This is fundamental to understand 
the essential role of the 2 diamagnetic [4Fe-4S]2+ clusters identified in this study. 
Recently, the X-ray structure at 2.8 Å resolution of the complete ABCE1 protein from 
Pyrococcus abyssi has been solved (PDB: 3BK7). It starts to become evident that these 
clusters are involved in recognition and modification of RNA assemblies. Next step 
would be to characterize different electronic states for the protein by spectroscopycal 
methods and demonstrate at molecular level the mechanism of action of this enzyme. 
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6 Appendix A: material 
Chemicals for cloning 
• Agarose: purchased from Carl-ROTH. 
• AGE buffer: purchased from Carl-ROTH. 
• Ampicillin: purchased from Sigma Aldrich. 
• Antarctic phosphatase: purchased from NEB. 
• BSA: the Bovine Serum Albumin derived from NEB or Fermentas. 
• Chloramphenicol: purchased from Sigma Aldrich. 
• Competent bacterial strains: supplied internally by the lab. The different strains 
were propagated and made competent by internal members of the lab. Protocols 
for competent cells production can be commonly found on the web. 
• DNA ladders: 100bp and 1Kb ladders purchased from Fermentas and NEB. 
• dNTPs mix, ATPs, TTPs: purchased from NEB. 
• Ethidium bromide: purchased from Carl-ROTH. 
• Glycerol: purchased from Carl-ROTH. 
• Kanamicin: purchased from Sigma Aldrich. 
• LB-Agar: purchased from Carl-ROTH. 
• Luria-Bertani (LB) medium: purchased from Carl-ROTH. 
• Petri dishes: purchased from Greiner BioOne. 
• PfuTurbo-DNA polymerase: purchased from NEB. 
• Phusion-DNA-polymerase: purchased from Finnenzyme. 
• Plasmid vectors: supplied by the internal library managed by Dr. Arie Geerlof 
o pETM-11 (can fuse a tag at the N-terminal. The tag consists by a his6-tag 
and a TEV cleavable linker region). 
o pETM-13 (can fuse a 6-histidine tag at the C-terminal). 
o pETM-20 (can fuse a tag at the N-terminal. The tag consists by a Trx 
(thioredoxin enhancing solubility tag) moiety, a his6-tag and a TEV 
cleavable linker region. 
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o pETM-11_LIC (can fuse a tag at the N-terminal. The tag consists by a 
his6-tag and a TEV cleavable linker region). 
• Primers: purchased from Eurofins MWG Operon. 
• QuikChange Multi Site Directed Mutagenesis Kit chemicals: purchased from. 
• Restriction endonucleases type II: purchased from New England BioLabs (NEB) 
or Fermentas (NcoI, XhoI, PciI, XbaI, DpnI, BsaI). 
• SOC medium: purchased from Invitrogen. 
• Source clone: Homo sapiens ETHE1 full length cDNA clone was purchased 
from ImaGenes. The clone comes from a cDNA library of human eye 
retinoblastoma cell line. The gene has been supplied within DH10B TonA cells 
(E. coli) in a pCMV-SPORT6 vector. ID.: IRATp970H086D. 
• T4 DNA ligase and quick ligase: purchased from NEB. 
• T4-DNA-polymerase: purchased from NEB. 
• Taq-DNA-polymerase: purchased from NEB. 
 
Kits for cloning 
• Plasmid purification kit: purchased from Macherey Nagel. 
• Plasmid purification kit (mini prep): purchased from Qiagen. 
• PCR purification kit: purchased from Qiagen. 
• Gel extraction kit: purchased from Quiagen. 
• QuickChange multi site directed mutagenesis kit: purchased from Stratagene. 
 
Chemicals for protein expression 
• Ammonium iron(II) sulfate 6-hydrate : purchased from Riedel-de Haën. 
• Ammonium sulfate: purchased from Carl-ROTH. 
• Ampicillin (sodium salt): purchased from Carl-ROTH. 
• Chloramphenicol: purchased from Carl-ROTH. 
• Glucose: purchased from Carl-ROTH. 
• Glycerol: purchased from Carl-ROTH. 
• Isopropyl β-D-1 thiogalactopyranoside (IPTG): purchased from Carl-ROTH. 
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• Kanamycin (sulfate): purchased from Carl-ROTH. 
• Lactose: purchased from Carl-ROTH. 
• Luria-Bertani (LB) medium: purchased from Carl-ROTH. 
• Magnesium sulfate: purchased from Carl-ROTH. 
• Potassium di-hydrogen phosphate: purchased from Carl-ROTH. 
• Sodium chloride: purchased from Carl-ROTH. 
• Sodium hydrogen phosphate: purchased from Sigma Aldrich. 
• Terrific Broth (TB): purchased from Carl-ROTH. 
• Tryptone: purchased from Carl-ROTH. 
• Yeast extract: purchased from Carl-ROTH. 
 
Equipment for protein expression 
• Flasks: purchased from Schott/Duran (glass) or NALGENE (plastic). 
• Shakers Multitron: purchased from Infors. 
• Spectrophotometer cuvette: BRAND (Plastibrand). 
• Spectrophotometer: purchased from Eppendorf. 
 
Chemicals for protein purification 
• 2-(N-morpholino)ethanesulfonic acid (MES): purchased from Carl-ROTH. 
• 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): purchased from 
Carl-ROTH. 
• Acetic acid (CH3COOH): purchased from Carl-ROTH. 
• Acrylamide: purchased from Carl-ROTH. 
• Ammonium persulfate (APS): purchased from Carl-ROTH. 
• BisTris: purchased from Carl-ROTH. 
• Brilliant blue G (coomassie): purchased from Sigma Aldrich. 
• Bromophenol blue: purchased from Merck. 
• Chelex 200 (divalent cations unspecific chelator): purchased from BioRad. The 
chelex version with the bigger beads has been used in order to facilitate the 
filtration of the treated solution. 
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• Deferoxamine mesylate: purchased from Sigma Aldrich. 
• Disodium hydrogen phosphate (Na2HPO4): purchased from Sigma Aldrich. 
• Dithiotreithol (DTT): purchased from Carl-ROTH. 
• Ethanol (CH4CH3OH): purchased from Carl-ROTH. 
• Ethylenediaminetetraacetic acid (EDTA): purchased from Carl-ROTH. 
• Glycerol: purchased from Carl-ROTH. 
• Glycine: purchased from Carl-ROTH. 
• Hydrogen Chloride (HCL): purchased from Carl-ROTH. 
• Imidazole: purchased from Carl-ROTH. 
• Methanol (CH3OH) : purchased from Carl-ROTH. 
• N,N,N’,N’-tetramethylethylenediamine (TEMED): purchased from Carl-ROTH. 
• NuPAGE protein dye: purchased Invitrogen. 
• Phenanthroline: purchased from Fluka. 
• Protein ladder: purchased from NEB. 
• Sodium ascorbate: purchased from Sigma Aldrich. 
• Sodium chloride (NaCl): purchased from Carl-ROTH. 
• Sodium dihydrogen phosphate (NaH2PO4): purchased from Sigma Aldrich. 
• Sodium dithionite: purchased from Fluka. 
• Sodium dodecyl sulfate (SDS): purchased from Carl-ROTH. 
• Sodium hydroxide (NaOH): purchased from Carl-ROTH. 
• Tobacco Etch Virus protease (TEV): produced internally by Arie Geerolf or by 
single users. Protocols for TEV production can be commonly found on the web. 
• Tricine: purchased from Omni Life Science. 
• tris(2-carboxyethyl)phosphine (TCEP): purchased from Soltec Ventures. 
• Trizma base (tris): purchased from Carl-ROTH. 
• Urea: purchased from Carl-ROTH. 
• Β-mercaptoethanol: purchased from Sigma Aldrich. 
 
Buffers for protein purification 
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All the buffers were filtered by a 0.22 µm cut-off membrane and degassed before usage. 
The following buffers have been applied during the purification steps (X 1 L): 
 
• Buffer A: 
o 4.4 mL NaH2PO4 0.4 M 
o 78.9 mL Na2HPO4 0.4 M 
o NaCl 200 mM 
o Imidazole 20/50 mM 
o Fine adjust to pH 8.0 with HCl/NaOH 
o Add water up to 1 L 
 
This is a PBS buffer with a final 50 mM concentration of phosphate. The pH is given by 
the ratio between monobasic and dibasic phosphate. 
 
• Buffer B: 
o 4.4 mL NaH2PO4 0.4 M 
o 78.9 mL Na2HPO4 0.4 M 
o NaCl 200 mM 
o Imidazole 500 mM 
o Fine adjust to pH 8.0 with HCl/NaOH 
 
• Buffer C: 
o NaH2PO4 4.4 mL 0.4 M 
o Na2HPO4 78.9 mL 0.4 M 
o NaCl 1M mM 
o Fine adjust to pH 8.0 with HCl/NaOH 
 
• Buffer S: 
o Tris-HCL 20/50 mM 
o NaCl 100/150 mM 
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o TCEP 1/2 mM 
o Adjust  to pH 8.0 with HCl 
o The buffer is incubated o/n with chelex at 4°C under stirring. This step 
avoids the presence of transition metal contaminants in the protein 
solution. 
 
• Buffer H: 
o HEPES 50 mM 
o NaCl 100 mM 
o TCEP 1 mM 
o Adjust the pH to 8.0 (wild type) or 7.2 (mutants: this is due to the change 
in the isoelectric point  with NaOH. 
o The buffer is incubated o/n with chelex at 4°C under stirring. This step 
avoids the presence of transition metal contaminants in the protein 
solution. 
 
• Buffer Apo: 
o TrisHCL 100 mM 
o Urea 4M 
o NaCl 200mM 
o Deferoxamine mesylate 50 mM (solubilized freshly in the fraction to be 
used) 
 
Equipment for protein purification 
• AKTA purifiers (several distributions): purchased from Amersham Bioscience. 
• Polyacrylamide gels caster: designed by Dr. Young-Hwa Song and produced by 
the EMBL-Hamburg workshop. 
• Centrifuge (J-20 XP): purchased from Avanti. 
• Chromatographic columns (HiTrap IMAC HP 5 mL; HiLoad 16/60 Superdex 75; 
HiLoad 16/60 Superdex 200): purchased from Amersham Bioscience. 
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• Concentrators (Amicon, Centricon): Sartorius Stedim and Millipore. 
• Disposable filtering units for solution filtering and degassing (Steritop): 
purchased from MILLIPPORE. 
• Disposable filters for syringe (0.45 and 0.22 µm cut-off): purchased from Carl-
ROTH, Sartorius Stedim and Millex GP. 
• Filtering unit for solution filtering and degassing: purchased from NALGENE. 
• Filters for filtering units (J-Cat): purchased from Sartorius Stedim. 
• Microfuges (5415 R and Minispin): purchased from Eppendorf. 
• Peristaltic pump: purchased from Pharmacia. 
• Poly-Acrylamide Gel Electrophoresis (PAGE) apparatus: purchased from 
Invitrogen. 
• Sonicator (Sonoplus): purchased from BANDELIN. 
• Spectrophotometer Nanodrop: purchased from Thermo Scientific. 
• Stirrers: purchased from IKMAG RCT, Heidelph and Thermo Scientific. 
• Syringes: purchased from Henke-Sass Wolf. 
• Ultracentrifuge (RC26 Plus): purchased from Sorvall. 
 
Chemicals used for Poly Acrylamide Gel Electrophoresis (PAGE) 
• 2-(N-morpholino)ethanesulfonic acid (MES): purchased from Carl-ROTH. 
• 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES): purchased from 
Carl-ROTH. 
• Acetic acid (CH3COOH): purchased from Carl-ROTH. 
• Acrylamide: purchased from Carl-ROTH. 
• Ammonium persulfate (APS): purchased from Carl-ROTH. 
• BisTris: purchased from Carl-ROTH. 
• Brilliant blue G (coomassie): purchased from Sigma Aldrich. 
• Bromophenol blue: purchased from Merck. 
• Dithiotreithol (DTT): purchased from Carl-ROTH. 
• Ethylenediaminetetraacetic acid (EDTA): purchased from Carl-ROTH. 
• Ethanol (CH4CH3OH): purchased from Carl-ROTH. 
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• Glycerol: purchased from Carl-ROTH. 
• Glycine: purchased from Carl-ROTH. 
• Methanol (CH3OH) : purchased from Carl-ROTH. 
• N,N,N’,N’-tetramethylethylenediamine (TEMED): purchased from Carl-ROTH. 
• NuPAGE protein dye: purchased Invitrogen. 
• Protein ladder: purchased from NEB. 
• Sodium dodecyl sulfate (SDS): purchased from Carl-ROTH. 
• Tricine: purchased from Omni Life Science. 
• Trizma base (tris): purchased from Carl-ROTH. 
 
Buffers and solutions for PAGE 
• Tricine running buffer (1 L 10X) 
o tris 121 g 
o Tricine 179 g 
o SDS 10 g 
o H2O up to 1 L 
 
o Tricine separating gel buffer (pH 8.5) 
o Tris 3M 
o SDS 0.3% 
 
• Tricine gradient gels (X10 gels) 
o Solution L (8%) 
? Tricine gel buffer 13 mL 
? A40 (Acrylamide 40%) 10 mL 
? H2O 27 mL 
? TEMED 50 µL 
? APS 10% 510 µL 
o Solution H (20%) 
? Tricine gel buffer 13mL 
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? A40 25 mL 
? H2O 8 mL 
? Glycerol 4 mL 
? TEMED 50 µL 
? APS 10% 510 µL 
 
o Glycine gel running buffer (1 L, 10X, pH 8.3/8.6) 
o Tris 30 g 
o Glycine 144 g 
o SDS 10 g 
o H2O up to 1 L 
 
• Glycine separating gel buffer (15% X2 gels) 
o Lower buffer 2.2 mL. For the preparation of 200 mL of Lower buffer pH 
8.8: 
? Tris 36g 
? SDS 0.8 g 
? H2O up to 200 mL 
o A40 3.1 mL 
o H2O 3.2 mL 
o TEMED 5 µL 
o APS 10% 50 µL 
 
• Glycine stacking gel buffer (x2 gels) 
o Upper buffer 1.25 mL. For the preparation of 200 mL of Lower buffer: 
? Tris 12 g 
? SDS 0.8 g 
? pH 6.8 
? H2O up to 200 mL 
o A40 0.5 mL 
o H2O 3 mL 
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o TEMED 5 µL 
o APS 10% 25 µL 
 
• Bis-tris gel running buffer (1 L 20X) 
o MES 195 g 
o Tris 121 g 
o SDS 20 g 
o EDTA 6 g 
o H2O up to 1 L 
 
• Bis-tris separating gel buffer (15% X10 gels) 
o Bis-tris (1.6 M, pH 6.8) 25 ml 
o SDS 10% 1 mL 
o H2O 36 mL 
o A40 37.5 
o TEMED 50 µL 
o APS 500 µL 
 
• Bis-tri stacking gel buffer 
o Bis-tris (1 M, pH 6.3) 7.5 mL 
o SDS 10% 1 mL 
o H2O 23.25 mL 
o A40 4.6 mL 
o TEMED 30 µL 
o APS 300 µL 
 
• Gel staining solution (600 mL) 
o Ethanol 272 mL 
o Acetic acid 55 mL 
o Brilliant blue G (coomassie) 0.6 g 
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o H2O 272 mL 
 
• Gel destaining solution (1 L) 
o Acetic acid 75 mL 
o Methanol 50 mL 
o H2O 875 mL 
 
• Protein loading dye (20 mL FBS dye 5X, pH 6.8) 
• Tris HCl 250 mM 
• DTT 500 mM 
• SDS 10% 
• Bromophenol blue 0.5% 
• Glycerol 50% 
Alternatively the Invitrogen NuPAGE protein loading dye has been used. 
 
Material for Dynamic Light Scattering (DLS) 
• Apparatus: DynaPro99 purchased from PROTEIN SOLUTIONS, now available 
from Wyatt Technologies. 
• UV sample cuvettes: purchased from PROTEIN SOLUTIONS. 
• Dynamics 5.26: supplied with the apparatus by PROTEIN SOLUTIONS. 
• Microfuges (5415 R and Minispin): purchased from Eppendorf. 
• Disposable filters for syringe (0.45 and 0.22 µm cut-off): purchased from Carl-
ROTH, Sartorius Stedim and Millex GP. 
 
Material for protein stability investigation 
• Dithiotreithol (DTT): purchased from Carl-ROTH. 
• Β-mercaptoethanol: purchased from Sigma Aldrich. 
• Sodium dithionite: purchased from Fluka. 
• tris(2-carboxyethyl)phosphine (TCEP): purchased from Soltec Ventures. 
• Sypro Orange protein stain: purchased from Invitrogen. 
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• Thermofluor device: MyiQ RT-PCR thermo cycler machine adapted to 
thermofluor functionality. Purchased from BioRad. 
• Thermofluor 96 condition plate (96 well plate with a different buffer condition 
per well): prepared internally by lab technicians. 
• Microfuges (5415 R and Minispin): purchased from Eppendorf. 
• Apparatus: DynaPro99 purchased from PROTEIN SOLUTIONS, now available 
from Wyatt Technologies. 
• UV sample cuvettes: purchased from PROTEIN SOLUTIONS. 
• Dynamics 5.26: supplied with the apparatus by PROTEIN SOLUTIONS. 
• Optical microscope Leica MZ 16: purchased from Leica. 
 
Materials for Static Light Scattering (SLS) 
• miniDAWN apparatus: purchased from Wyatt Technologies. 
• Software ASTRA 5.3.4.11. 
• Microfuges (5415 R and Minispin): purchased from Eppendorf. 
• AKTA purifier (several distributions): purchased from Amersham Bioscience. 
• Analytical gel filtration column: purchased from Amersham Bioscience. 
 
Material used for crosslinking experiments 
• 2 mg/mL protein samples: protein as isolated with and without TCEP, apo-
protein. The buffers without free ammines should be preferred (e.g. HEPES and 
PBS are ok, TrisHCl should be avoided. 
• BSA 2 mg/mL sample as negative-interaction control: various sources (e.g. NEB) 
• Glutaraldehyde stock solution (25%): purchased from Sigma Aldrich. 
• UV transilluminator:  purchased from Vilbert Lourmat. 
 
Material for Total X-ray Reflection Fluorescence (TXRF) 
• PicoTAX Automatic: purchased from Röntec, Berlin, Germany. The PicoTAX is 
a cooling-free portable bench-top device. It operates with an air-cooled Mo based 
tube working at 40 KeV, 1 mA. It contains a compact fine-focus x-ray tube 
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specially constructed in metal-ceramics. The x-ray beam is focused by a Ni/C-
multi layer monochromator.  The detector is a Peltier-cooled XFlash, 10 mm2 
with a resolution of 160 eV. Its power consumption is about only 180 Ws. 
• PicoTAX software: modular software used for the device control, spectra 
collection, calibration. 
• Python script for data conversion: written by Dr. Gerd Wellenreuther to convert 
files with spx extension (PicoTAX outputs) to files mca (readable by the PyMCA 
program). 
• PyMCA program: python based program for data analysis and freely available on 
the web.[137] 
• Python script for the tabulation of PyMCA output values: written by Dr. Gerd 
Wellenreuther to create a single table from the individual output values generate 
by PyMCA calculations for each specimen. 
• Plexus: ultra-flat round-shaped plexyglass samples trays (1.5 mm Ø x 3 mm) 
manufactured by the EMBL-Heidelberg work shop. 
• Standards: purchased from Bernd Kraft GmbH. 
o ICP-Standard Gallium 1.000 g/L 
o ICP-Standard Scandium 1.000 g/L 
 
Material for Isothermal Titration Calorimetry (ITC) 
• Microfuges (5415 R and Minispin): purchased from Eppendorf. 
• Disposable filters for syringe (0.45 and 0.22 µm cut-off): purchased from Carl-
ROTH, Sartorius Stedim and Millex GP. 
• 2 mL of freshly dialyzed protein solution 20/50 µM. 
• Metal solution 0.1/1 mM: use the protein dialysis buffer for preparation. 
• ITC apparatus and relative accessories (VP-ITC MicroCalorimeter): purchased 
from Microcal. 
• VPviewer software (to run the experiment): supplied with the ITC machine. 
• Origin analysis software (for data analysis): supplied with the ITC machine. 
• Ammonium iron(II) sulfate 6-hydrate : purchased from Riedel-de Haën. 
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• Dithionite sodium salt: purchased from Fluka. 
• Iron(III) citrate: purchased from CarlROTH. 
• Nitrilo Triacetic Acid (NTA): purchased from CarlROTH. 
• Nickel(II) sulfate: purchased from CarlROTH. 
• Zinc(II) chloride: purchased from CarlROTH. 
• Manganese(II) chloride tetrahydrat: purchased from CarlROTH. 
• Reduced glutathione: purchased from Sigma Aldrich. 
 
Material for spectrophotometry 
• Spectrophotometer cuvette: BRAND (Plastibrand). 
• Spectrophotometer: purchased from Eppendorf. 
• Spectrophotometer Nanodrop: purchased from Thermo Scientific. 
 
Material for Mass Spectrometry (MS) 
• Mass spectrometry experiments have been carried out at EMBL-Hamburg with a 
Voyager-DE STR apparatus purchased from Applied Biosystems. This is a 
MALDI-TOF (Matrix Assisted Laser Desorption and Ionization with Time Of 
Flight) type machine. 
• The Voyager software has been used for data collection and analysis. 
• Sample grid-plates: supplied by Applied Biosystem with the machine. 
• Sinapic acid (SAPA): purchased from Fluka. 
• Acetonitrile: purchased from Carl-ROTH. 
• Tri-fluoroacetic acid (TFA): purchased from Merk. 
• Protein sample in salt-free buffer at a concentration of 0.5-2 mg/mL. 
 
Material for Circular Dichroism (CD) 
• CD apparatus: JASCO-810 (JASCO corporation). 
• Quarz UV-cuvettes : purchased from JASCO. 
• Analysis software: JASCO software. 
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Materials for crystallization 
• EMBL crystallization facility.[77] 
• Bio-robot for solution preparation: Lissy 2002 purchased form Zinsser Analytic. 
• Pipetting robot: HYDRAII+I purchased from MATRIX. 
• Plates sealing robot: RoboSeal robot purchased from HJ-Bioanalytik. 
• EMBL crystallization facility chemicals for crystallization reservoir solutions: 
purchased from Fluka. A list of the stock solutions is available at 
http://intranet.embl-
hamburg.de/facilities/external_facilities/htpx/stocks_HTX.xls. 
• Chemicals for manual crystallization trays preparation: 
o Magnesium chloride, magnesium formate, tris, bis-tris, Poly Ethylene 
Glycol (PEG 3350, PEG 6000, MME 5000, MME 2000, 8000), 
magnesium sulfate, zinc acetate, HEPES, MES, sodium, malonate, zinc 
sulfate, zinc acetate, ammonium sulfate, succininc acid, ammonium 
acetate, MPD, purchased from Carl-ROTH. 
 
Material for reductive methylation 
• Dimethylamine-borane complex: purchased from Fluka. 
• Formaldehyde: purchased from Sigma Aldrich. 
 
Construct and screens used for crystallization 
• Every plate, except the manual ones, contains 96 conditions. 
• The protein used was ∆14HsETHE1 unless specified. 
• Incubation occurs at 19°C unless specified. 
• 1mM = ~ 25mg/ml. 
• Asiso = HsETHE1 as isolated. 
• Apo = apo-HsETHE1. 
• Met = Reductively methylated protein. 
• His-tagged = HsETHE1 not processed with TEV protease and thus still bearing 
the histidine tag. 
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• 14E4 = Δ14-HsETHE1-Δ4. 
• 19E4 = Δ19-HsETHE1-Δ4. 
 
For each condition 0.5 µL protein drops are mixed with 0.5 µL of reservoir solution.  
Screens: 
 
• HR_Index  
o Asiso 2mM; 1mM; 10mg/ml; 1mM 4°C 
o Apo 1mM 
o Red 1mM 
o Met 20mg/ml; 10 mg/ml 
o His-tagged 1mM 
o 14E4 1mM; 10mg/ml 
o 19E4 1mM; 10mg/ml 
• HR_Crystal  
o Asiso 2mM; 1mM; 10mg/ml; 1mM 4°C 
o Apo 1mM 
o Red 1mM 
o Met 20mg/ml; 10 mg/ml 
o His-tagged 1mM 
o 14E4 1mM; 10mg/ml 
o 19E4 1mM; 10mg/ml 
• HR_Grid  
o Asiso 1mM; 1mM 4°C 
o Apo 1mM 
o Red 1mM 
• Nx_Cryo  
o Asiso 1mM; 1mM 4°C 
o Jena 1-4 
o Asiso 1mM 
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• Jena 5-8 
o Asiso 1mM 
• Jena 9-10 
o Asiso 1mM 
• Optimizations plates 
o Asiso, 192 conditions 1mM; 10mg/ml 
o Asiso, 192 conditions 1mM 
o Asiso, 192 conditions 40mg/ml; 10mg/ml 
• Manual optimization: For each condition 0.5 µL protein drops are mixed with 0.5 
µL of reservoir solution. 
o Asiso, 144 conditions 1mM; 1mM 4°C 
 
Material for substrate screening 
• UV-96-well-plates: purchased from Greiner. 
• Ammonium iron (II) sulfate (6-hydrate): purchased from Riedel-de Haën. 
• Ethylenediaminetetraacetic acid (EDTA): purchased from Carl-ROTH. 
• Enzymes: 
o ZiPD protein: MβL-like protein with phosphodiesterase activity. It has 
been obtained from an old stock of my group kept at -80°C. 
o Penicillinase type III: is a lactamase, purchased from Sigma Aldrich. 
o Antarctic phosphatase: purchased from Sigma Aldrich. 
o Aryl-sulfatase type VIII: purchased from Sigma Aldrich. 
o Esterase: purchased from Sigma Aldrich. 
• Cromogenic substrates: for qualitative analysis you don’t need a plate reader, the 
reaction can be followed optically. 
o Nitrocefin: substrate of any lactamase. It is light sensitive and should be 
handled in a dark place. It has been purchased from Sigma Aldrich. The 
compound turns from yellow to red upon hydrolysis and absorbs at 486 
nm. The compound must be dissolved in di-methyl sulfoxide (DMSO). 
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o bis-p-nitrophenyl phosphate (bpNPP): substrate of phosphodiesterases, 
purchased from Sigma Aldrich. One of the products (p-nitrophenyl) 
absorbs at 405 nm. 
o p-nitrophenyl phosphate (pNPP): substrate of the phosphatases, 
purchased from Sigma Aldrich. The product (p-nitrophenyl) absorbs at 
405 nm. 
o p-nitrochatecol sulfate: substrate of the aryl-sulfatase, purchased from 
Sigma Aldrich. The product (p-nitrophenyl) absorbs at 405 nm. 
o p-nitrophenyl sulfate: substrate of the aryl-sulfatase, purchased from 
Sigma Aldrich. The product (p-nitrophenyl) absorbs at 405 nm. 
o Glucose-3-sulfate: negative control. No color change should be detected. 
o p-nitrophenyl acetate: substrate of the esterase, purchased from Sigma 
Aldrich. The product (p-nitrophenyl) absorbs at 405 nm. 
• Buffers: 
o TrisHCL 50 mM, NaCl 100 mM, TCEP 1mM, pH 8.5. 
o PBS buffer (phosphate buffer), NaCl 100 mM, pH 7.2. 
 
Materials for Small Angle X-ray Scattering (SAXS) 
• The data were collected at the EMBL beamline X33 of the storage ring DORIS 
III (DESY, Hamburg, Germany). We used a photon counting Pilatus 1M detector 
placed at a distance of 2.7 m. The incoming x-ray had a  wavelength of λ = 1.5 Å, 
the range of momentum transfer 0.01 < s < 0.6 Å-1 was covered (s = 4π sinθ/λ, 
where 2θ is the scattering angle). 
 
X-ray Absorption Spectroscopy (XAS) beamlines 
 
DESY (Deutsches Elektronen-SYnchrotron): DORIS III accumulation ring: 
 
Beamline E4 
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The EXAFS II beamline is designed to achieve a focused, high intensity photon beam in 
the energy range from ~2.8 keV to ~11 keV and is predominantly used for X-ray 
absorption spectroscopy. The layout of the beamline is schematically shown in the Fig. 2. 
   The beamline is equipped with two mirrors. The first mirror, which is situated half 
way between the source and the sample, collects ~30% of the bending magnet radiation 
vertically and 4 mrad horizontally and focuses it onto the sample with a magnification of 
~1x. The second mirror (a plane mirror) is coated with three stripes (C, Ni, Au) to 
achieve the optimum higher order reduction at different energies. 
 
 
Beamline parameters  
Source (4.5 GeV) bending magnet, Ec=16.6 keV
beam size 1.3 x 3.0 mm FWHM
vert. electron beam divergence 0.06 mrad 
FWHM. 
Mirrors 1. toroidal mirror with Au-coating, 1:1 
focusing. 
2. plane mirror with C-, Ni- or Au-coating 
(7 mrad incidence/exit angle for both 
mirrors). 
Monochromator Si(111) double crystal (+/-) (UHV)
Digital-MOSTAB feedback system and 
water cooling on first crystal. 
Detectors Ionisation chambers in front of and behind 
experimental chamber and reference 
chamber. 
Energy range 2.8 - 5 keV (C-mirror)
4.5 - 8.5 keV (Ni-mirror)
8 - 11.0 keV (Au-mirror). 
Flux at sample 1010 photons/s/mm2 (4.5 GeV, 100mA). 
Appendix A: material 
_______________________________________________________________________ 
170 
Energy resolution 0.8 eV at 3.2 keV. 
 
 
Beamline C1 
Beamline C is dedicated to bulk X-ray absorption spectroscopy experiments at energies 
between 5 and 43 keV. It is equipped with a fixed-exit double-crystal monochromator 
suitable for step-by step energy scans and quick continuous energy scanning (QEXAFS). 
Gas lines and a supervision system allow for in-situ experiments and the handling of 
toxic/reactive gases. In addition, the experimental station is equipped with a vertical 
diffractometer which can be used for DAFS (diffraction anomalous fine structure) and 
diffraction experiments. Besides monochromatic applications, the white beam may be 
used. The large hutch area enables the installation of specific user set-ups e.g. for X-ray 
standing-wave experiments. 
 
Beamline parameters  
Source Bending magnet. 
Monochromator 2 .0x 10-4     Si[111] 
Energy range 2.4 - 43.4 keV. 
Flux 109 ph/mm2/10-4BW at 9 keV. 
 
Beamline D2 
This is the former EMBL-Hamburg outstation XAS beamline. Presently, it is not 
operational anymore. The D2 beamline worked at energy from 5 to 40 GeV. It used a 
Si[111]- or Si[311]-monochromator, a toroidal segmented focusing Au-coated mirror 
with an angle of incidence of ~ 3.8 mrad and cut-off energy of 21.5 keV and a Canberra 
13-elements germanium solid-state detector. 
 
SLS (Swiss Light Source): 
 
Beamline SuperXAS 
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X10DA is a dedicated beamline to X-ray Absorption Spectroscopy (XAS) in the applied 
science. 
 
Beamline parameters  
Monochromator Double Crystal Monochromator (DCM) 
for normal XAFS scanning mode . 
Quick scanning monochromator 
(QEXAFS) for time resolved scanning 
mode (few ms to sec). 
Detector 13 element Ge detector with fast digital 
amplifiers. 
Energy range 4.5 - 35      keV. 
Flux 1 x 1012      ph/s/400 mA. 
Energy resolution 2 .0x 10-4     for Si[111]
0.5 x 10-4     for Si[311] 
 
ESRF (European Synchrotron Radiation Facility): 
 
Beamline BM26A 
BM26A is designed to perform high quality XAFS measurements in a broad range of 
elements and samples.. The high-brilliance X-ray beam allows for absorption studies on 
very dilute samples. X-ray emission spectroscopy is performed by means of a crystal 
spectrometer. By combining the tuneable incident energy with an emission spectrometer, 
advantage of resonance effects that can provide detailed information on the electronic 
structure is taken. BM26A is equipped for different sample environments to perform in 
situ studies and we can adapt to a variety of user experimental stations. 
The local coordination and electronic structure of an X-ray absorbing atom are studied 
by Extended X-ray Absorption Fine Structure (EXAFS) and X-ray Absorption Near 
Edge Structure (XANES) spectroscopy.  
Beamline parameters  
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Source Bending magnet 
Mirrors Meridionally focusing mirror with either 
an Si or Pt coating  
Monochromator Double-crystal monochromator. 
Monochromator crystals:  Si[111] and 
Si[311]. 
 
Detector Three low noise ion chambers Oxford 
Instruments for transmission experiments 
at high concentrations. 
A 9-element monolithic Ge detector with a 
max. count rate per element ~150kHz and 
an energy resolution < 250 eV at 5.9 keV 
for fluorescence measurements at low 
concentrations. 
A position sensitive INEL CPS 590 
detector for combined WAXS / XAFS 
measurements. 
A MarCCD 165 detector. 
Energy range 4.9 - 32 keV. 
Flux 1 × 1011 photons/sec. 
Energy resolution dE/E of 2 × 10-4 
 
SSRL (Stanford Synchrotron Radiation Lightsource): 
This beamline is specifically dedicated to biological x-ray absorption spectroscopy. 
 
Beamline BioXAS BM7-3 
Beamline parameters  
Source 20-pole, 2-Tesla wiggler, 0.8 mrad beam, 
side station 
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Mirrors M0 mirror: Flat, bent, vertically 
collimating, 1 m, Si, Rh-coated, LN2 
cooled monochromator. 
Monochromator Si[220] phi=0°, Si[220] phi=90° double-
crystal, non-fixed exit slit. 
Detector 30-element Ge detector array LHe cryostat 
(4-200 K) Ion chambers, PIPS detector. 
Energy range 4.6 - 37 keV 
Flux 1012 ph/sec @100 mA / 9 keV w 2x15 mm 
aperture. 
Energy resolution 104 DE / E 
 
Molecular visualization programs 
PyMol 2r1 (http://www.pymol.org/): user-sponsored molecular visualization system on 
an open-source foundation. PyMol is a molecular viewer, render tool, and 3D molecular 
editor intended for visualization of 3D chemical structures including atomic resolution 
X-ray crystal structures of proteins, nucleic acids (DNA, RNA, & tRNA), and 
carbohydrates, as well as small molecule structures of drug leads, inhibitors, metabolites, 
sugars, nucleoside phosphates, and other ligands including inorganic salts and solvent 
molecules.  
 
DS Visualizer 2.5 (http://accelrys.com): molecular visualization software. 
The program features: 
• Simultaneous data views (3D graphics, sequences, charts, graphics, data tables). 
• Standard file-format support (3D structures, SMILES, sequences, graphics). 
• Structure building, editing, and analysis functionality. 
• Scripting capabilities (for automating molecular manipulation workflows). 
• High-quality graphic rendering and visual adjustment functionality. 
• Access to expert-level modeling and simulation functionality, as well as shared 
custom protocols. 
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RasMol 2.7 (http://rasmol.org/): RasMol is a molecular graphics program intended for 
the visualization of proteins, nucleic acids and small molecules. Supported input file 
formats include Protein Data Bank (PDB), Tripos Associates' Alchemy and Sybyl Mol2 
formats, Molecular Design Limited's (MDL) Mol file format, Minnesota Supercomputer 
Center's (MSC) XYZ (XMol) format, CHARMm format, CIF format and mmCIF format 
files. 
 
Spdbv 4.0 (http://spdbv.vital-it.ch/): Swiss-PdbViewer (aka DeepView) is an application 
that provides a user friendly interface, allowing the analysis of several proteins at the 
same time. The proteins can be superimposed in order to deduce structural alignments 
and compare their active sites or any other relevant parts. Amino acid mutations, H-
bonds, angles and distances between atoms are easy to obtain thanks to the intuitive 
graphic and menu interface. 
 
UCSF Chimera (http://www.cgl.ucsf.edu/chimera/): UCSF Chimera is a highly 
extensible program for interactive visualization and analysis of molecular structures and 
related data, including density maps, supramolecular assemblies, sequence alignments, 
docking results, trajectories, and conformational ensembles. High-quality images and 
animations can be generated. 
 
VMD (http://www.ks.uiuc.edu/Research/vmd/): VMD is designed for modeling, 
visualization, and analysis of biological systems such as proteins, nucleic acids, lipid 
bilayer assemblies, etc. VMD can be used to animate and analyze the trajectory of a 
molecular dynamics (MD) simulation. In particular, VMD can act as a graphical front 
end for an external MD program by displaying and animating a molecule undergoing 
simulation on a remote computer. 
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7 Appendix B: abbreviations 
Å: Angstrom 
A40: Acrylamide 40% 
aa: aminoacids 
ABC: ATP Binding Cassette 
ABCE1: ATP-binding cassette, sub-family E (OABP), member 
ACV: isopenicilline-N from ä-(L-R-aminoadipoyl)-L-cysteinyl-D-valine 
AGE: Agarose Gel Electrophoresis 
AIM: Auto Inducing Media 
APS: Ammonium PerSulfate 
Asp: aspartate 
AtETHE1: Arabidopsis thaliana ETHE1 
BioXAS: Biological XAS 
BVS: Bond Valence Sum 
bpNPP: bis-p-nitrophenyl phosphate 
CD: Circular Dichroism 
CDO: Cysteine Dioxygenase 
CN: CyaNide 
CO: Carbon Monoxide 
COX: Cytochrome c Oxidase 
CV: Column Volume 
dNTP: deoxy Nucleotide Three Phosphate 
DTT: dithiotreithol 
EDTA: ethylenediaminetetraacetic acid 
EE: Ethylmalonic Encephalopathy 
EMA: EthylMalonic Aciduria 
EPR: Electron Paramagnetic Resonance 
ETHE1: Ethylmalonic Encephalopathy protein 1 
eV: electron volts 
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EXAFS: Extended X-ray Absorption Fine Structure 
FeGP: iron-guanylyl pyridone cofactor 
FI: Fit-Index 
FT: Fourier Transform 
GIFtS: gene card identifier 
GSH: reduced glutathione 
GSSH: glutathione perulfide 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
His: histidine 
HSCO1: Hepatoma Subtracted Clone One 
HsETHE1: Homo sapiens ETHE1 
IMAC: Immobilized Metal Affinity Chromatography 
IPTG: Isopropyl β-D-1 thiogalactopyranoside 
IR: Infra Red 
IS: Isomeric Shift 
ITC: Isothermal Titration Calorimetry 
LB: Lauria Bertani culturing medium 
LIC: Ligase Independent Cloning 
LN: Liquid Nitrogen 
MALDI-TOF: Matrix Assisted Laser Desorption and Ionization with Time Of Flight 
MES: 2-(N-morpholino)ethanesulfonic acid 
M-L: Metal-Ligand 
MS: Magnetic Splitting or hyperfine splitting 
MS: Mass Spectrometry 
MβL: Metallo-β-Lactamase 
NEB: New England BioLabs 
NSD: Normalized Spatial Discrepancy 
o/n: over-night 
OD600: Optical Density at 600 nm 
PAGE: Poly-Acrylamide Gel Electrophoresis 
par.: paragraph  
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PCR: Polymerase Chain Reaction 
PDB: Protein Data Bank 
pNPP: p-nitrophenyl phosphate 
pPCRp(s): purified PCR product(s) 
QS: ΔEQ = Quadrupole Splitting 
Rg: radius of gyration 
SAPA: sinapic acid 
SAS: Small-Angle Scattering 
SAXS: Small Angle X-ray Scattering 
SCAD: Short Chain Acyl-CoA Dehydrogenase 
SCAD: Short Chain Acyl-CoA Dehydrogenase 
SDM: Site Directed Mutagenesis 
SDO: Sulfur Di-Oxigenase 
SDS: Sodium Dodecyl Sulfate 
SEC: Size Exclusion Chromatography 
see par.: see paragraph 
SO: sulfite oxidase 
SQR: Sulfide:Quinone Oxidoreductase 
Ta: Ambient Temperature 
TB: Terrific Broth 
TCEP: tris(2-carboxyethyl)phosphine 
TEMED: N,N,N’,N’-tetramethylethylenediamine 
TEV: Tobacco Etch Virus protease 
TFA: tri-fluoroacetic acid 
TXRF: Total X-ray Reflection Fluorescence 
UV-Vis: Ultra Violet - Visible 
wt: wild type 
XANES: X-ray Absorption Near Edge Structure 
XAS: X-ray Absorption Spectroscopy 
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The ABC protein ABCE1, formerly named
RNase L inhibitor RLI1, is one of the most
conserved proteins in evolution, expressed in
all organisms, except eubacteria. Due to its
fundamental role in translation initiation
and/or ribosome biosynthesis, ABCE1 is
essential for life. Its molecular mechanism has
however not been elucidated. In addition to
two ABC ATPase domains, ABCE1 contains a
unique N-terminal region with eight
conserved cysteines, predicted to coordinate
iron-sulfur clusters. Here, we present detailed
information on the type and on the structural
organization of the Fe-S clusters in ABCE1.
Based on biophysical, biochemical and yeast
genetic analyses, ABCE1 harbors two
essential diamagnetic [4Fe-4S]2+ clusters with
different electronic environments, one
ferredoxin-like (CPXnCX2CX2C; Cys-Pos.
4/5/6/7) and one unique ABCE1-type cluster
(CXPX2CX3CXnC P ;  C y s - P o s . 1 / 2 / 3 / 8 ) .
Strikingly, only seven of the eight conserved
cysteines coordinating the Fe-S clusters are
essential for cell viability. Mutagenesis of the
cysteine at position 6 yielded a functional
ABCE1 with the ferredoxin-like Fe-S cluster
in a paramagnetic [3Fe-4S]1+ state. Notably, a
lethal mutation of the cysteine at position 4
can be rescued by ligand swapping with an
adjacent, extra cysteine conserved among all
eukaryotes.
Iron-sulfur (Fe-S)1 clusters constitute an
ancient prosthetic group, which can be found in
proteins from all living organisms. They are only
composed of the inorganic components, sulfur
and iron. In the most common cluster variants,
[2Fe-2S], [3Fe-4S] and [4Fe-4S], the metal ions
are directly coordinated by the inorganic sulfur
and the adjunct cysteinyl groups from the protein
backbone (1). Nevertheless, amino acids like
histidine can also contribute to the iron
coordination, as known for [2Fe-2S] Rieske
clusters. Additionally, much more complicated
structural arrangements can be found. The
complex FeMoco and P-cluster of nitrogenase
are just one example of clusters with higher
nuclearity, arising from smaller substructures
and clusters containing additional metal atoms
l ike  molybdenum (2).  Furthermore,
interconversion of Fe-S cluster is a widely
distributed phenomenon, reflecting the dynamic
arrangement and behavior (3). Despite their
relative simple composition of only iron and
sulfur (in most cases), Fe-S clusters are often
essential components for the enzymatic function
and thereby involved in a vast variety of cellular
processes. Beside their obvious role in electron
transport, they operate as sensors for e.g. iron,
modulate protein stability and play a role in
nucleic acid binding and modification (1,4).
Although Fe-S clusters can be synthesized in
vitro (5), their assembly and maturation in vivo
requires a highly complex and regulated
 http://www.jbc.org/cgi/doi/10.1074/jbc.M700825200The latest version is at 
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machinery (6). Mitochondria are the central
compartment in Fe-S cluster biogenesis, which is
also the only essential function of this organelle
to date (6,7). The underlying concept is not
understood so far, since mitochondrial Fe-S
cluster proteins are not essential for cell viability.
The cytosolic Fe-S protein ABCE1 could explain
this phenomenon, due to the fact that Fe-S
clusters can be transported from mitochondria to
the cytosol (8,9), where they are incorporated
into the protein moiety.
ABCE1 is found evolutionary conserved in
all archaea and eukaryota, where it is essential
for life (9-13). ABCE1 belongs to the
superfamily of ATP-binding cassette (ABC)
proteins with twin ABC ATPase domains, which
are arranged in a head-to-tail orientation via a
flexible linker and hinge region (14). Most of
these members constitute membrane proteins that
mediate ATP-driven unidirectional transport of a
variety of molecules across biological
membranes. Because ABCE1 does not contain
any transmembrane domain, its function cannot
be related to a membrane transport process. The
protein was originally identified as the RNase L
inhibitor in the innate immune response and
therefore called RLI1 (15). It was subsequently
shown that the assembly of the HIV-1 capsids
requires ABCE1 in a strictly ATP-dependent
manner (16). Very recently, an even more
fundamental and general role was proposed in
the process of translation initiation and ribosome
biosynthesis (9,12,13,17). ABCE1 was found to
interact with translation initiation factors, eIF2,
eIF3, eIF5, the 40S ribosomal subunit and
several ribosomal RNAs. Depletion of the
protein causes defects in the assembly of the
preinitiation complex, rRNA processing, and
accumulation of ribosomal subunits in the
nucleus. Nevertheless, the underlying molecular
mechanism remains enigmatic.
ABCE1 harbors a unique N-terminal region
including eight conserved cysteine residues with
the CX4CX3CX3CPXnCX2CX2CX3P consensus
sequence. A specific incorporation of iron, the
interaction with members of the Fe-S cluster
assembly machinery, and the functional
importance of two of these eight cysteine
residues (Pos. 3 and 7) have been demonstrated
(9). However, information regarding the type and
structural organization of the Fe-S cluster has not
been available until now.
By using homologously and heterologously
expressed ABCE1 from the hyperthermophilic
crenarchaeote Sulfolobus solfataricus (S. solf.),
we provide detailed information on the Fe-S
clusters. Highlighted by functional studies in
yeast, we show the pivotal role of conserved
cysteines coordinating the prosthetic group. We
finally present a model for the structural
organization of the Fe-S clusters in this essential
and evolutionary conserved protein.
EXPERIMENTAL PROCEDURES
Expression of ABCE1 in Sulfolobus
solfataricus–For over-expression of affinity-
tagged ABCE1, a stable and selectable shuttle
vector based on the virus SSV1 of Sulfolobus
shibatae was used (18). The open reading frame
SSO0287 (abce1) was amplified by PCR using
genomic DNA of S. solf. and the primers, P1f 5’-
CCATATCCCATGGTGAGAGTTGC-3’ and
P4r 5’-GGGCCCTTAATGGTGATGGTGATG
GTGATGGTGTTTTTCAAATTGTGGATGTA
CCAATTCTGGGTAGAAAGAA-3’. This
resulted in the introduction of NcoI and ApaI
restriction sites in the flanking regions of the
gene and a tandem-affinity (His8 and StrepII) tag
at the C-terminus. The gene was cloned into
pSVA5 (18), using the NcoI and ApaI sites
yielding pSVA30. To transfer the araS promoter
together with the gene to be expressed into the
virus-based vector, the BlnI/EagI insert from
pSVA30 was ligated into pMJ02 (19), resulting
in the plasmid pSVA31. Electroporation of S.
solf. pyrEF mutant PH1-16 with pSVA31 and the
isolation of single transformants were carried out
as described (20,21). Integration of the viral
vector into the genome was confirmed by
Southern blot analysis using standard
procedures. S. solf. PH1-16 cells (21) harboring
pSVA31 were inoculated in 50 ml Brock´s
medium containing 0.1% tryptone. After two
days of growth (A600 ~ 0.5) at 80ºC and pH 3.5,
these cells (10 ml) were transferred to 400 ml
medium containing 0.1% tryptone and 0.2%
arabinose to induce expression of ABCE1. After
two days of growth (A600 ~ 0.8), the cells were
harvested and resuspended in 10 mM Tris/HCl,
100 mM NaCl, pH 7.4.
Expression of Sulfolobus solfataricus ABCE1
in E. coli–The ORF SSO0287 of S. solf. ABCE1
was amplified by PCR using genomic DNA of S.
solfataricus and the primers, P1f 5’-
CCATATCCCATGGTGAGAG TTGC-3’ a n d
P1r 5’-CCATATGGATCCCTGGGTAGAAAG
AACCAAGGAG-3’, and cloned into the NcoI
and BamHI sites of the pSA4 expression vector
(22). The resulting plasmid (pSD1) codes for
wildtype ABCE1 of S. solf. with a C-terminal
His6-tag. The two conserved cysteines, C24 and
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C54, were individually exchanged for serine
residues (C24S and C54S) by QuikChange site-
directed mutagenesis (Stratagene). PCR and
mutagenesis products were confirmed by DNA
sequencing. The E. coli strain BL21(DE3)
(Novagen) was co-transformed with either of the
ABCE1 constructs and the pRARE plasmid
(Novagen) coding for rare tRNAs and grown in
LB medium supplemented with 100 µg/ml
ampicillin and 25 µg/ml chloramphenicol at
37°C. Expression was induced at an A600 of 0.6
for 3 h at 30ºC by adding 0.2 mM isopropyl-β-D-
thiogalactopyranoside.
Purification of ABCE1–All purification steps
and experimental analysis were carried out under
argon atmosphere or in an anaerobic chamber
containing 95% N2/5% H2 (Coy Laboratories).
Before use, buffers were degassed and
equilibrated inside the anaerobic chamber for
several days. Cell pellets of S. solf. were
resuspended in lysis buffer A (20 mM NaH2PO4,
300 mM NaCl, 20 mM imidazole, pH 7.4),
disrupted by using a Branson Sonifier 250 at
60% output in eight pulses of 30 s on ice and
centrifuged for 30 min at 114,000 x g.
Afterwards, ABCE1 was purified to
homogeneity via metal affinity chromatography
(HisSelect, Sigma) by washing/elution with
20 mM/300 mM imidazole. For purification of
ABCE1 expressed in E. coli, frozen cells were
thawed, resuspended in lysis buffer B (20 mM
Tris-HCl, 100 mM NaCl, 1 mM DTT, 1 mM
EDTA, pH 7.4) and disrupted by sonication as
described before. After centrifugation at 114,000
x g for 30 min, the supernatant was heated at
70ºC for 10 min and additionally centrifuged for
1 h at 114,000 x g. The solution was
subsequently applied to metal affinity
chromatography (HisTrap, GE Healthcare).
ABCE1 was purified by washing/elution with
60 mM/200 mM of imidazole. Protein fractions
were exchanged to buffer C (20 mM Tris-HCl,
100 mM NaCl, pH 7.4) using a Centricon device
(Millipore). The protein concentration was
determined by the Coomassie PlusTM Bradford
Assay (Pierce) using bovine serum albumin as a
standard.
Determination of Iron and Sulfur–Total
reflection X-ray fluorescence (TXRF) as a trace
multi-element analytical method was applied to
quantify the iron and sulfur content of purified
ABCE1. The measurement was carried out using
an EXTRA IIA spectrometer (Atomica
Instruments) with a sample volume of 4 µl in
50 mM Tris-acetate buffer (pH 7.5). 20 µl of
protein solution were placed onto siliconized
quartz carrier plates and evaporated to dryness.
By excitation with the Mo(Kα) line for 1000
seconds, a multi-element fluorescence spectrum
was obtained. The intensities of the sulfur and
iron peaks were related to a rubidium peak as an
internal standard. The iron content of ABCE1
was further determined colorimetrically by the
method of Fish (23) and the inorganic sulfur was
quantified according to Beinert (24).
UV/VIS Spectroscopy–Spectra of wildtype
and ABCE1 mutants were recorded on a Cary 50
spectrophotometer (Varian) in buffer C. ABCE1
was titrated with sodium dithionite or freshly
prepared potassium ferricyanide (both in
buffer C). The spectra of the oxidant and
reductant solutions alone were subtracted from
the corresponding curves.
EPR Spectroscopy–ABCE1 was analyzed by
continuous wave (cw) electron paramagnetic
resonance (EPR), either untreated, reduced with
sodium dithionite or ascorbate, or oxidized with
potassium ferricyanide in buffer C. X-band EPR
spectra were measured on a Bruker E-500
eleXsys spectrometer using a standard
rectangular Bruker EPR cavity equipped with an
ESR900 helium flow cryostat (Oxford
Instruments). The spectra were recorded under
following experimental conditions: microwave
frequency, 9.424 GHz; microwave power, 8 mW,
field modulation frequency, 100 kHz, field
modulation depth, 5 Gauss (peak to peak);
temperature 10 K.
To study the immediate environment around
the Fe-S cluster pulsed EPR was performed on a
Bruker E-580 spectrometer using a Bruker EPR
cavity (MD5-W1) equipped with a helium flow
cryostat (CF935, Oxford Instruments). The
pulses were amplified using a 1 kW pulsed
traveling wave tube amplifier. A conventional
two-pulse (π/2 – τ  – π ) sequence was used. A
two-pulse, echo modulation experiment
(ESEEM) was performed by integrating the area
under the Hahn echo as a function of time
between the two microwave pulses. The
frequency domain spectrum was obtained by
Fourier transformation of the time domain trace
after subtraction of a mono-exponential decay
function. This measurement was performed at
10 K at a microwave frequency of 9.745 GHz
using a π/2 pulse length of 8 ns, a starting τ of
132 ns and a shot repetition rate of 1 ms.
Mössbauer Spectroscopy–For preparation of
the Mössbauer sample, metallic 57Fe
(Chemotrade, 96% enrichment) was dissolved in
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37% (v/v) HCl at 80ºC for several days. The
obtained 57FeCl3 solution was directly added to
the S. solf. medium (without FeCl3) to a final
concentration of 41 µM. Mössbauer spectra of
purified ABCE1 were recorded in buffer C by
using a conventional spectrometer in the constant
acceleration mode. Isomer shifts are given
relative to α-Fe at room temperature. Zero-field
spectra were measured in bath cryostat (Oxford
Instruments), whereas for the high field spectra
(4 T ⊥  γ ), a cryostat equipped with a
superconducting magnet was used (Oxford
Instruments). Magnetically split spectra were
simulated within the spin Hamilton formalism
(25), otherwise, spectra were analyzed by last-
square fits using Lorenzian line shape.
X-ray Absorption Spectroscopy (XAS)–
ABCE1 was concentrated to 1.2 mM in Fe.
Afterwards, XAS sample was filled into the
25 µl plastic XAS cuvettes and stored at
cryogenic temperatures. The K-edge iron X-ray
absorption spectrum was recorded at the beam
line D2 of the EMBL Outstation Hamburg at
DESY (Germany). The DORIS storage ring
operated at 4.5 GeV with the positron beam
current ranging from 145 mA to 80 mA. An 111Si
double-crystal monochromator scanned X-ray
energies around Fe K-edge (6.9–8.1 keV).
Harmonic rejection was achieved by a focusing
mirror (cut-off energy at 20.5 keV) and a
monochromator detuning to 50% of its peak
intensity. The sample cells were mounted in a
two-stage Displex cryostat and kept at about
20 K. The X-ray absorption spectra were
recorded as Fe Kα fluorescence spectra with a
Canberra 13-element Ge solid-state detector.
Data reduction, such as background removal,
normalization and extraction of the fine
structure, was performed with KEMP (26)
assuming a threshold energy E0,Fe = 7120 eV.
Sample integrity during exposure to synchrotron
radiation was checked by monitoring the position
and shape of the absorption edge on sequential
scans. No changes were detectable. The extracted
Fe K-edge (25–860 eV) EXAFS data were
analyzed as reported previously (27).
Functional Analysis of ABCE1 Mutants in
Yeast–To investigate various cysteines mutants
of ABCE1, we used a yeast strain, in which the
endogenous promoter was replaced by a
tetracycline-regulated one (28). The cells were
transformed with the multi-copy plasmid
pRS423 harboring the wildtype or ABCE1
mutants. A plasmid coding for abce1 from S.
cerevisiae was generated by PCR using the
primers P2f 5’-ATGGTCGACGCCCTCGTAT
CTGCAACG-3’ and P2r 5’-ATACCCGGGA
GTACGGATCACCGAAGAGG-3’  wi th
chromosomal DNA as a template. The amplified
construct was inserted into the SalI and SmaI
restriction sites of the vector pRS423. ABCE1
was expressed under the control of the
endogenous promoter. The highly conserved N-
terminal cysteine residues C16, C21, C25, C29,
C55, C58, C61 and C65 as well as the cysteine
C38 were exchanged to serines or to alanines by
site-directed mutagenesis. Single, double and
triple mutations were created and transformed
into yeast cells. Following doxycycline
treatment, the chromosomal expression of
ABCE1 was repressed and the ABCE1 mutants
substituted for the endogenous protein in the
cells. The pRS423 vector containing the wildtype
ABCE1 gene and the empty vector served as
control plasmids.
RESULTS
Expression and Isolation of ABCE1–To
analyze the structural organization and function
of Fe-S clusters in ABCE1, we used a double
tracked approach: (i) functional studies of each
cysteine in Fe-S cluster assembly of ABCE1
were performed in yeast. (ii) For biophysical and
biochemical analyses of the Fe-S cluster, we
choose ABCE1 from the hyperthermophilic
crenarchaeote Sulfolobus solfataricus. Notably,
this thermostable protein contains only the eight
conserved cysteines putatively coordinating Fe-S
clusters. The yeast and archaeal protein are
highly homologous (43% identity and 66%
similarity, see also alignment of the N-terminal
domain in Fig. 7B).
Based on a newly developed inducible
expression system in S. solf. (18), ABCE1 was
over-expressed and purified to homogeneity in
quantities sufficient for biophysical studies
(Fig. 1A). 0.5 mg of protein (68 kDa) was
obtained from one liter culture. Because of the
unexpected finding of viable ABCE1 cysteine
mutants, we transferred the corresponding
mutations into ABCE1 from S. solf. for further
analysis. Genetic manipulations in archaea are
still time-consuming and by far no routine
method. Therefore, wildtype and the ABCE1
mutants were heterologously expressed in E. coli
and purified to homogeneity as described above.
In this case, 1-2 mg of protein was obtained from
one liter E. coli culture. Interestingly, some
degradation products were copurified with the
C24S mutant (Fig. 1B). This behavior is typical
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for Fe-S proteins, in which clusters are absent or
not correctly assembled.
All ABCE1 preparations, except the C24S
mutant, showed a brownish color, typical for Fe-
S cluster proteins (Fig. 1C). After exposure to
oxygen, the C54S mutant rapidly lost its color,
whereas wt ABCE1 isolated either from S. solf.
or E. coli remained brownish for at least several
hours (data not shown).
Assembly of two Fe-S clusters in ABCE1–
ABCE1 isolated from S. solf. exhibits a
characteristic UV/VIS spectrum with a
maximum at 280 nm, a shoulder at 320 nm and a
broad peak around 410 nm (Fig. 2A), indicative
for cuban [4Fe-4S] or cuboidal [3Fe-4S] type
clusters (29). The molar extinction coefficient
ε410 of 29,000 M
–1*cm–1 is in the range of
proteins containing two of these clusters (30).
The absorption spectrum of wt ABCE1 isolated
from E. coli differed only by the extinction
coefficient ε410 of 24,000 M
-1*cm-1 (17%
reduction compared to ABCE1 isolated from S.
solf.). Surprisingly, the C54S mutant showed an
absorption spectrum very similar to wt ABCE1
purified from E. coli (ε410 = 22,500 M
-1*cm-1),
demonstrating that the assembly of the Fe-S
clusters is comparable in both proteins. In
contrast, the C24S mutant showed no specific
absorption at 410 nm revealing a defect in Fe-S
cluster assembly. As addressed below, the
functional consequences of these mutations have
been examined in yeast.
Titration of wt ABCE1 with the reductant
sodium dithionite (Fig. 2B) or ascorbate (not
shown) did not significantly change the UV/VIS
spectra. This demonstrates the stability of the Fe-
S cluster at low redox potential.  In contrast,
titration with the oxidant potassium ferricyanide
resulted in loss of the 410-nm peak and the
appearance of new absorption bands at 340 nm
and 450 nm (Fig. 2C). Remarkably, the C54S
mutant exhibited a greater sensitivity to
oxidation by ferricyanide as compared to wt
ABCE1, resulting in an immediate loss of the
absorption at 410 nm (data not shown).
We next quantified the amount of
incorporated iron and sulfur in the wt and
ABCE1 mutants by total X-ray reflection
fluorescence (TXRF) spectroscopy and
colorimetric assays. Wt ABCE1 (1 nmol)
isolated from S. solf. contains 7.0 nmol iron and
6.1 nmol acid-labile sulfur per nmol protein
(Tab. 1). In comparison, wt ABCE1 purified
from E. coli harbors 13% less iron (6.1 nmol)
and 10% less acid labile sulfur (5.5 nmol).
Considering a small amount of impurities and the
intrinsic error in protein quantification, it seems
likely that the iron and sulfur content are slightly
underestimated. Especially for the protein
isolated from E. coli a small population of non-
assembled Fe-S cluster can be found.
Together with the UV/VIS data, these
findings clearly demonstrate the presence of two
cuban or one cuban and one cuboidal Fe-S
clusters in the ABCE1. The C54S mutant
showed also incorporation of iron and acid-labile
sulfur but with decreased values compared to wt
ABCE1. It is worth mentioning that the Fe-S
clusters in the C54S mutant were extremely
labile, resulting in a loss of iron and sulfur
during buffer exchange  (e.g. dialysis). In the
C24S mutant, no significant iron and acid-labile
sulfur were detected, consistent with the
colorless protein solution (Fig. 1C) and the
UV/VIS spectra (Fig. 2A). Importantly, no other
metal ions such as copper, nickel, zinc or
molybdenum were found in all ABCE1 proteins
by TXRF analysis.
ABCE1 Harbors Diamagnetic Fe-S Clusters–
We next examined the Fe-S clusters in ABCE1
by electron paramagnetic resonance (EPR)
spectroscopy. The two Fe-S clusters found in
ABCE1 are EPR-silent and therefore in a
diamagnetic state (Fig. 3A). It should be
mentioned that ABCE1 isolated from S. solf. or
E. coli showed identical spectroscopic behavior
(data not shown). Interestingly, oxidation of the
same sample with ferricyanide leads to an EPR
signal (Fig. 3A), which, based on the relatively
isotropic g-tenors, is characteristic for the
formation of a [3Fe-4S]+ cluster (31,32). Further
addition of the oxidation reagent did not increase
the EPR signal, which finally disappeared (data
not shown). In agreement with the UV/VIS
spectra, the two diamagnetic Fe-S clusters in
ABCE1 could be reduced neither by ascorbate
(not shown) nor by the strong reductant
dithionite at pH 9.0 (Fig. 3B).
Notably, already without oxidation the C54S
mutant showed an EPR signal (with regard to g-
tensor and spin intensity) similar to oxidized wt
ABCE1 (Fig. 3C). In contrast to wt ABCE1,
oxidation of the C54S mutant leads to a decrease
in the EPR signal even at low concentrations of
ferricyanide (Fig. 3C). The slight difference in
the overall line shape of the C54S mutant and the
oxidized wildtype protein may result from a
different electronic environment and the
influence of the mutant on the g-tensor and/or
some of the small proton hyperfine interactions,
which determine this line shape. Indeed, two-
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pulse ESEEM experiments of the C54S mutant
did not reveal any other magnetic nuclei (e.g.
14N) in the immediate environment of the cluster
(data not shown). In conclusion, ABCE1
contains two diamagnetic [4Fe-4S]2+ clusters,
one being converted into a [3Fe-4S]+ state upon
oxidation or cysteine mutagenesis.
Two [4Fe-4S]2+ Clusters of ABCE1 Exist in
Different Electronic Environments–To finally
confirm the type of the two diamagnetic Fe-S
clusters, wt ABCE1 was analyzed by Mössbauer
spectroscopy. ABCE1 was labeled with 57Fe in S.
s o l f .  and purified as described in the
Experimental Procedures. The Mössbauer
spectrum of ABCE1 obtained at 77 K has been
analyzed with three quadrupole doublets
(Fig. 4A). Species 1 has an isomer shift of δ1 =
0.43 mms-1, a quadrupole splitting of ΔEQ1 =
1.32 mms-1 and a relative contribution of 44%.
Species 2 exhibits an isomer shift of δ2 =
0.42 mms-1, a quadrupole splitting of ΔEQ2 =
–0.86 mms-1 and also a relative contribution of
44%. The negative sign of ΔEQ2 has been
determined by the analysis of the high-field
Mössbauer spectra (see Fig. 4B). The isomer
shifts of species 1 and 2 are characteristic for
Fe2.5+-pairs of [4Fe-4S]2+ clusters (25,33).
Figure 4B shows a Mössbauer spectrum of
ABCE1 taken at 4.2 K in a field of 4 T
perpendicular to the γ-beam. The observed
magnetic splitting was successfully reproduced
by the simulation shown in Figure 4B. The input
parameters for the simulation are the hyperfine
parameters of components 1 and 2 as obtained
from the analysis of the spectrum taken at 77 K
(Fig. 4A) and show diamagnetic ground states of
both species. This spectroscopic signature is
again indicative for [4Fe-4S]2+ clusters (25,33).
Species 3 with δ3 = 0.26 mms
-1, ΔEQ3 = 0.63
mms-1 and a relative contribution of 12%
(Fig. 4A) does lead to a broad magnetic
background in the high-field spectrum. Such a
behavior is characteristic for an unspecific Fe3+
(33). Therefore, species 3 has been disregarded
in the simulation. Considering the facts that iron
quantification yields almost the amount of iron
expected for two [4Fe-4S] clusters and that
species 1 and 2 are present at equal ratio,
Mössbauer spectroscopy consistent with the
model that ABCE1 has two [4Fe-4S]2+ clusters in
a slightly different electronic environment.
Coordination of Iron in the Clusters–The
edge shape of the XANES spectra (Fig. 5A),
which can be used as a fingerprint for the
electronic structure of the metal ions, resembles
the one reported for oxidized hydrogenase II
from Clostridium pasteurianum, which harbors
[4Fe-4S]2+ clusters (34). Typical features are the
resonance in the rising edge and the rather flat
maximum followed by a sharp minimum. The
extracted fine structure (EXAFS) is dominated
by a single frequency with a shift at about 8 Å-1.
The high intensity at wave numbers larger than
10 Å-1 in biological samples indicates the
presence of a multinuclear metal center. This is
consistent with the peak at about 2.8 Å in the
corresponding Fourier transformation (FT). The
high intensity of the main peak at about 2.3 Å in
the FT points towards a homogenous first
coordination sphere formed by sulfur ligands.
The FT is very similar to the one observed for
the [4Fe-4S]2+ clusters mentioned above (34).
Models based on the assumption of [4Fe-4S]2+
clusters resemble the data very well (Fig. 5B and
5C). All attempts to replace one of the sulfur
ligands in the fit by light atoms such as oxygen
or nitrogen lead to artificially long Fe-O/N
distances. Thus, recognizable contributions
above 10% of the average ligand sphere are
excluded. The Fe-S distance of 2.29 Å and the
Fe-Fe distances of 2.74 Å match the literature
values for oxidized [4Fe-4S] clusters very well
(35).
Essential Function of the Fe-S Clusters in
A B C E 1 –By means of biophysical and
biochemical analyses, we resolved that ABCE1
from Sulfolobus solfataricus contains two
diamagnetic [4Fe-4S]2+ clusters. However, the
functional impact of the two different Fe-S
clusters cannot easily be addressed in archaea.
Therefore, we initiated a genetic analysis in
Saccharomyces cerevisiae, where ABCE1 has
been shown to be essential for viability due to its
fundamental role in translation initiation and
ribosome biosynthesis (9,12,17). By systematic
mutation of all conserved cysteine residues,
individually or in combination, we addressed the
functional role of the Fe-S clusters in
S. cerevisiae ABCE1. Plasmids encoding
wildtype or ABCE1 mutants were transformed
into a yeast strain, in which a tetracycline-
repressible one replaced the endogenous
promoter of ABCE1. After repression of
endogenous ABCE1 by addition of doxycycline,
we analyzed single clones for viability.
Remarkably, only five out of the eight
conserved cysteines (C16, C25, C55, C61 and
C65; pos. 1/3/5/7/8) were found to be essential
for cell survival (Fig. 6A). To our very surprise
the C21S, C29S and C58S mutants (pos. 2/4/6)
are still viable (Fig. 6A). It should be mentioned
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that the C21S mutant shows a slow growth
phenotype. Since it is known that serine residues
can coordinate Fe-S clusters in certain cases, we
subsequently mutated each of these three
cysteine residues to alanine. Here, C29A and
C58A (pos. 4 and 6) were still viable, but the
C21A mutant (pos. 2) was lethal (Fig. 6B). In
conclusion, six coordinating cysteines, of which
serine at position can partially be accepted, are
strictly required for the formation of the Fe-S
clusters and cell survival. The inviability of the
C25S and C61S mutant is in agreement with
previous studies, which further demonstrated that
substitution of these cysteines had no effect on
the expression level and stability of the protein
(9).
Interestingly, the viable yeast C58 mutant
corresponds to the C54S mutant in S. solf..
Biophysical and biochemical analyses indicate
that this mutant contains a [4Fe-4S]2+ and a
paramagnetic [3Fe-4S]+ center. In conclusion,
the cysteine at position 6 is not essential for the
assembly of the Fe-S cluster and vital function of
ABCE1.
The viability of the C29 mutants remained
enigmatic, since the corresponding mutant in
ABCE1 from S. solf. (C24S) showed a defect in
Fe-S cluster assembly (see Fig. 1 and 2). We
excluded that the adjacent S28 rescues the C29
mutation (Fig. 6B). However, by in silico
analysis, we noticed that, in contrast to most
archaeal homologues, all ABCE1 in eukarya
carry an extra cysteine in close proximity to the
iron-sulfur centers. This corresponds to C38 in S.
cerevisiae ABCE1. In a process called ligand
swapping, such a cysteine, originally not
involved in Fe-S cluster coordination, can take
over the function of a missing or mutated
cysteine residue. To test this hypothesis, we
generated the double C29A/C38A mutant.
Indeed, this double mutation was lethal, whereas
cells with the double mutation C58A/C38A as a
control grew normal, demonstrating a site-
specific ligand swapping between C29 and C38
(Fig. 6B).
Finally, double and triple mutants comprising
the dispensable cysteines were generated.
Notably, any combination of the otherwise viable
mutations shows an additive effect, leading to a
lethal phenotype (Fig. 6C).
DISCUSSION
The presence of Fe-S clusters discriminates
the evolutionary highly conserved protein
ABCE1 from all other members of the ABC
superfamily. In this study, we determined the
type, coordination and functional relevance of
the Fe-S clusters in ABCE1 of archaea and
eukarya. For detailed biophysical and
biochemical analyses, we used ABCE1 from the
hyperthermophilic crenarchaeote Sulfolobus
solfataricus, which contains only the eight
conserved cysteine residues, putatively
coordinating Fe-S clusters. By means of a novel
expression system, ABCE1 was over-expressed
and isolated from the homologous host, which
ensured the complete machinery for Fe-S cluster
assembly. Expression in E. coli was used to
examine various mutants efficiently. The
functional role of the Fe-S clusters was however
addressed in yeast, where ABCE1 is essential for
cell viability (9,12,17).
The combination of structural and functional
analyses clearly demonstrates the presence of
two diamagnetic [4Fe-4S]2+ clusters in ABCE1
and further highlights the essential role of the
conserved cysteines for Fe-S cluster assembly.
Sequence comparison shows that the Fe-S cluster
coordination in ABCE1 (Fig. 7A) partially
resembles those of 8 Fe ferredoxins, e.g. in
Desulfovibrio africanus ferredoxin III or
Azotobacter vinelandii ferredoxin I (36,37). We
therefore conclude that ABCE1 contains one
ferredoxin-like [4Fe-4S]2+ cluster formed by the
cysteines at position 4/5/6/7. Indeed, this cluster
perfectly matches the ferredoxin-type consensus
sequence CPXnCX2CX2C (Fig. 7B). The
coordination of the second Fe-S cluster in
ABCE1 (cysteines 1/2/3/8) has not been
described in any other protein. Hence, we
propose a unique ABCE1-type [4Fe-4S]2+ cluster
w i t h  t h e  c o n s e n s u s  s e q u e n c e
CXPX2CX3CXnKCP. This model shall be
clarified by a high-resolution structure of the
full-length protein.
Both clusters are equally present, but have a
slightly different electronic environment as
demonstrated by Mössbauer spectroscopy (see
Fig. 4). Based on the quadrupole splitting,
species 1 (δ1 = 0.43 mms
-1
, ΔEQ1 = 1.32 mms
-1) is
typical for a ferredoxin-like cluster (38,39),
whereas species 2 (δ2 = 0.42 mms
-1
, ΔEQ2 =
–0.86 mms-1) should reflect the ABCE1-type
cluster. Additional atoms, such as oxygen or
nitrogen from e.g. aspartate, histidine or serine
residues, do not contribute to the cluster
coordination in wt ABCE1 and the C54S mutant,
according to both XAS and ESEEM analysis.
The systematic mutagenesis of all conserved
cysteines in ABCE1 revealed that, surprisingly,
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three cysteine-to-serine mutants (C21S, C29S,
C58S) are not lethal. The C21S mutant has a
slow growth phenotype, demonstrating that
serine at position 2 can partially substitute
cysteine in coordination and assembly of the Fe-
S clusters. Nevertheless, four sites (position
1/2/3/8) are strictly required for formation of the
ABCE1-type cluster and ABCE1 function (see
Fig. 6).
In contrast, position 6, which is part of the
ferredoxin-like cluster, is dispensable for the
essential ABCE1 function. Strikingly, this cluster
can also exist in a [3Fe-4S]+ state. Although
interconversion between [4Fe-4S] and [3Fe-4S]
clusters has been reported, as e.g. in ferredoxin II
form Desulfovibrio gigas (39) or ferredoxin III
from Desulfovibrio africanus (36), we have
presently no evidence, whether this state exists
for wt ABCE1 in vivo. Remarkably, the mutant
at position 6 was extremely labile towards
oxidation, resulting in a loss of iron and acid-
labile sulfur. These findings further support the
“all-or-nothing” behavior of the two Fe-S
clusters in ABCE1, meaning that they assemble
simultaneously and depend on each other (9).
Double and triple mutants of the dispensable
positions display additive effects resulting in
lethality (see Fig. 6). The fact that the Fe-S
clusters in ABCE1 are stable down to redox-
potentials of approx. E°´ = –560 mV and that the
ferredoxin-like cluster is functional in different
states indicates a structural rather than redox-
catalytic role for this cluster, similar to E. coli
endonucleases III (40). In this enzyme, the Fe-S
cluster serves as a scaffold for proper positioning
catalytic amino acids involved in DNA
recognition and binding. Notably, the N-terminal
Fe-S domains of ABCE1 are rich in conserved
basic residues, which could, similarly to the E.
coli endonuclease III or MutY, sense and modify
nucleic acids (40-42). Despite the potential role
in scaffolding a ligand-binding site, the Fe-S
clusters of ABCE1 are not required for the
folding and the structural integrity of the twin
ABC ATPase domains (14). From the x-ray
structure it was anticipated that the two NBDs
perform an ATP-driven clamp-like motion.
Nevertheless, the impact of the Fe-S domain on
conformation changes and the ATP-hydrolysis
cycle of ABCE1 needs to be addressed in future
experiments.
The dispensable cysteine at position 4 of
yeast ABCE1(C29A or C29S) is remarkable,
since the corresponding mutation in S. solf.
ABCE1 (C24S) completely abolishes the
incorporation of iron and acid-labile sulfur (see
Table 1, Fig. 1/2). Strikingly, all eukaryotic
ABCE1 proteins contain a conserved, extra
cysteine within the N-terminal Fe-S cluster
domain, which can rescue C29 (position 4) by
ligand swapping. This extra cysteine, absent in
most archaea, explains why the mutation at
position 4 (C24S) in S. solf. ABCE1 showed no
assembled Fe-S clusters. Noteworthy, mutation
of C38 (extra cysteine) has no effect on ABCE1
function in yeast. It is therefore questionable if
ligand swapping occurs in vivo.
ABC-type proteins are evolutionarily highly
conserved molecular machines, coupling ATP
binding and hydrolysis to conformational
changes (43,44). The smallest functional unit
appears to be an ABC dimer, which operates in a
processive engagement/disengagement cycle
(44-46). These chemomechanical engines drive
not only membrane translocation but also a
variety of other crucial biological processes, such
as DNA repair and chromosome segregation.
The fundamental role of ABCE1 in RNase L
inhibition, HIV capsid maturation, translation
initiation and ribosome biosynthesis (8,12,13,15-
17), suggests that the two essential diamagnetic
[4Fe-4S]2+ clusters identified in this study are
involved in recognition and modification
(chemical or conformational) of RNA
assemblies.
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Table 1: Incorporation of iron and sulfur in ABCE1
TXRFMethylenblueTXRFFerrozine
12.1 ± 0.60.0 ± 0.00.4 ± 0.1n.d.C24S (E. coli)
n.d.3.1 ± 0.1n.d.4.4 ± 0.1C54S (E. coli)
21.8 ± 0.65.5 ± 0.16.0 ± 0.26.2 ± 0.2WT   (E. coli)
25.0 ± 0.66.1 ± 0.26.8 ± 0.37.2 ± 0.5WT   (S. solf.)
Total sulfur
[nmol]
Inorganic sulfur
[nmol]
Iron
[nmol]
TABLE 1
Iron and sulfur determination from ABCE1 (1 nmol)
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FIGURE LEGENDS
Fig. 1: Expression and purification of wildtype and ABCE1 mutants. Wt ABCE1 expressed in S.
solf. (A) and wt ABCE1, C54S and C24S mutants heterologously expressed in E. coli (B) were
purified under strictly anaerobic conditions via metal affinity chromatography and subsequently
analyzed by SDS-PAGE (15%, Coomassie). 0.5-1 mg of ABCE1 was isolated per liter S. solf. culture,
whereas the yield for the heterologous system was approx. 2 mg/l. (C) wt ABCE1 isolated from S.
solf. (75 µM) or from E. coli (35 µM) as well as the C54S mutant (35 µM) showed a brownish color,
except for the C24S mutant (35 µM).
Fig. 2: UV/VIS absorption spectroscopy of wildtype and ABCE1 mutants. (A) Spectra of wt
ABCE1 isolated from S. solf. (black line) or from E. coli (red line) as well as the mutants C54S (green
line) and C24S (orange line) were recorded in the buffer C. Wt ABCE1 isolated from S. solf. was
incubated with the oxidant potassium ferricyanide (B) or the reductant sodium dithionite (C) at
indicated concentrations for 2 min. All spectra were recorded at a protein concentrations of 50 µM.
Fig. 3: EPR spectroscopy of wildtype ABCE1 and C54S mutant. (A) EPR spectra of wt ABCE1
purified from S. solf. (solid line) were recorded in buffer C before (solid line) and after oxidation with
a 10-fold excess of ferricyanide (dotted line). The g-tensor principal values of oxidized ABCE1, g(1):
2.031, g(2): 2.017, g(3): 2.002 (error ±0.002), extracted by numerical simulation (data not shown), are
indicative for a [3Fe-4S]+ cluster. (B) Spectra of wt ABCE1 reduced with 50-fold molar excess of
sodium dithionite in 20 mM Tris, 100 mM NaCl, pH 9.0. (C) Spectra of the C54S mutant were
recorded in buffer C before (solid line) and after oxidation with an 1:1 molar ratio of ferricyanide
(dotted line). The g-tensor determined by numerical simulation (data not shown) yields principal
values of: g(1): 2.033, g(2): 2.018, g(3): 2.002 (error ±0.002). All spectra were recorded at 40 µM
protein concentration with the following parameters: microwave frequency, 9.424 GHz; microwave
power, 8 mW, field modulation frequency, 100 kHz, field modulation depth, 5 Gauss (peak to peak);
temperature 10 K.
Fig. 4: Mössbauer spectroscopy of ABCE1. Spectra of wt ABCE1 were recorded at 77 K in a zero
magnetic field (A) and at 4.2 K in a field of 4 T perpendicular to the γ-beam (B). The solid lines
represent simulations with the parameters given in the Experimental Procedures. Species 1 and 2,
present at equimolar ratio (44% both), are diamagnetic and exhibit parameters typical for [4Fe-4S]2+
clusters. Species 1: δ1 = 0.43 mms
-1
, ΔE Q1 = 1.32 mms
-1; Species 2: δ2 = 0.42 mms
-1
, ΔEQ2 =
–0.86 mms-1. Species 3 (12%) is characteristic for unspecific Fe3+ and has been disregarded in the
simulations shown in (B). ABCE1 isolated from S. solf. was analyzed in buffer C at 1.2 mM in iron.
Fig. 5: X-ray absorption analysis of the Fe-S cluster in ABCE1. (A) Fe K-edge X-ray absorption
spectra of wt ABCE1 (S. solf.) (B) Fe K-edge k3 weighed EXAFS spectra and (C) the corresponding
Fourier transformation. The EXAFS is dominated by two contributions, the Fe-4S signal at 2.29 Å
±0.01 Å and the Fe-3Fe signal at 2.74 Å ±0.01 Å. The Debye-Waller factors (2 σ2) for these
contributions were refined to 0.010 Å2 ±0.001 Å2 and 0.008 Å2 ±0.001 Å2, respectively. EF was –3 eV
±1 eV. ABCE1 was analyzed in buffer C at an iron concentration of 1.2 mM.
Fig. 6: Functional analysis of ABCE1 in S. cerevisiae. Plasmids of ABCE1 harboring the indicated
mutations were transformed into a yeast strain, in which the endogenous promoter was replaced by a
tetracycline repressible promoter and plated on minimal agar using histidine as a selection marker.
Single colonies were then spread on minimal agar plates containing doxycycline. The plasmid
containing wt ABCE1 served as a positive control (wt), and the empty vector as a negative control
(–K). (A) Mutation of the eight conserved cysteine residues to serine. (B) Single cysteine-to-alanine
mutations of the viable mutants from the first screen, as well as the double mutant S28A/C29A. (C)
Mutation of the extra cysteine residue C38 to alanine individually and in combination with selected
conserved residues. Double and triple mutants of the viable mutants from the first screen are lethal.
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Fig. 7: Model for the structural organization of the Fe-S cluster in ABCE1. (A) Consensus
sequcnce of 8 Fe ferredoxins and the consensus sequence of Fe-S cluster in ABCE1 by comparison
(B) Sequence alignment of the N-terminal Fe-S cluster domain of ABCE1 from archaeal and
eukaryotic organisms generated by ClustalW:  Sulfolobus solfataricus (gi:15897231), Sulfolobus
acidocaldarius (gi:70606479), Thermofilum pendens (gi:119719130), Pyrococcus furiosus
(gi:18977042), Thermococcus kodakarensis (gi:57640966), Pyrococcus horikoshii (gi:14590719),
Thermoplasma volcanium (gi:13542329), Methanococcus maripaludis (gi:45357945), Archaeoglobus
fulgidus (gi:11497625), Halobacterium salinarum (gi:15791346), Guillardia theta (gi:13811968),
Trypanosoma brucei (gi:21212953), Leishmania major (gi:68223887), Caenorhabditis elegans
(gi:17555800), Dictyostelium discoideum (gi:66803577), Toxoplasma gondii (gi:111145381),
Schizosaccharomyces pombe (gi:19113524), Saccharomyces cerevisiae (gi:74676343), Candida
glabrata (gi:50288565), Kluyveromyces lactis (gi:50306045), Oryza sativa (gi:115485837), Tricitum
aestivum (gi:16755057), Arabidopsis thaliana (gi:110742163), Bombyx mori (gi:112982681),
Drosophila melanogaster (gi:24661270), Xenopus laevis (gi:28302203), Danio rerio (gi:63102477),
Gallus gallus (gi:57530144), Homo sapiens (gi:987870). Essential cysteines are marked with an
asterix. Ligand swapping occurs between C29 and the extra C39, conserved among all eukaryotes.
C58 is not essential, since this cluster is also functional in a [3Fe-4S] state.
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Figure 1
 at EM
BL (European Molecular Biology Laboratory) on March 20, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
- 15 -
Figure 2:
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 at EM
BL (European Molecular Biology Laboratory) on March 20, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
- 18 -
Figure 5:
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ined the binding of BiP with a DnaJ-domain
mutant of ERdj5 in which histidine 63 in the HPD
motif is replaced with glutamine (ERdj5/H63Q)
(13). ERdj5/H63Q did not bind to BiP, even in
the presence of ATP (Fig. 4A). Thus, ERdj5 in-
teracts through its DnaJ domain with BiP.
We examined the in vivo effect of the
ERdj5/H63Q mutant on HMW complex formation
andon theERADof J chains.Accumulation of the J
chain HMW complex was considerably decreased
48 hours after transfection with wild-type ERdj5
compared with amounts after mock transfection
(Fig. 4B). In contrast, neither transfection with
ERdj5/H63Q nor with the ERdj5/SS mutant
repressed the accumulation of J chain HMW com-
plexes. Transfection with the ERdj5/H63Q mutant
did not accelerate J-chain degradation (Fig. 4C and
fig. S3) even though thismutant retains the disulfide
reductase activity (fig. S2). Thus, both the reductase
activity of ERdj5, which is conferred by its CXXC
motifs, and the association of ERdj5 with the
molecular chaperone BiP are necessary to prevent
multimer formation by the misfolded proteins and
also to promote efficient ERAD of such proteins.
We next examined the involvement of ERdj5
in the EDEM-mediated ERAD pathway. EDEM
coimmunoprecipitated with both wild-type ERdj5
and the ERdj5/AA mutant in HEK293 cells,
which suggests that the binding of EDEM with
ERdj5 is CXXC-independent (fig. S8). Accelera-
tion of ERAD by EDEM overexpression is de-
pendent on mannose-trimming and is inhibited
by kifunensine, an inhibitor of ER mannosidase I
(3). Promotion of ERAD by ERdj5 overexpression
was totally abolished in the presence of kifunensine
(Fig. 4D), which suggests that ERdj5-mediated
ERAD requires EDEM to function.
Thus, ERdj5, either overexpressed or endoge-
nous, can serve as a key component for the ERAD
ofmisfolded proteins. The following are all required
for ERdj5-mediated ERAD acceleration: (i) the
reductase activity of ERdj5, which is conveyed
through its CXXC motif; (ii) the binding of ERdj5,
through its DnaJ domain, to the ER-resident Hsp70
family chaperone BiP; and (iii) the functional
interaction of ERdj5 with EDEM, a lectin-like
molecule that may recognize theMan8N-glycan on
misfolded proteins to be degraded. ERdj5-mediated
cleavage of intermolecular disulfide bridges
decreased the accumulation of covalent multimeric
forms of misfolded proteins in the ER; such
accumulations are expected to hinder the retrograde
transport of misfolded proteins through the retro-
translocation channel. ERdj5may prevent disulfide-
linked aggregation and/or misfolding of substrates
by maintaining them in reduced states and may en-
hance their ERAD by increasing retrotranslocation-
competent misfolded proteins.
The redox potential of ERdj5 is even more re-
ducing than the ER redox status (16) or the redox
potential of PDI (17). ERdj5 has threeCXPCmotifs,
consistent with reports that the redox potential of
CXPC motifs contained in thioredoxin superfamily
proteins is reducing (18). Its reducing redox potential
indicates that ERdj5 is thermodynamically stable in
an oxidized form in the ER redox environment and
that ERdj5 can function as a strong disulfide reduc-
tase once it accepts electrons from electron donors.
Electrons might be transported into the ER from the
reducing cytosol or provided from the high ER
concentration of the reduced form of nicotinamide
adenine dinucleotide phosphate (NADPH) (19).
These possibilities remain to be addressed.
Here, we have established the presence of a
supramolecular functional ERAD complex, com-
prising EDEM,ERdj5, andBiP, which have distinct,
but linked and concerted, roles (fig. S9). In this
model, after the transfer of terminally misfolded
proteins from calnexin to EDEM, ERdj5 bound to
EDEMcleaves their disulfide bonds,which results in
dissociation of the covalentmultimeric substrates. At
the same time, ERdj5 activates the conversion of the
ATP-form of BiP to adenosine diphosphate form,
resulting in dissociation of BiP from ERdj5, which,
in turn, strongly binds the substrates (20) and holds
them in a dislocation-competent state until they are
transferred to the retrotranslocation channel.
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The Crystal Structure of
[Fe]-Hydrogenase Reveals the
Geometry of the Active Site
Seigo Shima,1*† Oliver Pilak,1* Sonja Vogt,1 Michael Schick,1 Marco S. Stagni,2
Wolfram Meyer-Klaucke,2 Eberhard Warkentin,3 Rudolf K. Thauer,1 Ulrich Ermler3†
Biological formation and consumption of molecular hydrogen (H2) are catalyzed by hydrogenases,
of which three phylogenetically unrelated types are known: [NiFe]-hydrogenases, [FeFe]-hydrogenases,
and [Fe]-hydrogenase. We present a crystal structure of [Fe]-hydrogenase at 1.75 angstrom
resolution, showing a mononuclear iron coordinated by the sulfur of cysteine 176, two carbon
monoxide (CO) molecules, and the sp2-hybridized nitrogen of a 2-pyridinol compound with
back-bonding properties similar to those of cyanide. The three-dimensional arrangement of the
ligands is similar to that of thiolate, CO, and cyanide ligated to the low-spin iron in binuclear
[NiFe]- and [FeFe]-hydrogenases, although the enzymes have evolved independently and the CO
and cyanide ligands are not found in any other metalloenzyme. The related iron ligation pattern of
hydrogenases exemplifies convergent evolution and presumably plays an essential role in H2
activation. This finding may stimulate the ongoing synthesis of catalysts that could substitute for
platinum in applications such as fuel cells.
Molecular hydrogen (H2) is a relativelyinert molecule. The dissociation ener-gy of the H-H bond is 436 kJ mol−1,
and its pKa is 35 (1, 2). Despite this, H2 is used or
produced by many microorganisms in their ener-
gymetabolism. Indeed, H2was one of the earliest
energy sources available on Earth when life
evolved. H2/H
+ interconversion reactions (H2 ⇋
2H+ + 2e–) are catalyzed by hydrogenases that
contain nickel and/or iron as key components in
their active sites; these hydrogenases are more
efficient catalysts than platinum, which is used
industrially to catalyze hydrogenation. H2 is con-
sidered a major fuel in future energy technology,
but the amounts of catalyst required for large-
scale H2 production and use will require alter-
natives to platinum, which is expensive and not
abundant. One approach of current research is to
learn from hydrogenases (Fig. 1), and model com-
pounds mimicking the metal centers of hydro-
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genase have recently been synthesized that can
interact with protons and/or H2 (3–7).
Themost prominent hydrogenases are [NiFe]-
hydrogenase (in bacteria and archaea) and [FeFe]-
hydrogenase (in bacteria and eukaryotes) (8).
The structures of their binuclear metal active
sites are pictured in Fig. 1, A and B (9–17). In
addition to the binuclear metal center, both
types of hydrogenases harbor at least one es-
sential [4Fe-4S] cluster. The iron in the binuclear
[NiFe] center (Fig. 1A) is redox-inactive and
low-spin (18), as probably is the iron proximal to
the [4Fe-4S] cluster in the binuclear [FeFe] center
(19) (Fig. 1B). The third type of hydrogenases,
the [Fe]-hydrogenase—formerly named iron-
sulfur cluster–free hydrogenase or H2-forming
methylenetetrahydromethanopterin (methylene-
H4MPT) dehydrogenase (20)—contains a mono-
nuclear iron center (Fig. 1C) and is found only in
some hydrogenotrophic methanogenic archaea,
where it catalyzes one step involved in CO2 re-
duction to methane (Fig. 2). Each subunit of the
homodimeric enzyme contains one iron (which is
not redox-active) and no iron-sulfur clusters.
In [Fe]-hydrogenase, the iron center is the
catalytically active constituent of an iron gua-
nylyl pyridone cofactor (FeGP cofactor), which
can be extracted from the enzyme by denatura-
tion in the presence of mercaptoethanol and used
for reconstitution of the active enzyme from
inactive heterologously produced apoenzyme (21).
The FeGP cofactor is light- and temperature-
sensitive (22), which hampers purification to
homogeneity. Observed decomposition products
are guanylyl pyridone (see below), two CO mol-
ecules, and one iron ion (23). Infrared (IR) spec-
troscopic analysis (24) revealed two COmolecules
as iron ligands; x-ray absorption analysis (25) pre-
dicted two CO, one sulfur, and one or two N/O
ligands at coordination distance to iron;Mössbauer
spectroscopic data (26) identified the iron as low
spin, either in the Fe(0) or Fe(II) oxidation state;
and x-ray structure analysis of the [Fe]-hydrogenase
without the FeGP cofactor (apoenzyme) estab-
lished the overall architecture of the enzyme (27)
(Fig. 3). Here, we describe the structure of the
[Fe]-hydrogenase–FeGP complex (holoenzyme)
at 1.75 Å resolution (Fig. 3A) (28). This allows a
detailed three-dimensional view of the structure
and binding of the intact FeGP cofactor—the site
of H2 activation—and thereby integrates previ-
ous biochemical and biophysical data into a com-
prehensive and consistent picture.
To elucidate the holoenzyme structure, we
reconstituted the heterologously produced apoen-
zyme of Methanocaldococcus jannaschii with the
labile FeGP cofactor under completely anaerobic
and red-light conditions and crystallized the recon-
stituted enzyme. The crystal structure of [Fe]-
hydrogenase contains the FeGP cofactor with a
highoccupancy embedded in front of theC-terminal
end of the parallel b sheet of both Rossmann fold–
like peripheral units and capped by an a-helical
subdomain (Fig. 3). The specific amino acid
residues involved in binding of the FeGP cofactor
to the enzyme are shown in fig. S1. The guanosine
monophosphate moiety functions to anchor the
FeGP cofactor, and its binding mode essentially
corresponds to the adenosine monophosphate
moiety of dinucleotide binding proteins (Fig. 4).
The catalytically relevant iron-center moiety is
located close to the intersubunit clefts (Fig. 3) and
consists of a mononuclear iron atom surrounded by
a distorted square pyramidal or an octahedral liga-
tion shell dependent on the enzymatic state (Fig. 5).
1Max-Planck-Institut für Terrestrische Mikrobiologie and Lab-
oratorium für Mikrobiologie, Fachbereich Biologie, Philipps-
Universität Marburg, Karl-von-Frisch-Straße, D-35043 Marburg,
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Straße 3, D-60438 Frankfurt/Main, Germany.
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†To whom correspondence should be addressed. E-mail:
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Fig. 1. Superimposed active-site structure of the three phylogenetically unrelated hydrogenases. (A)
[NiFe]-hydrogensase from Desulfovibrio gigas (9, 12). (B) [FeFe]-hydrogenase from Clostridium
pasteurianum (13) andDesulfovibrio desulfuricans (14, 16). (C) [Fe]-hydrogenase fromMethanocaldococcus
jannaschii (this work). In [Fe]-hydrogenase, the fifth and sixth ligation sites are marked by gray spheres. All
three hydrogenase types have in common a low-spin iron (brown) ligated by thiolate(s), CO, and cyanide or
pyridinol (considered as cyanide functional analog), which acts together with a redox-active partner (dark
gray). The partners—Ni, the distal iron, and methenyl-H4MPT
+ (modeled), respectively—take over the
electrons or the hydride and perhaps play a role in the heterolytic cleavage of H2.
Fig. 2. Reaction catalyzed by [Fe]-
hydrogenase in methanogenic archaea.
The heterolytic cleavage of H2 by the
enzyme is dependent on the presence of
methenyl-H4MPT
+, whose methenyl C14a
has carbocation character and is there-
fore an excellent hydride acceptor. H4MPT,
tetrahydromethanopterin.
Fig. 3. Ribbon diagrams of the [Fe]-
hydrogenase of M. jannaschii. The ho-
modimeric enzyme is composed of three
folding units. The two peripheral units
(N-terminal segments) consist of a Rossmann
fold–like domain (green) which can be
further subdivided into a classical Rossmann
fold, an extension (bab), and an a-helical
insertion region. The unique central unit
(in blue) constitutes an intertwined helix
bundle formed by the C-terminal segments
of both subunits (27). The structure of the
holoenzyme (A) is in an open conforma-
tion and that of the apoenzyme (B) is in a
closed conformation with respect to the
cleft between the central and the periph-
eral units (27). The rotation angle between
the states is 37°. The FeGP cofactor is bound
to the peripheral units and is depicted as a
color-coded stick model.
www.sciencemag.org SCIENCE VOL 321 25 JULY 2008 573
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One iron ligand is the pyridinol nitrogen atom,
which links the organic guanylylpyridinolmolecule
with the iron center (Fig. 4). The hydroxylate and
carboxylate substituents of pyridinol are not used as
iron ligands, although the latter is partly disordered
and must be analyzed with caution. Because of its
planarity, the heterocyclic ring is present in a
pyridinol and not in a pyridone tautomeric form
(Fig. 4C), and therefore the nitrogen atom is in a p-
accepting sp2 configuration. The pyridinol group—
in particular, if the hydroxyl group is in a de-
protonated state—might have ligand back-bonding
properties similar to those of cyanide (29, 30),
which acts as an iron ligand in the [NiFe]- and
[FeFe]-hydrogenases. Further ligands are two CO
molecules that are optimally accommodated be-
tween several nonpolar atoms of the polypeptide
chain. The CO molecules form an angle of 90°, in
agreement with the interpretation of the IR
spectrum of the holoenzyme (24). The sole pro-
teinaceous ligand originates from the thiolate sulfur
of Cys176 that points toward the iron from a loop
following strand 169:174 at the bottom of the
intersubunit cleft.
The chemical nature of the fifth ligand is
unknown, and its electron density cannot defi-
nitely be assigned as a monatomic or diatomic
ligand, although it is clearly connected with that
of the iron and of relatively high occupancy
(i.e., corresponds to a completely occupied water
molecule). The electron density (s = 1.2) at
the position of the unknown ligand (fig. S2) is
increased (by a factor of 1.6) after soaking of the
crystals with 3 mM cyanide, which suggests
that this is the binding site of the reversible and
noncompetitive inhibitor cyanide (22).
The vacant sixth coordination site of the iron
contains a spherical electron density interpreted
as a monatomic solvent molecule (i.e., a com-
pletely occupiedwatermolecule) that is, however,
at a distance of 2.7 Å too far away to be con-
sidered as a ligand (Fig. 4). We predict this site to
be the binding position of extrinsic CO (Fig. 5)
known to inhibit [Fe]-hydrogenase, as the Fourier-
transformed IR spectrum of the CO inhibited
enzyme predicts a perpendicular orientation of
the extrinsic CO relative to the two intrinsic COs
(24). Because CO is a competitive inhibitor with
respect to H2, the latter most likely also binds to
this site (Figs. 1 and 5). The solvent close to the
iron interacts with a second solvent molecule,
which in turn is linked to the carbonyl group of
the strictly conserved Cys250 (Fig. 4A). Interest-
ingly, the Cys250 → Ala mutant shows reduced
enzyme activity (table S2).
A comparison of the active-site metal centers of
the three hydrogenase types reveals unexpected
common features (Fig. 1) previously recognized for
the two binuclear hydrogenases. All three types
contain a redox-inactive low-spin iron, presumably
in the oxidation state II, that is asymmetrically
ligated by five or six ligands arranged as a distorted
square pyramid or octahedron. Moreover, three p-
accepting ligands comprising CO, cyanide, or
pyridinol (considered as a cyanide functional
analog) are oriented perpendicular to each other in
a geometrically related manner, and a thiolate sulfur
always coordinates the iron trans to a diatomic
molecule (Fig. 1). All three iron centers act together
with a redox-active partner—methenyl-H4MPT
+ in
the case of [Fe]-hydrogenase, the distal iron in the
case of [FeFe]-hydrogenase, and nickel in the case
of [NiFe] hydrogenase—whose spatial position
relative to the other ligands is also similar.
Apparently, these related iron centers, with unusual
nonproteinaceous ligands thought to be synthesized
by three different enzymatic machineries (31) and
embedded into three architecturally different hydro-
Fig. 4. The FeGP cofactor. (A) Stereoview of electron density (in
blue) (s = 1.2) of the FeGP cofactor bound to [Fe]-hydrogenase.
The density fits almost perfectly (from right to left) to a guanine, a
ribofuranose, a phosphate, and a pyridinol (with its carboxymethyl
and two methyl substituents), which are covalently connected with
each other via a b-N-glycosidic bond and a phosphodiester bond,
respectively. The pyridinol nitrogen, two diatomic ligands, most
certainly CO, the sulfur of Cys176, and an unknown ligand have
been identified as iron ligands. A spherical electron density 2.7 Å apart from the iron was assigned as solvent. (B)
Electron density map of the solvent close to the iron that interacts with the carbonyl of Cys250 via a bridging solvent. (C)
The structure of the guanylylpyridone (in its 2-pyridinol tautomeric form) as determined by NMR and mass spectrometry
in the enzyme-free state (23). (D) Fourier-transformed EXAFS of [Fe]-hydrogenase as crystallized. The peaks at 1.8 Å (C)
and 2.9 Å (O) are dominated by the CO contribution. The fit is, at best, compatible with the presence of two COs, one N/O,
one S ligand, and of another not fully occupied first-shell ligand (see table S1).
Fig. 5. Coordination of the iron in
the active site of [Fe]-hydrogenase.
The iron sits in the plane of the square
spanned by the Cys176 sulfur, two COs,
and the unknown ligand; the nitrogen
is at the top of the pyramid. The sixth
ligation site trans to the pyridinol
nitrogen is presumably the binding site
of the competitive inhibitor CO (ac-
cording to IR spectroscopy data) and of the substrate H2. A
structural confirmation of the extrinsic CO binding failed, as the
quality of the resulting electron density map does not allow a
distinction between a water and CO. The noncompetitive inhibitor
cyanide presumably occupies the binding site of the unknown
ligand as derived from x-ray crystallographic studies (fig. S2). Note that the iron, one of the intrinsic COs,
the unknown ligand (or the cyanide), and probably the extrinsic CO are located in the plane of the
pyridinol ring. The distances and angles between the irons and ligands are drawn in, except for those
between the four ligands in the plane and the pyridinol’s nitrogen and the nearby solvent assigned as
water [N/S, 86°; N/CO (left), 102°; N/CO (right), 91°; N/cyanide, 94°; H2O/S, 90°; H2O/CO (left), 72°;
H2O/CO (right), 91°; H2O/cyanide, 90°]. The distances between iron and the four identifiable ligands
agree well with those determined in parallel by EXAFS spectroscopy (Fig. 4C and table S1).
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genase structures, evolved independently. Remark-
ably, hydrogenases are the only metalloenzymes
that use toxic CO and cyanide (or pyridinol) as
metal ligands. Thus, hydrogenases are an
impressive example of convergent evolutionary
development as a consequence of specific
biological and/or chemical restraints. However,
the intrinsic physicochemical properties of the
unique iron ligation pattern are not yet under-
stood, nor are their implications for the techno-
logically important H2 activation reaction.
Despite the related low-spin iron centers, the
enzymatic mechanism of [Fe]-hydrogenase differs
fundamentally from that of the other types because
of the different nature of the redox-active partner
and the accompanying electron delivery mode. In
[NiFe]- and [FeFe]-hydrogenases, the electrons of
H2 reduction flow one by one through the redox-
active metals and several iron-sulfur clusters over a
large distance to an electron acceptor. The active-site
structures essentially remain fixed during H2 cleav-
age, and H2 reaches the deeply buried active site
by a long diffusion channel. In [Fe]-hydrogenase,
however, the found ternary reactionmechanism and
the exchange betweenH2 and protons of water sole-
ly in the presence of methenyl-H4MPT
+ (32) (see
partial structure in Fig. 2) suggests that methenyl-
H4MPT
+ directly accepts the hydride fromH2. This
conclusion is supported by the x-ray structure, as the
cleft between the peripheral and central units can
accommodate the bulky methenyl-H4MPT
+ mole-
cule and the C14a atom can be positioned
sufficiently close to the iron without causing severe
clasheswith thepolypeptide chain (fig. S3).Because
the intersubunit cleft in the holoenzyme is, in fact,
too large for an optimal methenyl-H4MPT
+ adjust-
ment, we assume that its binding is accompanied by
an induced-fit movement constituting the catalysis-
competent active-site before each turnover. The
expected large-scale conformational changes are
reflected in the different positions of the peripheral
unit relative to the central unit found in the structures
of the holo- and apoenzymes (Fig. 3), mainly
induced by crystal forces. H2 can readily reach the
solvent-exposedFe center, which is probably encap-
sulated upon methenyl-H4MPT
+ binding.
The most attractive hypothesis for the mecha-
nism of H2 cleavage in [Fe]-hydrogenases is based
on a concerted action of the strong hydride acceptor
methenyl-H4MPT
+ and the Lewis acid Fe(II) that
lowers the pKa value of H2, preferably when bound
in a side-on conformation. The polarized H2 ligated
to the postulated binding site (Fig. 5) is attacked
from the adjacent carbocation C14a of methenyl-
H4MPT
+ from the Re-face of the ring system (see
Fig. 2), generating methylene-H4MPT. Acceptors
for the released proton within 6.5 Å from the iron
include the Cys176 thiolate ligand, the pyridinol ni-
trogen, oxygen, and carboxyl oxygen as well as two
conserved histidines, His14 and His201 (for the
position of the two histidines relative to the iron,
see fig. S1B). A His14→Ala mutation drastically
reduces the hydrogenase activity of the enzyme,
whereas His201 → Ala has only a minor effect
(table S2).
Although there are still many questions to be
answered, the crystal structure allows us to draw the
following conclusions: (i) The active-site iron is
definitely mononuclear, not dinuclear as in the
[FeFe]- and [NiFe]-hydrogenases. (ii) The presented
structural data, together with results of studies using
various spectroscopic methods [nuclear magnetic
resonance (NMR), mass, IR, Mössbauer, and
extended x-ray absorption fine structure (EXAFS)
(23–26)] and information from mutational analysis
(25), converge to a coherent result. (iii) The struc-
tures of the [Fe]-, [FeFe]-, and [NiFe]-hydrogenases
are completely different but share features in their
active site that can only have evolved convergently
(Fig. 1). (iv) The detailed three-dimensional struc-
ture will allow density functional theory (DFT)
calculations of energy profiles, which will help to
exclude some of the proposed mechanisms of H2
activation. (v)Model complexes can be constructed
on the basis of the iron center of [Fe]-hydrogenase,
and their analysis will provide further insight into
its essential but not yet understood function in H2
activation (3–7).
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Manipulating the Metazoan
Mitochondrial Genome
with Targeted Restriction Enzymes
Hong Xu, Steven Z. DeLuca, Patrick H. O’Farrell*
High copy number and random segregation confound genetic analysis of the mitochondrial
genome. We developed an efficient selection for heritable mitochondrial genome (mtDNA)
mutations in Drosophila, thereby enhancing a metazoan model for study of mitochondrial genetics
and mutations causing human mitochondrial disease. Targeting a restriction enzyme to
mitochondria in the germline compromised fertility, but escaper progeny carried homoplasmic
mtDNA mutations lacking the cleavage site. Among mutations eliminating a site in the cytochrome
c oxidase gene, mt:CoI A302T was healthy, mt:CoIR301L was male sterile but otherwise healthy,
and mt:CoIR301S exhibited a wide range of defects, including growth retardation,
neurodegeneration, muscular atrophy, male sterility, and reduced life span. Thus, germline
expression of mitochondrial restriction enzymes creates a powerful selection and has allowed
direct isolation of mitochondrial mutants in a metazoan.
Atypical animal cell contains hundredsto thousands of copies of the mitochon-drial genome (mtDNA), which encodes
13 essential subunits of the electron transport
chain complexes and RNAs (2 rRNAs and 22
tRNAs) required for mitochondrial translation
(1, 2). It is not clear how the genetic integrity
of this amitotically distributed genome is main-
www.sciencemag.org SCIENCE VOL 321 25 JULY 2008 575
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[Fe]-hydrogenase is one of three types of enzymes known to activate H2. Crystal structure analysis
recently revealed that its active site iron is ligated square-pyramidally by Cys176-sulfur, two CO,
an ‘‘unknown” ligand and the sp2-hybridized nitrogen of a unique iron–guanylylpyridinol-cofactor.
We report here on the structure of the C176A mutated enzyme crystallized in the presence of dithi-
othreitol (DTT). It suggests an iron center octahedrally coordinated by one DTT-sulfur and one DTT-
oxygen, two CO, the 2-pyridinol’s nitrogen and the 2-pyridinol’s 6-formylmethyl group in an acyl-
iron ligation. This result led to a re-interpretation of the iron ligation in the wild-type.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The reversible oxidation of molecular hydrogen, which serves
many microorganisms as electron supplier or electron sink in their
energy metabolism, is catalyzed by hydrogenases fromwhich three
basic types have been discovered [1]. [NiFe]- and [FeFe]-hydroge-
nases use a binuclear [NiFe] and [FeFe] center for H2 activation,
respectively, and several Fe/S clusters for electron delivery
(H2 2H+ + 2e) [2]. [Fe]-hydrogenase contains a mononuclear
iron center that somehow facilitates the generation of a hydride
(H2 H+ + H) to be abstracted by methenyl-tetrahydrometha-
nopterin (methenyl-H4MPT+) [3]. Despite their different protein
architectures and not being phylogenetically related the active
sites reveal amazing similarities as result of a convergent evolu-chemical Societies. Published by E
ydromethanopterin; methy-
eGP, iron–guanylylpyridinol;
IR, attenuated total reﬂection
; GP, guanylylpyridinol
Ermler), +49 6421 178109 (S.
S. Shima), ulermler@mpibp-tionary process presumably provoked by special chemical require-
ments for H2 activation [1,4,5]. In all three types the iron (in [FeFe]-
hydrogenase the iron proximal to the 4Fe–4S cluster) is redox-
inactive, low-spin, presumably present in the oxidation state II,
and ligated by at least one sulfur and three unusual p-accepting li-
gands such as CO, cyanide and/or a pyridinol that are arranged
similarly in a square-pyramidal or octahedral geometry [1]. How-
ever, why these ligands and this arrangement are applied for the
heterolytic cleavage of H2 is not well understood. Large efforts
are undertaken to elucidate the catalytic mechanism because H2/
H+ interconversion is considered as one of the major reactions in
future energy storage/transformation processes [3].
[Fe]-hydrogenase catalyzes a reaction involved in many metha-
nogenic archaea in CO2 reduction to methane by reducing methe-
nyl-H4MPT+ to methylene-H4MPT at the expense of H2 [3]. The
enzyme consists of a homodimer of 38 kDa per monomer built
up of the C-terminal segments of both subunits forming a central
helical unit and of two peripheral N-terminal domain units adopt-
ing a Rossmann-like fold [6] (Fig. 1A). Each of the latter domains
binds at the C-terminal end of their parallel b-sheet a unique
iron–guanylylpyridinol (FeGP)-cofactor whose catalytically com-
petent iron complex points into the reaction site located inside alsevier B.V. All rights reserved.
Fig. 1. Iron-ligation structure of wild-type [Fe]-hydrogenase and of its iron-guanylylpyridinol-cofactor as proposed previously [1]. (A) Ribbon diagram shows that the dimeric
enzyme is composed of one central (orange) and two peripheral (blue) units. The two active sites are located within the two clefts between these units. (B) Structure of the
FeGP-cofactor when it covalently binds to the enzyme via Cys176 as published [1]. (C) Schematic representation of the iron square-pyramidally ligated to the Cys176-sulfur,
an ‘‘unknown” ligand, two CO and the pyridinol’s sp2-hybridized nitrogen. A solvent is associated to the iron trans to the pyridinol’s nitrogen. Bond length was derived from
the X-ray crystallographic data [1].
586 T. Hiromoto et al. / FEBS Letters 583 (2009) 585–590cleft between the central and the peripheral units [1]. Based on the
interpretation of IR, Mössbauer, extended X-ray absorption ﬁne
structure (EXAFS) and X-ray crystallographic data from the holoen-
zyme (apoenzyme reconstituted with FeGP-cofactor) the iron com-
plex consists of a low-spin iron square-pyramidally ligated by
Cys176-sulfur of the polypeptide chain, two CO, an ‘‘unknown” li-
gand and the sp2-hybridized nitrogen of the cofactor’s pyridinol
nitrogen [1,7–11]. The sixth position appears to be occupied by a
hydrogen-bonded solvent molecule, however, too distant to be a
direct ligand (Fig. 1B and C).
We report here on the crystal structure at 1.95 Å resolution of
the holoenzyme of [Fe]-hydrogenase from Methanocaldococcus
jannaschii in which the active site Cys176 was mutated to an ala-
nine. It revealed that the Cys176 sulfur and the ‘‘unknown” ligands
of the iron complex of the wild-type enzyme are replaced in the
C176A enzyme by the dithiothreitol (DTT) present in the crystalli-
zation solution. The obtained electron density prompted us to re-
interpret the iron ligation structure recently published for the
wild-type enzyme [1]. A better ﬁt was obtained when the 2-pyrid-
inol moiety contributes two rather than one ligands to the iron, thesp2-hybridized nitrogen and the 6-formylmethyl group, the latter
in an acyl-iron ligation. The modiﬁed iron-ligation pattern in the
C176A mutated enzyme is compatible with the previously ob-
tained IR and EXAFS data of the mutated and wild-type enzymes.
2. Materials and methods
2.1. C176A holoenzyme preparation, crystallization and X-ray
structure determination
The C176A mutant from M. jannaschii was prepared as de-
scribed previously [7]. The apoenzyme was overproduced in Esch-
erichia coli BL21(DE3) cells, puriﬁed and reconstituted with FeGP-
cofactor [12]. The resulting catalytically inactive holoenzyme was
crystallized and diffraction data were collected at the Swiss Light
Source beamline PXII (Villigen). The data were processed and
scaled with the programs HKL [13] and XDS [14] (Table 1). The ob-
tained isomorphous crystals allowed a straightforward structure
determination using the wild-type enzyme model solved previ-
ously [1]. Model reﬁnement was performed with REFMAC5 [15]
Table 1
Data collection and reﬁnement statistics.
Data set [Fe]-hydrogenase
C176A
[Fe]-hydrogenase
wild-type
A. Data collection
Wavelength (Å) 0.992 0.992
Space group I4122 I4122
Unit cell parameter
a, c (Å) 96.4, 166.6 95.9, 165.8
Resolution range (Å) (highest
shell)
41.7–1.95 (2.0–
1.95)
26.2–1.75 (1.80–1.75)
Redundancy 7.9 (7.7) 5.2 (3.6)
Completeness (%) 96.9 (95.8) 95.5 (81.6)
Rmerge (%) 6.4 (70.1) 5.6 (50.8)
I/r(I) 17.2 (4.2) 16.0 (2.6)
B. Reﬁnement
Resolution limit (Å) 40.0–1.95 25.0–1.75
Rwork/Rfree (%) 16.5/20.5 17.3/20.5
Number of Residues 345 344
Number of solvent molecules 169 238
Rmsd bond lengths (Å) 0.016 0.016
Rmsd bond angles () 1.6 1.6
Cruickshank’s DPI (Å) 0.13 0.10
Average B (Å2) protein/FeGP/
solvent, DTT
37.5/28.2/46.4, 40.2 32.8/26.7/43.2
T. Hiromoto et al. / FEBS Letters 583 (2009) 585–590 587and model building/manual inspections with COOT [16]. The Rwork
and Rfree factor converged to 16.5% and 20.5% in the resolution
range 1.95–40.0 Å (Table 1). Figs. 1A–3A are produced by PYMOL
(DeLano Scientiﬁc). The coordinates of the C176A mutated enzyme
model and the re-reﬁned wild-type enzyme model were deposited
at the RCSD Protein Data Bank under the PDB accession codes 3F46
and 3F47.
2.2. Infrared spectroscopy
Attenuated total reﬂection infrared (ATR-IR) spectroscopy was
performed using Bruker VERTEX 70 IR spectrometer with Liquid
nitrogen cooling system for the MCT detector equipped with Sili-Fig. 2. Iron-ligation structure of C176A mutated [Fe]-hydrogenase. (A) Fo–Fc omit electr
Schematic representation of the iron octahedrally ligated to a dithiothreitol (DTT)-sulfur,
length was derived from the EXAFS data (see Table 2).cone Prism (DuraSampleIRTM, SENSIR TECHNOLOGIES) under red
light. Five microliters of the C176A and wild holoenzyme (20 mg/
ml) was dried on the window of the prism under an argon stream
at 20 C. During drying IR spectra were continuously recorded
thereby averaging 1280 scans for each spectrum. The enzyme
recovered from the crystallization drops were analyzed in the same
manner.
2.3. X-ray absorption data re-analysis
The extracted iron K-edge (mutants: 25–680 eV; wild-type: 25–
800 eV) EXAFS data were converted to photoelectron wave vector
k-space and weighted by k3. The spectra were reﬁned with EX-
CURV98 [17]. The program calculated the theoretical EXAFS for de-
ﬁned structural model. In addition to single scattering
contributions, multiple scattering linear units were deﬁned for
Fe–C@O. The potential acyl group in the vicinity of the iron has
been modelled by a single carbon ion, because its other atoms do
not contribute to multiple scattering by a linear orientation to-
wards the iron and therefore they are not identiﬁable in the EXAFS.
Parameters of each structural model, namely the atomic distances
(R), the Debye–Waller factors (2r2), and a residual shift of the en-
ergy origin, were optimized, minimizing the ﬁt index.3. Results
3.1. Iron-coordination in the C176A holoenzyme
The overall structure of the C176A enzyme is highly similar to
the wild-type enzyme, reﬂected in the root-mean-square (r.m.s.)
deviation of 0.2 Å using 344 Ca atoms. Signiﬁcant differences were
exclusively found around the mutated residue and the FeGP-cofac-
tor whose occupancy is nearly 100%.
The structure of the iron complex is primarily characterized by
the ligation of DTT (present in the crystallization solution) in a
bidentate manner (Fig. 2). The eliminated iron-coordinatingon density map around the iron complex contoured at the 3.0r level (in blue). (B)
a DTT-oxygen, two CO and the pyridinol’s nitrogen and pyridinol’s acyl carbon. Bond
Fig. 3. Re-interpreted iron-ligation structure of wild-type [Fe]-hydrogenase (A) Fo–Fc omit electron density map around the iron complex contoured at the 2.8r level (in
blue), shown in the same orientation as in Fig. 2A. (B) Schematic representation of the iron octahedrally surrounded by the pyridinol’s nitrogen, the pyridinol’s formylmethyl-
acyl carbon, one CO, and the Cys176 sulfur ligands as well as by the ‘‘unknown” and ‘‘solvent” binding sites. According to the current data the second COmore likely sits at the
‘‘solvent” binding site (see Sections 3.2. and 4). Bond length was derived from the EXAFS data (see Table 2).
588 T. Hiromoto et al. / FEBS Letters 583 (2009) 585–590Cys176-sulfur is replaced by the 1-sulfur of DTT and its 2-hydroxyl
group also ligates to the iron from that site which was occupied in
the wild-type enzyme by the ‘‘unknown” ligand (Fig. 1) [1]. The en-
tire molecule of DTT is clearly visible in the electron density and its
temperature factor is only moderately higher than that of the poly-
peptide (Table 1). The 3-hydroxyl group of DTT is anchored to the
protein matrix via a hydrogen bond to the hydroxyl group of Thr13
and the 4-thiol group of DTT interacts with hydrophobic regions of
the surrounding residues.
The binding of DTT to the iron creates a serious problem in that
the 2-hydroxyl group of DTT severely interferes with the 6-car-
boxymethyl substituent of the pyridinol ring if assumed to be in
the conformation of the wild-type enzyme (Fig. 1B) [1]. This
prompted us to rotate the pyridinol ring of FeGP-cofactor by
180 compared to the orientation reported for the wild-type en-
zyme. The shape of the electron density in the rotated conforma-
tion, however, did not allow the incorporation of a carboxylate
group with an oxygen as the iron ligand but it did allow the mod-
eling of an acyl group with an iron-ligating carbon. In this arrange-
ment the acyl oxygen is linked to the polypeptide chain by a
hydrogen bond with the amide group of Ala176. In the rotated con-
formation the pyridinol’s hydroxyl group points towards the cleft
between the central and peripheral unit. The hydroxyl group ﬁts
well into the electron density and interacts with the imidazole
group of His14 and the 2- and 3-hydroxyl group of DTT.
While one of the intrinsic CO-binding sites corresponds to that
reported for the wild-type enzyme the second CO-binding site now
appears to be positioned trans to the pyridinol’s nitrogen in the
C176A enzyme (Fig. 2A). ATR-IR measurements before and after
crystallization of the C176A enzyme veriﬁed the existence of the
two CO ligands in an angle of 90 as previously found in the
wild-type (Supplementary Fig. S1).
Based on the presented X-ray structure a re-analysis of the
C176A holoenzyme’s EXAFS data was performed (Table 2 and Sup-
plementary Table). The EXAFS spectra are dominated by sulfur and
CO contributions (Supplementary Fig. S2) but additional backscat-tering from similar light atoms could be identiﬁed already in the
previous study [7]. However, EXAFS data analysis is hampered by
the destructive interference of similar ligands at slightly different
distances yielding to an underestimation of their occupancy. This
effect is well established for metal–metal contributions [18,19].
Accordingly, the best ﬁt between experimental and simulated data
was previously obtained when the light atoms in the C176A mu-
tant were assigned to two O/N atoms. The presence of a carbon
as iron ligand is atypical and had not been considered in former
models. The application of the new iron-ligation structure contain-
ing three light atoms (N and acyl C from pyridinol, O from DTT) im-
proves the ﬁt index and yields typical bond lengths [20–23]. A
minor improvement is possible if the occupancy of one CO ligand
of the C176S and C176A enzymes is lowered by 0.25 or 0.5, respec-
tively. The slightly better reﬁnement value points towards a labile
ligand. Thus the re-analysis of EXAFS data from C176 mutants sup-
ports the presence of the coordinating acyl group in solution. Its
identiﬁcation in a standard ab-initio data analysis would require
a data range up to 2000 eV above the edge, which is almost
impossible to achieve for metalloproteins.
3.2. Re-interpretation of iron-coordination in the wild-type
holoenzyme
Taking into account the unprecedented iron-ligation pattern in
the C176A enzyme the structure of the wild-type enzyme was re-
reﬁned. And indeed, the resulting electron density also ﬁts better
to the reversed orientation of the pyridinol ring and to an acyl-iron
ligation (Fig. 3). A re-inspection of further [Fe]-hydrogenase struc-
tures (the cyanide or CO inhibited enzyme) based on different dif-
fraction data also argue for the postulated acyl-iron coordination
(data not shown). While the interactions between the protein
and the acyl group are identical in the C176A- and wild-type en-
zymes, the pyridinol’s hydroxyl group of the wild-type enzyme is
not hydrogen-bonded to His14 but to a solvent molecule that is an-
chored to the protein matrix via Thr13.
Table 2
Structural parameters extracted from the EXAFS reﬁnement for wild-type [Fe]-
hydrogenase, and C176A and C176S mutated enzymes. For alternative models
compared to the data see Supplementary table. The numbers (n) of ligand atoms (L) to
the iron, their distance to the iron (R), the respective Debye-Waller factor (2r2), the
C–O or C–N bond length (RCX), the Fermi energy for all shells (EF), and the ﬁt index
(U), indicating the quality of the ﬁt are shown.
n Fe L R (Å) 2r2 (Å2) RCO (Å) EF (eV) U x103
Wild-type enzyme
2 Fe Ca 1.769(5) 0.0050(7) 1.170(8) 10.6(5) 0.1664
1 Fe Cb 1.88(1) 0.0020(1)
1 Fe O 2.052(9) 0.014(2)
1 Fe N 2.052(9) 0.014(2)
1 Fe S 2.335(4) 0.0064(7)
2 Fe Oc 2.939(3) 0.0025(4)
Mutated enzymes
C176A
1.5 Fe Ca 1.76(1) 0.010(3) 1.16(2) 12(1) 0.2758
1 Fe Cb 1.87(7) 0.0038(3)
1 Fe O 2.01(1) 0.005(1)
1 Fe N 2.01(1) 0.005(1)
1 Fe S 2.303(7) 0.005(1)
1.5 Fe Oc 2.922(7) 0.004(1)
C176S
1.75 Fe Ca 1.75(1) 0.017(8) 1.16(2) 10.4(8) 0.3685
1 Fe Cb 1.83(2) 0.0029(2)
1 Fe O 1.997(8) 0.005(1)
1 Fe N 1.997(8) 0.005(1)
1 Fe S 2.295(7) 0.0048(9)
1.75 Fe Oc 2.91(1) 0.003(2)
a Carbon of CO.
b Carbon of acyl group.
c Oxygen of CO.
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the lack of imagination concerning the possibility of an acyl group
as iron ligand and on the subsequent conclusion that the orientation
of a negatively charged carboxylate group towards the rather unpo-
lar protein interior is unlikely. Moreover, the hydroxyl group of the
pyridinol ring in van derWaals contact to the iron-ligating CO group
is almost isoelectronically and structurally identical to a formylm-
ethyl substituent resulting in a related electron density. In the
wild-type holoenzyme there is a second conformation of the
Cys176-sulfur unanchored to the FeGP- cofactor suggesting re-
duced occupancy of its iron that complicates ligand modelling.
On the basis of EXAFS data the acyl coordination can only be
identiﬁed when the slight differences in backscattering for the
three light elements (C, N, and O) are considered (see above). These
ligands are typically indistinguishable by this method. Based on
the new coordination model an improved reﬁnement was also pos-
sible for the wild-type enzyme (Table 2 and Supplementary Table),
yielding a coordination by 5 or 6 ligands instead of 4–5 ligands as
in our previous models [1,7]. Both, the incorporation of the nitro-
gen ligand of the cofactor identiﬁed before and the carbon from
the acyl group improved the ﬁt index. However, the presence of
the oxygen ligand (perhaps from a solvent) cannot be judged on
the basis of these data. The reﬁnements of wild-type and mutant
enzymes are of similar quality although the energy range for the
wild-type enzyme is longer than for the mutant samples (Table
2). Thus in solution the iron in wild-type enzyme is coordinated
by two CO, the sulfur from C176, the nitrogen and the acyl-carbon
of the cofactor, and potentially an easily removable oxygen ligand
from the solvent.
4. Discussion
In the new model the pyridinol moiety contributes two ligands
to the iron, the sp2-hybridized nitrogen and the 6-formylmethyl
group in an acyl-iron ligation (Fig. 3). This bidentate iron-ligationmay better explain the stability of the protein free FeGP-cofactor
in 10 mM EDTA at pH 8 [12].
The proposed acyl group as iron ligand, although not extracted
from previous IR, EXAFS and even X-ray crystallographic data, is
not in contradiction to them but has still to be unambiguously con-
ﬁrmed in future studies. The existence of the acyl group is consis-
tent with the results of the NMR andmass spectroscopic analysis of
the guanylylpyridinol (GP) part, which was derived from the light
sensitive FeGP–cofactor. Upon light inactivation, the proposed
acyl-iron bond in FeGP-cofactor could be converted into the 6-car-
boxymethyl group of GP by hydrolysis [10]. Alternatively, photoly-
sis of iron carbonyl complexes containing an acyl-iron bond has
been shown to be associated with a decarbonylation of the acyl
group [24]. In this respect it is of interest that the enzyme bound
FeGP-cofactor decomposes under acid condition (5% HClO4) at
60 C into a GP, an iron and 2.4 ± 0.2 CO per one iron [8]. An acyl
carbon–iron bond is also compatible with IR spectroscopic data
as the FeGP-cofactor in the active enzyme shows CO stretching fre-
quencies at 2011 cm1 and 1944 cm1 in water [8] and at
1996 cm1 and 1928 cm1 in the dried state (Supplementary
Fig. S1). These CO stretching frequencies are similar to those from
(g5-cyclopentadienyl)dicarbonylacyliron complexes in organic sol-
vents or in the dried state [24,25]. Apparently, the electronic state
of iron in both complexes is related arguing for an acyl-iron liga-
tion in the FeGP cofactor of [Fe]-hydrogenase. Therefore, from
now on acyl-iron complexes should be included in the list of pos-
sible biomimetic compounds for [Fe]-hydrogenase. Interestingly,
an acyl group as metal ligand (to nickel) in an enzyme has so far
only been reported for the acetyl-CoA synthase/decarbonylase
reaction as possible intermediate in the formation of acetyl-CoA
from CO and a methyl group [26,27].
The positions of the Cys176-sulfur and of the intrinsic CO ar-
ranged trans to the Cys176-sulfur are not changed by the re-inter-
pretation. This leaves the positions of the ‘‘unknown” ligand and
of the ‘‘solvent” in the previous wild-type enzyme model (Fig. 1C)
as possible binding sites for the second intrinsic CO (Fig. 3). While
the C176A structure favors the ‘‘solvent” binding site for the second
intrinsic CO its position in the wild-type enzyme cannot be identi-
ﬁed on a structural basis. The electron density at the ‘‘solvent” bind-
ing site, although compatible with a (partially bound) intrinsic CO is
not clearly connected to that of the iron and the weaker electron
density of the ‘‘unknown” binding site is not sufﬁciently shaped.
A deﬁnitive assignment of the second intrinsic CO-binding site
is difﬁcult since the C176A enzyme structure is not active and that
both of the mutant and the wild-type structure might be modiﬁed
during the structure determination process especially at the sol-
vent-exposed ‘‘unknown” ligand and ‘‘solvent” binding sites be-
cause of the instability of the FeGP-cofactor.Acknowledgements
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Abstract. Optical excited molecules play an increasingly important role in research at light 
sources. Here we compare two approaches to structurally characterize such states, pumped-
XAS and an innovative combination of EXAFS spectroscopy and resonant Raman scattering. 
The later combination allows to study efficiently charge-transfer complexes in their ground and 
excited state. The design of the experimental setups for pumped-XAS and resonant Raman 
scattering at different temperatures as well as results obtained are presented. We receive two-
fold information on the structural and electronic properties of both states elucidating the 
alterations upon induced charge transfer in the Cu2O2-core of a system mimicking the active 
site of tyrosinase and hemocyanin.  
1.  Introduction  
The availability of new photon-sources with pulse lengths in the fs-regime will permit fascinating 
research on triggerable compounds [1]. The relaxation of excited states into the ground state will 
provide new insights into the dynamics of the systems under study. Of particular interest to the 
molecular biological and bioinorganic communities will be the dynamics of metal-donor interactions. 
Excited states of biomolecules can be made available to the structural and spectroscopic analysis by a 
variety of strategies, ranging from optical pumping to stabilization of chemical mimics. Here, we 
focus on a system mimicking the Cu2O2-core in hemocyanin and tyrosinases. Hemocyanin serves in 
many arthropods as an oxygen carrier, similar to hemoglobin in vertebrates. The enzyme tyrosinase is 
present in plant and animal tissue and shares the dinuclear copper binding site as well as most of the 
structural features of hemocyanin. In fact, many hemocyanins even exhibit tyrosinase activity [2]. 
Tyrosinase catalyses the oxidation of phenols, required for the production of melanin and other 
pigments. This phenol oxidase activity is of considerable interest for industrial applications [3]. 
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Figure 1. Potential Oxo-form (O-state, left) and Peroxo-form (P-state, center) of complexes modell-
ing hemocyanin and tyrosinase active sites.  Formation of [Cu2L2(µ-O)2]I2 (right) upon oxidation of 
[Cu(L)I] with dioxygen at 25 °C monitored by the absorption intensity for λmax (366 nm).  
 
In both metalloproteins molecular oxygen is binding to two copper ions in the side-on peroxo mode 
(P-state) [4]. Each of these copper ions is stabilised by three histidine groups. Complexes modelling 
these features have the potential to serve as highly specific oxidation catalysts [3]. In these complexes 
the biomimetic donor ligand has the function to stabilize the complex after reaction with molecular 
oxygen either in the P-or O-state: with a peroxo-dianion or two µ-oxo donors bridging the Cu ions, 
respectively (Figure 1). Typically, these systems are stable at cryogenic temperatures only [5]. 
Recently, we presented the first system stabilizing the O-state at room temperature [6]. It is formed 
by the reaction of molecular oxygen with the Cu(I)-complex, Cu(L)I with L= (B(TMPip)G2p) [7] 
within several hours as visualized by the increasing absorption at 366 nm (Figure 1, right). In its 
ground state the complex comprises an O-state as shown by XAFS data, collected at 20 K in 
fluorescence mode at beamline D2 (EMBL Hamburg, DESY, Germany) [6]: A Cu-dimer with 
terminal N-donors at 2.00(4) Å, two bridging µ-oxo donors at 1.93(1) Å and a Cu-Cu distance of 
2.84(1) Å could be identified in the EXAFS. Such systems typically can be optically excited by UV-
light [5]. Here, we compare strategies to characterize this excited state either by optical-pumping or by 
resonance Raman spectroscopy.  
2.  Material and Methods 
[Cu2L2(µ-O)2]I2 has been synthesised as described before [6]. For Raman and EXAFS measurements, 
the following Cu(I) solution was prepared for subsequent oxygenation: 0.05 mmol of B(TMPip)G2p 
(33 mg) in 5 mL of THF were added under stirring to a solution of 0.05 mmol of CuI (9 mg) in 5 mL 
of THF. The resulting concentration is 5 mmol/L which corresponds to 3.1 g Cu/L. 
For optical excitation a custom designed UV-LED source with a 1 mm focal spot has been installed 
at beamline C (HASYLAB, DESY, Hamburg, Germany). This source is based on a NSSU100A LED 
(NICHIA, Tokyo, Japan) with optics comprising 3 UV-transparent lenses (f=9mm, f=100mm and 
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Figure 2. Spectral distribution of the light emitted by our UV source (left). Setup for the XAS 
experiments on optical excited solution of [Cu2L2(µ-O)2]I2 with optics of the UV-source (black), 
multi-element fluorescence detector, safety shield (Kapton, orange), and UV-excited sample in an Al-
sample holder with Mylar windows. (center: in direction of the x-ray beam, right: top view).  
 
 
 
 
 
 
 
    
Figure 3. Axially symmetrical sketch of the custom-made cuvette for temperature dependent 
measurements (left). Setup for the temperature dependent Raman experiments on solution of 
[Cu2L2(µ-O)2]I2 (center: picture of the cuvette, right: top view on the cryostat). 
f=50mm). The maximum wavelength at 365nm is in line with the Raman active transition [6]. The 
resulting total power is 14.5mW, of which 70% are localized in the spot. Cuvettes were sealed with 
Mylar windows, because it is transparent at this wavelength. Kapton, in contrast, strongly absorbs this 
UV-light and thus has been used for safety precautions (Figure 2).   
Resonant Raman experiments were performed using a custom made UV resonance Raman 
spectrometer with a completely reflective optics being located in a cleanroom [8]. Because all other 
compounds mimicking the O-state are unstable at room temperature we compared the quality of 
Raman spectra collected at different temperatures. A custom-build cuvette was mounted within a 
liquid helium cryostat (KONTI cryostat Spectro 6111, Cryovac). A suprasil window defines the 
sample volume of 200 µl. The solution was inserted through a small hole that was closed by a screw 
afterwards (Figure 3). 
3.  Results and Discussion  
The ground state of [Cu2L2(µ-O)2]I2 has been characterized by Cu-K edge fluorescence XAS at 20 K 
(Figure 4, left). Upon optical excitation at room temperature the x-ray transmission signal at 8990 eV 
increases immediately (Figure 4, center), whereas the fluorescence signal follows with a few seconds 
delay. The reasons for these observations are enigmatic: The UV-light might heat up the sample 
causing lower absorption of x-rays in the 1mm thick cuvette. The second effect causing higher x-ray 
absorption after switching off the UV light source could not be identified so far. Maybe due to the 
high concentrations of the Cu-complex a small percentage precipitated prior to the experiment and 
dissolves at elevated temperatures. Anyhow, difference in the fluorescence XANES with and without 
UV-light illumination could not be identified for a variety of concentrations indicating a to low UV-
photon intensity. Based on the width of the resonance Raman profile of the first and second order 
Raman peaks, the lifetime of the excited state is estimated to ∆t ≈ h/∆E ≈ h/ 0.2 eV ≈ 20 fs. At the 
given UV intensity ~10  photons are generated per second; considering the absorption probability of 
~40% for the 1mm thick cuvette only a small fraction of the 10  Cu ions elucidated by the 1 x 1 mm  
x-ray beam are optically excited when the pulsed synchrotron beam hits the sample. 
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Thus optical excitation is only feasible for such complexes with the help of a synchronized, pulsed 
UV-source, because a several orders of magnitude more intense UV-source would evaporate the 
sample and cause even more artefacts. But even in this case the total power absorbed by the sample 
will potentially lead to effects similar to the ones shown in figure 4.  
For these reasons we looked into a more elegant and instrumentally less demanding approach: the 
utilization of a method elucidating the structural change induced upon charge-transfer. The Raman 
spectrum of  [Cu2L2(µ-O)2]I2 exhibits strong vibrational excitations that can be assigned to the bending 
vibration of the copper-oxygen core at 114.3 cm-1 and its integer multiples. For a given local 
symmetry the structural change is calculated from the Huang-Rhys parameter given by the intensity 
 
 
 
 
 
 
  
       
Figure 4. left: EXAFS and corresponding FT plus XANES;  center: Normalized transmission and 
fluorescence at 8990 eV; right: Raman spectra of [Cu2L2(µ-O)2]I2 and THF at 350.7 nm. For data at  
293 K and 77 K 10 minutes were given to reach stable temperature. Data around the melting point of 
THF (165 K) were taken while cooling down (144K/145K). Offset was added for better visualization. 
decrease in the Raman spectra  [5, 6]. This results in a change of the copper-oxygen distance by +0.01 
Å and of the oxygen-oxygen distance by -0.13 Å [6].  
Up to now to the limited stability of such complexes restricted such measurements to cryogenic 
temperatures. Here, a direct comparison of cryogenic and room temperature conditions is possible. 
Below the freezing point of the solvent THF (165 K) additional contributions become apart (green 
curve). These signals can be assigned to THF (dotted blue line)(Figure 4). Due to the huge relative 
difference in intensity and similar energy transfers no difference spectra were calculated to avoid 
artifacts. Interestingly, in contrast to X-ray absorption experiments, where due to the decreasing 
Debye-Waller factor a higher radial resolution is obtained at lower temperatures, no significant 
difference in resolution was detected in the Raman experiments. 
This combination of resonant Raman spectroscopy and X-ray absorption spectroscopy gives direct 
access to structural and electronic (not shown) parameters of optical excited systems. In future, 
resonance Raman experiments at copper M-edges at free electron laser sources such as FLASH will 
provide new experimental tools to go even beyond the characterization presented here.  
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Abstract. Hydrogenases are enzymes that catalyze the reversible oxidation of molecular 
hydrogen. Although their structure and catalytic mechanism are of considerable applied 
interest as models for the development of efficient catalysts for hydrogen fueled processes, the 
understanding of how hydrogenases react with H2 is only in its infancy. Two of the three 
known types of hydrogenases are iron-sulfur proteins that contain a dinuclear metal center, 
either [NiFe] or [FeFe]. In contrast, [Fe]-hydrogenase is the only mononuclear hydrogenase 
and thus a perfect system for studying the structural and electronic determinants of these 
enzymes. Here we summarize recent improvements in modeling based on the EXAFS signal 
and the geometric structure of this metalloenzyme in its as isolated or reconstituted form. The 
individual contributions to the EXAFS resulting in two different structural models are 
presented and discussed. Inspired by the new crystal structure, we show an advanced EXAFS 
model for the enzyme from Methanothermobacter marburgensis.  
1.  Introduction  
Many microorganisms utilize the reversible oxidation of molecular hydrogen as an electron supply or 
electron sink. This reaction is catalyzed by hydrogenases of which three basic types have been 
discovered [1, 2]. [NiFe]- and [FeFe]-hydrogenases use a dinuclear active site for activation of H2 and 
typically a chain of Fe/S clusters for electron delivery (H2 ⇋  2H+ + 2e-) [2]. In contrast, [Fe]-
hydrogenase activity depends on an unique cofactor, iron-guanylyl pyridone (FeGP), forming the 
active site of the enzyme, which catalyzes reversible hydride transfer from H2 to 5,10-
methenyltetrahydromethanopterin [3].  
These three enzymes reveal several similarities although neither being phylogenetically related nor 
sharing major motifs in the protein architecture: In [FeFe]-hydrogenase, the iron ion proximal to the 
Fe/S cluster is redox-inactive and present in the formal oxidation state II. It is ligated by three sulfur 
and three π-accepting ligands such as carbon monoxide and cyanide. The Fe-ion in [NiFe]-
hydrogenase is coordinated by a very similar set of ligands: two sulfur ligands, three carbon monoxide 
/ cyanide donors and a yet not fully identified bridging ligand X (Figure 1).  
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 Mononuclear [Fe]-hydrogenase shares several features with these enymes: the initial EXAFS 
characterization of the enzyme isolated from Methanothermobacter marburgensis (mHmd) identified 
a single sulfur ligand bound to the iron ion of the FeGP-cofactor. Site directed mutagenesis studies on 
all three cysteine residues of [Fe]-hydrogenase from Methanocaldococcus jannaschii (jHmd) (i.e.: 
C10A, C176A, C176S, C250A), together with EXAFS studies on these mutants and on a Se-Cys form, 
determined that the sulfur donor is provided by Cys176 [4]. In addition, two CO-donor groups were 
clearly visible in the EXAFS and the corresponding Fourier transform in line with earlier IR studies 
[6]. Interestingly, the contribution of the remote oxygen ion from carbon monoxide to the EXAFS is in 
jHmd as well as in mHmd much stronger than that observed for [NiFe]-hydrogenase HoxC [7]. 
Following a conservative approach for ab initio EXAFS data analysis, the remaining FT signal 
bracketed by the CO and sulfur contributions were refined as oxygen groups, because the 
backscattering potentials are highly similar for the donor types oxygen and nitrogen.  
                                                  
Figure 1. Fe-coordination for the Fe ion proximal to the FeS-clusters in [FeFe]-hydrogenase (left), 
the Fe-ions in [NiFe]-hydrogenase (center) and [Fe]-hydrogenase (right). The position of the CO 
ligand trans to N, and O trans to acyl-C in [Fe]-hydrogenase are not assigned unambiguously in the 
crystal structure.  
 Recent structural information obtained by EXAFS and protein crystallography allows an advanced 
analysis of these data: In the C176A-mutant of jHmd in addition to the nitrogen donor of the pyridinol 
group of the FeGP-cofactor its acyl-carbon donor is modeled to be bound to the iron ion. Re-analysis 
of the jHmd wild type EXAFS shows that this model better fits both crystallographic electron density 
 
Figure 2. EXAFS and corresponding Fourier transform for mHmd and wild-type jHmd isolated 
under different conditions and refined with different structural models (black: measurements):  
mHmd(1): Hmd from M. marburgensis modelled as tetrahedral Fe-coordination as initially published 
[4]; jHmd(2): Hmd apoenzyme  from  M. jannaschii heterologously produced in E. coli and 
reconstituted with FeGP-cofactor with pentacoordination as published in [4]; jHmd(3):  a sample 
similar to jHmd(2) but of higher quality and metal concentration with tetrahedral structural model for 
Fe-coordination [5]; jHmd(4): the protein under crystallization conditions as published in [5]; 
jHmd(5): advanced, octahedral structural model for jHmd(3) as published in [1]. Note, the sensitivity 
of jHmd to different buffer conditions.    
14th International Conference on X-Ray Absorption Fine Structure (XAFS14) IOP Publishing
Journal of Physics: Conference Series 190 (2009) 012197 doi:10.1088/1742-6596/190/1/012197
2
 
 
 
 
 
 
and EXAFS data [1]. Here, we show that distinguishing between individual contributions of light 
ligands can improve the fit quality considerably.  
2.  Material and Methods 
 
The jHmd samples from M. jannaschii and mHmd from M. marburgensis were prepared as described 
previously [6, 4, 5]. Whereas the wild type form of Hmd from M. marburgensis has been isolated from 
the organism, for jHmd and its mutants the apoenzyme was overproduced in Escherichia coli 
BL21(DE3) cells, purified and reconstituted with the FeGP-cofactor [8].  
All Fe-K edge XAFS spectra were recorded at the EMBL Hamburg EXAFS beamline (DESY, 
Germany) in fluorescence mode. The extracted iron K-edge EXAFS data were converted to 
photoelectron wave vector k-space by KEMP [9] and weighted by k3. The spectra were refined with 
EXCURV98 [10]. The program calculated the theoretical EXAFS for defined structural models. In 
addition to single scattering contributions, multiple scattering linear units were defined for Fe-C=O 
and Fe-C-N. The acyl group has been modelled by a single carbon ion, because its other atoms do not 
contribute to multiple scattering by a linear orientation towards the iron and therefore they are not 
identifiable in the EXAFS. Parameters of each structural model, namely the atomic distances (R), the 
Debye-Waller factors (2σ2), and a residual shift of the energy origin, were optimized, minimizing the 
fit index (Table 1).  
3.  Results and Discussion  
In our initial study we identified the cysteinic sulfur ligand as well as two CO groups in Hmd from 
M. jannaschii and from M. marburgensis. The remaining backscattering contributions at about 2 Å 
were refined by 1 or 2 oxygen donor atoms, respectively, as shown in Figure 2. The spectrum obtained 
for the enzyme from M. jannaschii overexpressed in E. coli and reconstituted with the FeGP-cofactor 
differs considerably from the mHmd spectrum. This has been modeled by an additional oxygen.  
 
Figure 3. EXAFS and corresponding Fourier transform for reconstituted jHmd(3) (black: 
measurement, red: refinement) with individual components contributing to tetrahedral EXAFS model 
(green: one out of two CO, blue: S,  magenta: O). Due to the multiple scattering within the CO unit 
the contribution by the oxygen ions is strongly enhanced.  No destructive interference at lower 
photoelectron wave-vectors (yellow area) for sulphur and oxygen backscattering is observed. At 
higher waver vectors the oxygen signal is strongly damped due to its nature and the Debye-Waller 
factor obtained in the refinement (Table 1).  
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Preparations of jHmd with different buffer conditions yielded different EXAFS traces much more 
similar to mHmd. This spectrum, jHmd(3), was initially refined as a tetracoordinated Fe-ion (see 
below) [4]. In the crystal structure of jHmd one ligand could not clearly be identified, prompting the 
speculation that it might be caused by the buffer conditions. This has been tested by EXAFS on jHmd 
under such conditions (jHmd(4)). Here, only small changes occur and no additional ligand can be 
identified by EXAFS [5]. Prompted by the crystal structure of the C176A-mutant of jHmd [1] an 
octahedral Fe-coordination has been modeled in the corresponding EXAFS as well, assuming for the 
first time binding of the acyl-carbon to the metal ion. This resulted in an improvement of the EXAFS 
fit [1]. Based on this structural model the fit for jHmd(3) improves slightly as well.  
The individual components contributing to the EXAFS of jHmd using the tetrahedral model are 
shown in Figure 3: The backscattering from the two CO groups, of which only one is shown, and the 
sulfur donor are dominating. As visualized in the Fourier transform the oxygen from CO contributes 
even stronger to the EXAFS than the carbon ion. 
This is caused by the focusing of the photo electron wave by the carbon ion. The signals for sulfur 
and oxygen represent each a single contribution at an average distance with a disorder defined by the 
Debye-Waller factors. For small photo electron wave vectors these signals are in phase. At higher 
wave vectors when they get out of phase the oxygen contribution is small, reflecting of the higher 
Debye-Waller factor obtained in the fit (Table 1). 
 
Figure 4. EXAFS and corresponding Fourier transform for reconstituted jHmd(5) (black: 
measurement, red: refinement) with individual components contributing to octahedral EXAFS model 
(green: CO, blue: S, orange: N, magenta: O, light blue: (acyl-)carbon). The destructive interference 
of the carbon ascribed to the acyl-group and the N/O contribution at lower photoelectron wave-
vectors (yellow area) results in a quasi-cancellation of these two contributions in this energy range. 
At higher energies mainly interference with the sulphur contribution can be observed. Here, the O 
and N contributions are very small due to their higher Debye-Waller factor that we ascribe to a 
weaker binding of the oxygen donor. In the Fourier transform magnitude the negative interference is 
not visible.   
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Table 1: EXAFS parameters for models shown in this paper. The numbers (n) of ligand atoms (L) 
to the iron ion, their distance to the iron ion (R), the Debye-Waller factor (2σ2), the C–O, the Fermi 
energy for all shells (EF), and the fit index (Φ), indicating the quality of the fit are shown. 
n Fe L R 2σ2 RCX(Ǻ) EF Φ 
 
mHmd (1) 
2 
1 
1 
2 
 
 
Fe 
Fe 
Fe 
Fe 
 
 
Ca 
O 
S 
Oa 
Ǻ 
 
1.801 (4) 
2.034 (6) 
2.308 (3) 
2.922 (4) 
Ǻ2 
 
0.0084 (8) 
0.007 (1) 
0.0051 (6) 
0.0083 (5) 
Ǻ 
 
1.121 (8) 
 
 
eV 
 
-9.0 (4) 
 
 
x103 
 
0.01196 
 
 
jHmd (2) 
2 
2 
1 
2 
 
Fe 
Fe 
Fe 
Fe 
 
Ca 
O 
S 
Oa 
 
1.813 (5) 
2.004 (5) 
2.34 (1) 
2.923 (8) 
 
0.007 (1) 
0.007 (1) 
0.008 (1) 
0.013 (1) 
 
1.100 (13) 
 
 
-7.3 (4) 
 
 
 
0.4825 
 
jHmd (3) 
2 
1 
1 
2 
 
Fe 
Fe 
Fe 
Fe 
 
Ca 
O 
S 
Oa 
 
1.792 (4) 
2.040 (9) 
2.321 (4) 
2.934 (4) 
 
0.0077 (9) 
0.013 (2) 
0.0071 (8) 
0.0081 (5) 
 
1.142 (8) 
 
 
-8.9 (4) 
 
 
 
0.2005 
 
jHmd (4) 
2 
1 
1 
2 
 
Fe 
Fe 
Fe 
Fe 
 
Ca 
O 
S 
Oa 
 
1.795 (5) 
2.03 (1) 
2.351 (6) 
2.921 (7) 
 
0.007 (1) 
0.008 (2) 
0.007 (1) 
0.0098 (9) 
 
1.12 (1) 
 
 
-8.3 (7) 
 
 
 
0.3643 
 
jHmd (5)  
2 
1 
1 
1 
1 
2 
New fit 
Fe 
Fe 
Fe 
Fe 
Fe 
Fe 
 
Ca 
C 
O 
N 
S 
Oa 
 
1.769(5) 
1.88(1) 
2.052(9) 
2.052(9) 
2.335(4) 
2.939(3) 
 
0.0050(7) 
0.0020(1) 
0.014(2) 
0.014(2) 
0.0064(7) 
0.0025(4) 
 
1.170 (8) 
 
 
 
 
-10.6(5) 
 
 
 
 
 
0.1664 
 
 
 
 
In Figure 4 the individual contributions are shown for the octahedral Fe-coordination. Note that the 
major contributions to the EXAFS (cysteinic sulfur, carbon and oxygen of the carbon monoxide 
ligands) differ only marginally from the one for tetrahedral coordination (Figure 3). The residual 
signal has initially been modeled only by one oxygen contribution, which is based on its small size 
fully justified. When additional information became available more complex models were considered, 
allowing for partially destructive interference of these components. Here, the carbon and the oxygen 
contribution nearly cancel out at small wave-vectors and the carbon backscattering contributes to a 
much better fit at higher wave-vectors. 
This is as well visualized by the corresponding Fourier transform: Measurement and fit match 
much nicer than for the tetrahedral model. The values resulting from this fit are given in table 1 
showing that the other contributions are only marginally affected. Based on these considerations we 
re-analysed the mHmd (1) data and compared them to the new structural model for the Hmd active 
site. As shown in table 1 the model again improves slightly. This is inline with the optical representa-
tion (Figure 5) and allows concluding that the active sites in mHmd and jHmd are virtually identical. 
Moreover, this work highlights the need for additional criteria in XAS data analysis. Here, the XANES 
as well as methods considering target values for bond lengths, bond valance sum, Debye-Waller 
factors and Fermi energy shift will play an important role [11, 12].   
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Figure 5. EXAFS and corresponding Fourier transform for mHmd (black: measurement, red: 
refinement) assuming an octahedral Fe-coordination as indicated in Figure 1.  
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The iron-site structure of [Fe]-hydrogenase and model systems: an X-ray
absorption near edge spectroscopy study†‡
Marco Salomone-Stagni,a Francesco Stellato,b C. Matthew Whaley,c Sonja Vogt,d Silvia Morante,b
Seigo Shima,d Thomas B. Rauchfussc and Wolfram Meyer-Klaucke*a
Received 28th October 2009, Accepted 8th January 2010
First published as an Advance Article on the web 28th January 2010
DOI: 10.1039/b922557a
The [Fe]-hydrogenase is an ideal system for studying the electronic properties of the low spin iron site
that is common to the catalytic centres of all hydrogenases. Because they have no auxiliary iron-sulfur
clusters and possess a cofactor containing a single iron centre, the [Fe]-hydrogenases are well suited for
spectroscopic analysis of those factors required for the activation of molecular hydrogen. Speciﬁcally, in
this study we shed light on the electronic and molecular structure of the iron centre by XAS analysis of
[Fe]-hydrogenase from Methanocaldococcus jannashii and ﬁve model complexes (Fe(ethanedithiolate)-
(CO)2(PMe3)2, [K(18-crown-6)]2[Fe(CN)2(CO)3], K[Fe(CN)(CO)4], K3[Fe(III)(CN)6], K4[Fe(II)(CN)6]).
The different electron donors have a strong inﬂuence on the iron absorption K-edge energy position,
which is frequently used to determine the metal oxidation state. Our results demonstrate that the
K-edges of Fe(II) complexes, achieved with low-spin ferrous thiolates, are consistent with a ferrous
centre in the [Fe]-hydrogenase from Methanocaldococcus jannashii. The metal geometry also strongly
inﬂuences the XANES and thus the electronic structure. Using in silico simulation, we were able to
reproduce the main features of the XANES spectra and describe the effects of individual donor
contributions on the spectra. Thereby, we reveal the essential role of an unusual carbon donor coming
from an acyl group of the cofactor in the determination of the electronic structure required for the
activity of the enzyme.
Introduction
Molecular hydrogen was one of the earliest energy sources
available on earth. As a consequence, many microorganisms
continue to use it as electron donor.1 To do so, these organisms rely
on the hydrogenase enzymes, which catalyze the production and
oxidation of molecular hydrogen. Their active sites exploit ﬁrst-
row transition metals exhibiting turnover rates comparable to that
of platinum.2,3 Nature’s use of the most abundant metal on earth,
iron, is obviously attractive,4 but synthetic iron catalysts typically
are not highly active toward hydrogen.5 It is therefore of obvious
value to fully characterize the catalytic centres that mediate H2
heterolysis under mild conditions. This knowledge may lead to
new biomimetic methods for the generation and utilization of
H2.6
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Although the three known classes of hydrogenases are not phy-
logenetically related, their active sites share striking similarities.2,7
[NiFe]- and [FeFe]-hydrogenases feature binuclear 3d-transition
metal centres, complemented by iron-sulfur clusters.8 The third
class, the [Fe]-hydrogenases, lacks FeS clusters.9 This enzyme
has been found exclusively in some methanogenic archea and it
exploits only one metal-ion incorporated in FeGP-cofactor.2,10
In all three hydrogenases, this iron centre is ligated by at
least one thiolate sulfur and three potential p-accepting ligands,
consisting of CO and CN- molecules in the [NiFe]- and [FeFe]-
hydrogenases and of two COs and an acyl-carbon in case of [Fe]-
hydrogenases.2,11,12 These commonalities point towards convergent
evolution, indicating speciﬁc ligand structures that facilitate H2
activation by iron.
The ﬁrst step of enzymatic H2 activation is heterolysis, giving
a proton and a hydride, which is bound to the metal. This
transformation is well known to proceed with the help of low-
spin iron centres.13,14 Although it is understood that ligands on Fe
must stabilize the low-spin ferrous state, speciﬁc electronic roles of
the various ligands in facilitating hydrogen activation are not well
understood.
Even though extensive studies over the past decade have
advanced our understanding of the electronic structure and the
catalytic mechanism of [NiFe]- and [FeFe]-hydrogenases,8 our
understanding of the mononuclear [Fe]-hydrogenase is still rather
primitive. This situation is due to the fact that only recently
its active site structure has been described (Fig. 1).2,15 Due to
the presence of a single metal ion and the absence of other
This journal is © The Royal Society of Chemistry 2010 Dalton Trans., 2010, 39, 3057–3064 | 3057
Fig. 1 On the left: structure of the [Fe]-hydrogenase octahedral metal binding site as modelled by EXAFS analysis.1 The iron is coordinated to: the
Cys176-sulfur, two CO and the pyridinol-sp2-hybridized nitrogen and the acyl-carbon of the cofactor. An “unknown” donor, here represented as X, is
associated to the iron trans to the acyl carbon. This is considered the vacant position ready for H2 binding. The model complexes are represented in A–E:
Fe(II)(edt)(CO)2(PMe3)2 (A); K2[Fe(0)(CN)2(CO)3] (B); K[Fe(0)(CN)(CO)4] (C); K3[Fe(III)(CN)6] (D); K4[Fe(II)(CN)6] (E).
metal chromophores, this enzyme is an ideal target for studying
the relationship between electronic structure of the low-spin
iron-site and hydrogen activation. Furthermore, the FeGP-
cofactor,16-17 can be removed from the enzyme and examined
independently (see below). [Fe]-hydrogenase is also named
H2-forming methylenetetrahydromethanopterin (methylene-
H4MPT) dehydrogenase (Hmd), because its function is the
reversible reduction of methenyl-H4MPT+ (acceptor) to
methylene-H4MPT. This conversion, a methenyl-H4MPT+
hydrogenation, occurs instead of H2 oxidation, which is typical
for other hydrogenases.9,15,18 The reaction is reversible, Hmd also
catalyzes the release of H2 from methylene-H4MPT. This class
of hydrogenases only transfers hydride and it is independent of
electron transfer by FeS clusters. According to a recently proposed
catalytic mechanism,19 the molecular hydrogen is heterolytically
cleaved by the functions of Fe(II) and the carbocation of the
acceptor and the hydride produced is transferred to the acceptor.
The emerging model for the iron coordination in Hmd from
Methanocaldococcus jannashii (jHmd) (Fig. 1) comprises ﬁve to six
ligands: two carbon monoxides, the sulfur of Cys176, the nitrogen
and the acyl-carbon of the pyridinol derivative, and an unknown
ligand modelled as a “solvent-oxygen” in agreement with EXAFS
and a recent X-ray diffraction model inspired by the crystal struc-
ture of theC176Amutated [Fe]-hydrogenase.15,20 This oxygen atom
occupies the position where the hydrogen molecule (substrate) is
proposed to bind. The iron coordination of the active site appears
to be very similar to that of isolated (protein-free) cofactor. The
sulfur now appears to be supplied by 2-mercaptoethanol used
in the extraction of FeGP-cofactor.15,21 Mo¨ssbauer spectroscopy
studies on FeGP-cofactor revealed low spin iron with an oxidation
state of 2+ or 0, indicative of the highly covalent nature of the Fe-
ligand bonding.22 Recently reported infrared analyses of model
compounds are consistent with a low-spin Fe(II) oxidation state
of the iron centre.23,24
XANES (X-ray Absorption Near Edge Spectroscopy) is a
powerful technique to study the electronic structure of metal
centres. The shape and position of the X-ray absorption edge serve
as ﬁngerprints of a speciﬁc binding motif and, if good reference
systems are available, allow the determination of oxidation states,
number of ligands and symmetry of the coordination sphere.25
In fact, both edge position and electronic structure of a system
depend on the nature of the donor groups.26
Herein,we compare theXANESofHmdwith a variety ofmodel
complexes that exhibit a range of oxidation states and contain
ligands similar to the ones found in the enzyme. Speciﬁcally, we
have analyzed the K-edge XANES of iron in jHmd wild type
(jHmd-wt), in a cyanide inhibited form of jHmd (jHmd-CN)
and in Fe(edt)(CO)2(PMe3)2, [K(18-crown-6)]2[Fe(CN)2(CO)3],
K[Fe(CN)(CO)4]; K3[Fe(III)(CN)6], and K4[Fe(II)(CN)6] (Fig. 1).
The program FEFF8.2 was used for ab initio self-consistent ﬁeld,
full multiple scattering calculations, allowing us to reproduce the
major features of the edge proﬁles.27
Based on the present analysis, recent EXAFS analysis20 and
high resolution crystal structures2,15 we identify the dominating
features that dictate the electronic structure of [Fe]-hydrogenases
manifested in XANES spectra of Hmd.
Results and discussion
Since the iron coordination in Hmd is unique, its XANES can
not be compared with spectra of known metalloproteins. Thus,
we selected model compounds as anchor points for assessing
the inﬂuence of iron oxidation state and its coordination sphere
on the spectroscopic features. These model compounds are
octahedral or ﬁve-coordinate iron centres with ligands similar
to the donor groups in the enzyme. Here, we present data
from Fe(II)(edt)(CO)2(PMe3)2 (A, edt = 1,2-ethanedithiolate),
[K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B), K[Fe(0)(CN)(CO)4] (C),
K3[Fe(III)(CN)6] (D) and K4[Fe(II)(CN)6] (E). The two iron hexa-
cyanides,D andE, were selected to enlighten the inﬂuence ofmetal
oxidation states on the absorption edgeproﬁles. Both formalFe(0)-
compounds are trigonal bipyramidal and highlight the differences
between CN and CO groups on the electronic structure of the
metal ion, whereas compound A is square pyramidal and shows
the inﬂuence of a P/S donor.
These ﬁve compounds, jHmd-wt, and jHmd-CN were analysed
by XANES. The analysis of the EXAFS based on the crystal-
lographic coordinates and symmetry proved sample integrity of
the model complexes and provided average metal donor distances
comparable to the enzyme data (electronic supplementary infor-
mation, ESI, Tab. S1‡).
Model complexes
TheXANES spectra for compoundsA–E reveal strong differences
in rising edge position and shape (Fig. 2). CompoundsD andE are
highly symmetrical and only differ in the formal oxidation state of
iron, which results in highly similar spectra. The small shift in their
absorption edges reﬂects the slightly different effective charges at
the iron ion. In line with the high symmetry of these iron centres,
3058 | Dalton Trans., 2010, 39, 3057–3064 This journal is © The Royal Society of Chemistry 2010
Fig. 2 Comparison among the experimental XANES of the
model systems and jHmd-wt. Black line: jHmd-wt; black broken
line: jHmd-CN; red line: Fe(II)(edt)(CO)2(PMe3)2 (A); blue line:
[K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B); green line: K[Fe(0)(CN)(CO)4]
(C); orange line: K3[Fe(III)(CN)6] (D); purple line: K4[Fe(II)(CN)6] (E).
the white-lines [Footnote: In XAS the white-line denotes the main
peak formed by the rising edge and the following minimum] of
complexesD andE are very sharp.28 In accordance with the formal
charge, the ferrocyanide compound (E) has an edge position at
lower energies than the ferricyanide D, 7127 eV and 7127.5 eV,
respectively (orange and purple lines in Fig. 2).
In compounds B and C, iron is in the formal oxidation
state 0. These pentacoordinate complexes are structurally similar,
differing only in the relative ratio of CO/CN- donors. This
similarity is reﬂected by their XANES (green and blue lines in
Fig. 2). Compared to the data for D and E, the white-lines of
B and C are less sharp, indicative of their lower symmetry. As
expected, both edge positions are at lower energies with respect to
D and E. The differences observed in the peak intensities might be
ascribed to the exchange of one CO by CN-: CO is a good s donor
and a strong p acceptor, while CN- is a good s donor and poor
p acceptor, which inﬂuences in this case only the matrix element
for transitions into the unoccupied orbitals, but not their energy
levels.13
In compound A, the Fe(II) ion is bound to two CO ligands,
two sulfur and two phosphine donors. The S and P donor ligands
mimic to some extent the sulfur ligand bound to Fe in Hmd.
The low-symmetry of the iron coordination results in a broadened
white-line. Interestingly, the edge is positioned at the lowest energy,
despite the formal oxidation state of the iron (red line in Fig. 2).
This shift is ascribed to the inﬂuence of the phosphine and sulfur
atoms. Thus, the nature of the ligands has for these complexes a
stronger inﬂuence on the absorption edge position than the formal
oxidation state.
The model compounds are chosen to illustrate the two com-
peting effects determining the edge position and the metal–ligand
distances: metal oxidation state and ligand type. An additional
effect becomes apparent: the shape of the XANES depends on the
homogeneity of the electrondonors. Themore cyanides are present
in the sample the sharper is the white-line. A conﬁrmation of the
Table 1 Edge positions, pre-edge peak positions and pre-edge peak areas
for jHmd-wt, jHmd-CN and the model complexes. For simplicity, only the
distances for the donor groups carbon monoxide, cyanide and sulfur from
the iron ion are given here. In parentheses the error margins on the last
digit are given
Sample edge position
pre-edge peak
position
1s→3d pre-edge
peak area
eV eV 10-2 eV
jHmd-wt 7119.2(2) 7112.7(2) 60(1)
jHmd-CN 7117.0(2) 7112.7(2) 28(2)
A 7116.0(2) 7112.0(2) 9(2)
B 7124.6(2) 7112.9(2) 8(1)
C 7123.8(2) 7112.6(2) 18(2)
D 7127.4(2) 7112.3(2) 2(1)
E 7126.6(2) 7111.9(2) 1(1)
trend comes from compound A. Its coordination is heterogeneous
and thus the white-line is small.
jHmd-wt and jHmd-CN
Intriguingly, the XANES-spectrum of jHmd-wt (full black line in
Fig. 2) revealed characteristics very similar to compound A, with
smooth maxima and minima. This similarity makes the latter the
spectroscopic model closest to jHmd. Nevertheless, the spectra of
jHmd-wt and A do not exhibit similar rising edges. The spectrum
of jHmd-CN (broken black line in Fig. 2) shares with the wild
type the position of the pre-edge peak as well as the maxima and
minima above the edge, but not the relative intensities. jHmd-
wt and jHmd-CN also share most of the rising edge. Thus, the
electronic structures for wild type and the cyanide-inhibited form
are similar, consistent with the similarity of the IR spectra in
the nCO region.12 The higher white-line intensity in jHmd-CN is
indicative of a higher symmetry. This is in line with the pre-edge
peak area that is much smaller for jHmd-CN than for jHmd-
wt (Tab. 1). This feature is frequently used as a measure of the
symmetry and homogeneity of the iron coordination.29 Deviation
from an ideal octahedral coordination increases the 1 s to 3d/4p
transition probability and thus the pre-edge peak intensity.
The ﬁrst derivative of the XANES spectra of the wild type (full
line in Fig. 3B) helps identifying features that are smoothed by
the energy resolution of the monochromator (~4000 at 7.2 keV;
note that its accuracy is ~0.1–0.2 eV). The jHmd-wt derivative is
characterized by the splitting of the second peak into three peaks
representing unoccupied orbitals (white-line range: from 7115 to
7130 eV, Fig. 3B). This feature is absent in the inhibited form
(Fig. S1‡). Thus, the presence of the characteristic can be
considered as an indicator of the active form of jHmd.
Comparison of the absorption edges
The absorption edges reﬂect the inﬂuence of both the formal
oxidation state of the iron centre and its ligands (Fig. 4). The
edge positions have the following order: 7118.8 (jHmd-wt), 7119.0
(jHmd-CN), 7119.5 (A), 7124.0 (C), 7125.0 (B), 7127.0 (E), and
7127.5 eV (D). For the complexesB,C,E andD, with only diatomic
ligands and oxidation states 0, 0, 2+ and 3+, respectively, the
edges shift towards lower energies upon reduction. Interestingly,
the edges of B and C differ by 1 eV from each other, although
they are both Fe(0). This difference indicates the sensitivity of the
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Fig. 3 Comparison between experimental and simulated spectra of
jHmd-wt. (A) the XANES and in (B) its 1st derivative is shown. The
full lines represent the experimental data, while the broken lines represent
the simulations.
Fig. 4 Comparison between the edge positions of the model com-
pounds, jHmd-wt and jHmd-CN. Black line: jHmd-wt; black bro-
ken line: jHmd-CN; red line: Fe(II)(edt)(CO)2(PMe3)2 (A); blue line:
[K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B); green line: K[Fe(0)(CN)(CO)4]
(C); orange line: K3[Fe(III)(CN)6] (D); purple line: K4[Fe(II)(CN)6] (E).
For each sample, the edge position—ﬁrst maximum of the ﬁrst derivative
in the rising edge—is indicated.
effective charges at the metal ion to the donor types. E and D,
which share the same coordination sphere but differ in oxidation
state, are separated along the entire rising edges indicating that
the corresponding molecular orbitals are only shifted in energy
and the matrix elements for the transition from the 1 s orbital
are unaffected (Fig. 2, 4). In contrast, compound A shows the
profound inﬂuence of the ligand type. Here, the donors P and
S strongly affect the edge position, which is shifted towards
lower energies by 7.5 eV from the other ferrous compound E.
In accordance, the edge positions of jHmd-wt and jHmd-CN are
similar to that of A, suggesting a comparable effective charge at
the iron ion.
Comparison of pre-edge peak intensities
The pre-edge peak intensity correlates with the symmetry of metal
binding site: for octahedral sites and homogenous donor types
it is lower than for tetrahedral sites and inhomogeneous donor
types.29 In line with their octahedral iron-coordination and their
homogenous ligand sphere, the hexacyanides D and E possess
the smallest pre-edge peak intensity of about 1 and 2 ¥ 10-2 eV,
respectively. ComplexA exhibits a pre-edge peak intensity of about
9 ¥ 10-2 eV, which reﬂects the heterogeneity of its octahedral
ligand set. Complexes B and C are square pyramidal and as a
consequence, the pre-edge peak areas are higher: complex C, has
an area of about 18 ¥ 10-2 eV. An interesting exception to the
rule is complex B with an area of only 9 ¥ 10-2 eV. This indicates
higher symmetry potentially caused by the compensation of p-
accepting and p-donating ligands. For jHmd-wt and jHmd-CN the
largest pre-edge peak intensities are observed. The heterogeneity
and asymmetry of the coordination sphere and likely the steric
constraints by the protein environment result in a highly distorted
geometry at the iron site. Interestingly, jHmd-wt pre-edge peak
intensity (60 ¥ 10-2 eV) is twice of that of the inhibited form (28 ¥
10-2 eV) and considerably higher than that of the isolated cofactor
(44 ¥ 10-2 eV).21 These differences suggest a correlation between
distortions of the active site geometry and catalytic activity of
Hmd.Moreover also a partial occupation of the “oxygen position”
can increase the intensity of the pre-edge peak. In fact, ourEXAFS
reﬁnements without a sixth ligand are only slightly worse than
the ones for six-fold coordination (Fig. S4‡). Partial occupancy
may indicate that ligands at this site are labile. We can conclude
that octahedral geometry is consistent with low spin ferrous state
and with all experimental results from protein crystallography and
spectroscopy. This does not exclude a transient pentacoordination.
Metal-donor distances
The metal-carbon distances of the model systems do not differ
signiﬁcantly for Fe(II) and Fe(0) complexes (Tab. S1); the values
are similar to those reported for other iron ions ligated by carbon
monoxide.23,30 The Fe-CO distances observed in Hmd fall within
this region as well (Tab. S1). The iron-sulfur distances obtained
in the EXAFS reﬁnement for jHmd-wt (2.33 A˚) is closer to the
ones of compound A and related models with nitrogen donors
in place of phosphines (2.31 A˚),31 than to those calculated by
molecular modelling for [Fe]-hydrogenases32 (2.38 A˚) and the ones
measured for the [FeFe]-hydrogenases (2.25 A˚).33 In general, Fe(II)-
S distances are poorly sensitive to oxidation state, but highly
sensitive to spin state.34,35 For example, the Fe–S distance in
Et3NH[Fe(0)(SPh)(CO)4] (2.332(5) A˚)34 is almost identical to that
in Fe(II)H(SPh)(CO)2[P(OPh)3]2 (2.343(3) A˚).35
XANES analysis
To gain further insights into the electronic structure of the iron ion
in [Fe]-hydrogenases, in silico simulations of theXANES spectra of
the model complexes and jHmd-wt were carried out with the pro-
gram FEFF8.2 (see experimental). We analyzed both the XANES
and their ﬁrst derivatives in order to highlight homologies and
differences among spectra and withdrawn qualitative information
about the iron ion electronic structure.
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Structure-based EXAFS reﬁnement
The coordinates used in our simulations were extracted from
EXAFS reﬁnements based on crystal structure models reﬂecting
the different geometries of the iron sites (see Fig. 1). The
X-ray diffraction coordinates were read into Excurv98 as starting
parameters for the reﬁnement of the EXAFS data. Interestingly,
the solvent oxygen of jHmd-wt is for this geometry slightly better
modelled at 2.49 A˚ (Fig. S3‡), instead of 2.05 A˚ as presented
in Hiromoto et al. 2009 for ideal octahedral coordination.15
Attempts to model the EXAFS with an oxygen contribution at
other distances led to poorer ﬁt indexes (Fig. S3‡) in line with the
periodicity/interference of the EXAFS signal. Besides, we tried
modelling this contribution by other elements (e.g. phosphorus,
sulfur, ﬂuorine, bromine, iodine) and obtaining comparable results
for ﬂuorine and bromine (Fig. S4‡). These results are indicative for
the presence of an atom/molecule at the “solvent oxygen” position
but do not allow an unambiguous identiﬁcation. Thus, we favor
oxygen for consistecy with the crystallographic model.
XANES simulations of the model systems
Simulations of theXANES for themodel systems served as a proof
of principles and deﬁned the required cluster size in this study
(ﬁrst two to three shells). The principal features of the spectra
have been reproduced: the curves trend matches the experimental
data and the sequence of the rising edge positions is reﬂected by
the simulations (Fig. 5). Moreover, the white-lines correlate with
the symmetry and homogeneity of the coordination sphere.
Fig. 5 Comparison among the simulated XANES of the model systems
and jHmd-wt. Black line: jHmd-wt; red line Fe(II)(edt)(CO)2(PMe3)2
(A); blue line: [K(18-crown-6)]2[Fe(0)(CN)2(CO)3] (B); green line:
K[Fe(0)(CN)(CO)4] (C); orange line: K3[Fe(III)(CN)6] (D); purple line:
K4[Fe(II)(CN)6] (E).
In our simulations, the pre-edge peak regions are not reproduced
very well. This problem is connected to the inaccurate calculation
of transition probabilities into pre-edge states. Thus, the over
intense pre-edge area characteristics are considered as artefacts.
XANES simulations of jHmd-wt
The positions of maxima and minima and the general shape of
the experimental data are reproduced indicating the agreement be-
tween the electronic states in jHmd-wt and the simulation (Fig. 3A
and B). Only the relative intensities and thus the magnitude of the
transition matrix element are not adequately modelled. In the ﬁrst
derivative of the simulated spectrum a distinctive three-fold split
white-line peak is preserved, highlighting the existence of three
narrow energy levels.
Impact of individual donors on the electronic structure
In order to evaluate the impact of individual donors on the elec-
tronic structure of Hmd-wt, we successively omitted one of them
in the simulations. Nowwe focused on ﬁrst derivatives to highlight
the impact on the electronic structure induced by systematically
removing one metal donor (Fig. 6). Omitting one of the two CO
ligands (CO1 and CO2) has a strong inﬂuence on most of the
XANES spectrum, in the energy interval from 7117 to 7167 eV, in
line with their intense multiple scattering contributions (Fig. 6A,
B). The differences between these simulations show the importance
of the geometry. In the XANES simulations this geometry is taken
into account bymultiple scattering contributions (from the central
iron ion to a donor, continuing via the central iron atom to the
donor in trans position and back to the iron ion); for CO1 this
multiple scattering pathway includes the sulfur (2.3 A˚ away from
the iron ion) and for CO2 the nitrogen atom opposite to CO2
(2.0 A˚ away from the metal ion) resulting in different phase and
amplitude of these contributions (Fig. 1). Interestingly, in both
spectra the white-line peak splitting is conserved, indicating that
these ligands can not strongly contribute to the identity of the
three unoccupied orbitals that give rise to this rising edge.
The donors from the pyridinol derivative signiﬁcantly inﬂuence
the region from 7115 to 7150 eV, corresponding to the white-line
till the following minimum (Fig. 6C, D). The characteristics at
7155 and 7175 eV remain unchanged. Pyridinol-N and acyl-C
omissions change the structure of the white-line peak, indicating
their function in ﬁne tuning the electronic structure. The sulfur
contribution to the white-line feature is rather mild. The region
from 7115 to 7120 eV is appreciably affected (ﬁrst transition to
an unoccupied orbital in the XANES) (Fig. 6E). It seems that
here the COs and the other ligands give a contribution stronger
than found for typical metal binding enzymes, thus diminishing
the inﬂuence of sulfur. Removing the “solvent-oxygen” in the
simulation affected the entire rising edge (Fig. 6F from 7114 to
7128 eV). This inﬂuence is small except for the ﬁrst characteristic
of the white-line peak at 7117 eV, which is lost.
The above results highlight the distinctive contribution from
each of the six ligands. The differing contributions of the two CO
ligands suggest that they play a key electronic role, as expected
because of their strong tendency to back-bond.
The comparison of the jHmd-wt XANES with the model
complexes identiﬁed the ferrous complex A as a mimic for the
enzyme’s electronic structure. Moreover, jHmd-wt and complex
A share the CO and sulfur ligand types. These similarities
and the identical absorption edge positions concludes that the
enzyme harbours a ferrous ion. The analysis of the pre-edge peak
intensities shows that in contrast to complex A the octahedral
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Fig. 6 Comparison between the ﬁrst derivative of jHmd-wt XANES
simulation in the full coordination (dotted lines) and simulations omitting
one donor at the time (full lines): (A) CO1 omitted, (B) CO2 omitted, (C)
acyl-C of the cofactor omitted, (D) pyridol-N of the cofactor omitted, (E)
Cys176-S omitted, (F) oxygen omitted. The comparisons for the XANES
simulations are shown in Fig. S4.‡
symmetry is much more distorted in the enzyme, pointing to a
speciﬁc tuning of the electronic structure (and thus most likely
of the reactivity) by the protein environment, namely by the
pockets harbouring the CO groups (Fig. S7‡). This hypothesis is
supported by the much smaller pre-edge peak intensity observed
for the isolated FeGP-cofactor.21 An appreciable difference in the
symmetry of the iron site in jHmd-wt and in the isolated cofactor
could be inferred also from the electric ﬁeld gradient sensed by
the 57-Fe Mo¨ssbauer nucleus and the corresponding quadrupole
splitting of the Mo¨ssbauer spectra (0.65 mm s-1 in wt-Hmd and
0.43 mm s-1 for FeGP).22 The jHmd-CN experimental XANES
showed that the CN- binding alters signiﬁcantly the electronic
structure of the iron ion. This change, as well as the saturation
of the coordination sphere of Fe(II), is relevant to its inhibitory
effect.
In the XANES simulations the essential contributions of the
acyl-carbon and of the pyridinol nitrogen to the electronic
structure were visualized by changes in the three unoccupied
orbitals of the rising edge. Indeed, the identity of the feature
representing the white-line transitions to unoccupied orbitals
vanished when one of these donors was omitted. The ligand trans
to H2 is known to have a strong inﬂuence on hydrogen back
donation, the intra molecular distance and metal-hydrogen bond
length.13 Herein, we show that this is likely for jHmd-wt, where the
acyl-carbon is trans to the supposed H2 binding site. Interestingly,
the omission of the oxygen smoothed down the ﬁrst transition.
Conclusions
A formal 2+ oxidation state is consistent with all the available data
on jHmd-wt: Mo¨ssbauer spectroscopy22 and our experimental
data. The octahedral geometry is compatiblewith the 2+oxidation
state but not with Fe(0).36 In addition, the rising edge of jHmd-
wt’s XANES overlaps nicely with that for the HoxC subunit of the
hydrogen-sensing [NiFe]-hydrogenase from Ralstonia eutropha,
which is accepted as Fe(II) (Fig. S6‡).37 The experimental and
simulated spectra of jHmd-wt are consistent with the recently
proposed acyl-carbon ligand. It is interesting that nature has
chosen a very low symmetry site for H2 activation. While the two
CO ligands ensure low-spin state, the arrangement of the other
four donors tune the reactivity towardH2, which is activated at the
labile site trans to the acyl ligand reminiscent of theCO ligand trans
to the hydride binding site in the [FeFe]- and [NiFe]-hydrogenases.8
Our analysis demonstrates that in the resting enzyme, Fe has
an octahedral geometry with a ﬁve- to six-fold coordination. This
geometry, which was indicated in our recent C176-mutated and
DTT-bound enzyme,15 is incompatible with Fe(0), but is expected
for low spin ferrous iron. Collectively, all these ﬁndings help to
deﬁne the features that lead to efﬁcient utilization of H2, especially
the speciﬁc positioning of the threep-accepting ligands. The results
of this work may provide a useful guide to the design of new
catalysts aiming at cheaper and greener energy processing.
Experimental
Preparation of the samples for XAS analysis
All the samples were homogenized with degassed BN and ﬁlled in
Hesar glass R© cuvettes coveredwithKapton R© ﬁlm.After freezing,
the samples were stored in liquid nitrogen for the data collection.
Protein samples
All protein samples were prepared in anaerobic condition as
described by Pilak et al.38 The holoenzyme was reconstituted from
the apoenzyme and FeGP-cofactor isolated from Hmd puriﬁed
from Methanothermobacter marburgensis as described by Shima
et al.2
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Model system samples
The model complexes A, B, C were prepared under anaerobic
conditions following our published procedures.39 Complexes D
and E were obtained from commercial sources (Sigma-Aldrich).
XAS measurements
XAS data collection of the enzyme samples is described by
Korbas et al.21 XAS data for the model systems were collected
in transmission mode at D2 beamline of the EMBL Outsta-
tion Hamburg at DESY, Germany. A Si(111) double-crystal
monochromator scanned X-ray energies around Fe K-edge (6.8–
8.1 keV). Harmonic rejection was achieved by a focusing mirror
(cut-off energy at 20.5 KeV) and a monochromator detuning
to 50% of its peak intensity. Sample cells were mounted in a
two-stage Displex cryostat and kept at about 20 K. For each of
these samples three scans were collected and averaged to ensure
good statistics. Spectrometer energy was calibrated by recording
Bragg reﬂections from a static Si(220) crystal in back-reﬂection
geometry during each scan.40 Data reduction, such as background
removal, normalization and extraction of the ﬁne structure, was
performed with KEMP21 assuming a threshold energy E0,Fe =
7120 eV. EXAFS data were analysed in an energy range from
3 A˚-1 to 14.5 A˚-1 with Excurv98.41
X-ray absorption near edge structure (XANES) analysis
Qualitative analysis and comparison of the XANES was carried
out using the software ATHENA.42 The intensities and energies
of the 1s→3d pre-edge features of the normalized Fe K-edge
absorption spectra were quantiﬁed using the program WinXAS.43
Spectra were ﬁtted over 13 eV around the pre-edge features and
modelled by pseudo-Voigt peak shapes. Energy positions, full
width at half maximums (FWHMs) and heights were reﬁned. The
background underneath the pre-edge features was modelled as
well by a pseudo-Voigt function. The total intensity of the 1s→3d
pre-edge feature was assigned to the area of the pseudo-Voigt peak
at about 7112.5 eV. Features in the rising edge were not included.
The absolute edge positions were identiﬁed as the ﬁrst maximum
of the ﬁrst derivatives within the rising edge (Fig. S2‡).
FEFF simulations
The XANES spectra were simulated by ab initio self-consistent
ﬁeld full multiple scattering calculations with FEFF8.2.27 We used
as input for the calculations the atomic coordinates extracted
from EXAFS modelling, which was carried out with the program
Excurve98 on the basis of the available structures.2,15 Attempts
to directly use X-ray diffraction coordinates led to less accurate
results (data not shown). No corrections or exchange potentials
were introduced in the simulation. Attempts to impose a given
ionicity on the metal ion yield results where the edge position
remains unchanged and the intensities varies less than 2.5%. Thus
the simulations of our samples are not sensitive to this feature and
this possibility was ignored here. All simulated spectra have been
shifted by 3 to 6 eV towards lower energy for comparison with
experimental data. This is standard and reﬂects small inaccuracies
in the calculation of the 1s-continuum transitions. The simulations
were aligned with respect to the white-line peak positions of the
XANES and their ﬁrst derivatives.
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